Original Article

Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction

Arthur J. Moss, M.D., Wojciech Zareba, M.D., Ph.D., W. Jackson Hall, Ph.D., Helmut Klein, M.D., David J. Wilber, M.D., David S. Cannom, M.D., James P. Daubert, M.D., Steven L. Higgins, M.D., Mary W. Brown, M.S., and Mark L. Andrews, B.B.S. for the Multicenter Automatic Defibrillator Implantation Trial II Investigators

N Engl J Med 2002; 346:877-883March 21, 2002DOI: 10.1056/NEJMoa013474

Abstract

Background

Patients with reduced left ventricular function after myocardial infarction are at risk for life-threatening ventricular arrhythmias. This randomized trial was designed to evaluate the effect of an implantable defibrillator on survival in such patients.

Methods

Over the course of four years, we enrolled 1232 patients with a prior myocardial infarction and a left ventricular ejection fraction of 0.30 or less. Patients were randomly assigned in a 3:2 ratio to receive an implantable defibrillator (742 patients) or conventional medical therapy (490 patients). Invasive electrophysiological testing for risk stratification was not required. Death from any cause was the end point.

Results

The clinical characteristics at base line and the prevalence of medication use at the time of the last follow-up visit were similar in the two treatment groups. During an average follow-up of 20 months, the mortality rates were 19.8 percent in the conventional-therapy group and 14.2 percent in the defibrillator group. The hazard ratio for the risk of death from any cause in the defibrillator group as compared with the conventional-therapy group was 0.69 (95 percent confidence interval, 0.51 to 0.93; P=0.016). The effect of defibrillator therapy on survival was similar in subgroup analyses stratified according to age, sex, ejection fraction, New York Heart Association class, and the QRS interval.

Conclusions

In patients with a prior myocardial infarction and advanced left ventricular dysfunction, prophylactic implantation of a defibrillator improves survival and should be considered as a recommended therapy.

Media in This Article

Figure 2Kaplan–Meier Estimates of the Probability of Survival in the Group Assigned to Receive an Implantable Defibrillator and the Group Assigned to Receive Conventional Medical Therapy.
Figure 1Sequential Monitoring in the Triangular Design.
Article

Patients with myocardial infarction and reduced left ventricular function are at risk for congestive heart failure and arrhythmia-related sudden death. In 1996, the implantation of a defibrillator was reported to improve survival in patients with coronary heart disease, reduced ventricular function, unsustained ventricular tachycardia, and inducible ventricular tachycardia,1 and this finding was confirmed in 1999.2 In both studies, patients underwent invasive electrophysiological testing to determine their risk of arrhythmia. The prognostic value of electrophysiological testing for the identification of patients with coronary heart disease who are at risk for ventricular arrhythmias is uncertain.3 We reasoned that in patients with a prior myocardial infarction and advanced left ventricular dysfunction, the scarred myocardium would serve as a trigger for malignant ventricular arrhythmias. The Multicenter Automatic Defibrillator Implantation Trial II was designed to evaluate the potential survival benefit of a prophylactically implanted defibrillator (in the absence of electrophysiological testing to induce arrhythmias) in patients with a prior myocardial infarction and a left ventricular ejection fraction of 0.30 or less.

Methods

Organization of the Trial

The trial began on July 11, 1997, and enrolled patients from 76 hospital centers (71 in the United States and 5 in Europe). The protocol was approved by the institutional review boards of the participating hospitals. A data and safety monitoring board independently reviewed the results at regular intervals throughout the trial. All investigators agreed to abide by the conflict-of-interest guidelines described by Healy et al.4 A description of the design and study protocol has been published previously.5

Recruitment and Follow-up

Patients of either sex who were more than 21 years of age (there was no upper age limit) were eligible for the study if they had had a myocardial infarction one month or more before entry, as documented by the finding of an abnormal Q wave on electrocardiography, elevated cardiac-enzyme levels on laboratory testing during hospitalization for suspected myocardial infarction, a fixed defect on thallium scanning, or localized akinesis on ventriculography with evidence of obstructive coronary disease on angiography, and an ejection fraction of 0.30 or less within three months before entry, as assessed by angiography, radionuclide scanning, or echocardiography. Potentially eligible patients were referred by local cardiologists, internists, and primary care physicians. Patients were not required to undergo electrophysiological screening for inducible ventricular arrhythmias.

Patients were excluded from enrollment if they had an indication approved by the Food and Drug Administration (FDA) for an implantable defibrillator; were in New York Heart Association functional class IV at enrollment; had undergone coronary revascularization within the preceding three months; had had a myocardial infarction within the past month, as evidenced by measurement of cardiac-enzyme levels; had advanced cerebrovascular disease; were of childbearing age and were not using medically prescribed contraceptive measures; had any condition other than cardiac disease that was associated with a high likelihood of death during the trial; or were unwilling to sign the consent form for participation.

When the trial began in July 1997, eligible patients had to have frequent or repetitive ventricular ectopic beats during 24-hour Holter monitoring. On January 1, 1998, after the enrollment of 23 patients, the executive committee eliminated this requirement because almost all eligible patients had such arrhythmias. On May 4, 2001, the executive committee increased the enrollment goal from 1200 to 1500 patients, so that enrollment would be ongoing while data on outcomes were still accruing.

Randomization

After patients had provided written informed consent, a base-line clinical history and 12-lead electrocardiogram were obtained and a physical examination was conducted. The patients were randomly assigned in a 3:2 ratio to receive either an implantable defibrillator or conventional medical therapy. Patients who were assigned to the defibrillator group were not responsible for the costs of the defibrillator, implantation, or the hospitalization for the procedure.

Therapy

Transvenous defibrillator systems (Guidant, St. Paul, Minn.) that had been approved by the FDA were used in the trial. Standard techniques were used to implant the defibrillators. The defibrillators were tested during the implantation procedure, and every effort was made to achieve defibrillation within a 10-J safety margin. Programming the defibrillator and prescribing medications were left to the discretion of the patients' physicians. The appropriate use of beta-blockers, angiotensin-converting–enzyme inhibitors, and lipid-lowering drugs was strongly encouraged in both study groups.

Statistical Analysis

The primary end point was death from any cause. Analysis was performed according to the intention-to-treat principle. The trial was designed to have 95 percent power to detect a 38 percent reduction in the two-year mortality rate among the patients in the defibrillator group, given a postulated two-year mortality rate of 19 percent among patients assigned to conventional therapy, with a two-sided significance level of 0.05. For proportional-hazards modeling, power was maintained for a true hazard ratio of 0.63, after allowance for crossovers. We used a triangular sequential design, which was modified for two-sided alternatives6 and corrected for the lag in obtaining data accrued but not reported before the termination of the trial, for weekly monitoring, with preset boundaries to permit termination of the trial if the defibrillator therapy was found to be superior to, inferior to, or equal to conventional medical therapy. Secondary analyses were performed with use of the Cox proportional-hazards regression model.7 We determined survival curves according to the method of Kaplan and Meier,8 with comparisons of cumulative mortality based on logarithmic transformations. P values were termed nominal when they were not adjusted for sequential monitoring. All P values were two-tailed.

At the recommendation of the data and safety monitoring board the trial was stopped on November 20, 2001, shortly after an analysis revealed that the difference in mortality between the two groups had reached the prespecified efficacy boundary (P=0.027) (Figure 1Figure 1Sequential Monitoring in the Triangular Design.). Analyses used version 2.0 of the data base, which was released on January 16, 2002. The investigators had full access to the data and performed the data analysis with no limitations imposed by the sponsor.

Results

Study Population

The clinical characteristics of the 1232 randomized patients are provided in Table 1Table 1Clinical Characteristics of the 1232 Patients.. Follow-up averaged 20 months (range, 6 days to 53 months). The base-line characteristics and the prevalence of the use of various cardiac medications at the time of the last follow-up visit were similar in the two groups. Fifty-four crossovers occurred. Twenty-two patients in the conventional-therapy group (4.5 percent) received a defibrillator during the trial, 21 for documented or suspected malignant ventricular arrhythmias and 1 at the physician's discretion. Twenty-one patients assigned to the defibrillator group (2.8 percent) did not have a defibrillator implanted, and 11 had their defibrillator removed during the trial (1.5 percent), including 9 who underwent heart transplantation. Twelve patients had their defibrillator deactivated during the trial, usually as a result of terminal illness.

There were 8749 scheduled follow-up visits during the trial, with a 94 percent rate of attendance in the conventional-therapy group and a 97 percent rate in the defibrillator group. The status of three patients was not known at the termination of the trial (one patient in the conventional-therapy group and two in the defibrillator group). All three patients were known to be alive within six months before the trial ended.

Outcome

The sample path of the sequential trial is presented in Figure 1. The trajectory of the path indicates the superiority of defibrillator therapy over nondefibrillator therapy, with P=0.016 (two-sided, adjusted for the stopping rule).

The numbers of deaths in each group and the hazard ratio for death per unit of time are presented in Table 2Table 2Hazard Ratio for Death.. The hazard ratio of 0.69 indicates a 31 percent reduction in the risk of death at any interval among patients in the defibrillator group as compared with patients in the conventional-therapy group.

Kaplan-Meier estimates of survival in the two groups are shown in Figure 2Figure 2Kaplan–Meier Estimates of the Probability of Survival in the Group Assigned to Receive an Implantable Defibrillator and the Group Assigned to Receive Conventional Medical Therapy.. The two survival curves began to diverge at approximately nine months and continued their separate paths thereafter (nominal P=0.007). These survival curves represent reductions in the rates of death after defibrillator therapy of 12 percent at one year (nominal 95 percent confidence interval, –27 to 40 percent), 28 percent at two years (nominal 95 percent confidence interval, 4 to 46 percent), and 28 percent at three years (nominal 95 percent confidence interval, 5 to 46 percent). There were no significant differences in the effect of defibrillator therapy on survival in subgroup analyses stratified according to age, sex, ejection fraction, New York Heart Association class, or the QRS interval (Figure 3Figure 3Hazard Ratios and 95 Percent Confidence Intervals for Death from Any Cause in the Defibrillator Group as Compared with the Group Assigned to Receive Conventional Medical Therapy, According to Selected Clinical Characteristics.). There were also no significant differences in the effect of defibrillator therapy on survival in subgroup analyses classified according to the presence or absence of hypertension, diabetes, left bundle-branch block, or atrial fibrillation; the interval since the most recent myocardial infarction (six months or less vs. more than six months); the type of defibrillator implanted (single chamber vs. dual chamber); or the blood urea nitrogen level (25 mg per deciliter or less vs. more than 25 mg per deciliter).

Adverse Effects

Serious complications related to defibrillator therapy were infrequent. No deaths occurred during implantation. Thirteen lead problems (1.8 percent) and five nonfatal infections (0.7 percent) required surgical intervention in the defibrillator group. The incidence of new or worsened heart failure was slightly higher in the defibrillator group than in the conventional-therapy group. Specifically, 73 patients (14.9 percent) in the conventional-therapy group and 148 in the defibrillator group (19.9 percent) were hospitalized with heart failure, representing 9.4 and 11.3 patients so hospitalized per 1000 months of active follow-up, respectively (nominal P=0.09).

Discussion

Our findings indicate that the implantation of a defibrillator improves survival among patients with a prior myocardial infarction and a left ventricular ejection fraction of 0.30 or less. As compared with conventional medical therapy, defibrillator therapy was associated with a 31 percent reduction in the risk of death. Electrophysiologic testing or inducible ventricular arrhythmias were not eligibility criteria. The two groups were balanced and received appropriate therapy with standard cardiac agents; high percentages of patients in both groups received angiotensin-converting–enzyme inhibitors, beta-blockers, diuretics, and lipid-lowering statin drugs.

In contrast with the earlier Multicenter Automatic Defibrillator Implantation Trial, in which the survival rate improved within the first few months after the implantation of the device,1 in the current study the survival benefit began approximately nine months after the device was implanted. The difference may reflect a somewhat lower mortality rate in the conventional-therapy group in the current study, the absence of risk stratification for arrhythmia as an entry criterion, the use of a lower cutoff value for the ejection fraction as a criterion for eligibility, and the use of more vigorous medical treatment. These same population differences may also explain the relatively higher hazard ratio in our study than in the earlier study (0.69 vs. 0.46).1

We are concerned by the finding that new or worsened heart failure requiring hospitalization was slightly more frequent in the defibrillator group than in the conventional-therapy group. Patients saved from malignant ventricular arrhythmias by the implantation of a defibrillator live longer than conventionally treated patients and would thus have more time for heart failure to develop. Defibrillator shocks might contribute to rehospitalization9 and myocardial injury.10 Backup ventricular pacing may impair ventricular function.11 Patients with a reduced ejection fraction who receive an implantable defibrillator should be carefully monitored for the development or exacerbation of heart failure.

An estimated 3 million to 4 million patients have coronary heart disease and advanced left ventricular dysfunction in the United States, and there are approximately 400,000 new cases annually.12,13 If a meaningful number of these patients receive an implantable defibrillator prophylactically, the cost to the health care system would be substantial. We hope that market forces will drive down the cost of this therapy.

Our findings show that the implantation of a defibrillator improves survival in patients with a prior myocardial infarction and advanced left ventricular dysfunction. Thus, prophylactic implantation of a defibrillator is recommended in these patients.

Supported by a research grant from Guidant, St. Paul, Minn., to the University of Rochester School of Medicine and Dentistry.

Drs. Cannom, Daubert, and Higgins have given lectures sponsored by Guidant.

We are indebted to the patients who participated in this trial, to the study coordinators at each of the enrolling centers, and to Guidant Corporation for its support, sustained commitment, and the independence it provided to the investigators in the conduct of this study.

Source Information

From the Cardiology Unit of the Department of Medicine (A.J.M, W.Z., J.P.D, M.W.B., M.L.A.) and the Department of Biostatistics (W.J.H.), University of Rochester Medical Center, Rochester, N.Y.; the Division of Cardiology, University Hospital, Magdeburg, Germany (H.K.); the Cardiology Unit, Loyola University Medical Center, Maywood, Ill. (D.J.W.); Cardiology Associates, Good Samaritan Hospital, Los Angeles (D.S.C.); and the Department of Cardiology, Scripps Memorial Hospital, La Jolla, Calif. (S.L.H.).

Address reprint requests to Dr. Moss at the Heart Research Follow-up Program, Box 653, University of Rochester Medical Center, Rochester, NY 14642, or at .

The investigators who participated in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II) are listed in the Appendix.

Appendix

The following investigators also participated in the MADIT-II (listed in descending order of the number of randomly assigned patients): Investigators — L. Berenbom, Mid-America Research Organization and University of Kansas Medical Center Research Institute, Kansas City; D. Glascock, Toledo Hospital, Toledo, Ohio; H. Klein, University Hospital Magdeburg, Magdeburg, Germany; H. Pitschner, Kerkhoff Clinic, Bad Nauheim, Germany; J. Butler, Florida Heart Association, Fort Myers; A. Leon, Crawford Long Hospital, Atlanta; J. Steinberg, St. Luke's–Roosevelt Hospital Center, New York, and Valley Hospital, Ridgewood, N.J.; S. Wittenberg, Baystate Medical Center, Springfield, Mass.; D. Switzer, Buffalo Medical Group, Buffalo, N.Y.; R. Corbisiero, Deborah Heart & Lung Center, Brown Mills, N.J.; D.J. Wilber, University of Chicago, Chicago; Northwest Community Hospital, Chicago; Loyola University Medical Center, Maywood, Ill.; W. Brodine, Kansas City Cardiology Associates, Kansas City, Kans.; D. Weiss, Florida Arrhythmia Consultants, Fort Lauderdale; A. Waldo, University Hospitals of Cleveland, Cleveland; J. Jentzer, Northeast Cardiology Associates, Bangor, Me.; M. Akhtar, Heart Care Associates, Milwaukee; K. Tucker, Orange County Heart Institute, Orange, Calif.; J. Baker, Heart Group, Nashville; D. Cannom, Good Samaritan Heart Institute, Los Angeles; C. Schuger, Henry Ford Hospital, Detroit; D. Hoch, St. Francis Hospital–Heart Center, Roslyn, N.Y.; J. Daubert, University of Rochester Medical Center, Rochester, N.Y.; M. Rashtian, Foothill Cardiology, Pasadena, Calif.; S. Higgins, Scripps Memorial Hospital, La Jolla, Calif.; G. Ziady, University of Pittsburgh Medical Center, Pittsburgh; B. Crevey, Clarian Health Methodist Hospital, Indianapolis; J. Herre, Sentara Norfolk General Hospital, Norfolk, Va.; S. Klein, Le Bauer Cardiovascular Research Foundation, Greensboro, N.C.; J. Merillat, Valley Heart Associates, Modesto, Calif.; C. Sueta, University of North Carolina, Chapel Hill; C. Kim, Rochester General Hospital, Rochester, N.Y.; S. Compton, Alaska Heart Institute, Anchorage; I. Singer, University of Louisville, Louisville, Ky.; K. Adams, Jacksonville Heart Center, Jacksonville, Fla.; J. Patterson, St. Vincent's Medical Center, Jacksonville, Fla.; M. Estes, New England Medical Center, Boston; D. Zhu, Minnesota Heart Clinic, Edina; S. Saksena, Eastern Heart Institute, Passaic, N.J.; J. Ruskin, Massachusetts General Hospital, Boston; G. Sosa-Suarez, St. Peter's Hospital, Albany, N.Y.; D. Wilkinson, Swedish Medical Center–Providence Campus, Seattle; D. Fitzgerald, Wake Forest University, Winston-Salem, N.C.; Y. Greenberg, Maimonides Medical Center, Brooklyn, N.Y.; T. Talbert, Park Ridge Medical Center, Chattanooga, Tenn.; R. Jadonath, North Shore University Hospital, Manhasset, N.Y.; J. Windle, University of Nebraska Medical Center, Omaha; L. Siddoway, York Hospital, York, Pa.; D. Borowski, Consultants in Cardiology, Inc., Erie, Pa.; E. Nsah, Peninsula Cardiology Associates, Salisbury, Md.; S. Geraci, University of Florida, Jacksonville; S. Brownstein, St. Vincent Mercy Medical Center, Toledo, Ohio; M. Schalij, Leiden University Hospital, Leiden, the Netherlands; A. Medina, Bikur Cholim Hospital, Jerusalem, Israel; E. Platia, Washington Hospital Center, Washington, D.C.; P. Friedman, Cardiovascular Specialists, Hyannis, Mass.; J. Zebede, Mount Sinai Medical Center, Miami; F. Leonelli, Cardiology Associates of Mobile, Mobile, Ala.; E.W. Grogan, Wisconsin Heart, Madison; W. Crawford, Montgomery Cardiovascular Associates, Montgomery, Ala.; D. Wattoo, Heart Center of Nevada, Las Vegas; J. Souza, Asheville Cardiology Associates, Asheville, N.C.; C. Fuenzalida, Western Cardiology Associates, Aurora, Colo.; S. Lanza, Florida Heart Group, Orlando; B. Belhassen, Tel Aviv Medical Center, Tel Aviv, Israel; R. Winkle, Sequoia Hospital, Palo Alto, Calif.; M. Illovsky, National Naval Medical Center, Bethesda, Md.; A. Dougherty, University of Texas, Houston; O. Fujimura, State University of New York Upstate Medical University, Syracuse; H. Lee, University of Iowa Health Care, Iowa City; C. Rizo-Patron, Cardiology Associates of Lubbock, Lubbock, Tex.; D. Pederson, Austin Heart, Austin, Tex.; F. Gilliam, Virginia Cardiovascular Specialists, Richmond; Data and Safety Monitoring Committee — D. Oakes (chair), T. Pearson, R. Pomerantz; End-Point Review Committee — H. Greenberg (chair), R. Case; Noninvasive Electrocardiology — W. Zareba (head), J. Palma, D. Passantino; Rochester Coordination and Data Center — M. Brown (head), M. Andrews, D. Johnsen, D. Ramsell, B. MacKecknie, A. Sorce, P. Severski, E. Carroll; Biostatisticians — W. Hall (head), V. Dragalin, P. Huang, K. Ding, C. Feng, J. Whitehead (consultant); Executive Committee — A. Moss (chair), M. Brown, D. Cannom, J. Daubert, W. Hall, S. Higgins, H. Klein, D. Wilber, W. Zareba.

References

References

  1. 1

    Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1940
    Free Full Text | Web of Science | Medline

  2. 2

    Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999;341:1882-1890[Erratum, N Engl J Med 2000;342:1300.]
    Free Full Text | Web of Science | Medline

  3. 3

    Buxton AE, Lee KL, DiCarlo L, et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. N Engl J Med 2000;342:1937-1945
    Free Full Text | Web of Science | Medline

  4. 4

    Healy B, Campeau L, Gray R, et al. Conflict-of-interest guidelines for a multicenter clinical trial of treatment after coronary-artery bypass-graft surgery. N Engl J Med 1989;320:949-951
    Full Text | Web of Science | Medline

  5. 5

    Moss AJ, Daubert JP, Hall WJ, et al. Multicenter Automatic Defibrillator Implantation Trial II (MADIT II): design and clinical protocol. Ann Noninvasive Electrocardiol 1999;4:83-91
    CrossRef

  6. 6

    Whitehead J. The design and analysis of sequential clinical trials. Rev. 2nd ed. Chichester, England: John Wiley, 1997.

  7. 7

    Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34:187-220

  8. 8

    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481
    CrossRef | Web of Science

  9. 9

    The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-1583
    Free Full Text | Web of Science | Medline

  10. 10

    Hurst TM, Hinrichs M, Breidenbach C, Katz N, Waldecker B. Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators. J Am Coll Cardiol 1999;34:402-408
    CrossRef | Web of Science | Medline

  11. 11

    Ellenbogen KA, Thames MD, Mohanty PK. New insights into pacemaker syndrome gained from hemodynamic, humoral and vascular responses during ventriculo-atrial pacing. Am J Cardiol 1990;65:53-59
    CrossRef | Web of Science | Medline

  12. 12

    Cohn JN, Bristow MR, Chien KR, et al. Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation 1997;95:766-770
    Web of Science | Medline

  13. 13

    Myerburg RJ. Sudden cardiac death: exploring the limits of our knowledge. J Cardiovasc Electrophysiol 2001;12:369-381
    CrossRef | Web of Science | Medline

Citing Articles (2095)

Citing Articles

  1. 1

    Tomas Drabek, Jan Němec. (2013) Anesthetic Management of Electrophysiological Procedures for Heart Failure. International Anesthesiology Clinics 50:3, 22-42

  2. 2

    Kyung W. Park. (2013) Nonsurgical Therapy for Heart Failure. International Anesthesiology Clinics 50:3, 1-21

  3. 3

    Komal D. Patel, Ryan Crowley, Aman Mahajan. (2013) Cardiac Electrophysiology Procedures in Clinical Practice. International Anesthesiology Clinics 50:2, 90-110

  4. 4

    L. F. H. J. Robbers, R. Delewi, R. Nijveldt, A. Hirsch, A. M. Beek, M. J. B. Kemme, Y. van Beurden, A. M. van der Laan, P. A. van der Vleuten, R. A. Tio, F. Zijlstra, J. J. Piek, A. C. van Rossum. (2013) Myocardial infarct heterogeneity assessment by late gadolinium enhancement cardiovascular magnetic resonance imaging shows predictive value for ventricular arrhythmia development after acute myocardial infarction. European Heart Journal - Cardiovascular Imaging

  5. 5

    P. Barthel, R. Wensel, A. Bauer, A. Muller, P. Wolf, K. Ulm, K. M. Huster, D. P. Francis, M. Malik, G. Schmidt. (2013) Respiratory rate predicts outcome after acute myocardial infarction: a prospective cohort study. European Heart Journal 34:22, 1644-1650

  6. 6

    Sana M. Al-Khatib, Gregg C. Fonarow, David L. Hayes, Anne B. Curtis, Samuel F. Sears, Gillian D. Sanders, Adrian F. Hernandez, Michael J. Mirro, Kevin L. Thomas, Zubin J. Eapen, Andrea M. Russo, Clyde W. Yancy. (2013) Performance measures to promote quality improvement in sudden cardiac arrest prevention and treatment. American Heart Journal 165:6, 862-868

  7. 7

    S. C. Wijers, B. Y. M. Kolk, A. E. Tuinenburg, P. A. F. Doevendans, M. A. Vos, M. Meine. (2013) Implementation of guidelines for implantable cardioverter-defibrillator therapy in clinical practice: Which patients do benefit?. Netherlands Heart Journal 21:6, 274-283

  8. 8

    Larisa G. Tereshchenko. (2013) Controversy surrounding the best time for ICD implantation after myocardial infarction. Heart Rhythm 10:6, 836-837

  9. 9

    Paul L. Hess, Amy Laird, Rex Edwards, Gust H. Bardy, J. Thomas Bigger, Alfred E. Buxton, Arthur J. Moss, Kerry L. Lee, W.J. Hall, Richard Steinman, Paul Dorian, Al Hallstrom, Riccardo Cappato, Alan H. Kadish, Peter J. Kudenchuk, Daniel B. Mark, Sana M. Al-Khatib, Jonathan P. Piccini, Lurdes Y.T. Inoue, Gillian D. Sanders. (2013) Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: Does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials. Heart Rhythm 10:6, 828-835

  10. 10

    Xiaozhong Chen, Larisa G. Tereshchenko, Ronald D. Berger, Natalia A. Trayanova. (2013) Arrhythmia risk stratification based on QT interval instability: An intracardiac electrocardiogram study. Heart Rhythm 10:6, 875-880

  11. 11

    Lian-Yu Lin, Jiunn-Lee Lin. (2013) QT interval instability: An added piece for an incomplete jigsaw puzzle. Heart Rhythm 10:6, 881-882

  12. 12

    U. Lusebrink, D. Duncker, M. Hess, I. Heinrichs, A. Gardiwal, H. Oswald, T. Konig, G. Klein. (2013) Clinical relevance of slow ventricular tachycardia in heart failure patients with primary prophylactic implantable cardioverter defibrillator indication. Europace 15:6, 820-826

  13. 13

    T. R. Betts, P. P. Sadarmin, D. R. Tomlinson, K. Rajappan, K. C. K. Wong, J. P. de Bono, Y. Bashir. (2013) Absolute risk reduction in total mortality with implantable cardioverter defibrillators: analysis of primary and secondary prevention trial data to aid risk/benefit analysis. Europace 15:6, 813-819

  14. 14

    B. Shi, S. A. Harding, A. Jimenez, P. D. Larsen. (2013) Standard 12-lead electrocardiography measures predictive of increased appropriate therapy in implantable cardioverter defibrillator recipients. Europace 15:6, 892-898

  15. 15

    Mark A Brown, Susan M Crail, Rosemary Masterson, Celine Foote, Jennifer Robins, Ivor Katz, Elizabeth Josland, Frank Brennan, Elizabeth J Stallworthy, Brian Siva, Cathy Miller, A Katalin Urban, Cherian Sajiv, R Naida Glavish, Steven May, Robyn Langham, Robert Walker, Robert G Fassett, Rachael L Morton, Cameron Stewart, Lisa Phipps, Helen Healy, Ilse Berquier. (2013) ANZSN Renal Supportive Care Guidelines 2013. Nephrology 18:6, 401-454

  16. 16

    Xiangkui Wan, Kanghui Yan, Minggui Li, Dingcheng Xiang. (2013) A MODIFIED CORRELATION METHOD FOR T-WAVE ALTERNANS DETECTION. Biomedical Engineering: Applications, Basis and Communications 25:03, 1350030

  17. 17

    Niyada Naksuk, Ali Saab, Jian-Ming Li, Viorel Florea, Mehmet Akkaya, Inder S. Anand, David G. Benditt, Selcuk Adabag. (2013) Incidence of Appropriate Shock in Implantable Cardioverter-Defibrillator Patients With Improved Ejection Fraction. Journal of Cardiac Failure 19:6, 426-430

  18. 18

    SAADIA SHERAZI, SCOTT MCNITT, MEHMET K. AKTAS, BRONISLAVA POLONSKY, ABRAR H. SHAH, ARTHUR J. MOSS, JAMES P. DAUBERT, WOJCIECH ZAREBA. (2013) End-of-Life Care in Patients with Implantable Cardioverter Defibrillators: A MADIT-II Substudy. Pacing and Clinical Electrophysiologyn/a-n/a

  19. 19

    Mitchell A. Psotka, John R. Teerlink. (2013) Strategies to Prevent Postdischarge Adverse Events Among Hospitalized Patients with Heart Failure. Heart Failure Clinics

  20. 20

    PAUL L. HESS, MARIA V. GRAU-SEPULVEDA, ADRIAN F. HERNANDEZ, ERIC D. PETERSON, DEEPAK L. BHATT, LEE H. SCHWAMM, CLYDE W. YANCY, GREGG C. FONAROW, SANA M. AL-KHATIB, . (2013) Age Differences in the Use of Implantable Cardioverter-Defibrillators Among Older Patients Hospitalized with Heart Failure. Journal of Cardiovascular Electrophysiology 24:6, 664-671

  21. 21

    YOSHIO FURUKAWA, TAKAHISA YAMADA, TAKASHI MORITA, YUSUKE IWASAKI, MASATO KAWASAKI, ATSUSHI KIKUCHI, TAKASHI NAITO, TADAO FUJIMOTO, KENTARO OZU, TAKUMI KONDO, KAORUKO SENGOKU, HIRONORI YAMAMOTO, TOHRU MASUYAMA, MASATAKE FUKUNAMI. (2013) Early Repolarization Pattern Associated with Sudden Cardiac Death: Long-Term Follow-Up in Patients with Chronic Heart Failure. Journal of Cardiovascular Electrophysiology 24:6, 632-639

  22. 22

    ANNE-CHRISTINE H. RUWALD, NITESH SOOD, MARTIN H. RUWALD, CHRISTIAN JONS, CHRISTOPHER A. CLYNE, SCOTT MCNITT, PAUL WANG, WOJCIECH ZAREBA, ARTHUR J. MOSS. (2013) Frequency of Inappropriate Therapy in Patients Implanted with Dual- Versus Single-Chamber ICD Devices in the ICD Arm of MADIT-CRT. Journal of Cardiovascular Electrophysiology 24:6, 672-679

  23. 23

    AMMAR M. KILLU, JIA-HUI WU, PAUL A. FRIEDMAN, WIN-KUANG SHEN, TRACY L. WEBSTER, KELLY L. BROOKE, DAVID O. HODGE, HEATHER J. WISTE, YONG-MEI CHA. (2013) Outcomes of Cardiac Resynchronization Therapy in the Elderly. Pacing and Clinical Electrophysiology 36:6, 664-672

  24. 24

    Tiffany Randolph, Jonathan P. Piccini. (2013) Optimal Utilization and Management of Implanted Cardiac Rhythm Devices in Patients Hospitalized for Heart Failure. Heart Failure Clinics

  25. 25

    R. Verlato, D. Facchin, D. Catanzariti, G. Molon, G. Zanotto, G. Morani, M. Brieda, F. Zanon, P. Delise, L. Leoni, J. Comisso, C. Campo. (2013) Clinical outcomes in patients with implantable cardioverter defibrillators and Sprint Fidelis leads. Heart 99:11, 799-804

  26. 26

    Zak Loring, Wojciech Zareba, Scott McNitt, David G. Strauss, Galen S. Wagner, James P. Daubert. (2013) ECG Quantification of Myocardial Scar and Risk Stratification in MADIT-II. Annals of Noninvasive Electrocardiologyn/a-n/a

  27. 27

    Shinichi Niwano, Jun Oikawa, Hidehira Fukaya. (2013) Prophylactic catheter ablation for ventricular tachycardia reduces morbidity and mortality in patients with implantable cardioverter–defibrillator devices. Journal of Arrhythmia

  28. 28

    Arthur R. Garan, Melana Yuzefpolskaya, Paolo C. Colombo, John P. Morrow, Rosie Te-Frey, Drew Dano, Hiroo Takayama, Yoshifumi Naka, Hasan Garan, Ulrich P. Jorde, Nir Uriel. (2013) Ventricular Arrhythmias and Implantable Cardioverter-Defibrillator Therapy in Patients With Continuous-Flow Left Ventricular Assist Devices. Journal of the American College of Cardiology 61:25, 2542-2550

  29. 29

    H. U. Klein, I. Goldenberg, A. J. Moss. (2013) Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator. European Heart Journal

  30. 30

    Jeffrey R. Winterfield, Srijoy Mahapatra, David J. Wilber. (2013) Catheter ablation of ventricular arrhythmias. Current Opinion in Cardiology 28:3, 344-353

  31. 31

    Thomas Klein, Vasken Dilsizian, Qi Cao, Wengen Chen, Timm-Michael Dickfeld. (2013) The Potential Role of Iodine-123 Metaiodobenzylguanidine Imaging for Identifying Sustained Ventricular Tachycardia in Patients with Cardiomyopathy. Current Cardiology Reports 15:5,

  32. 32

    Jens Kreuz, Dirk Skowasch, Fritz Horlbeck, Carolin Atzinger, Jan W. Schrickel, Henning Lorenzen, Georg Nickenig, Jörg O. Schwab. (2013) Usefulness of Sleep-Disordered Breathing to Predict Occurrence of Appropriate and Inappropriate Implantable-Cardioverter Defibrillator Therapy in Patients With Implantable Cardioverter-Defibrillator for Primary Prevention of Sudden Cardiac Death. The American Journal of Cardiology 111:9, 1319-1323

  33. 33

    Pamela J. Bradshaw, Paul Stobie, Tom Briffa, Michael S.T. Hobbs. (2013) Use and long-term outcomes of implantable cardioverter-defibrillators, 1990 to 2009. American Heart Journal 165:5, 816-822

  34. 34

    Shinsuke Miyazaki, Takashi Uchiyama, Yuki Komatsu, Hiroshi Taniguchi, Shigeki Kusa, Hiroaki Nakamura, Hitoshi Hachiya, Mitsuaki Isobe, Kenzo Hirao, Yoshito Iesaka. (2013) Long-Term Complications of Implantable Defibrillator Therapy in Brugada Syndrome. The American Journal of Cardiology 111:10, 1448-1451

  35. 35

    Sanjeev P. Bhavnani, Craig I. Coleman, Danette Guertin, Ravi K. Yarlagadda, Christopher A. Clyne, Jeffrey Kluger. (2013) Evaluation of the Charlson Comorbidity Index to Predict Early Mortality in Implantable Cardioverter Defibrillator Patients. Annals of Noninvasive Electrocardiologyn/a-n/a

  36. 36

    Daniel J. Friedman, Seth R. Bender, Steven M. Markowitz, Bruce B. Lerman, Peter M. Okin. (2013) T-Wave Alternans and ST Depression Assessment Identifies Low Risk Individuals with Ischemic Cardiomyopathy in the Absence of Left Ventricular Hypertrophy. Annals of Noninvasive Electrocardiologyn/a-n/a

  37. 37

    Tomasz Chwyczko, Rafał Dąbrowski, Aleksander Maciąg, Maciej Sterliński, Edyta Smolis-Bąk, Anna Borowiec, Ilona Kowalik, Andrada Łabęcka, Agnieszka Jankowska, Marek Kośmicki, Jadwiga Janas, Mariusz Pytkowski, Hanna Szwed. (2013) Potential Prevention of Pacing-Induced Heart Failure Using Simple Pacemaker Programming Algorithm. Annals of Noninvasive Electrocardiologyn/a-n/a

  38. 38

    Niyada Naksuk, Mehmet Akkaya, Selcuk Adabag. (2013) Application of the Multicenter Automatic Defibrillator Implantation Trial II Risk Score in a Nontrial Setting. The American Journal of Cardiology

  39. 39

    NITESH SOOD, ERIC CRESPO, MEIR FRIEDMAN, DANETTE GUERTIN, STEVEN ZWEIBEL, JEFFREY KLUGER, CHRISTOPHER A. CLYNE. (2013) Predictors of Pacemaker Dependence and Pacemaker Dependence as a Predictor of Mortality in Patients with Implantable Cardioverter Defibrillator. Pacing and Clinical Electrophysiologyn/a-n/a

  40. 40

    Zak Loring, David G. Strauss, Gary Gerstenblith, Gordon F. Tomaselli, Robert G. Weiss, Katherine C. Wu. (2013) Cardiac MRI scar patterns differ by sex in an implantable cardioverter-defibrillator and cardiac resynchronization therapy cohort. Heart Rhythm 10:5, 659-665

  41. 41

    Rachel Lampert. (2013) Is Electricity Useful When the Pump Is Failing?. Journal of the American College of Cardiology 61:21, 2151-2152

  42. 42

    Chih-Ying Chen, Lynne Warner Stevenson, Garrick C. Stewart, John D. Seeger, Lauren Williams, Jessica J. Jalbert, Soko Setoguchi. (2013) Impact of Baseline Heart Failure Burden on Post-Implantable Cardioverter-Defibrillator Mortality Among Medicare Beneficiaries. Journal of the American College of Cardiology 61:21, 2142-2150

  43. 43

    Steven L Higgins. (2013) A novel patch for heart rhythm monitoring: is the Holter monitor obsolete?. Future Cardiology 9:3, 325-333

  44. 44

    Micha T Maeder, Peter Ammann. (2013) Changes in BNP and QTc for prediction of sudden death in heart failure. Future Cardiology 9:3, 317-320

  45. 45

    GUY ROZEN, ROI KOBO, ROY BEINART, SHLOMO FELDMAN, MICHAL SAPUNAR, DAVID LURIA, MICHAEL ELDAR, JACOB LEVITAN, MICHAEL GLIKSON. (2013) Multipole Analysis of Heart Rate Variability as a Predictor of Imminent Ventricular Arrhythmias in ICD Patients. Pacing and Clinical Electrophysiologyn/a-n/a

  46. 46

    HEMAL SHAH, URE MEZU, DIVYANG PATEL, SUSAN FLANIGAN, HAITHAM HREYBE, EVAN ADELSTEIN, SANDEEP JAIN, VOLKER LANG, SAMIR SABA. (2013) Mechanisms of Inappropriate Defibrillator Therapy in a Modern Cohort of Remotely Monitored Patients. Pacing and Clinical Electrophysiology 36:5, 547-552

  47. 47

    Reinoud E. Knops, Louise R.A. Olde Nordkamp, Joris.R. de Groot, Arthur A.M. Wilde. (2013) The two incision technique for the implantation of the subcutaneous implantable cardioverter defibrillator. Heart Rhythm

  48. 48

    Eldrin F. Lewis. (2013) Assessing the Impact of Heart Failure Therapeutics on Quality of Life and Functional Capacity. Current Treatment Options in Cardiovascular Medicine

  49. 49

    Joerg Honold, Ulrich Fischer-Rasokat, Florian H. Seeger, David Leistner, Saskia Lotz, Stefanie Dimmeler, Andreas M. Zeiher, Birgit Assmus. (2013) Impact of intracoronary reinfusion of bone marrow-derived mononuclear progenitor cells on cardiopulmonary exercise capacity in patients with chronic postinfarction heart failure. Clinical Research in Cardiology

  50. 50

    Luis E. Rohde, Eduardo G. Bertoldi, Livia Goldraich, Carísi A. Polanczyk. (2013) Cost-effectiveness of heart failure therapies. Nature Reviews Cardiology 10:6, 338-354

  51. 51

    Elena Salmoirago-Blotcher, Sybil L. Crawford, James Carmody, Lawrence Rosenthal, Gloria Yeh, Mary Stanley, Karen Rose, Clifford Browning, Ira S. Ockene. (2013) Phone-Delivered Mindfulness Training for Patients with Implantable Cardioverter Defibrillators: Results of a Pilot Randomized Controlled Trial. Annals of Behavioral Medicine

  52. 52

    Maria Vittoria Matassini, Jeff S. Healey. (2013) How to Manage a High Defibrillation Threshold in ICD Patients: and Does it Really Matter?. Current Treatment Options in Cardiovascular Medicine

  53. 53

    C. S. P. Lam, I. Anand, S. Zhang, W. Shimizu, C. Narasimhan, S. W. Park, C.-M. Yu, T. Ngarmukos, R. Omar, E. B. Reyes, B. Siswanto, L. H. Ling, A. M. Richards. (2013) Asian Sudden Cardiac Death in Heart Failure (ASIAN-HF) registry. European Journal of Heart Failure

  54. 54

    K. Kraaier, A. H. Starrenburg, R. M. Verheggen, J. Palen, M. F. Scholten. (2013) Incidence and predictors of phantom shocks in implantable cardioverter defibrillator recipients. Netherlands Heart Journal 21:4, 191-195

  55. 55

    J. Lonborg, N. Vejlstrup, H. Kelbaek, L. Holmvang, E. Jorgensen, S. Helqvist, K. Saunamaki, K. A. Ahtarovski, H. E. Botker, W. Y. Kim, P. Clemmensen, T. Engstrom. (2013) Final infarct size measured by cardiovascular magnetic resonance in patients with ST elevation myocardial infarction predicts long-term clinical outcome: an observational study. European Heart Journal - Cardiovascular Imaging 14:4, 387-395

  56. 56

    Jonathan P. Piccini, Anne S. Hellkamp, David J. Whellan, Stephen J. Ellis, Steven J. Keteyian, William E. Kraus, Adrian F. Hernandez, James P. Daubert, Ileana L. Piña, Christopher M. O’Connor. (2013) Exercise Training and Implantable Cardioverter-Defibrillator Shocks in Patients With Heart Failure. JACC: Heart Failure 1:2, 142-148

  57. 57

    Hussein Rayatzadeh, Shalin J. Patel, Thomas H. Hauser, Long L. Ngo, Jaime L. Shaw, Alex Tan, Alfred E. Buxton, Peter Zimetbaum, Mark E. Josephson, Evan Appelbaum, Warren J. Manning, Reza Nezafat. (2013) Volumetric Left Ventricular Ejection Fraction is Superior to 2-Dimensional Echocardiography for Risk Stratification of Patients for Primary Prevention Implantable Cardioverter-Defibrillator Implantation. The American Journal of Cardiology 111:8, 1175-1179

  58. 58

    David O. Arnar. (2013) Syncope in patients with structural heart disease. Journal of Internal Medicine 273:4, 336-344

  59. 59

    Fadi G. Hage, Wael AlJaroudi, Himanshu Aggarwal, Vikas Bhatia, John Miller, Harish Doppalapudi, Oussama Wazni, Ami E. Iskandrian. (2013) Outcomes of patients with chronic kidney disease and implantable cardiac defibrillator: Primary versus secondary prevention. International Journal of Cardiology 165:1, 113-116

  60. 60

    Mark S. Kremers, Stephen C. Hammill, Charles I. Berul, Christina Koutras, Jeptha S. Curtis, Yongfei Wang, Jim Beachy, Laura Blum Meisnere, Del M. Conyers, Matthew R. Reynolds, Paul A. Heidenreich, Sana M. Al-Khatib, Ileana L. Pina, Kathleen Blake, Mary Norine Walsh, Bruce L. Wilkoff, Alaa Shalaby, Frederick A. Masoudi, John Rumsfeld. (2013) The National ICD Registry Report: Version 2.1 including leads and pediatrics for years 2010 and 2011. Heart Rhythm 10:4, e59-e65

  61. 61

    Andrea M. Russo, Raymond F. Stainback, Steven R. Bailey, Andrew E. Epstein, Paul A. Heidenreich, Mariell Jessup, Suraj Kapa, Mark S. Kremers, Bruce D. Lindsay, Lynne Warner Stevenson. (2013) ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy. Heart Rhythm 10:4, e11-e58

  62. 62

    Mário Oliveira, Pedro Silva Cunha, Nogueira da Silva. (2013) Remote monitoring for follow-up of patients with implantable cardiac devices. Revista Portuguesa de Cardiologia (English Edition)

  63. 63

    SANJEEV P. BHAVNANI, VAMSIMOHAN PAVULURI, CRAIG I. COLEMAN, DANETTE GUERTIN, RAVI K. YARLAGADDA, CHRISTOPHER A. CLYNE, JEFFERY KLUGER. (2013) The Gender-Paradox among Patients with Implantable Cardioverter-Defibrillators: A Propensity-Matched Study. Pacing and Clinical Electrophysiologyn/a-n/a

  64. 64

    SABA DARDA, YAZAN KHOURI, RONY GORGES, MERSHED AL SAMARA, SACHIN K. Amruthlal JAIN, MARCOS DACCARETT, CHRISTIAN MACHADO. (2013) Feasibility and Safety of Same-Day Discharge after Implantable Cardioverter Defibrillator Placement for Primary Prevention. Pacing and Clinical Electrophysiologyn/a-n/a

  65. 65

    DANIEL J. CANTILLON, KIEU HA, ROBERT STYPEREK, PITAYADET JUMRUSSIRIKUL, MICHAEL MIRRO, WILSON WONG, BRUCE L. WILKOFF, . (2013) Clinical Experience and Procedural Outcomes Associated with the DF4 Implantable Cardioverter Defibrillator System: The SJ4 Postapproval Study. Pacing and Clinical Electrophysiologyn/a-n/a

  66. 66

    Thomas A. Dewland, Jonathan C. Hsu, Jorge M. Castellanos, Lisa M. Smith, Gregory M. Marcus. (2013) Consideration of patient age and life expectancy in implantable cardioverter-defibrillator referral. American Heart Journal

  67. 67

    Pierre S. Aoukar, Jeanne E. Poole, George W. Johnson, Jill Anderson, Anne S. Hellkamp, Daniel B. Mark, Kerry L. Lee, Gust H. Bardy. (2013) No Benefit of a Dual Coil over a Single Coil ICD Lead: Evidence from the Sudden Cardiac Death in Heart Failure Trial. Heart Rhythm

  68. 68

    Sameer M. Jamal, Ronald D. Berger. (2013) VT begets VT—and other bad stuff—in CRT-D patients. Heart Rhythm

  69. 69

    Akihiko Shimizu. (2013) Indication of ICD in Brugada syndrome. Journal of Arrhythmia 29:2, 110-116

  70. 70

    Kristina Wasmer, Julia Köbe, Dietrich Andresen, Ralf Zahn, Stefan G. Spitzer, Joachim Jehle, Johannes Brachmann, Christoph Stellbrink, Eimo Martens, Matthias Hochadel, Jochen Senges, Helmut Klein, Lars Eckardt. (2013) Comparing outcome of patients with coronary artery disease and dilated cardiomyopathy in ICD and CRT recipients: data from the German DEVICE—registry. Clinical Research in Cardiology

  71. 71

    Arjun Sharma, Anthony Blank, Parashar Patel, Kenneth Stein. (2013) Health care policy and regulatory implications on medical device innovations: a cardiac rhythm medical device industry perspective. Journal of Interventional Cardiac Electrophysiology

  72. 72

    Sandra L. Carroll, Patricia H. Strachan, Sonya de Laat, Lisa Schwartz, Heather M. Arthur. (2013) Patients’ decision making to accept or decline an implantable cardioverter defibrillator for primary prevention of sudden cardiac death. Health Expectations 16:1, 69-79

  73. 73

    John M. Nicklas, Barry E. Bleske, Richard Van Harrison, Robert V. Hogikyan, Yeong Kwok, William E. Chavey. (2013) Heart Failure. Primary Care: Clinics in Office Practice 40:1, 17-42

  74. 74

    Nicolas W. Shammas, Rafat F. Padaria, Edmund P. Coyne. (2013) Pericarditis, Myocarditis, and Other Cardiomyopathies. Primary Care: Clinics in Office Practice 40:1, 213-236

  75. 75

    Mohamed ElMaghawry, Federico Migliore, Alessandro Zorzi, Barbara Bauce, Loira Leoni, Emanuele Bertaglia, Sabino Iliceto, Domenico Corrado. (2013) Implantable Cardioverter-Defibrillator Therapy in Athletes. Cardiac Electrophysiology Clinics 5:1, 123-130

  76. 76

    Raul D. Mitrani, Amanda Mcardle, Michele Slane, John Cogan, Robert J. Myerburg. (2013) Wearable defibrillators in uninsured patients with newly diagnosed cardiomyopathy or recent revascularization in a community medical center. American Heart Journal 165:3, 386-392

  77. 77

    NICK VAN BOVEN, KJELL BOGAARD, JAAP RUITER, GEERT KIMMAN, DOMINIC THEUNS, ISABELLA KARDYS, VICTOR UMANS. (2013) Functional Response to Cardiac Resynchronization Therapy is Associated with Improved Clinical Outcome and Absence of Appropriate Shocks. Journal of Cardiovascular Electrophysiology 24:3, 316-322

  78. 78

    SAJAD A HAYAT, PIPIN KOJODJOJO, ANTHONY MASON, ANN BENFIELD, IAN WRIGHT, ZACHARY WHINNETT, PHANG BOON LIM, D. WYN DAVIES, DAVID LEFROY, NICHOLAS S PETERS, PRAPA KANAGARATNAM. (2013) Malfunction of Subpectorally Implanted Cardiac Resynchronization Therapy Defibrillators Due to Weakened Header Bond. Journal of Cardiovascular Electrophysiology 24:3, 351-355

  79. 79

    GRACE LIN, ANGELA DISPENZIERI, ROBERT KYLE, MARTHA GROGAN, PETER A. BRADY. (2013) Implantable Cardioverter Defibrillators in Patients with Cardiac Amyloidosis. Journal of Cardiovascular Electrophysiologyn/a-n/a

  80. 80

    Mário Oliveira, Pedro Silva Cunha, Nogueira da Silva. (2013) Monitorização à distância no seguimento de portadores de dispositivos cardíacos implantados. Revista Portuguesa de Cardiologia 32:3, 185-190

  81. 81

    Andrea M. Russo, Raymond F. Stainback, Steven R. Bailey, Andrew E. Epstein, Paul A. Heidenreich, Mariell Jessup, Suraj Kapa, Mark S. Kremers, Bruce D. Lindsay, Lynne Warner Stevenson. (2013) ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy. Journal of the American College of Cardiology

  82. 82

    Ramesh Daggubati, Pradeep Arumugham, T. Bruce Ferguson. (2013) The World Post STICH: Is This a “Game Changer?” A Surgeon's Perspective — Revascularization Is Still the Treatment of Choice. Progress in Cardiovascular Diseases 55:5, 470-475

  83. 83

    Beat A. Kaufmann, Son Y. Min, Kaatje Goetschalckx, Alain M. Bernheim, Peter T. Buser, Matthias E. Pfisterer, Hans-Peter Brunner-La Rocca. (2013) How reliable are left ventricular ejection fraction cut offs assessed by echocardiography for clinical decision making in patients with heart failure?. The International Journal of Cardiovascular Imaging 29:3, 581-588

  84. 84

    D. Herman, P. Stros, K. Curila, V. Kebza, P. Osmancik. (2013) Deactivation of implantable cardioverter-defibrillators: results of patient surveys. Europace

  85. 85

    Brian Hiestand, Said Laribi, Alexandre Mebazaa. (2013) Implantable Cardiac Devices and the Acute Care Management of Decompensated Heart Failure. Current Emergency and Hospital Medicine Reports

  86. 86

    Shuai Chen, Hongwei Zhao. (2013) Generalized Redistribute-to-the-right Algorithm: Application to the Analysis of Censored Cost Data. Journal of Statistical Theory and Practice130225143010009

  87. 87

    G. Morani, M. Gasparini, F. Zanon, E. Casali, A. Spotti, A. Reggiani, E. Bertaglia, F. Solimene, G. Molon, M. Accogli, C. Tommasi, A. Paoletti Perini, C. Ciardiello, L. Padeletti. (2013) Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry. Europace

  88. 88

    S. Pecha, M. A. Aydin, Y. Yildirim, B. Sill, B. Reiter, I. Wilke, H. Reichenspurner, H. Treede. (2013) Transcutaneous lead implantation connected to an externalized pacemaker in patients with implantable cardiac defibrillator/pacemaker infection and pacemaker dependency. Europace

  89. 89

    S. Chen, Z. Ling, M. G. Kiuchi, Y. Yin, M. W. Krucoff. (2013) The efficacy and safety of cardiac resynchronization therapy combined with implantable cardioverter defibrillator for heart failure: a meta-analysis of 5674 patients. Europace

  90. 90

    B. N. Shah, R. S. Khattar, R. Senior. (2013) The hibernating myocardium: current concepts, diagnostic dilemmas, and clinical challenges in the post-STICH era. European Heart Journal

  91. 91

    P. Weeke, J. B. Johansen, O. D. Jorgensen, J. C. Nielsen, M. Moller, R. Videbaek, M. V. Hojgaard, S. Riahi, P. K. Jacobsen. (2013) Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD Register. Europace

  92. 92

    S. Nayyar, A. N. Ganesan, A. G. Brooks, T. Sullivan, K. C. Roberts-Thomson, P. Sanders. (2013) Venturing into ventricular arrhythmia storm: a systematic review and meta-analysis. European Heart Journal 34:8, 560-571

  93. 93

    Giuseppe Stabile, Carlo D’Agostino, Paolo Gallo, Natale Marrazzo, Assunta Iuliano, Antonio De Simone, Pietro Turco, Michele Palella, Giovanni Donnici, Carmine Ciardiello, Giovanni Napolitano, Francesco Solimene. (2013) Appropriate therapies predict long-term mortality in primary and secondary prevention of sudden cardiac death. Journal of Cardiovascular Medicine 14:2, 110-113

  94. 94

    Mark I. Travin. (2013) Cardiac autonomic imaging with SPECT tracers. Journal of Nuclear Cardiology 20:1, 128-143

  95. 95

    GIOVANNI LUCA BOTTO, COSIMO DAMIANO DICANDIA, MASSIMO MANTICA, CONCETTO LA ROSA, ANTONIO D’ONOFRIO, MARIA GRAZIA BONGIORNI, GIULIO MOLON, ROBERTO VERLATO, GIOVANNI QUINTO VILLANI, ALBERTO SCACCIA, GIOVANNI RACITI, ERALDO OCCHETTA. (2013) Clinical Characteristics, Mortality, Cardiac Hospitalization, and Ventricular Arrhythmias in Patients Undergoing CRT-D Implantation: Results of the ACTION-HF Study. Journal of Cardiovascular Electrophysiology 24:2, 173-181

  96. 96

    EDWARD F. LIN, DARSHAN DALAL, ALAN CHENG, JOSEPH E. MARINE, SAMAN NAZARIAN, SUNIL SINHA, DAVID D. SPRAGG, HARIKRISHNA TANDRI, HENRY HALPERIN, HUGH CALKINS, RONALD D. BERGER, GORDON F. TOMASELLI, CHARLES A. HENRIKSON. (2013) Predictors of High Defibrillation Threshold in the Modern Era. Pacing and Clinical Electrophysiology 36:2, 231-237

  97. 97

    Edward J. Vigmond, Shane Kimber, Go Suzuki, Peter Faris, L. Joshua Leon. (2013) Defibrillation Success Is Not Associated With Near Field Electrogram Complexity or Shock Timing. Canadian Journal of Cardiology

  98. 98

    Chieh Suai Tan, Cui Jie, Jennifer Joe, Zubin D. Irani, Suvranu Ganguli, Sanjeeva Prasad Kalva, Stephan Wicky, Steven Wu. (2013) The Impact of Transvenous Cardiac Devices on Vascular Access Patency in Hemodialysis Patients. Seminars in Dialysisno-no

  99. 99

    Demosthenes G. Katritsis, Konstantinos C. Siontis, J. Thomas Bigger, Alan H. Kadish, Richard Steinman, Wojciech Zareba, George C.M. Siontis, Gust H. Bardy, John P.A. Ioannidis. (2013) Effect of left ventricular ejection fraction and QRS duration on the survival benefit of implantable cardioverter-defibrillators: Meta-analysis of primary prevention trials. Heart Rhythm 10:2, 200-206

  100. 100

    Patricia Tung, Christine M. Albert. (2013) Causes and prevention of sudden cardiac death in the elderly. Nature Reviews Cardiology 10:3, 135-142

  101. 101

    Apoor S. Gami, David L. Hayes, Samuel J. Asirvatham, Paul A. Friedman. Indications for Pacemakers, ICDs and CRT: Identifying Patients Who Benefit from Cardiac Rhythm Devices. In: Cardiac Pacing, Defibrillation and Resynchronization. Wiley-Blackwell, 2013:93-132.

  102. 102

    T. Jared Bunch, David L. Hayes, Charles D. Swerdlow, Samuel J. Asirvatham, Paul A. Friedman. Pacing and Defibrillation: Clinically Relevant Basics for Practice. In: Cardiac Pacing, Defibrillation and Resynchronization. Wiley-Blackwell, 2013:1-39.

  103. 103

    D. Erkapic, J. Sperzel, S. Stiller, U. Meltendorf, J. Mermi, K. Wegscheider, B. Hugl, . (2013) Long-term benefit of implantable cardioverter/defibrillator therapy after elective device replacement: results of the INcidence free SUrvival after ICD REplacement (INSURE) trial--a prospective multicentre study. European Heart Journal 34:2, 130-137

  104. 104

    Mark A. Wood, Kenneth A. Ellenbogen. Role of Implantable Cardioverter-Defibrillators in Primary and Secondary Prevention of Sudden Cardiac Death. In: Cardiovascular Therapeutics: A Companion to Braunwald's Heart Disease. Elsevier, 2013:396-407.

  105. 105

    James V. Freeman, Frederick A. Masoudi. (2013) Effectiveness of Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy in Heart Failure. Heart Failure Clinics 9:1, 59-77

  106. 106

    Michael M. Givertz, Wilson S. Colucci. Strategies for Management of Acute Decompensated Heart Failure. In: Cardiovascular Therapeutics: A Companion to Braunwald's Heart Disease. Elsevier, 2013:281-306.

  107. 107

    Frederick G. Kushner, Eric R. Bates. ST-Segment Elevation Myocardial Infarction. In: Cardiovascular Therapeutics: A Companion to Braunwald's Heart Disease. Elsevier, 2013:178-213.

  108. 108

    Jaimie Manlucu, William T. Abraham. Implantable Devices for the Management of Heart Failure. In: Cardiovascular Therapeutics: A Companion to Braunwald's Heart Disease. Elsevier, 2013:270-280.

  109. 109

    Dongsheng Gao, John L. Sapp. (2013) Electrical storm. Current Opinion in Cardiology 28:1, 72-79

  110. 110

    Ronald Freudenberger, John B. Kostis. Heart Failure in Hypertension. In: Hypertension: A Companion to Braunwald’s Heart Disease. Elsevier, 2013:262-269.

  111. 111

    Nathan E. Goldstein, Deborah D. Ascheim. What Is the Clinical Course of Advanced Heart Failure and How Do Implanted Cardiac Devices Alter This Course?. In: Evidence-Based Practice in Palliative Medicine. Elsevier, 2013:330-335.

  112. 112

    Gary A. Wright, George J. Klein, Lorne J. Gula. (2013) Ethical and legal perspective of implantable cardioverter defibrillator deactivation or implantable cardioverter defibrillator generator replacement in the elderly. Current Opinion in Cardiology 28:1, 43-49

  113. 113

    A. Schuchert, C. Muto, T. Maounis, R. Frank, E. Boulogne, A. Polauck, L. Padeletti, . (2013) Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker. Europace 15:1, 71-76

  114. 114

    B. Risgaard, J. B. Nielsen, R. Jabbari, S. Haunso, A. G. Holst, B. G. Winkel, J. Tfelt-Hansen. (2013) Prior myocardial infarction in the young: predisposes to a high relative risk but low absolute risk of a sudden cardiac death. Europace 15:1, 48-54

  115. 115

    Benoit Daneault, Philippe Généreux, Ajay J. Kirtane, Bernhard Witzenbichler, Giulio Guagliumi, Jean-Michel Paradis, Martin P. Fahy, Roxana Mehran, Gregg W. Stone. (2013) Comparison of Three-Year Outcomes After Primary Percutaneous Coronary Intervention in Patients With Left Ventricular Ejection Fraction <40% Versus ≥40% (from the HORIZONS-AMI Trial). The American Journal of Cardiology 111:1, 12-20

  116. 116

    Stanley S. Liu, Jennifer Monti, Hamid M. Kargbo, Muhammad W. Athar, Kapil Parakh. (2013) Frontiers of Therapy for Patients With Heart Failure. The American Journal of Medicine 126:1, 6-12.e6

  117. 117

    Edward P. Gerstenfeld. (2013) Recurrent Ventricular Tachycardia After Catheter Ablation in Post-Infarct Cardiomyopathy. Journal of the American College of Cardiology 61:1, 74-76

  118. 118

    Tali Shafat, Yael Baumfeld, Victor Novack, Yuval Konstantino, Guy Amit. (2013) Significant differences in the expected versus observed longevity of implantable cardioverter defibrillators (ICDs). Clinical Research in Cardiology 102:1, 43-49

  119. 119

    Ge Gao, Samuel C. Dudley. (2013) RBM25/LUC7L3 Function in Cardiac Sodium Channel Splicing Regulation of Human Heart Failure. Trends in Cardiovascular Medicine 23:1, 5-8

  120. 120

    T. Smith, L. Jordaens, D. A. M. J. Theuns, P. F. van Dessel, A. A. Wilde, M. G. M. Hunink. (2013) The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis. European Heart Journal 34:3, 211-219

  121. 121

    A. S. Banning, G. A. Ng. (2013) Driving and arrhythmia: a review of scientific basis for international guidelines. European Heart Journal 34:3, 236-244

  122. 122

    Cynthia M. Tracy, Andrew E. Epstein, Dawood Darbar, John P. DiMarco, Sandra B. Dunbar, N.A. Mark Estes, T. Bruce Ferguson, Stephen C. Hammill, Pamela E. Karasik, Mark S. Link, Joseph E. Marine, Mark H. Schoenfeld, Amit J. Shanker, Michael J. Silka, Lynne Warner Stevenson, William G. Stevenson, Paul D. Varosy. (2013) 2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. Journal of the American College of Cardiology 61:3, e6-e75

  123. 123

    Patrick T. O'Gara, Frederick G. Kushner, Deborah D. Ascheim, Donald E. Casey, Mina K. Chung, James A. de Lemos, Steven M. Ettinger, James C. Fang, Francis M. Fesmire, Barry A. Franklin, Christopher B. Granger, Harlan M. Krumholz, Jane A. Linderbaum, David A. Morrow, L. Kristin Newby, Joseph P. Ornato, Narith Ou, Martha J. Radford, Jacqueline E. Tamis-Holland, Carl L. Tommaso, Cynthia M. Tracy, Y. Joseph Woo, David X. Zhao. (2013) 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. Journal of the American College of Cardiology 61:4, e78-e140

  124. 124

    Patrick T. O'Gara, Frederick G. Kushner, Deborah D. Ascheim, Donald E. Casey, Mina K. Chung, James A. de Lemos, Steven M. Ettinger, James C. Fang, Francis M. Fesmire, Barry A. Franklin, Christopher B. Granger, Harlan M. Krumholz, Jane A. Linderbaum, David A. Morrow, L. Kristin Newby, Joseph P. Ornato, Narith Ou, Martha J. Radford, Jacqueline E. Tamis-Holland, Carl L. Tommaso, Cynthia M. Tracy, Y. Joseph Woo, David X. Zhao. (2013) 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary. Journal of the American College of Cardiology 61:4, 485-510

  125. 125

    Theodore F. Saad, Dirk M. Hentschel, Bruce Koplan, Haimanot Wasse, Arif Asif, Daniel V. Patel, Loay Salman, Roger Carrillo, Jeff Hoggard, . (2013) Cardiovascular Implantable Electronic Device Leads in CKD and ESRD Patients: Review and Recommendations for Practice. Seminars in Dialysis 26:1, 114-123

  126. 126

    XiangKui Wan, Kanghui Yan, Dehan Luo, Yanjun Zeng. (2013) A combined algorithm for T-wave alternans qualitative detection and quantitative measurement. Journal of Cardiothoracic Surgery 8:1, 7

  127. 127

    Mohamed A. Khalil, Abdelhay A. Ebade, Mohsen S. Abdel Azeem. (2013) The role of intravenous paracetamol in conscious sedation during Internal Cardioverter Defibrillator (ICD) insertion in geriatric patients. Egyptian Journal of Anaesthesia 29:1, 41-45

  128. 128

    Mohamed R. Labedi, Rami Alharethi, A.G. Kfoury, Deborah Budge, Reid Bruce, Brad Rasmusson, T. Jared Bunch. (2013) Electromagnetic Interference of Automatic Implantable Cardioverter Defibrillator and HeartWare Left Ventricular Assist Device. ASAIO Journal 59:2, 136-139

  129. 129

    Laura Ajello, Giuseppe Coppola, Egle Corrado, Eluisa La Franca, Antonino Rotolo, Pasquale Assennato. (2013) Diagnosis and Treatment of Asymptomatic Left Ventricular Systolic Dysfunction after Myocardial Infarction. ISRN Cardiology 2013, 1-7

  130. 130

    Brian Olshansky, Renee M. Sullivan. (2013) Sudden Death Risk in Syncope: The Role of The Implantable Cardioverter Defibrillator. Progress in Cardiovascular Diseases 55:4, 443-453

  131. 131

    Andrea Sarkozy, Gian-Battista Chierchia, Moisés Rodríguez-Mañero, Pedro Brugada. (2013) Muerte súbita cardiaca en las cardiopatías estructurales. Revista Española de Cardiología Suplementos 13, 7-13

  132. 132

    John Somberg, Janos Molnar. (2013) The Dark Side of Implantable Cardioverter Defibrillator Therapy. Cardiology 124:4, 213-215

  133. 133

    Lucinda A. Harris, Stephanie L. Hansel, Elizabeth Rajan, Komandoor Srivathsan, Robert Rea, Michael D. Crowell, David E. Fleischer, Shabana F. Pasha, Suryakanth R. Gurudu, Russell I. Heigh, Arthur D. Shiff, Janice K. Post, Jonathan A. Leighton. (2013) Capsule Endoscopy in Patients with Implantable Electromedical Devices is Safe. Gastroenterology Research and Practice 2013, 1-5

  134. 134

    Barry London. Arrhythmias. In: Genomic and Personalized Medicine. Elsevier, 2013:587-601.

  135. 135

    Andreas Keyser, Michael K Hilker, Ekrem Ücer, Sigrid Wittmann, Christof Schmid, Claudius Diez. (2013) Significance of intraoperative testing in right-sided implantable cardioverter-defibrillators. Journal of Cardiothoracic Surgery 8:1, 77

  136. 136

    Nekane Murga. (2013) Seguimiento del paciente en la fase crónica de la enfermedad coronaria. Revista Española de Cardiología Suplementos 13, 35-41

  137. 137

    Attila Roka, Mark H. Schoenfeld. (2012) The pathway to physician reimbursement for cardiac implantable electronic devices (CIEDs): a history and brief synopsis. Journal of Interventional Cardiac Electrophysiology

  138. 138

    Moss , Arthur J. , Schuger , Claudio , Beck , Christopher A. , Brown , Mary W. , Cannom , David S. , Daubert , James P. , Estes , N.A. Mark III , Greenberg , Henry , Hall , W. Jackson , Huang , David T. , Kautzner , Josef , Klein , Helmut , McNitt , Scott , Olshansky , Brian , Shoda , Morio , Wilber , David , Zareba , Wojciech , . (2012) Reduction in Inappropriate Therapy and Mortality through ICD Programming. New England Journal of Medicine 367:24, 2275-2283
    Free Full Text

  139. 139

    William T. Abraham, Sakima A. Smith. (2012) Devices in the management of advanced, chronic heart failure. Nature Reviews Cardiology 10:2, 98-110

  140. 140

    K. D. Rizas, A. Bauer. (2012) Risk stratification after myocardial infarction: it is time for intervention. Europace 14:12, 1684-1686

  141. 141

    S. González-Enríquez, F. Rodríguez-Entem, V. Expósito, C. Castrillo-Bustamante, A. Canteli, A. Solloso, I. Madrazo, J. J. Olalla. (2012) Single-chamber ICD, single-zone therapy in primary and secondary prevention patients: the simpler the better?. Journal of Interventional Cardiac Electrophysiology 35:3, 343-349

  142. 142

    Mikhael F. El-Chami, Fadi J. Sawaya, Patrick Kilgo, William Stein, Michael Halkos, Vinod Thourani, Omar M. Lattouf, David B. Delurgio, Robert A. Guyton, John D. Puskas, Angel R. Leon. (2012) Ventricular Arrhythmia After Cardiac Surgery. Journal of the American College of Cardiology 60:25, 2664-2671

  143. 143

    FRITZ W. HORLBECK, FRITZ MELLERT, JENS KREUZ, GEORG NICKENIG, JOERG O. SCHWAB. (2012) Real-World Data on the Lifespan of Implantable Cardioverter-Defibrillators Depending on Manufacturers and the Amount of Ventricular Pacing. Journal of Cardiovascular Electrophysiology 23:12, 1336-1342

  144. 144

    ALFRED G. VALLES, FARHAN J. KHAWAJA, BERNARD J. GERSH, MAURICE ENRIQUEZ-SARANO, PAUL A. FRIEDMAN, SOON J. PARK, DAVID O. HODGE, YONG-MEI CHA. (2012) Implantable Cardioverter Defibrillators in Patients with Valvular Cardiomyopathy. Journal of Cardiovascular Electrophysiology 23:12, 1326-1332

  145. 145

    ANDREW BRENYO, GRZEGORZ PIETRASIK, ALON BARSHESHET, DAVID T. HUANG, BRONISLAVA POLONSKY, SCOTT McNITT, ARTHUR J. MOSS, WOJCIECH ZAREBA. (2012) QRS Fragmentation and the Risk of Sudden Cardiac Death in MADIT II. Journal of Cardiovascular Electrophysiology 23:12, 1343-1348

  146. 146

    JEFF S. HEALEY, LORNE J. GULA, DAVID H. BIRNIE, LAWRENCE STERNS, STUART J. CONNOLLY, JOHN SAPP, EUGENE CRYSTAL, CHRIS SIMPSON, DEREK V. EXNER, TERESA KUS, FRANCOIS PHILIPPON, GEORGE WELLS, ANTHONY SL. TANG. (2012) A Randomized-Controlled Pilot Study Comparing ICD Implantation with and Without Intraoperative Defibrillation Testing in Patients with Heart Failure and Severe Left Ventricular Dysfunction: A Substudy of the RAFT Trial. Journal of Cardiovascular Electrophysiology 23:12, 1313-1316

  147. 147

    Andrew H. Ha, Inje Ham, Girish M. Nair, Stuart J. Connolly, Paul Dorian, Carlos A. Morillo, Jeff S. Healey. (2012) Implantable cardioverter-defibrillator shock prevention does not reduce mortality: A systemic review. Heart Rhythm 9:12, 2068-2074

  148. 148

    Alessandro Proclemer, Daniele Muser, Andrea Campana, Massimo Zoni-Berisso, Massimo Zecchin, Alessandro Locatelli, Marco Brieda, Lorena Gramegna, Mauro Santarone, Leandro Chiodi, Patrizio Mazzone, Luca Rebellato, Domenico Facchin. (2012) Indication to cardioverter-defibrillator therapy and outcome in real world primary prevention. Data from the IRIDE [Italian registry of prophylactic implantation of defibrillators] study. International Journal of Cardiology

  149. 149

    Roger A. Winkle. (2012) Evolution of the Implantable Cardioverter-Defibrillator. Journal of the American College of Cardiology 60:23, 2399-2401

  150. 150

    Klaudia Židová, Miroslav Novák, Jolana Lipoldová. (2012) Contribution of remote monitoring to the early diagnosis of implantable cardioverter-defibrillator shocks in the patient with cardiac resynchronisation therapy. Cor et Vasa

  151. 151

    Wilbert S. Aronow. Ischaemic Heart Disease. In: Cardiovascular Disease and Health in the Older Patient. John Wiley & Sons, Ltd, 2012:152-171.

  152. 152

    Abhay Bajpai, A. John Camm. Arrhythmias. In: Cardiovascular Disease and Health in the Older Patient. John Wiley & Sons, Ltd, 2012:90-134.

  153. 153

    T. Vogtmann, S. Stiller, A. Marek, S. Kespohl, M. Gomer, V. Kuhlkamp, G. Zach, S. Loscher, G. Baumann. (2012) Workload and usefulness of daily, centralized home monitoring for patients treated with CIEDs: results of the MoniC (Model Project Monitor Centre) prospective multicentre study. Europace

  154. 154

    Irina Suman-Horduna, Sabine Ernst. Electrophysiology and Pacing. In: Cardiovascular Clinical Trials. Blackwell Publishing Ltd., 2012:174-204.

  155. 155

    Christopher M. O'Connor, Wendy Gattis Stough. Heart Failure. In: Cardiovascular Clinical Trials. Blackwell Publishing Ltd., 2012:117-142.

  156. 156

    George M. Zawadowski, Andre C. Lapeyre. (2012) 74-Year-Old Man With Palpitations. Mayo Clinic Proceedings 87:11, e87-e91

  157. 157

    Daniel D. Matlock, Lynne Warner Stevenson. (2012) Life-Saving Devices Reach the End of Life with Heart Failure. Progress in Cardiovascular Diseases 55:3, 274-281

  158. 158

    S. Chen, Y. Yin, M. W. Krucoff. (2012) Effect of cardiac resynchronization therapy and implantable cardioverter defibrillator on quality of life in patients with heart failure: a meta-analysis. Europace 14:11, 1602-1607

  159. 159

    Daniel B. Kramer, Susan L. Mitchell, Dan W. Brock. (2012) Deactivation of Pacemakers and Implantable Cardioverter-Defibrillators. Progress in Cardiovascular Diseases 55:3, 290-299

  160. 160

    Jana M. Hoffmeister, N. A. Mark Estes, Ann C. Garlitski. (2012) Prevention of sudden cardiac death in patients with chronic kidney disease: risk and benefits of the implantable cardioverter defibrillator. Journal of Interventional Cardiac Electrophysiology 35:2, 227-234

  161. 161

    Leslie A. Saxon, Bruce L. Wilkoff. (2012) CRT or CRT-D devices? The case for ‘high energy’ devices. Heart Failure Reviews 17:6, 777-779

  162. 162

    Arthur J. Moss. (2012) Selection of high-risk patients for device intervention with the new advances in technology. Journal of Electrocardiology 45:6, 670-672

  163. 163

    K. M. Holzem, I. R. Efimov. (2012) Arrhythmogenic remodelling of activation and repolarization in the failing human heart. Europace 14:suppl 5, v50-v57

  164. 164

    J. A. Kobashigawa. (2012) The Future of Heart Transplantation. American Journal of Transplantation 12:11, 2875-2891

  165. 165

    Jonathan P. Man, Andrew E. Epstein. (2012) Ventricular Arrhythmias. Clinics in Geriatric Medicine 28:4, 679-691

  166. 166

    Giuseppe Inama, Claudio Pedrinazzi, Maurizio Landolina, Fabrizio Oliva, Michele Senni, Alessandro Proclemer, Massimo Zoni Berisso, Salvatore Pirelli. (2012) Use of implantable cardioverter defibrillator and cardiac resynchronization therapy. Journal of Cardiovascular Medicine 13:11, 675-683

  167. 167

    MARTINO MARTINELLI, SÉRGIO F. DE SIQUEIRA, LEANDRO I. ZIMERMAN, VICENTE Á. NETO, ANTÔNIO V. MORAES, GUILHERME FENELON. (2012) Sudden Cardiac Death in Brazil: Study Based on Physicians’ Perceptions of the Public Health Care System. Pacing and Clinical Electrophysiology 35:11, 1326-1331

  168. 168

    J.-Y. Le Heuzey, E. Marijon, T. Lavergne, A. Otmani. (2012) Management of ventricular and atrial arrhythmias in humans: towards a patient-specific approach. Europace 14:suppl 5, v125-v128

  169. 169

    INGVILD M. MORKEN, KJETIL ISAKSEN, BJØRG KARLSEN, TONE M. NOREKVÅL, EDVIN BRU, ALF INGE LARSEN. (2012) Shock Anxiety among Implantable Cardioverter Defibrillator Recipients with Recent Tachyarrhythmia. Pacing and Clinical Electrophysiology 35:11, 1369-1376

  170. 170

    Durgesh Das, Lichy Han, Ronald D. Berger, Larisa G. Tereshchenko. (2012) QT variability paradox after premature ventricular contraction in patients with structural heart disease and ventricular arrhythmias. Journal of Electrocardiology 45:6, 652-657

  171. 171

    G. L. Botto, G. Russo. (2012) Effect of cardiac resynchronization therapy on quality of life: the best gets the least. Europace 14:11, 1537-1539

  172. 172

    Louise R.A. Olde Nordkamp, Lara Dabiri Abkenari, Lucas V.A. Boersma, Alexander H. Maass, Joris R. de Groot, Antonie J.H.H.M. van Oostrom, Dominic A.M.J. Theuns, Luc J.L.M. Jordaens, Arthur A.M. Wilde, Reinoud E. Knops. (2012) The Entirely Subcutaneous Implantable Cardioverter-Defibrillator. Journal of the American College of Cardiology 60:19, 1933-1939

  173. 173

    M. Levy. (2012) Cardiologie nucléaire. EMC - Cardiologie 7:4, 1-26

  174. 174

    Brett D. Atwater, David Dai, Nancy M. Allen-Lapointe, Sana M. Al-Khatib, Louise O. Zimmer, Gillian D. Sanders, Eric D. Peterson. (2012) Is heart failure guideline adherence being underestimated? The impact of therapeutic contraindications. American Heart Journal 164:5, 750-755.e1

  175. 175

    Fabrizio Sansone, Edoardo Zingarelli, Roberto Flocco, Guglielmo Mario Actis Dato, Francesco Parisi, Giuseppe Punta, Pier Giuseppe Forsennati, Gian Luca Bardi, Stefano del Ponte, Francesco Patanè, Riccardo Casabona. (2012) Pulsed or continuous flow in long-term assist devices: a debated topic. Transplantation Reviews 26:4, 241-245

  176. 176

    G. S. Mendenhall, F. Zahr, S. Bhattacharya, C. Toma, S. Saba. (2012) Effect of coronary occlusion on intracardiac electrogram morphology. Europace 14:10, 1524-1531

  177. 177

    Christopher P. Rowley, S. Suave Lobodzinski, Michael R. Gold. (2012) The Subcutaneous Defibrillator. Current Treatment Options in Cardiovascular Medicine 14:5, 550-557

  178. 178

    H. Immo Lehmann, Carmen Wolke, Wiebke Malenke, Friedrich-Wilhelm Röhl, Matthias Hammwöhner, Alicja Bukowska, Uwe Lendeckel, Andreas Goette. (2012) Enzymatic activity of DPIV and renin–angiotensin system (RAS) proteases in patients with left ventricular dysfunction and primary prevention implantable cardioverter/defibrillator (ICD). International Journal of Cardiology

  179. 179

    Mark I. Travin, Gayathri Kamalakkannan. (2012) A key role for nuclear cardiac imaging in evaluating and managing patients with heart failure. Journal of Nuclear Cardiology 19:5, 879-882

  180. 180

    A John Camm. (2012) Cardiac arrhythmias—trials and tribulations. The Lancet 380:9852, 1448-1451

  181. 181

    Roy M. John, William G. Stevenson. (2012) Ventricular Arrhythmias in Patients With Implanted Cardioverter Defibrillators. Trends in Cardiovascular Medicine 22:7, 169-173

  182. 182

    INDRAJIT CHOUDHURI, DIPAN DESAI, JON WALBURG, PHYLLIS AUGUST, SETH I KELLER, RANJIT SURI. (2012) Feasibility of Early Discharge After Implantable Cardioverter-Defibrillator Procedures. Journal of Cardiovascular Electrophysiology 23:10, 1123-1129

  183. 183

    A. Leenhardt, P. Defaye, E. Mouton, M. Delay, N. Delarche, J.-M. Dupuis, O. Bizeau, P. Mabo, S. Cheggour, D. Babuty, . (2012) First inappropriate implantable cardioverter defibrillator therapy is often due to inaccurate device programming: analysis of the French OPERA registry. Europace 14:10, 1465-1474

  184. 184

    Jason S. Bradfield, Eric Buch, Kalyanam Shivkumar. (2012) Interventions to decrease the morbidity and mortality associated with implantable cardioverter-defibrillator shocks. Current Opinion in Critical Care 18:5, 432-437

  185. 185

    Vadim Babokin, Vladimir Shipulin, Roman Batalov, Sergey Popov. (2012) Surgical ventricular reconstruction with endocardectomy along radiofrequency ablation-induced markings. The Journal of Thoracic and Cardiovascular Surgery

  186. 186

    DAVID S. HIRSH, LARRY A. CHINITZ, NEIL E. BERNSTEIN, DOUGLAS S. HOLMES, SATYA RAO, ANTHONY AIZER. (2012) Clinical Comparison of ICD Detection Algorithms that Include Rapid-VT Zones. Pacing and Clinical Electrophysiology 35:10, 1222-1231

  187. 187

    Taner Ulus, Gulmira Kudaiberdieva, Bulent Gorenek. (2012) The onset mechanisms of ventricular tachycardia. International Journal of Cardiology

  188. 188

    Roy M John, Usha B Tedrow, Bruce A Koplan, Christine M Albert, Laurence M Epstein, Michael O Sweeney, Amy Leigh Miller, Gregory F Michaud, William G Stevenson. (2012) Ventricular arrhythmias and sudden cardiac death. The Lancet 380:9852, 1520-1529

  189. 189

    Begoña Benito, Mark E. Josephson. (2012) Ventricular Tachycardia in Coronary Artery Disease. Revista Española de Cardiología (English Edition) 65:10, 939-955

  190. 190

    Begoña Benito, Mark E. Josephson. (2012) Taquicardia ventricular en la enfermedad coronaria. Revista Española de Cardiología 65:10, 939-955

  191. 191

    Olena Dotsenko, Alon Barsheshet, David T Huang. (2012) Cardiac resynchronization therapy for prevention of heart failure events in elderly patients with left ventricular dysfunction. Expert Review of Cardiovascular Therapy 10:10, 1319-1327

  192. 192

    Joep Thijssen, Johannes B van Rees, Martin J Schalij, C Jan Willem Borleffs. (2012) Primary prevention implantable cardioverter–defibrillator treatment: how to identify patients most likely to benefit?. Expert Review of Cardiovascular Therapy 10:10, 1197-1199

  193. 193

    Stefan H. Hohnloser, Richard J. Cohen. (2012) Microvolt T-wave alternans testing provides a reliable means of guiding anti-arrhythmic therapy. American Heart Journal 164:4, e7

  194. 194

    Andreas A. Werdich, Anna Brzezinski, Darwin Jeyaraj, M. Khaled Sabeh, Eckhard Ficker, Xiaoping Wan, Brian M. McDermott, Calum A. MacRae, David S. Rosenbaum. (2012) The zebrafish as a novel animal model to study the molecular mechanisms of mechano-electrical feedback in the heart. Progress in Biophysics and Molecular Biology 110:2-3, 154-165

  195. 195

    D. Mylotte, R. G. Sheahan, P. N. G. Nolan, M. A. Neylon, B. McArdle, O. Constant, A. Diffley, D. Keane, P. J. Nash, J. Crowley, K. Daly. (2012) The implantable defibrillator and return to operation of vehicles study. Europace

  196. 196

    J. Gonzalez-Zuelgaray, O. Pellizon, C. A. Muratore, E. S. Oropeza, R. Rabinovich, J. L. Ramos, M. C. Tentori, N. Reyes, R. Aguayo, J. Marin, B. J. Peterson. (2012) Lack of current implantable cardioverter defibrillator guidelines application for primary prevention of sudden cardiac death in Latin American patients with heart failure: a cross-sectional study. Europace

  197. 197

    Seth R. Bender, Daniel J. Friedman, Steven M. Markowitz, Bruce B. Lerman, Peter M. Okin. (2012) Electrocardiographic left ventricular hypertrophy predicts arrhythmia and mortality in patients with ischemic cardiomyopathy. Journal of Interventional Cardiac Electrophysiology 34:3, 237-245

  198. 198

    Helen Høgh Petersen, Mie Christa Jensen Larsen, Olav Wendelboe Nielsen, Finn Kensing, Jesper Hastrup Svendsen. (2012) Patient satisfaction and suggestions for improvement of remote ICD monitoring. Journal of Interventional Cardiac Electrophysiology 34:3, 317-324

  199. 199

    Jens Kreuz, Fritz Horlbeck, Jan Schrickel, Markus Linhart, Rolf Fimmers, Fritz Mellert, Georg Nickenig, Jörg Otto Schwab. (2012) Kidney Dysfunction and Deterioration of Ejection Fraction Pose Independent Risk Factors for Mortality in Implantable Cardioverter-Defibrillator Recipients for Primary Prevention. Clinical Cardiology 35:9, 575-579

  200. 200

    Richard Sheppard, Paul J. Mather, Jeffrey D. Alexis, Randall C. Starling, John P. Boehmer, Vinay Thohan, Daniel F. Pauly, David W. Markham, Mark Zucker, Kevin E. Kip, Dennis M. McNamara. (2012) Implantable Cardiac Defibrillators and Sudden Death in Recent Onset Nonischemic Cardiomyopathy: Results From IMAC2. Journal of Cardiac Failure 18:9, 675-681

  201. 201

    Alfred E. Buxton. (2012) Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Death. Journal of the American College of Cardiology

  202. 202

    Javier Alzueta, José María Fernández. (2012) Registro Español de Desfibrilador Automático Implantable. VIII Informe Oficial del Grupo de Trabajo de Desfibrilador Automático Implantable de la Sociedad Española de Cardiología (2011). Revista Española de Cardiología

  203. 203

    Raul R. Blanco, Harland Austin, Richard N. Vest, Ravinder Valadri, Wei Li, Bernard Lassegue, Qing Song, Barry London, Samuel C. Dudley, Heather L. Bloom, Charles D. Searles, A. Maziar Zafari. (2012) Angiotensin Receptor Type 1 Single Nucleotide Polymorphism 1166A/C is Associated With Malignant Arrhythmias and Altered Circulating miR-155 Levels in Patients With Chronic Heart Failure. Journal of Cardiac Failure 18:9, 717-723

  204. 204

    Riccardo Cappato, Warren M. Smith, Margaret A. Hood, Ian G. Crozier, Luc Jordaens, Stefan G. Spitzer, Andrey V. Ardashev, Lucas Boersma, Pierpaolo Lupo, Andrew A. Grace, Gust H. Bardy. (2012) Subcutaneous chronic implantable defibrillation systems in humans. Journal of Interventional Cardiac Electrophysiology 34:3, 325-332

  205. 205

    Bun Yashiro, Morio Shoda, Yasuko Tomizawa, Tetsuyuki Manaka, Nobuhisa Hagiwara. (2012) Long-term results of a cardiovascular implantable electronic device wrapped with an expanded polytetrafluoroethylene sheet. Journal of Artificial Organs 15:3, 244-249

  206. 206

    Hongwei Zhao, Chen Zuo, Shuai Chen, Heejung Bang. (2012) Nonparametric Inference for Median Costs with Censored Data. Biometrics 68:3, 717-725

  207. 207

    H. Acosta, L. M. Viafara, D. Izquierdo, V. R. Pothula, J. Bear, S. Pothula, C. Antonio-Drabeck, K. Lee. (2012) Atrial lead placement at the lower atrial septum: a potential strategy to reduce unnecessary right ventricular pacing. Europace 14:9, 1311-1316

  208. 208

    Kenneth C. Bilchick, George J. Stukenborg, Sandeep Kamath, Alan Cheng. (2012) Prediction of Mortality in Clinical Practice for Medicare Patients Undergoing Defibrillator Implantation for Primary Prevention of Sudden Cardiac Death. Journal of the American College of Cardiology

  209. 209

    Javier Alzueta, José María Fernández. (2012) Spanish Implantable Cardioverter-Defibrillator Registry. Eighth Official Report of the Spanish Society of Cardiology Working Group on Implantable Cardioverter-Defibrillators (2011). Revista Española de Cardiología (English Edition)

  210. 210

    RICCARDO CAPPATO, SERENELLA CASTELVECCHIO, PAUL ERLINGER, RICK SANGHERA, DONALD SCHECK, ALAN OSTROFF, WILLIAM RISSMANN, CHARLES GROPPER, GUST H. BARDY. (2012) Feasibility of Defibrillation and Automatic Arrhythmia Detection Using an Exclusively Subcutaneous Defibrillator System in Canines. Journal of Cardiovascular Electrophysiologyno-no

  211. 211

    ROLAND X. STROOBANDT, FREDERIC E. Van HEUVERSWYN, ANDREAS KUCHER, S. S. BAROLD. (2012) Rise in ICD Shock Impedance: Lead Fracture or Death?. Pacing and Clinical Electrophysiology 35:9, 1103-1110

  212. 212

    PETER C. NETZLER, NAGAVARDHAN VASUKI, JENNIFER L. PEURA, MICHAEL R. GOLD. (2012) Interactions between a Left Ventricular Assist Device and Implantable Cardioverter-Defibrillator. Pacing and Clinical Electrophysiology 35:9, e272-e273

  213. 213

    FILIPPO STAZI, MASSIMO MAMPIERI, MARIO CARDINALE, M. TERESA LAUDADIO, ALESSIO GARGARO, GIOVANNI BATTISTA DEL GIUDICE. (2012) Implant and Long-Term Evaluation of Atrial Signal Amplification in a Single-Lead ICD. Pacing and Clinical Electrophysiology 35:9, 1119-1125

  214. 214

    Shannon M. Dunlay, Véronique L. Roger. (2012) Gender Differences in the Pathophysiology, Clinical Presentation, and Outcomes of Ischemic Heart Failure. Current Heart Failure Reports

  215. 215

    Peter O'Callaghan. (2012) Transient loss of consciousness. Medicine 40:8, 427-430

  216. 216

    D. P. Morin, M. N. Saad, O. F. Shams, J. S. Owen, J. Q. Xue, F. M. Abi-Samra, S. Khatib, O. S. Nelson-Twakor, R. V. Milani. (2012) Relationships between the T-peak to T-end interval, ventricular tachyarrhythmia, and death in left ventricular systolic dysfunction. Europace 14:8, 1172-1179

  217. 217

    Cecilia Linde, Kenneth Ellenbogen, Finlay A. McAlister. (2012) Cardiac resynchronization therapy (CRT): Clinical trials, guidelines, and target populations. Heart Rhythm 9:8, S3-S13

  218. 218

    Yasuhiro Yoshiga, Shibu Mathew, Erik Wissner, Roland Tilz, Alexander Fuernkranz, Andreas Metzner, Andreas Rillig, Melanie Konstantinidou, Miyako Igarashi, Karl-Heinz Kuck, Feifan Ouyang. (2012) Correlation between substrate location and ablation strategy in patients with ventricular tachycardia late after myocardial infarction. Heart Rhythm 9:8, 1192-1199

  219. 219

    Kimberly A. Parks, Maria Rosa Costanzo. (2012) Thinking beyond resynchronization therapy in the failing heart. Heart Rhythm 9:8, S36-S44

  220. 220

    ROBERT LEWIS, JAMES P. DAUBERT. (2012) Do ICD Lead Recalls Affect Physician-or Patient-Behavior? If Not, Why Not?. Journal of Cardiovascular Electrophysiology 23:8, 866-868

  221. 221

    WEI HUA, HONGXIA NIU, XIAOHAN FAN, LIGANG DING, YI-ZHOU XU, JING WANG, KEPING CHEN, FANGZHENG WANG, SHU ZHANG. (2012) Preventive Effectiveness of Implantable Cardioverter Defibrillator in Reducing Sudden Cardiac Death in Chinese Population: A Multicenter Trial of ICD Therapy versus Non-ICD Therapy. Journal of Cardiovascular Electrophysiologyno-no

  222. 222

    STEPHEN L. WINTERS, JAY H. CURWIN. (2012) Electrophysiology Testing and the National Cardiovascular Data Registry: Stimulating, yet Inconclusive. Pacing and Clinical Electrophysiology 35:8, 909-911

  223. 223

    Jason Chua, Komal Patel, Jacques Neelankavil, Aman Mahajan. (2012) Anesthetic management of electrophysiology procedures. Current Opinion in Anaesthesiology 25:4, 470-481

  224. 224

    Frank Ruschitzka. (2012) The challenge of nonresponders to cardiac resynchronization therapy: Lessons learned from oncology. Heart Rhythm 9:8, S14-S17

  225. 225

    Faisal M. Merchant, Takanori Ikeda, Roberto F.E. Pedretti, Jorge A. Salerno-Uriarte, Theodore Chow, Paul S. Chan, Cheryl Bartone, Stefan H. Hohnloser, Richard J. Cohen, Antonis A. Armoundas. (2012) Clinical utility of microvolt T-wave alternans testing in identifying patients at high or low risk of sudden cardiac death. Heart Rhythm 9:8, 1256-1264.e2

  226. 226

    M.-P. Douchet, B. Bakouboula, F. Bronner, M. Chauvin. (2012) Fibrillateur automatique implantable. Annales de Cardiologie et d'Angéiologie 61:4, 290-291

  227. 227

    PARAS BHATT, JEPTHA CURTIS, YONGFEI WANG, RACHEL LAMPERT. (2012) Impact of a Recent Lead Recall on Utilization of Implantable Cardioverter Defibrillators: Data from the NCDR ICD Registry™. Journal of Cardiovascular Electrophysiology 23:8, 861-865

  228. 228

    Jeff S. Healey, Stefan H. Hohnloser, Michael Glikson, Joerg Neuzner, Xavier Viñolas, Philippe Mabo, Josef Kautzner, Gilles O'Hara, Liselot Van Erven, Frederick Gadler, Ursula Appl, Stuart J. Connolly. (2012) The rationale and design of the Shockless IMPLant Evaluation (SIMPLE) trial: A randomized, controlled trial of defibrillation testing at the time of defibrillator implantation. American Heart Journal 164:2, 146-152

  229. 229

    D. Chong, B. Y. Tan, K. L. Ho, R. Liew, W. S. Teo, C. K. Ching. (2012) Clinical markers of organ dysfunction associated with increased 1-year mortality post-implantable cardioverter defibrillator implantation. Europace

  230. 230

    Eduardo Marbán, Eugenio Cingolani. (2012) Heart to heart: Cardiospheres for myocardial regeneration. Heart Rhythm

  231. 231

    Huong Q. Nguyen, Bonnie G. Steele, Cynthia M. Dougherty, Robert L. Burr. (2012) Physical Activity Patterns of Patients With Cardiopulmonary Illnesses. Archives of Physical Medicine and Rehabilitation

  232. 232

    Igor Klem, Jonathan W. Weinsaft, Tristram D. Bahnson, Don Hegland, Han W. Kim, Brenda Hayes, Michele A. Parker, Robert M. Judd, Raymond J. Kim. (2012) Assessment of Myocardial Scarring Improves Risk Stratification in Patients Evaluated for Cardiac Defibrillator Implantation. Journal of the American College of Cardiology 60:5, 408-420

  233. 233

    Ke Cheng, Agnieszka Blusztajn, Deliang Shen, Tao-Sheng Li, Baiming Sun, Giselle Galang, Thomas I. Zarembinski, Glenn D. Prestwich, Eduardo Marbán, Rachel R. Smith, Linda Marbán. (2012) Functional performance of human cardiosphere-derived cells delivered in an in situ polymerizable hyaluronan-gelatin hydrogel. Biomaterials 33:21, 5317-5324

  234. 234

    L. Dabiri Abkenari, L. Jordaens. (2012) So you implanted an implantable cardioverter defibrillator, now what to do with it?. Europace 14:7, 921-922

  235. 235

    Sandra L. Carroll, Maureen Markle-Reid, Donna Ciliska, Stuart J. Connolly, Heather M. Arthur. (2012) Age and Mental Health Predict Early Device-Specific Quality of Life in Patients Receiving Prophylactic Implantable Defibrillators. Canadian Journal of Cardiology 28:4, 502-507

  236. 236

    Yosuke Miwa, Hideaki Yoshino, Kyoko Hoshida, Mutsumi Miyakoshi, Takehiro Tsukada, Satoru Yusu, Takanori Ikeda. (2012) Risk Stratification for Serious Arrhythmic Events Using Nonsustained Ventricular Tachycardia and Heart Rate Turbulence Detected by 24-Hour Holter Electrocardiograms in Patients with Left Ventricular Dysfunction. Annals of Noninvasive Electrocardiology 17:3, 260-267

  237. 237

    Claudio Schuger, James P. Daubert, Mary W. Brown, David Cannom, N.A. Mark Estes, W. Jackson Hall, Torsten Kayser, Helmut Klein, Brian Olshansky, Keith A. Power, David Wilber, Wojciech Zareba, Arthur J. Moss. (2012) Multicenter Automatic Defibrillator Implantation Trial: Reduce Inappropriate Therapy (MADIT-RIT): Background, Rationale, and Clinical Protocol. Annals of Noninvasive Electrocardiology 17:3, 176-185

  238. 238

    Johan Denollet, Fetene B. Tekle, Susanne S. Pedersen, Pepijn H. van der Voort, Marco Alings, Krista C. van den Broek. (2012) Prognostic importance of distressed (Type D) personality and shocks in patients with an implantable cardioverter defibrillator. International Journal of Cardiology

  239. 239

    S. M. Frey, C. Sticherling, U. Bucher, R. Widmer, P. Ammann, M. Kuhne, S. Osswald, B. Schaer. (2012) Long-term performance of the Medtronic Sprint Fidelis lead: a matter of lead type?. Europace

  240. 240

    A. Foucault, M. Amelot, S. Gomes, L. Champ-Rigot, E. Saloux, A. Pellissier, F. Labombarda, P. Scanu, P. Milliez. (2012) Primary prevention with a defibrillator: are therapies always really optimized before implantation?. Europace

  241. 241

    Marlon A. G. M. Olimulder, Karin Kraaier, Michel A. Galjee, Marcoen F. Scholten, Jan Es, Lodewijk J. Wagenaar, Job Palen, Clemens Birgelen. (2012) Infarct tissue characterization in implantable cardioverter-defibrillator recipients for primary versus secondary prevention following myocardial infarction: a study with contrast-enhancement cardiovascular magnetic resonance imaging. The International Journal of Cardiovascular Imaging

  242. 242

    Susan J. Corcoran, Lloyd M. Davis. (2012) Cardiac Implantable Electronic Device Therapy for Bradyarrhythmias and Tachyarrhythmias. Heart, Lung and Circulation 21:6-7, 328-337

  243. 243

    R. Bastiaenen, V. Batchvarov, M. M. Gallagher. (2012) Ventricular automaticity as a predictor of sudden death in ischaemic heart disease. Europace 14:6, 795-803

  244. 244

    Larisa G. Tereshchenko, Ronald D. Berger. (2012) A Patient Presents with Longstanding, Severe LV Dysfunction. Is There a Role for Additional Risk Stratification Before ICD?. Cardiac Electrophysiology Clinics 4:2, 151-160

  245. 245

    Marshall W. Winner, John D. Hummel. (2012) Preventing Implantable Cardioverter Defibrillator Shocks Improves Survival. Cardiac Electrophysiology Clinics 4:2, 181-187

  246. 246

    Christine M. Tompkins, Wojciech Zareba. (2012) Should a Patient with Severe Left Ventricular Dysfunction, Congestive Heart Failure, and Right Bundle Branch Block QRS Receive Cardiac Resynchronization Therapy?. Cardiac Electrophysiology Clinics 4:2, 161-168

  247. 247

    Steven M. Markowitz. (2012) Guidelines for implantation of primary prevention defibrillators: Who is listening?. Heart Rhythm 9:6, 882-883

  248. 248

    Jorge M. Castellanos, Lisa M. Smith, Paul D. Varosy, Christine Dehlendorf, Gregory M. Marcus. (2012) Referring physicians' discordance with the primary prevention implantable cardioverter-defibrillator guidelines: A national survey. Heart Rhythm 9:6, 874-881

  249. 249

    Alon Barsheshet, Arthur J. Moss, David T. Huang, Scott McNitt, Wojciech Zareba, Ilan Goldenberg. (2012) Applicability of a Risk Score for Prediction of the Long-Term (8-Year) Benefit of the Implantable Cardioverter-Defibrillator. Journal of the American College of Cardiology 59:23, 2075-2079

  250. 250

    Suraj Kapa, Mathew D. Hutchinson. (2012) The Role of Preventive Ablation of Ventricular Tachycardia in the Patient with Coronary Artery Disease, Reduced Left Ventricular Function, and a New Implantable Cardioverter Defibrillator Implant. Cardiac Electrophysiology Clinics 4:2, 189-198

  251. 251

    A. Kolodzinska, A. Kutarski, M. Grabowski, I. Jarzyna, B. Malecka, G. Opolski. (2012) Abrasions of the outer silicone insulation of endocardial leads in their intracardiac part: a new mechanism of lead-dependent endocarditis. Europace 14:6, 903-910

  252. 252

    J. A. Lopez. (2012) Implantable cardioverter defibrillator lead placement in the middle cardiac vein after tricuspid valve surgery. Europace 14:6, 853-858

  253. 253

    D. G. Katritsis, M. E. Josephson. (2012) Sudden cardiac death and implantable cardioverter defibrillators: two modern epidemics?. Europace 14:6, 787-794

  254. 254

    Steve W. Leung, Claude-Samy Elayi, Richard J. Charnigo, Mushabbar A. Syed. (2012) Clinical significance of right ventricular dysfunction in left ventricular non-compaction cardiomyopathy. The International Journal of Cardiovascular Imaging 28:5, 1123-1131

  255. 255

    Jacob C. Jentzer, John H. Jentzer. (2012) Cardiac Resynchronization Therapy With and Without Defibrillator in a Commercial Truck Driver with Ischemic Cardiomyopathy and New York Heart Association Class III Heart Failure. Cardiac Electrophysiology Clinics 4:2, 169-180

  256. 256

    Timothy C. Tan, Andrew P. Sindone, A. Robert Denniss. (2012) Cardiac Electronic Implantable Devices in the Treatment of Heart Failure. Heart, Lung and Circulation 21:6-7, 338-351

  257. 257

    N. Klein, M. Klein, H. Weglage, O. Przibille, S. Fischer, H.-J. Trappe, F. Birkenhauer, D. Pfeiffer, . (2012) Clinical efficacy of left ventricular pacing vector programmability in cardiac resynchronization therapy defibrillator patients for management of phrenic nerve stimulation and/or elevated left ventricular pacing thresholds: insights from the Efface Phrenic Stim study. Europace 14:6, 826-832

  258. 258

    Lian-Yu Lin, Jien-Jiun Chen, Chang-Hsing Lee, Juey-Jen Hwang, Chiau-Suong Liau, Pau-Chung Chen, Jiunn-Lee Lin. (2012) Incidence and predictors of sudden death in patients having myocardial infarction — A population-based investigation in Taiwanese. International Journal of Cardiology 157:3, 439-440

  259. 259

    J. Kreuz, F. Horlbeck, M. Linhart, F. Mellert, R. Fimmers, J. Schrickel, G. Nickenig, J. O. Schwab. (2012) Independent predictors of mortality in patients with advanced heart failure treated by cardiac resynchronization therapy. Europace

  260. 260

    Miguel E. Lemmert, Jacqueline J.M. de Vreede-Swagemakers, Luc W.M. Eurlings, Luc Kalb, Harry J.G.M. Crijns, Hein J.J. Wellens, Anton P.M. Gorgels. (2012) Electrocardiographic Predictors of Out-of-Hospital Sudden Cardiac Arrest in Patients With Coronary Artery Disease. The American Journal of Cardiology 109:9, 1278-1282

  261. 261

    Eike Nagel, Andreas Schuster. (2012) Myocardial Viability. JACC: Cardiovascular Imaging 5:5, 509-512

  262. 262

    D. Wilson, B. Shi, S. Harding, N. Lever, P. Larsen. (2012) Implantable cardioverter-defibrillators: a long-term view. Internal Medicine Journal 42:5, 554-561

  263. 263

    Pier Paolo Lupo, Gabriele Pelissero, Hussam Ali, Rick Sanghera, Riccardo Cappato. (2012) Development of an Entirely Subcutaneous Implantable Cardioverter-Defibrillator. Progress in Cardiovascular Diseases 54:6, 493-497

  264. 264

    Jennifer L. Dorosz, Dennis C. Lezotte, David A. Weitzenkamp, Larry A. Allen, Ernesto E. Salcedo. (2012) Performance of 3-Dimensional Echocardiography in Measuring Left Ventricular Volumes and Ejection Fraction. Journal of the American College of Cardiology 59:20, 1799-1808

  265. 265

    Takashi Kurita, Takashi Noda, Takashi Nitta, Hiroshi Furushima, Akihiko Shimizu, Tohru Ohe, Yoshifusa Aizawa, Yasutaka Chiba. (2012) Nippon Storm Study design. Journal of Arrhythmia

  266. 266

    R. P. Ricci, A. D'Onofrio, L. Padeletti, A. Sagone, A. Vicentini, A. Vincenti, L. Morichelli, C. Cavallaro, G. Ricciardi, L. Lombardi, A. Fusco, G. Rovaris, P. Silvestri, T. Guidotto, A. Pollastrelli, M. Santini. (2012) Rationale and design of the health economics evaluation registry for remote follow-up: TARIFF. Europace

  267. 267

    Abhay Bajpai, A. John Camm. Arrhythmias. In: Pathy's Principles and Practice of Geriatric Medicine. John Wiley & Sons, Ltd, 2012:413-436.

  268. 268

    Wilbert S. Aronow. Ischaemic Heart Disease. In: Pathy's Principles and Practice of Geriatric Medicine. John Wiley & Sons, Ltd, 2012:437-447.

  269. 269

    Takashi Noda, Wataru Shimizu. (2012) Unresolved matters related to implantable cardioverter defibrillators: How can we avoid shock therapy?. Journal of Arrhythmia 28:2, 91-95

  270. 270

    Joep Thijssen, Johannes B. van Rees, Jeroen Venlet, C. Jan Willem Borleffs, Ulas Höke, Hein Putter, Enno T. van der Velde, Lieselot van Erven, Martin J. Schalij. (2012) The mode of death in implantable cardioverter-defibrillator and cardiac resynchronization therapy with defibrillator patients: Results from routine clinical practice. Heart Rhythm

  271. 271

    Jeffrey L. Williams. (2012) Modes of death in defibrillator patients: Learning from clinical experience. Heart Rhythm

  272. 272

    S. C. Wijers, M. A. Vos, M. Meine. (2012) Microvolt T-wave alternans in an unselected heart failure population: pros and cons. European Journal of Heart Failure 14:4, 344-347

  273. 273

    Ji-Hee Youn, Joanne Lord, Karla Hemming, Alan Girling, Martin Buxton. (2012) BAYESIAN META-ANALYSIS ON MEDICAL DEVICES: APPLICATION TO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS. International Journal of Technology Assessment in Health Care 28:02, 115-124

  274. 274

    Alan J. Bank, Ryan M. Gage, Kevin V. Burns. (2012) Right Ventricular Pacing, Mechanical Dyssynchrony, and Heart Failure. Journal of Cardiovascular Translational Research 5:2, 219-231

  275. 275

    Konstantinos A. Gatzoulis, Dimitris Tsiachris, Polichronis Dilaveris, Stefanos Archontakis, Petros Arsenos, Apostolis Vouliotis, Skevos Sideris, George Trantalis, Efstathios Kartsagoulis, Ioannis Kallikazaros, Christodoulos Stefanadis. (2012) Implantable cardioverter defibrillator therapy activation for high risk patients with relatively well preserved left ventricular ejection fraction. Does it really work?. International Journal of Cardiology

  276. 276

    Joep Thijssen, C. Jan Willem Borleffs, Johannes B. van Rees, SumChe Man, Mihály K. de Bie, Jeroen Venlet, Enno T. van der Velde, Lieselot van Erven, Martin J. Schalij. (2012) Implantable cardioverter-defibrillator longevity under clinical circumstances: An analysis according to device type, generation, and manufacturer. Heart Rhythm 9:4, 513-519

  277. 277

    Mihály K. de Bie, Johannes B. van Rees, J. Thijssen, C. Jan Willem Borleffs, Serge A. Trines, Suzanne C. Cannegieter, Martin J. Schalij, Lieselot van Erven. (2012) Cardiac device infections are associated with a significant mortality risk. Heart Rhythm 9:4, 494-498

  278. 278

    Akihiko Shimizu, Takashi Nitta, Takashi Kurita, Katsuhiko Imai, Yoshinori Kobayashi, Kyouko Soejima, Shinnichi Niwano, Shigeyuki Watanabe, Harushiko Abe, Yoshifusa Aizawa, Ken Okumura. (2012) Actual conditions of implantable defibrillation therapy over 5 years in Japan. Journal of Arrhythmia

  279. 279

    Nawaf S. Al-Majed, Justin A. Ezekowitz. (2012) The Timing of Implantable Cardioverter-Defibrillator Implantation in Patients with Heart Failure. Current Cardiology Reports

  280. 280

    PRAVEEN P. SADARMIN, KELVIN C. K. WONG, KIM RAJAPPAN, YAVER BASHIR, TIMOTHY R. BETTS. (2012) Questionnaire Survey of Cardiologists’ Knowledge, Attitudes, and Guideline Application of Implantable Cardioverter Defibrillator Therapy. Pacing and Clinical Electrophysiologyno-no

  281. 281

    Abdul Wase, Naga Garikipati, Omar Mufti, Zulfiqar Mirza, Aparna Innaparthy, Anwarul Kabir, Mohammed B. Quraishi, Ronald Markert. (2012) Effect of spironolactone on ventricular arrhythmias in patients with left ventricular systolic dysfunction and implantable cardioverter defibrillators. Indian Heart Journal 64:2, 123-127

  282. 282

    N. Clementy, B. Pierre, B. Lallemand, O. Marie, E. Lemoine, P. Cosnay, L. Fauchier, D. Babuty. (2012) Long-term follow-up on high-rate cut-off programming for implantable cardioverter defibrillators in primary prevention patients with left ventricular systolic dysfunction. Europace

  283. 283

    Pastora Gallego, Ana Elvira Gonzalez, Angel Sanchez-Recalde, Rafael Peinado, Luz Polo, Carmen Gomez-Rubin, Jose Luis Lopez-Sendon, Jose Maria Oliver. (2012) Incidence and Predictors of Sudden Cardiac Arrest in Adults With Congenital Heart Defects Repaired Before Adult Life. The American Journal of Cardiology

  284. 284

    Michael O. Sweeney, Scott Sakaguchi, Grant Simons, Christian Machado, John E. Connett, Fang Yang. (2012) Response to the Center for Medicare & Medicaid Services coverage with evidence development request for primary prevention implantable cardioverter-defibrillators: Data from the OMNI study. Heart Rhythm

  285. 285

    Anurag Gupta, Donald D. Hoang, Leah Karliner, Jeffrey A. Tice, Paul Heidenreich, Paul J. Wang, Mintu P. Turakhia. (2012) Ability of microvolt T-wave alternans to modify risk assessment of ventricular tachyarrhythmic events: A meta-analysis. American Heart Journal 163:3, 354-364

  286. 286

    Michelle M. O’Shaughnessy, David W. Lappin, Donal N. Reddan. (2012) Sudden Cardiac Death in Dialysis: Do Current Guidelines for Implantable Cardioverter Defibrillator Therapy Apply to Patients with End-stage Kidney Disease?. Seminars in Dialysisno-no

  287. 287

    John G. F. Cleland, Valentina Carubelli, Teresa Castiello, Ashraf Yassin, Pierpaolo Pellicori, Renjith Antony. (2012) Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis. Heart Failure Reviews 17:2, 133-149

  288. 288

    I. Andršová, T. Novotný, I. Valášková, J. Kadlecová, D. Kuderová, M. Sepši, M. Kozák, M. Křivan, R. Gaillyová, J. Špinar. (2012) Mutation analysis of RyR2 gene in patients after arrhythmic storm. Cor et Vasa 54:2, e84-e87

  289. 289

    Michael S. Lloyd. (2012) B groups and gray areas for implantable cardioverter-defibrillators: Insights from the OMNI Registry. Heart Rhythm

  290. 290

    Alon Barsheshet, Andrew Brenyo, Ilan Goldenberg, Arthur J. Moss. (2012) Sex-related differences in patients' responses to heart failure therapy. Nature Reviews Cardiology 9:4, 234-242

  291. 291

    M. Bracht, L. Skoljarev, M.W. Prull, H.-J. Trappe. (2012) Einfluss myokardialer Narben auf die Häufigkeit ventrikulärer Rhythmusstörungen bei ICD-Trägern. Der Kardiologe

  292. 292

    Eric J. Velazquez, Judson B. Williams, Eric Yow, Linda K. Shaw, Kerry L. Lee, Harry R. Phillips, Christopher M. O'Connor, Peter K. Smith, Robert H. Jones. (2012) Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy. The Annals of Thoracic Surgery 93:2, 523-530

  293. 293

    F. Blaschke, T. Knaus, O. Celebi, A. Krebs, A. Nitardy, D. Habedank, R. Dietz, M. Stockburger. (2012) Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators. Europace 14:2, 224-229

  294. 294

    Kenneth C. Bilchick. (2012) Integration of CMR Scar Imaging and Electroanatomic Mapping. JACC: Cardiovascular Imaging 5:2, 211-213

  295. 295

    Arnold J. Greenspon, Jordan M. Prutkin, Muhammad R. Sohail, Holenarasipur R. Vikram, Larry M. Baddour, Stephan B. Danik, James Peacock, Carlos Falces, Jose M. Miro, Elisabeth Blank, Christoph Naber, Roger G. Carrillo, Chi-Hong Tseng, Daniel Z. Uslan. (2012) Timing of the Most Recent Device Procedure Influences the Clinical Outcome of Lead-Associated Endocarditis. Journal of the American College of Cardiology 59:7, 681-687

  296. 296

    Christian W. Hamm, Jean-Pierre Bassand, Stefan Agewall, Jeroen Bax, Eric Boersma, Hector Bueno, Pio Caso, Dariusz Dudek, Stephan Gielen, Kurt Huber, Magnus Ohman, Mark C. Petrie, Frank Sonntag, Miguel Sousa Uva, Robert F. Storey, William Wijns, Doron Zahger. (2012) Guía de práctica clínica de la ESC para el manejo del síndrome coronario agudo en pacientes sin elevación persistente del segmento ST. Revista Española de Cardiología 65:2, 173.e1-173.e55

  297. 297

    SUSANNE S. PEDERSEN, PIER LAMBIASE, LUCAS V.A. BOERSMA, FRANCIS MURGATROYD, JENS BROCK JOHANSEN, HELEN REEVE, A. GRAHAM STUART, PEDRO ADRAGAO, DOMINIC A.M.J. THEUNS. (2012) Evaluation oF FactORs ImpacTing CLinical Outcome and Cost EffectiveneSS of the S-ICD: Design and Rationale of the EFFORTLESS S-ICD Registry. Pacing and Clinical Electrophysiologyno-no

  298. 298

    Raymond Cutro, Michael W. Rich, Paul J. Hauptman. (2012) Device therapy in patients with heart failure and advanced age: Too much too late?. International Journal of Cardiology 155:1, 52-55

  299. 299

    L. M. Biasucci, F. Bellocci, M. Landolina, R. Rordorf, A. Vado, E. Menardi, G. Giubilato, S. Orazi, M. Sassara, A. Castro, R. Massa, A. Kheir, G. Zaccone, C. Klersy, F. Accardi, F. Crea. (2012) Risk stratification of ischaemic patients with implantable cardioverter defibrillators by C-reactive protein and a multi-markers strategy: results of the CAMI-GUIDE study. European Heart Journal

  300. 300

    Nabel , Elizabeth G. , Braunwald , Eugene , . (2012) A Tale of Coronary Artery Disease and Myocardial Infarction. New England Journal of Medicine 366:1, 54-63
    Free Full Text

  301. 301

    Avi Fischer, Kevin T. Ousdigian, James W. Johnson, Jeffrey M. Gillberg, Bruce L. Wilkoff. (2012) The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients. Heart Rhythm 9:1, 24-31

  302. 302

    Sanjeev Saksena, Rangadham Nagarakanti, Nandini Madan, Mark Preminger. Implantable Cardioverter-Defibrillators. In: Electrophysiological Disorders of the Heart. Elsevier, 2012:1203-1218.

  303. 303

    Robert J. Myerburg, Agustin Castellanos. Cardiac Arrest and Sudden Cardiac Death. In: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Elsevier, 2012:845-884.

  304. 304

    Matthew Wright, Frederic Sacher, Michel Haïssaguerre. Electrophysiological Evaluation of Ventricular Fibrillation. In: Electrophysiological Disorders of the Heart. Elsevier, 2012:327-332.

  305. 305

    William T. Abraham. Devices for Monitoring and Managing Heart Failure. In: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Elsevier, 2012:578-585.

  306. 306

    Jacob S. Koruth, Conor D. Barrett, Vivek Reddy, Jeremy Ruskin. Sudden Cardiac Death. In: Electrophysiological Disorders of the Heart. Elsevier, 2012:709-719.

  307. 307

    Sumeet K. Mainigi, Khalid Almuti, Vincent M. Figueredo, Nils A. Guttenplan, Asma Aouthmany, Jessica Smukler, Bernadette Sheeron, Bryan Meldrum, Agustina D. Saenz, Gia Tran, Allan M. Greenspan. (2012) Usefulness of Radiofrequency Ablation of Supraventricular Tachycardia to Decrease Inappropriate Shocks from Implantable Cardioverter–Defibrillators. The American Journal of Cardiology 109:2, 231-237

  308. 308

    Iwona Cygankiewicz, Wojciech Zareba. Risk Stratification for Sudden Cardiac Death. In: Electrophysiological Disorders of the Heart. Elsevier, 2012:997-1006.

  309. 309

    Clinical Use and Mechanistic Implications of Microvolt T-Wave Alternans and Signal-Averaged Electrocardiography. In: Electrophysiological Disorders of the Heart. Elsevier, 2012:933-943.

  310. 310

    J. Eduardo Rame, David Spragg. Device Therapy for Systolic Ventricular Failure. In: Muscle. Elsevier, 2012:721-737.

  311. 311

    JAGMEET P. SINGH, KENNETH A. ELLENBOGEN, NIHAR R. DESAI, FINLAY A. MCALISTER. (2012) ICDs, Guidelines, and National Registries: Opportunities to Enhance Quality of Patient Care. Pacing and Clinical Electrophysiologyno-no

  312. 312

    Steven Singh. Evaluation and Management of Arrhythmias Associated with Congestive Heart Failure. In: Electrophysiological Disorders of the Heart. Elsevier, 2012:819-822.

  313. 313

    Jason A. Goebel, Michael R. Gold. Prevention of Sudden Cardiac Death with Implantable Cardiac Defibrillators and Cardiac Resynchronization Therapy. In: Electrophysiological Disorders of the Heart. Elsevier, 2012:1239-1252.

  314. 314

    Larry R. Jackson, James P. Daubert, Kevin L. Thomas. (2012) Expanding the Benefits of Implantable Cardioverter-Defibrillator Therapy: “Is Less More”?. Progress in Cardiovascular Diseases 54:4, 372-378

  315. 315

    Gus Theodos, Samir R. Kapadia. Hypertrophic Cardiomyopathy. In: Textbook of Interventional Cardiology. Elsevier, 2012:694-706.

  316. 316

    Paul Dorian, Saroja Bharati, Robert J. Myerburg, David Rosenbaum, Kara J. Quan, Mariah L. Walker, Bruce D. Lindsay, L. Brent Mitchell, William G. Stevenson, Paul Dorian, Michael Domanski. Ventricular Fibrillation. In: Electrophysiological Disorders of the Heart. Elsevier, 2012:681-706.

  317. 317

    Chang Kun Lee, Sang Yong Yoo, Man Yong Hong, Jin Kun Jang. (2012) Antithrombotic or Anti-Platelet Agents in Patients Undergoing Permanent Pacemaker Implantation. Korean Circulation Journal 42:8, 538

  318. 318

    Przemyslaw Guzik, Jaroslaw Piskorski, Petra Barthel, Axel Bauer, Alexander Müller, Nadine Junk, Kurt Ulm, Marek Malik, Georg Schmidt. (2012) Heart rate deceleration runs for postinfarction risk prediction. Journal of Electrocardiology 45:1, 70-76

  319. 319

    Barry J. Maron, Christopher Semsarian. (2012) Prevention of Sudden Death for Patients With Cardiomyopathies. Journal of the American College of Cardiology 59:5, 501-502

  320. 320

    Peter P. Toth, Nicolas W. Shammas, Eric J. Dippel, Blair Foreman. Cardiovascular Disease. In: Textbook of Family Medicine. Elsevier, 2012:478-549.

  321. 321

    Giuseppe Boriani, Gianluca Botto, Maurizio Lunati, Alessandro Proclemer, Boris Schmidt, Ali Erdogan, Werner Rauhe, Mauro Biffi, Elisabetta Santi, Daniel Becker, Marc Messier, Massimo Santini. (2012) Influence of time between last myocardial infarction and prophylactic implantable defibrillator implant on device detections and therapies. “Routine Practice” data from the SEARCH MI registry. BMC Cardiovascular Disorders 12:1, 72

  322. 322

    JiYeong Kim, Eue-Keun Choi, Min-Ho Lee, Do-Yoon Kang, Young-Jun Sung, Dong-Won Lee, Ilyoung Oh, Yun-Shik Choi, Seil Oh. (2012) The Relevance of the Primary Prevention Criteria for Implantable Cardioverter Defibrillator Implantation in Korean Symptomatic Severe Heart Failure Patients. Korean Circulation Journal 42:3, 173

  323. 323

    JCS Joint Working Group. (2012) Guidelines for Risks and Prevention of Sudden Cardiac Death (JCS 2010). Circulation Journal 76:2, 489-507

  324. 324

    Andrew J. Epstein, Daniel Polsky, Feifei Yang, Lin Yang, Peter W. Groeneveld. (2012) Geographic Variation in Implantable Cardioverter-Defibrillator Use and Heart Failure Survival. Medical Care 50:1, 10-17

  325. 325

    Subodh B Joshi, Kim A Connelly, Laura Jimenez-Juan, Mark Hansen, Anish Kirpalani, Paul Dorian, Iqwal Mangat, Abdul Al-Hesayen, Andrew M Crean, Graham A Wright, Andrew T Yan, Howard Leong-Poi. (2012) Potential clinical impact of cardiovascular magnetic resonance assessment of ejection fraction on eligibility for cardioverter defibrillator implantation. Journal of Cardiovascular Magnetic Resonance 14:1, 69

  326. 326

    Jeffrey L. Anderson. ST Segment Elevation Acute Myocardial Infarction and Complications of Myocardial Infarction. In: Goldman's Cecil Medicine. Elsevier, 2012:434-448.

  327. 327

    Dong Seop Jeong, Pyo Won Park, Young Tak Lee, Seung-Jung Park, June Soo Kim, Young Keun On. (2012) Thoracoscopic Left Ventricular Lead Implantation in Cardiac Resynchronization Therapy. Journal of Korean Medical Science 27:12, 1595

  328. 328

    John J. Atherton. (2012) Chronic Heart Failure: We Are Fighting the Battle, but Are We Winning the War?. Scientifica 2012, 1-16

  329. 329

    Christian Jons, Poul Erik Bloch Thomsen. (2011) Treating Cardiac Arrhythmias Detected With an Implantable Cardiac Monitor in Patients After an Acute Myocardial Infarction. Current Treatment Options in Cardiovascular Medicine

  330. 330

    Paban Saha, Jeffrey J. Goldberger. (2011) Risk Stratification for Prevention of Sudden Cardiac Death. Current Treatment Options in Cardiovascular Medicine

  331. 331

    H. Furushima, M. Chinushi, K. Iijima, K. Hasegawa, A. Sato, D. Izumi, H. Watanabe, Y. Aizawa. (2011) Is the coexistence of sustained ST-segment elevation and abnormal Q waves a risk factor for electrical storm in implanted cardioverter defibrillator patients with structural heart diseases?. Europace

  332. 332

    R. E. Knops, K. M. Kooiman, J. N. Sande, J. R. Groot, A. A. M. Wilde. (2011) First experience with the wearable cardioverter defibrillator in the Netherlands. Netherlands Heart Journal

  333. 333

    MANDEEP R. MEHRA, NANCY M. ALBERT, ANNE B. CURTIS, MIHAI GHEORGHIADE, J. THOMAS HEYWOOD, YANG LIU, CHRISTOPHER M. O’CONNOR, DWIGHT REYNOLDS, MARY NORINE WALSH, CLYDE W. YANCY, GREGG C. FONAROW. (2011) Factors Associated with Improvement in Guideline-Based Use of ICDs in Eligible Heart Failure Patients. Pacing and Clinical Electrophysiologyno-no

  334. 334

    Moustafa Banna, Julia H. Indik. (2011) Risk Stratification and Prevention of Sudden Death in Patients with Heart Failure. Current Treatment Options in Cardiovascular Medicine 13:6, 517-527

  335. 335

    E. Franco, I.J. Núñez-Gil, D. Vivas, B. Ruiz Mateos, B. Ibañez, N. Gonzalo, C. Macaya, A. Fernández Ortiz. (2011) Heart failure and non-ST-segment elevation myocardial infarction: A review for a widespread situation. European Journal of Internal Medicine 22:6, 533-540

  336. 336

    Gail K. Larsen, John Evans, William E. Lambert, Yiyi Chen, Merritt H. Raitt. (2011) Shocks burden and increased mortality in implantable cardioverter-defibrillator patients. Heart Rhythm 8:12, 1881-1886

  337. 337

    , C. W. Hamm, J.-P. Bassand, S. Agewall, J. Bax, E. Boersma, H. Bueno, P. Caso, D. Dudek, S. Gielen, K. Huber, M. Ohman, M. C. Petrie, F. Sonntag, M. S. Uva, R. F. Storey, W. Wijns, D. Zahger, , J. J. Bax, A. Auricchio, H. Baumgartner, C. Ceconi, V. Dean, C. Deaton, R. Fagard, C. Funck-Brentano, D. Hasdai, A. Hoes, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, D. Poldermans, B. A. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, A. Torbicki, A. Vahanian, S. Windecker, , S. Windecker, S. Achenbach, L. Badimon, M. Bertrand, H. E. Botker, J.-P. Collet, F. Crea, N. Danchin, E. Falk, J. Goudevenos, D. Gulba, R. Hambrecht, J. Herrmann, A. Kastrati, K. Kjeldsen, S. D. Kristensen, P. Lancellotti, J. Mehilli, B. Merkely, G. Montalescot, F.-J. Neumann, L. Neyses, J. Perk, M. Roffi, F. Romeo, M. Ruda, E. Swahn, M. Valgimigli, C. J. Vrints, P. Widimsky. (2011) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal 32:23, 2999-3054

  338. 338

    Krishnakumar Nair, Jack V. Tu, Douglas S. Lee. (2011) Why Are Implantable Cardioverter Defibrillator Outcomes in Practice Different from Clinical Trials?. Cardiac Electrophysiology Clinics 3:4, 511-520

  339. 339

    Ganesh Venkataraman, S. Adam Strickberger. (2011) Evaluation of Defibrillation Efficacy at Implantation is Unnecessary. Cardiac Electrophysiology Clinics 3:4, 559-563

  340. 340

    Simon Brüllmann, Wolfgang Dichtl, Ursula Paoli, Laurent Haegeli, Christian Schmied, Jan Steffel, Corinna Brunckhorst, Florian Hintringer, Burkhard Seifert, Firat Duru, Thomas Wolber. (2011) Comparison of Benefit and Mortality of Implantable Cardioverter–Defibrillator Therapy in Patients Aged ≥75 Years Versus Those <75 Years. The American Journal of Cardiology

  341. 341

    Renee M. Sullivan, Brian Olshansky. (2011) Is a Dual-Chamber ICD Always Better in Patients Requiring an ICD?. Cardiac Electrophysiology Clinics 3:4, 577-592

  342. 342

    M. E. Stone, B. Salter, A. Fischer. (2011) Perioperative management of patients with cardiac implantable electronic devices. British Journal of Anaesthesia 107:suppl 1, i16-i26

  343. 343

    Stavros E. Mountantonakis, Mathew D. Hutchinson. (2011) Indications for Implantable Cardioverter-Defibrillator Placement in Ischemic Cardiomyopathy and after Myocardial Infarction. Current Heart Failure Reports 8:4, 252-259

  344. 344

    Stephen C. Hammill, Mark S. Kremers, Sana M. Al-Khatib. (2011) Implantable Cardioverter–Defibrillator Registries—What Have We Learned?. Cardiac Electrophysiology Clinics 3:4, 521-527

  345. 345

    D. A. M. J. Theuns, L. Jordaens. (2011) Use of remote monitoring in the management of system-related complications in implantable defibrillator patients. Netherlands Heart Journal

  346. 346

    Tim Smith, Dominic A.M.J. Theuns, Kadir Caliskan, Luc Jordaens. (2011) Long-Term Follow-Up of Prophylactic Implantable Cardioverter-Defibrillator-Only Therapy: Comparison of Ischemic and Nonischemic Heart Disease. Clinical Cardiology 34:12, 761-767

  347. 347

    Mehul B. Patel, Swapnil Hiremath, Tahmeed Contractor, Ranjan K. Thakur. (2011) Implantable Cardioverter-Defibrillators in End-Stage Renal Disease. Cardiac Electrophysiology Clinics 3:4, 641-650

  348. 348

    Mohan Rao, Ilan Goldenberg, Arthur J. Moss, Helmut Klein, David T. Huang, Nicole R. Bianco, Steven J. Szymkiewicz, Wojciech Zareba, Andrew Brenyo, Jonathan Buber, Alon Barsheshet. (2011) Wearable Defibrillator in Congenital Structural Heart Disease and Inherited Arrhythmias. The American Journal of Cardiology 108:11, 1632-1638

  349. 349

    Deepak Bhakta, Lynne D. Foreman. (2011) Implantable cardioverter-defibrillator shock reduction: The new paradigm. Heart Rhythm 8:12, 1887-1888

  350. 350

    Marwan M. Refaat, Toshikazu Tanaka, Robert L. Kormos, Dennis Mcnamara, Jeffrey Teuteberg, Steve Winowich, Barry London, Marc A. Simon. (2011) Survival Benefit of Implantable Cardioverter-Defibrillators in Left Ventricular Assist Device–Supported Heart Failure Patients. Journal of Cardiac Failure

  351. 351

    Girish M. Nair, Jeffrey S. Healey, Syamkumar M. Divakaramenon, Stuart J. Connolly, Carlos A. Morillo. (2011) Antiarrhythmic Drug Therapy for New-Onset Ventricular Arrhythmia (VT/VF) in ICD Patients. Cardiac Electrophysiology Clinics 3:4, 651-661

  352. 352

    Laura Perrotta, Giuseppe Ricciardi, Paolo Pieragnoli, Luigi Padeletti. (2011) Device Recalls: What’s an Electrophysiologist to Do?. Cardiac Electrophysiology Clinics 3:4, 617-622

  353. 353

    Ashok J. Shah, Shinsuke Miyazaki, Amir S. Jadidi, Daniel Scherr, Stephen B. Wilton, Laurent Roten, Patrizio Pascale, Michala Pedersen, Nicolas Derval, Sebastien Knecht, Frederic Sacher, Pierre Jais, Michel Haissaguerre, Meleze Hocini. (2011) Catheter Ablation of Ventricular Fibrillation Storms: Will this Replace Defibrillators?. Cardiac Electrophysiology Clinics 3:4, 689-695

  354. 354

    Daniel B. Kramer, Mark E. Josephson. (2011) Expanding the Use of Cardiac Resynchronization Therapy: Words of Caution. Cardiac Electrophysiology Clinics 3:4, 529-537

  355. 355

    David J. Whellan, Anil Nigam, Malcolm Arnold, Aijing Z. Starr, James Hill, Gerald Fletcher, Stephen J. Ellis, Lawton Cooper, Anekwe Onwuanyi, Bleakley Chandler, Steven J. Keteyian, Greg Ewald, Andrew Kao, Mihai Gheorghiade. (2011) Benefit of exercise therapy for systolic heart failure in relation to disease severity and etiology—findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training study. American Heart Journal 162:6, 1003-1010

  356. 356

    DOMINIC A. M. J. THEUNS, TIM SMITH, TAMAS SZILI-TOROK, AGNES MUSKENS-HEEMSKERK R. N., PETTER JANSE, LUC JORDAENS. (2011) Prognostic Role of High-Sensitivity C-Reactive Protein and B-Type Natriuretic Peptide in Implantable Cardioverter-Defibrillator Patients. Pacing and Clinical Electrophysiologyno-no

  357. 357

    L. Paranskaya, I. Akin, T. Chatterjee, A. Ritz, P. Paranski, T. Rehders, H. Ince, H. Schneider, C.A. Nienaber, D. Bänsch. (2011) Ventricular tachycardia and sudden death after primary PCI-reperfusion therapy. Herzschrittmachertherapie + Elektrophysiologie

  358. 358

    T. Deneke, T. Lawo, J. Reinecke, C. Buttler, P.H. Grewe, D.-I. Shin, B. Gerritse, A. Mügge, B. Lemke, A. Kloppe. (2011) Predictors of sustained ventricular arrhythmia episodes in patients with primary ICD indication. Herzschrittmachertherapie + Elektrophysiologie

  359. 359

    J. Seegers, M. A. Vos, P. Flevari, R. Willems, C. Sohns, D. Vollmann, L. Luthje, D. T. Kremastinos, V. Flore, M. Meine, A. Tuinenburg, R. C. Myles, D. Simon, J. Brockmoller, T. Friede, G. Hasenfuss, S. E. Lehnart, M. Zabel, . (2011) Rationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotype. Europace

  360. 360

    M. Licka, L. Jahn, K. Kelemen, F. Voss, K. Trappe, R. Becker, O. Bikou, M. Hauck, M. Koch, H.A. Katus, A. Bauer. (2011) Is the determination of the defibrillation threshold in patients with an implantable cardioverter–defibrillator still required?. Herzschrittmachertherapie + Elektrophysiologie

  361. 361

    T. Weinmann, L. Károlyi, S.G. Spitzer. (2011) ICD-Therapie 2011. Zeitschrift für Herz-,Thorax- und Gefäßchirurgie

  362. 362

    U. Mezu, I. Ch, I. Halder, B. London, S. Saba. (2011) Women and minorities are less likely to receive an implantable cardioverter defibrillator for primary prevention of sudden cardiac death. Europace

  363. 363

    B. Schaer, C. Sticherling, T. Szili-Torok, S. Osswald, L. Jordaens, D. A. Theuns. (2011) Impact of left ventricular ejection fraction on occurrence of ventricular events in defibrillator patients with coronary artery disease. Europace 13:11, 1562-1567

  364. 364

    Ana Teresa Timóteo, Mário Martins Oliveira, Manuel Nogueira Silva, Alexandra Toste, Ruben Ramos, Joana Feliciano, Pedro Silva Cunha, Rui Soares, Sofia Santos, Rui Cruz Ferreira. (2011) Incidence of ventricular arrhythmias in patients with severe left ventricular systolic dysfunction: is there a benefit after cardiac resynchronization therapy?. Revista Portuguesa de Cardiologia (English Edition) 30:11, 823-828

  365. 365

    Javier Alzueta, José Maria Fernández. (2011) Registro Español de Desfibrilador Automático Implantable. VII Informe Oficial del Grupo de Trabajo de Desfibrilador Automático Implantable de la Sociedad Española de Cardiología (2010). Revista Española de Cardiología 64:11, 1023-1034

  366. 366

    J. Thijssen, C. J. W. Borleffs, J. B. van Rees, M. K. de Bie, E. T. van der Velde, L. van Erven, J. J. Bax, S. C. Cannegieter, M. J. Schalij. (2011) Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approach. European Heart Journal 32:21, 2678-2687

  367. 367

    Giovanni B. Forleo, Domenico G. Della Rocca, Lida P. Papavasileiou, Germana Panattoni, Domenico Sergi, Lucia Duro, Karim Mahfouz, Giulia Magliano, Luca Santini, Francesco Romeo. (2011) Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction. Journal of Cardiovascular Medicine 12:11, 779-784

  368. 368

    ALON BARSHESHET, ILAN GOLDENBERG, ARTHUR J. MOSS, DAVID T. HUANG, WOJCIECH ZAREBA, SCOTT McNITT, HELMUT U. KLEIN, VICTOR GUETTA. (2011) Effect of Elapsed Time From Coronary Revascularization to Implantation of a Cardioverter Defibrillator on Long-Term Survival in the MADIT-II Trial. Journal of Cardiovascular Electrophysiology 22:11, 1237-1242

  369. 369

    Javier Alzueta, José Maria Fernández. (2011) Spanish Implantable Cardioverter-Defibrillator Registry. Seventh Official Report of the Spanish Society of Cardiology Working Group on Implantable Cardioverter-Defibrillators (2010). Revista Española de Cardiología (English Edition) 64:11, 1023-1034

  370. 370

    Naohiko Nakanishi, Shinya Nishizawa, Yohei Kitamura, Takeshi Nakamura, Akiyoshi Matsumuro, Takahisa Sawada, Hiroaki Matsubara. (2011) Circadian, weekly, and seasonal mortality variations in out-of-hospital cardiac arrest in Japan: analysis from AMI-Kyoto Multicenter Risk Study database. The American Journal of Emergency Medicine 29:9, 1037-1043

  371. 371

    J. S. Perkiomaki, P.-E. Bloch Thomsen, A. M. Kiviniemi, M. D. Messier, H. V. Huikuri, . (2011) Risk factors of self-terminating and perpetuating ventricular tachyarrhythmias in post-infarction patients with moderately depressed left ventricular function, a CARISMA sub-analysis. Europace 13:11, 1604-1611

  372. 372

    Daniel Jacoby, Oltjan Albajrami, Lavanya Bellumkonda. (2011) Natural History of End-stage LV Dysfunction: Has It Improved from the Classic Franciosa and Cohn Graph?. Cardiology Clinics 29:4, 485-495

  373. 373

    Paul Angaran, George J. Klein, Raymond Yee, Allan C. Skanes, Lorne J. Gula, Peter Leong-Sit, Andrew D. Krahn. (2011) Syncope. Neurologic Clinics 29:4, 903-925

  374. 374

    Ana Teresa Timóteo, Mário Martins Oliveira, Manuel Nogueira Silva, Alexandra Toste, Ruben Ramos, Joana Feliciano, Pedro Silva Cunha, Rui Soares, Sofia Santos, Rui Cruz Ferreira. (2011) Incidência de arritmias ventriculares em doentes com disfunção sistólica ventricular esquerda grave: existe benefício após terapêutica de ressincronização cardíaca. Revista Portuguesa de Cardiologia 30:11, 823-828

  375. 375

    Y. Sobue, E. Watanabe, M. Yamamoto, K. Sano, H. Harigaya, K. Okuda, Y. Ozaki. (2011) Beat-to-beat variability of T-wave amplitude for the risk assessment of ventricular tachyarrhythmia in patients without structural heart disease. Europace 13:11, 1612-1618

  376. 376

    Luigi Padeletti, Lisa Innocenti, Alessandro Paoletti Perini, Edoardo Gronda. (2011) Arrhythmic complication in cardiorenal syndrome. Heart Failure Reviews 16:6, 569-573

  377. 377

    Maria Sheehan, Phillip J. Newton, Paul Stobie, Patricia Mary Davidson. (2011) Implantable cardiac defibrillators and end-of-life care—Time for reflection, deliberation and debate?. Australian Critical Care 24:4, 279-284

  378. 378

    Barak Pertzov, Victor Novack, Doron Zahger, Amos Katz, Guy Amit. (2011) Insufficient compliance with current implantable cardioverter defibrillator (ICD) therapy guidelines in post myocardial infarction patients is associated with increased mortality. International Journal of Cardiology

  379. 379

    M. Guenther, T. Rauwolf, B. Bruggemann, M. Gerlach, N. K. Wassnig, M. Christoph, M. U. Braun, R. H. Strasser, C. Wunderlich. (2011) Pre-hospital discharge testing after implantable cardioverter defibrillator implantation: A measure of safety or out of date? A retrospective analysis of 975 patients. Europace

  380. 380

    Fabrice Extramiana, Antoine Leenhardt. (2011) Prolonged QRS duration and sudden cardiac death risk stratification: Not yet ready for prime time. Heart Rhythm 8:10, 1568-1569

  381. 381

    Samir Saba, Haider Mehdi, Hemal Shah, Zahid Islam, Elie Aoun, Sammy Termanini, Reem Mahjoub, Ryan Aleong, Charles F. McTiernan, Barry London. (2011) Cardiac levels of NOS1AP RNA from right ventricular tissue recovered during lead extraction. Heart Rhythm

  382. 382

    Zhongwei Cheng, Kongbo Zhu, Taibo Chen, Peng Gao, Kang’an Cheng, Ligang Fang, Hua Deng, Wenling Zhu, Quan Fang. (2011) Poor Prognosis in Chronic Heart Failure Patients With Reduced Ejection Fraction in China. Congestive Heart Failureno-no

  383. 383

    Carmen Teodorescu, Kyndaron Reinier, Audrey Uy-Evanado, Jo Navarro, Ronald Mariani, Karen Gunson, Jonathan Jui, Sumeet S. Chugh. (2011) Prolonged QRS duration on the resting ECG is associated with sudden death risk in coronary disease, independent of prolonged ventricular repolarization. Heart Rhythm 8:10, 1562-1567

  384. 384

    Peter Oosterhoff, Larisa G. Tereshchenko, Marcel A.G. van der Heyden, Raja N. Ghanem, Barry J. Fetics, Ronald D. Berger, Marc A. Vos. (2011) Short-term variability of repolarization predicts ventricular tachycardia and sudden cardiac death in patients with structural heart disease: A comparison with QT variability index. Heart Rhythm 8:10, 1584-1590

  385. 385

    Ioanna Kosmidou, Keiichi Inada, Jens Seiler, Bruce Koplan, William G. Stevenson, Usha B. Tedrow. (2011) Role of repeat procedures for catheter ablation of postinfarction ventricular tachycardia. Heart Rhythm 8:10, 1516-1522

  386. 386

    D. B. Sims, A. Mignatti, P. C. Colombo, N. Uriel, L. I. Garcia, F. A. Ehlert, U. P. Jorde. (2011) Rate responsive pacing using cardiac resynchronization therapy in patients with chronotropic incompetence and chronic heart failure. Europace 13:10, 1459-1463

  387. 387

    P. A. Scott, P. A. Townsend, L. L. Ng, M. Zeb, S. Harris, P. J. Roderick, N. P. Curzen, J. M. Morgan. (2011) Defining potential to benefit from implantable cardioverter defibrillator therapy: the role of biomarkers. Europace 13:10, 1419-1427

  388. 388

    Olivera Gojkovic, Etienne M. Aliot, Alessandro Capucci, Stuart J. Connolly, Harry Crijns, Stefan H. Hohnloser, Piotr Kulakowski, Denis Roy, David Radzik, Bramah N. Singh, Peter R. Kowey. (2011) Celivarone in patients with an implantable cardioverter-defibrillator: Adjunctive therapy for the reduction of ventricular arrhythmia-triggered implantable cardioverter-defibrillator interventions. Heart Rhythm

  389. 389

    Benoit Desjardins. (2011) MR Imaging of Myocardial Scar, with Electrophysiology Applications. PET Clinics 6:4, 489-502

  390. 390

    Florian Streitner, Juergen Kuschyk, Claudia Dietrich, Eva Mahl, Ines Streitner, Christina Doesch, Christian Veltmann, Rainer Schimpf, Christian Wolpert, Martin Borggrefe. (2011) Comparison of Ventricular Tachyarrhythmia Characteristics in Patients With Idiopathic Dilated or Ischemic Cardiomyopathy and Defibrillators Implanted for Primary Prevention. Clinical Cardiology 34:10, 604-609

  391. 391

    H. I. Lehmann, A. Goette, J. Martens-Lobenhoffer, M. Hammwohner, F.-W. Rohl, A. Bukowska, A. Ghanem, H. U. Klein, S. M. Bode-Boger. (2011) Asymmetric dimethylarginine predicts appropriate implantable cardioverter-defibrillator intervention in patients with left ventricular dysfunction. Europace 13:10, 1428-1435

  392. 392

    DAN D. MATLOCK, CAROLYN T. NOWELS, FREDERICK A. MASOUDI, WILLIAM H. SAUER, DAVID B. BEKELMAN, DEBORAH S. MAIN, JEAN S. KUTNER. (2011) Patient and Cardiologist Perceptions on Decision Making for Implantable Cardioverter-Defibrillators: A Qualitative Study. Pacing and Clinical Electrophysiologyno-no

  393. 393

    MICHAEL R. GOLD, DOMINIC A. THEUNS, BRADLEY P. KNIGHT, J. LACY STURDIVANT, RICK SANGHERA, KENNETH A. ELLENBOGEN, MARK A. WOOD, MARTIN C. BURKE. (2011) Head-To-Head Comparison of Arrhythmia Discrimination Performance of Subcutaneous and Transvenous ICD Arrhythmia Detection Algorithms: The START Study. Journal of Cardiovascular Electrophysiologyno-no

  394. 394

    CHRISTINE TOMPKINS, RHONDALYN MCLEAN, ALAN CHENG, JEFFREY A. BRINKER, JOSEPH E. MARINE, SAMAN NAZARIAN, DAVID D. SPRAGG, SUNIL SINHA, HENRY HALPERIN, GORDON F. TOMASELLI, RONALD D. BERGER, HUGH CALKINS, CHARLES A. HENRIKSON. (2011) End-Stage Renal Disease Predicts Complications in Pacemaker and ICD Implants. Journal of Cardiovascular Electrophysiology 22:10, 1099-1104

  395. 395

    Brad Stuart. (2011) On Deactivating Cardiovascular Implanted Electronic Devices (CIEDs): Let Our People Go. Journal of Palliative Medicine 14:10, 1089-1090

  396. 396

    ZALMEN BLANCK, KATHI AXTELL, KATHY BRODHAGEN, LAURA O'HEARN, TAMMY ALBELO, CHERYL CERETTO, ANWER DHALA, JASBIR SRA, MASOOD AKHTAR. (2011) Inappropriate Shocks in Patients With Fidelis® Lead Fractures: Impact of Remote Monitoring and the Lead Integrity Algorithm. Journal of Cardiovascular Electrophysiology 22:10, 1107-1114

  397. 397

    T. Reichlin, M. Kuhne, C. Sticherling, S. Osswald, B. Schaer. (2011) Characterization and financial impact of implantable cardioverter-defibrillator patients without interventions 5 years after implantation. QJM 104:10, 849-857

  398. 398

    Michael R. Gold, Saleem Ahmad, Kevin Browne, Kellie Chase Berg, Lisa Thackeray, Ronald D. Berger. (2011) Prospective comparison of discrimination algorithms to prevent inappropriate ICD therapy: Primary results of the Rhythm ID Going Head to Head Trial. Heart Rhythm

  399. 399

    Brian C Hiestand. (2011) Research in acute decompensated heart failure: challenges and opportunities. Clinical Investigation 1:10, 1361-1373

  400. 400

    T. Smith, P. F. Dessel, D. A. M. J. Theuns, A. Muskens-Heemskerk, R. T. Domburg, A. A. Wilde, L. Jordaens. (2011) Health care utilisation after defibrillator implantation for primary prevention according to the guidelines in 2 Dutch academic medical centres. Netherlands Heart Journal 19:10, 405-411

  401. 401

    A. Auricchio, A. Meijer, T. Kurita, E. Schloss, K. Brinkman, M. Claessens-van Ooijen, L. Sterns. (2011) Safety, efficacy, and performance of new discrimination algorithms to reduce inappropriate and unnecessary shocks: the PainFree SST clinical study design. Europace 13:10, 1484-1493

  402. 402

    Jing Tian, Mark F. Smith, Timm Dickfeld. (2011) Clinical Application of FDG-PET Imaging for Three-Dimensional Myocardial Scar and Left Ventricular Anatomy During Ventricular Tachycardia Ablation. PET Clinics 6:4, 393-402

  403. 403

    Ian Crozier. (2011) The subcutaneous defibrillator will replace the transvenous defibrillator. Journal of Interventional Cardiac Electrophysiology 32:1, 73-77

  404. 404

    , Satoshi Shizuta, Kenji Ando, Masakiyo Nobuyoshi, Takanori Ikeda, Hideaki Yoshino, Shinichi Hiramatsu, Yukio Kazatani, Kohei Yamashiro, Katsunori Okajima, Teishi Kajiya, Yoshinori Kobayashi, Takao Kato, Satoki Fujii, Kazuaki Mitsudo, Koichi Inoue, Hiroshi Ito, Yoshisumi Haruna, Takahiro Doi, Yukiko Nishio, Neiko Ozasa, Kei Nishiyama, Toru Kita, Takeshi Morimoto, Takeshi Kimura. (2011) Prognostic utility of T-wave alternans in a real-world population of patients with left ventricular dysfunction: the PREVENT-SCD study. Clinical Research in Cardiology

  405. 405

    H. Tandri, S. H. Weinberg, K. C. Chang, R. Zhu, N. A. Trayanova, L. Tung, R. D. Berger. (2011) Reversible Cardiac Conduction Block and Defibrillation with High-Frequency Electric Field. Science Translational Medicine 3:102, 102ra96-102ra96

  406. 406

    J. B. van Rees, C. J. W. Borleffs, J. Thijssen, M. K. de Bie, L. van Erven, S. C. Cannegieter, J. J. Bax, M. J. Schalij. (2011) Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, and survival gain. Europace

  407. 407

    R. Mollo, A. Cosenza, A. Spinelli, I. Coviello, G. Careri, I. Battipaglia, M. Laurito, G. Pinnacchio, G. A. Lanza, F. Crea. (2011) T-wave alternans in apparently healthy subjects and in different subsets of patients with ischaemic heart disease. Europace

  408. 408

    Wolfgang Dichtl, Thomas Wolber, Ursula Paoli, Thomas Theurl, Simon Brüllmann, Markus Stühlinger, Thomas Berger, Karin Spuller, Alexander Strasak, Otmar Pachinger, Laurent Haegeli, Firat Duru, Florian Hintringer. (2011) Elevated γ-glutamyltransferase in implantable cardioverter defibrillator patients. Wiener klinische Wochenschrift

  409. 409

    Sean Balmain, Michael A McDonald. (2011) Cardiac resynchronization therapy in mildly symptomatic heart failure: the earlier the better. Expert Review of Cardiovascular Therapy 9:9, 1147-1153

  410. 410

    Ashish K Govil, Mohit D Gupta, MP Girish, Sanjay Tyagi. (2011) Prediction and Prevention in Sudden Cardiac Death. Apollo Medicine 8:3, 228-237

  411. 411

    DARÍO DI TORO, CLAUDIO MURATORE, LUIS AGUINAGA, LUIZ BATISTA, ANTONIO MALAN, OSWALDO GRECO, CHAMIA BENCHETRIT, MAURICIO DUQUE, ADRIAN BARANCHUK, JENNIFER MALONEY. (2011) Predictors of All-Cause 1-Year Mortality in Implantable Cardioverter Defibrillator Patients with Chronic Chagas’ Cardiomyopathy. Pacing and Clinical Electrophysiology 34:9, 1063-1069

  412. 412

    Eric Smith Ketchum, Wayne Cecil Levy. (2011) Establishing Prognosis in Heart Failure: A Multimarker Approach. Progress in Cardiovascular Diseases 54:2, 86-96

  413. 413

    Jayanthi N. Koneru, Karoly Kaszala, Jose F. Huizar, Kenneth A. Ellenbogen. (2011) Lead Fracture: Incidence, Diagnosis and Preventing Inappropriate ICD Therapy. Cardiac Electrophysiology Clinics 3:3, 409-420

  414. 414

    Jordan M. Prutkin, Jeanne E. Poole. (2011) Complications of ICD Generator Change and Implantations. Cardiac Electrophysiology Clinics 3:3, 389-401

  415. 415

    S. N. Burgess, S. A. Harding, I. C. Melton, N. A. Lever, A. H. Swain, B. Shi, P. D. Larsen. (2011) An unmet need for implantable cardioverter-defibrillators in New Zealand. Europace 13:9, 1299-1303

  416. 416

    Robert F. Rea, Douglas Beinborn, Tracy Webster, Nancy Acker, Tammy Kester, David L. Hayes, Mark McConnell. (2011) Definition of performance metrics and methods for screening for sudden cardiac arrest risk at a tertiary care medical center. Journal of Interventional Cardiac Electrophysiology 31:3, 185-189

  417. 417

    Marwan Refaat, Samir Saba. (2011) Total Subcutaneous Defibrillators: The Current Status and Future Prospect of a New Technology. Cardiac Electrophysiology Clinics 3:3, 403-408

  418. 418

    ARTHUR SHIYOVICH, AMOS KATZ. (2011) The “Shock Factor”: ICD Configuration and Programming to Optimize Shock Treatment. Journal of Cardiovascular Electrophysiology 22:9, 1030-1033

  419. 419

    Thomas A. Dewland, Jeffrey E. Olgin, Byron K. Lee. (2011) Indications for a Wearable Cardioverter-Defibrillator. Cardiac Electrophysiology Clinics 3:3, 339-347

  420. 420

    F. ROOSEVELT GILLIAM, DAVID L. HAYES, JOHN P. BOEHMER, JOHN DAY, PAUL A. HEIDENREICH, MILAN SETH, PAUL W. JONES, KENNETH M. STEIN, LESLIE A. SAXON. (2011) Real World Evaluation of Dual-Zone ICD and CRT-D Programming Compared to Single-Zone Programming: The ALTITUDE REDUCES Study. Journal of Cardiovascular Electrophysiology 22:9, 1023-1029

  421. 421

    David J. Whellan, Suzanne Adams, Lisa Bowerman. (2011) Review of Advanced Heart Failure Device Diagnostics Examined in Clinical Trials and the Potential Benefit from Monitoring Capabilities. Progress in Cardiovascular Diseases 54:2, 107-114

  422. 422

    James V. Freeman, Aditya Ullal, Mintu P. Turakhia. (2011) Cost-effectiveness of Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy. Cardiac Electrophysiology Clinics 3:3, 421-440

  423. 423

    Rajnish Sardana. (2011) Is Right Ventricular Pacing a Boon or a Curse?. Apollo Medicine 8:3, 198-199

  424. 424

    Samir Saba. (2011) Death during acute myocardial infarction: Dodging the first bullet. Heart Rhythm 8:9, 1467-1468

  425. 425

    Norman C. Wang, Jonathan P. Piccini, Mihai Gheorghiade. (2011) Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions. Heart Failure Reviews 16:5, 477-480

  426. 426

    Ngan Lam, Peter Leong-Sit, Amit X. Garg. (2011) The Role of Implantable Cardioverter-Defibrillators in Long-term Dialysis Patients. American Journal of Kidney Diseases 58:3, 338-339

  427. 427

    Lara Dabiri Abkenari, Dominic A. M. J. Theuns, Suzanne D. A. Valk, Yves Belle, Natasja M. Groot, David Haitsma, Agnes Muskens-Heemskerk, Tamas Szili-Torok, Luc Jordaens. (2011) Clinical experience with a novel subcutaneous implantable defibrillator system in a single center. Clinical Research in Cardiology 100:9, 737-744

  428. 428

    T. Jared Bunch, Heidi T. May, Tami L. Bair, Brian G. Crandall, J. Peter Weiss, Jeffrey S. Osborn, Jeffrey L. Anderson, Joseph B. Muhlestein, Benjamin D. Horne, Donald L. Lappe, John D. Day. (2011) Trends in early and late mortality in patients undergoing coronary catheterization for myocardial infarction: implications on observation periods and risk factors to determine ICD candidacy. Heart Rhythm 8:9, 1460-1466

  429. 429

    Norman C. Wang, Gregg C. Fonarow, Mihai Gheorghiade. (2011) The potential application of electrophysiology diagnostics and therapeutics in acute heart failure syndromes. Heart Failure Reviews 16:5, 437-439

  430. 430

    Jason Bradfield, Roderick Tung, Noel G. Boyle, Kalyanam Shivkumar. (2011) Managing patients with ICD shocks and programming tachycardia therapies during acute heart failure syndromes. Heart Failure Reviews 16:5, 449-456

  431. 431

    John A. Schoenhard, Paul C. Zei. (2011) Reducing ICD Shocks for Ventricular Arrhythmias. Cardiac Electrophysiology Clinics 3:3, 493-502

  432. 432

    Miyuki Tsuchihashi-Makaya, Hisashi Matsuo, Shigeo Kakinoki, Shigeru Takechi, Hiroyuki Tsutsui. (2011) Rationale and design of the Japanese Heart Failure Outpatients Disease Management and Cardiac Evaluation (J-HOMECARE). Journal of Cardiology 58:2, 165-172

  433. 433

    Afschin Gandjour, Astrid Holler Dipl-Ges-Ök, Charles Christian Adarkwah. (2011) Cost-Effectiveness of Implantable Defibrillators after Myocardial Infarction Based on 8-Year Follow-Up Data (MADIT II). Value in Health 14:6, 812-817

  434. 434

    David M. Charytan, Amanda R. Patrick, Jun Liu, Soko Setoguchi, Charles A. Herzog, M. Alan Brookhart, Wolfgang C. Winkelmayer. (2011) Trends in the Use and Outcomes of Implantable Cardioverter-Defibrillators in Patients Undergoing Dialysis in the United States. American Journal of Kidney Diseases 58:3, 409-417

  435. 435

    Tamam Mohamad, Sony Jacob, Naga VA Kommuri, Shalini Modi, Rajeev Aravindhakshan, Randy Lieberman. (2011) Low Referral Pattern for Implantable Defibrillator Therapy in a Tertiary Hospital: Referral Physician Survey and Monte Carlo Simulation. American Journal of Therapeutics 18:5, 350-354

  436. 436

    Daniel B. Kramer, Paul A. Friedman, Linda M. Kallinen, Thomas Ben Morrison, Daniel J. Crusan, David O. Hodge, Matthew R. Reynolds, Robert G. Hauser. (2011) Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators. Heart Rhythm

  437. 437

    Craig E. Tanner, Erik K. Fromme, Sarah J. Goodlin. (2011) Ethics in the Treatment of Advanced Heart Failure: Palliative Care and End-of-Life Issues. Congestive Heart Failure 17:5, 235-240

  438. 438

    Amala Chirumamilla, Mark I. Travin. (2011) Cardiac Applications of 123I-mIBG Imaging. Seminars in Nuclear Medicine 41:5, 374-387

  439. 439

    Vivian Tsai, Mary K. Goldstein, Henry H. Hsia, Yongfei Wang, Jeptha Curtis, Paul A. Heidenreich, . (2011) Age Differences in Primary Prevention Implantable Cardioverter-Defibrillator Use in U.S. Individuals. Journal of the American Geriatrics Society 59:9, 1589-1595

  440. 440

    Allison C. Hill, Anne M. Dubin. (2011) Implantable Cardioverter–Defibrillator Therapy in Pediatric Patients and Congenital Heart Disease. Cardiac Electrophysiology Clinics 3:3, 349-357

  441. 441

    M. K. de Bie, D. A. Fouad, C. J. W. Borleffs, J. B. van Rees, J. Thijssen, S. A. Trines, M. Bootsma, M. J. Schalij, L. van Erven. (2011) Trans-venous lead removal without the use of extraction sheaths, results of >250 removal procedures. Europace

  442. 442

    Juna Misiri, Shawn Candler, Fred M. Kusumoto. (2011) Evaluation of Syncope and Palpitations in Women. Journal of Women's Health110805095244005

  443. 443

    Björn C Knollmann. (2011) Carvedilol tweaks calcium release to ease arrhythmias. Nature Medicine 17:8, 923-924

  444. 444

    Johannes Holzmeister, Christophe Leclercq. (2011) Implantable cardioverter defibrillators and cardiac resynchronisation therapy. The Lancet 378:9792, 722-730

  445. 445

    Mark S. Link, Derek V. Exner, Mark Anderson, Michael Ackerman, Amin Al-Ahmad, Bradley P. Knight, Steven M. Markowitz, Elizabeth S. Kaufman, David Haines, Samuel J. Asirvatham, David J. Callans, J. Paul Mounsey, Frank Bogun, Sanjiv M. Narayan, Andrew D. Krahn, Suneet Mittal, Jagmeet Singh, John D. Fisher, Sumeet S. Chugh. (2011) HRS Policy Statement: Clinical Cardiac Electrophysiology Fellowship Curriculum: Update 2011. Heart Rhythm 8:8, 1340-1356

  446. 446

    Leon A. Cannizzaro, Jonathan P. Piccini, Uptal D. Patel, Adrian F. Hernandez. (2011) Device Therapy in Heart Failure Patients With Chronic Kidney Disease. Journal of the American College of Cardiology 58:9, 889-896

  447. 447

    Philipp Boyé, Hassan Abdel-Aty, Udo Zacharzowsky, Steffen Bohl, Carsten Schwenke, Rob J. van der Geest, Rainer Dietz, Alexander Schirdewan, Jeanette Schulz-Menger. (2011) Prediction of Life-Threatening Arrhythmic Events in Patients With Chronic Myocardial Infarction by Contrast-Enhanced CMR. JACC: Cardiovascular Imaging 4:8, 871-879

  448. 448

    Martin Stockburger, Alice Krebs, Oezlem Celebi, Aischa Nitardy, Dirk Habedank, Thomas Knaus, Mathias Rauchhaus, Rainer Dietz. (2011) Long-Term Survival of Routine Implantable Cardioverter/Defibrillator Recipients Appears to be Significantly Impaired with Concomitant Diuretics and Improved with Aldosterone Antagonists. Cardiovascular Therapeutics 29:4, 243-250

  449. 449

    Eric C. Stecker, Sumeet S. Chugh. (2011) Prediction of sudden cardiac death: next steps in pursuit of effective methodology. Journal of Interventional Cardiac Electrophysiology 31:2, 101-107

  450. 450

    Arnold J. Greenspon, Jasmine D. Patel, Edmund Lau, Jorge A. Ochoa, Daniel R. Frisch, Reginald T. Ho, Behzad B. Pavri, Steven M. Kurtz. (2011) 16-Year Trends in the Infection Burden for Pacemakers and Implantable Cardioverter-Defibrillators in the United States. Journal of the American College of Cardiology 58:10, 1001-1006

  451. 451

    Johannes B. van Rees, Mihály K. de Bie, Joep Thijssen, C. Jan Willem Borleffs, Martin J. Schalij, Lieselot van Erven. (2011) Implantation-Related Complications of Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy Devices. Journal of the American College of Cardiology 58:10, 995-1000

  452. 452

    Bianchi Stefano, Ricci Renato Pietro, Gasparini Maurizio, Lunati Maurizio, Marconi Renato, Landolina Maurizio, Rossi Pietro, Proclemer Alessandro, Botto Gianluca, Merico Monica, Canonaco Sergio, Santini Massimo. (2011) Defibrillation testing during implantable cardioverter-defibrillator implantation in Italian current practice: The Assessment of Long-term Induction clinical ValuE (ALIVE) project. American Heart Journal 162:2, 390-397

  453. 453

    Thomas A. Dewland, Cara N. Pellegrini, Yongfei Wang, Gregory M. Marcus, Edmund Keung, Paul D. Varosy. (2011) Dual-Chamber Implantable Cardioverter-Defibrillator Selection Is Associated With Increased Complication Rates and Mortality Among Patients Enrolled in the NCDR Implantable Cardioverter-Defibrillator Registry. Journal of the American College of Cardiology 58:10, 1007-1013

  454. 454

    LAURA PERROTTA, PAOLO PIERAGNOLI, GIUSEPPE RICCIARDI, STEFANIA SACCHI, GIUSEPPE MASCIA, MARGHERITA PADELETTI, MARIA GRAZIA BONGIORNI, ANTONIO CURNIS, FULVIO BELLOCCI, ANTONIO MICHELUCCI, MARIA CRISTINA PORCIANI, LUIGI PADELETTI. (2011) Multicenter Experience with Implantable Defibrillators Subject to Recall. Pacing and Clinical Electrophysiology 34:8, 998-1002

  455. 455

    Charles F. Jackson, Nanette K. Wenger. (2011) Cardiovascular Disease in the Elderly. Revista Española de Cardiología (English Edition) 64:8, 697-712

  456. 456

    BRIAN D. POWELL, YONG-MEI CHA, SAMUEL J. ASIRVATHAM, DAVID A. CESARIO, MICHAEL CAO, PAUL W. JONES, MILAN SETH, LESLIE A. SAXON, F. ROOSEVELT GILLIAM III. (2011) Implantable Cardioverter Defibrillator Electrogram Adjudication for Device Registries: Methodology and Observations from ALTITUDE. Pacing and Clinical Electrophysiology 34:8, 1003-1012

  457. 457

    Charles F. Jackson, Nanette K. Wenger. (2011) Enfermedad cardiovascular en el anciano. Revista Española de Cardiología 64:8, 697-712

  458. 458

    Amit K. Mehrotra, Bradley P. Knight, Matthew P. Smelley, Dipak P. Shah, Ian Weisberg, Jose Baez-Escudero, John F. Beshai, Martin C. Burke. (2011) Medtronic Sprint Fidelis lead recall: Determining the initial 5-year management cost to Medicare. Heart Rhythm 8:8, 1192-1197

  459. 459

    Sachin Logani, James N Kirkpatrick. (2011) Addressing end-of-life management in patients with implantable cardioverter defibrillators and pacemakers. Interventional Cardiology 3:4, 425-428

  460. 460

    Daniel Scharfstein, Georgiana Onicescu, Steven Goodman, Rachel Whitaker. (2011) Analysis of subgroup effects in randomized trials when subgroup membership is missing: application to the second Multicenter Automatic Defibrillator Intervention Trial. Journal of the Royal Statistical Society: Series C (Applied Statistics) 60:4, 607-617

  461. 461

    Amin Al-Ahmad, James V. Freeman. (2011) Is Less More?. Journal of the American College of Cardiology 58:10, 1014-1015

  462. 462

    Kyndaron Reinier, Celia Dervan, Tejwant Singh, Audrey Uy-Evanado, Shenghan Lai, Karen Gunson, Jonathan Jui, Sumeet S. Chugh. (2011) Increased left ventricular mass and decreased left ventricular systolic function have independent pathways to ventricular arrhythmogenesis in coronary artery disease. Heart Rhythm 8:8, 1177-1182

  463. 463

    S. McNicholas, B. McAdam, M. Flynn, H. Humphreys. (2011) The challenges of implantable cardiac device infection due to Helcococcus kunzii. Journal of Hospital Infection 78:4, 337-338

  464. 464

    Jennifer Franke, Christian Zugck, Jan Sebastian Wolter, Lutz Frankenstein, Matthias Hochadel, Philipp Ehlermann, Ralph Winkler, Manfred Nelles, Ralf Zahn, Hugo A. Katus, Jochen Senges. (2011) A decade of developments in chronic heart failure treatment: a comparison of therapy and outcome in a secondary and tertiary hospital setting. Clinical Research in Cardiology

  465. 465

    M. Tavenaux, D.M. Ginzburg, A. Boukacem, J. Sperzel, C. Hamm, J. Jordan. (2011) Veränderungen bei Depression, Angst und vitaler Erschöpfung bei Patienten nach einer ICD-Implantation. Herzschrittmachertherapie + Elektrophysiologie

  466. 466

    Paul Marshall, Alison Ketchell, Joan Maclean. (2011) Comparison of male and female psychological outcomes related to implantable cardioverter defibrillators (COMFORTID). European Journal of Cardiovascular Nursing

  467. 467

    WILLIAM STRIMEL, SHERI KOPLIK, H. ROBERT CHEN, JUHEE SONG, SHOEI K. STEPHEN HUANG. (2011) Safety and Effectiveness of Primary Prevention Cardioverter defibrillators in Octogenarians. Pacing and Clinical Electrophysiology 34:7, 900-906

  468. 468

    JENS KREUZ, FRITZ HORLBECK, FELIX HOYER, FRITZ MELLERT, ROLF FIMMERS, LARS LICKFETT, GEORG NICKENIG, JOERG O. SCHWAB. (2011) An Impaired Renal Function: A Predictor of Ventricular Arrhythmias and Mortality in Patients with Nonischemic Cardiomyopathy and Heart Failure. Pacing and Clinical Electrophysiology 34:7, 894-899

  469. 469

    GUIDO H. VAN WELSENES, JOHANNES B. VAN REES, JOEP THIJSSEN, SERGE A. TRINES, LIESELOT VAN ERVEN, MARTIN J. SCHALIJ, C.J.W. BORLEFFS. (2011) Primary Prevention Implantable Cardioverter Defibrillator Recipients: The Need for Defibrillator Back-Up After an Event-Free First Battery Service-Life. Journal of Cardiovascular Electrophysiologyno-no

  470. 470

    Qian Li, Robert J. Glynn, Nancy A. Dreyer, Jun Liu, Helen Mogun, Soko Setoguchi. (2011) Validity of claims-based definitions of left ventricular systolic dysfunction in Medicare patients. Pharmacoepidemiology and Drug Safety 20:7, 700-708

  471. 471

    Peter Bernhardt, Sascha Stiller, Eva Kottmair, Ludwig Binner, Jochen Spieß, Georg Großmann, Volker Rasche, Daniel Walcher, Vinzenz Hombach. (2011) Myocardial scar extent evaluated by cardiac magnetic resonance imaging in ICD patients: relationship to spontaneous VT during long-term follow-up. The International Journal of Cardiovascular Imaging 27:6, 893-900

  472. 472

    Andrea Alcaraz, Jorge González-Zuelgaray, Federico Augustovski. (2011) Costo-Efectividad del Cardiodesfibrilador Implantable en Pacientes con Factores de Riesgo de Muerte Súbita en Argentina. Value in Health 14:5, S33-S38

  473. 473

    J. Brachmann, M. Bohm, K. Rybak, G. Klein, C. Butter, H. Klemm, R. Schomburg, J. Siebermair, C. Israel, A.-M. Sinha, H. Drexler, . (2011) Fluid status monitoring with a wireless network to reduce cardiovascular-related hospitalizations and mortality in heart failure: rationale and design of the OptiLink HF Study (Optimization of Heart Failure Management using OptiVol Fluid Status Monitoring and CareLink). European Journal of Heart Failure 13:7, 796-804

  474. 474

    Eric J. Rashba. (2011) Dissecting the substrate for sudden cardiac death in the absence of ischemic heart disease. Heart Rhythm

  475. 475

    Wolfgang Dichtl, Thomas Wolber, Ursula Paoli, Simon Brüllmann, Markus Stühlinger, Thomas Berger, Karin Spuller, Alexander Strasak, Otmar Pachinger, Laurent M. Haegeli, Firat Duru, Florian Hintringer. (2011) Appropriate Therapy But Not Inappropriate Shocks Predict Survival in Implantable Cardioverter Defibrillator Patients. Clinical Cardiology 34:7, 433-436

  476. 476

    TREVOR A. VERGA, JEFFREY M. GILLBERG, RICHARD M. GREENBERG, FLORIN T. DEGER. (2011) True Bipolar and Integrated Bipolar Sensing and Detection by Implantable Defibrillators. Pacing and Clinical Electrophysiologyno-no

  477. 477

    Todd D. Miller. (2011) Stress testing. Current Opinion in Cardiology1

  478. 478

    Mauro Biffi, Matteo Ziacchi, Matteo Bertini, Beatrice Gardini, Andrea Mazzotti, Giulia Massaro, Cristian Martignani, Igor Diemberger, Giuseppe Boriani, Daniela Corsini. (2011) How to truly value implantable cardioverter-defibrillators technology: Up-front cost or daily cost?. International Journal of Technology Assessment in Health Care 27:03, 201-206

  479. 479

    GUO-HUI YAN, MEI WANG, WEN-SHENG YUE, KAI-HANG YIU, GUANG ZHI, CHU-PAK LAU, STEPHEN WL LEE, CHUNG-WAH SIU, HUNG-FAT TSE. (2011) Relationship between Ventricular Dyssynchrony and T-wave Alternans in Patients with Coronary Artery Disease. Pacing and Clinical Electrophysiologyno-no

  480. 480

    Serenella Castelvecchio, Lorenzo Menicanti, Marisa Di Donato. (2011) Cirugía de restauración ventricular para revertir el remodelado del ventrículo izquierdo. Cirugía Cardiovascular 18:3, 163-173

  481. 481

    Gregg C. Fonarow, Clyde W. Yancy, Adrian F. Hernandez, Eric D. Peterson, John A. Spertus, Paul A. Heidenreich. (2011) Potential impact of optimal implementation of evidence-based heart failure therapies on mortality. American Heart Journal 161:6, 1024-1030.e3

  482. 482

    S. Arnous, N. F. Murphy, P. Pyne-Daly, Z. Nawoor, D. Keane, M. Ledwidge, K. McDonald. (2011) Clinical and psychological impact of prophylactic implantable cardioverter-defibrillators in a community heart failure population. Irish Journal of Medical Science 180:2, 369-374

  483. 483

    John R. Wilson. (2011) Rhetorical Strategies Used in the Reporting of Implantable Defibrillator Primary Prevention Trials. The American Journal of Cardiology 107:12, 1806-1811

  484. 484

    Spyridon Deftereos, Georgios Giannopoulos, Charalampos Kossyvakis, Andreas Kaoukis, Konstantinos Raisakis, Vasiliki Panagopoulou, Olga Ntzouvara, Anastasia Perpinia, Ilias Rentoukas, Vlasios Pyrgakis, Antonios S. Manolis, Christodoulos Stefanadis. (2011) Relation of Ventricular Tachycardia/Fibrillation to Beta-Blocker Dose Maximization Guided by Pacing Mode Analysis in Nonpacemaker-Dependent Patients With Implantable Cardioverter–Defibrillator. The American Journal of Cardiology 107:12, 1812-1817

  485. 485

    N. A. Mark Estes, Munther Homoud, Jonathan Weinstock, Caroline Foote, Ania Garlitski, Mark Link, Afshin Ehsan. (2011) Interdisciplinary strategies for arrhythmia program development: measuring quality, performance, and outcomes. Journal of Interventional Cardiac Electrophysiology 31:1, 91-99

  486. 486

    Kurt C. Roberts-Thomson, Dennis H. Lau, Prashanthan Sanders. (2011) The diagnosis and management of ventricular arrhythmias. Nature Reviews Cardiology 8:6, 311-321

  487. 487

    E. T. Locati. (2011) Can non-invasive parameters of sympatho-vagal modulation derived from Holter monitoring contribute to risk stratification for primary implantable cardiac-defibrillator implantation?. Europace 13:6, 776-779

  488. 488

    K. Joshi, I. Alam, E. Ruden, I. Gradus-Pizlo, J. Mahenthiran, M. Kamalesh, H. Feigenbaum, S. Sawada. (2011) Effect of improvement in left ventricular ejection fraction on long-term survival in revascularized patients with ischaemic left ventricular systolic dysfunction. European Journal of Echocardiography 12:6, 454-460

  489. 489

    Allen E. Atchley, Ami E. Iskandrian, Dan Bensimhon, Stephen J. Ellis, Dalane W. Kitzman, Linda K. Shaw, Robert A. Pagnanelli, David J. Whellan, Julius M. Gardin, Andrew Kao, Khaled Abdul-Nour, Greg Ewald, Mary Norine Walsh, William E. Kraus, Christopher M. O'Connor, Salvador Borges-Neto. (2011) Relationship of technetium-99m tetrofosmin-gated rest single-photon emission computed tomography myocardial perfusion imaging to death and hospitalization in heart failure patients: results from the nuclear ancillary study of the HF-ACTION trial. American Heart Journal 161:6, 1038-1045

  490. 490

    K. Malliaras, E. Marban. (2011) Cardiac cell therapy: where we've been, where we are, and where we should be headed. British Medical Bulletin 98:1, 161-185

  491. 491

    I. A. Fazal, M. G. D. Bates, I. G. Matthews, A. J. Turley. (2011) Do implantable cardioverter defibrillators improve survival in patients with severe left ventricular systolic dysfunction after coronary artery bypass graft surgery?. Interactive CardioVascular and Thoracic Surgery 12:6, 1010-1016

  492. 492

    C. Wolpert, A. Lubinski, A. Bissinger, B. Merkely, S. Priori, J. Brugada. (2011) Barriers to implementation of evidence-based electrical therapies and the need for outcome research: role of European registries. Europace 13:Supplement 2, ii18-ii20

  493. 493

    M. Malik. (2011) Ventricular gradient and cardiac risk. Europace 13:5, 605-607

  494. 494

    F. Leyva, I. Fernandez Lozano, J. Morgan. (2011) Cardioverter-defibrillators: a cost or an investment?. Europace 13:suppl 2, ii25-ii31

  495. 495

    A. Lubinski, A. Bissinger, L. Boersma, A. Leenhardt, B. Merkely, A. Oto, A. Proclemer, J. Brugada, P. E. Vardas, C. Wolpert. (2011) Determinants of geographic variations in implantation of cardiac defibrillators in the European Society of Cardiology member countries--data from the European Heart Rhythm Association White Book. Europace 13:5, 654-662

  496. 496

    Domingo Palacios-Ceña, Marta E. Losa-Iglesias, Cristina Álvarez-López, Miguel Cachón-Pérez, Rosalie Ann R. Reyes, Paloma Salvadores-Fuentes, César Fernández-de-las-Peñas. (2011) Patients, intimate partners and family experiences of implantable cardioverter defibrillators: qualitative systematic review. Journal of Advanced Nursingno-no

  497. 497

    PETER STEMPNIEWICZ, ALAN CHENG, ALLISON CONNOLLY, XIN YUAN WANG, HUGH CALKINS, GORDON F. TOMASELLI, RONALD D. BERGER, LARISA G. TERESHCHENKO. (2011) Appropriate and Inappropriate Electrical Therapies Delivered by an Implantable Cardioverter-Defibrillator: Effect on Intracardiac Electrogram. Journal of Cardiovascular Electrophysiology 22:5, 554-560

  498. 498

    AMIN MANUCHEHRY, KARTIK AGUSALA, MAURO MONTEVECCHI, ALAN KADISH, ROD PASSMAN. (2011) Ventricular Tachyarrhythmias in Patients Receiving an Implantable Cardioverter-Defibrillator for Primary versus Secondary Prophylaxis Indications. Pacing and Clinical Electrophysiology 34:5, 571-576

  499. 499

    F. Streitner, J. Kuschyk, C. Veltmann, E. Mahl, C. Dietrich, R. Schimpf, C. Doesch, I. Streitner, C. Wolpert, M. Borggrefe. (2011) Predictors of electrical storm recurrences in patients with implantable cardioverter-defibrillators. Europace 13:5, 668-674

  500. 500

    Tara Bourke, Nilesh Mathuria, Yoav Michowitz, Kalyanam Shivkumar. (2011) Hybrid techniques and neuraxial modulation for treatment of ventricular tachycardia. Future Cardiology 7:3, 273-276

  501. 501

    Benthe Sjøli, Bjørnar Grenne, Otto A. Smiseth, Thor Edvardsen, Harald Brunvand. (2011) The Advantage of Global Strain Compared to Left Ventricular Ejection Fraction to Predict Outcome after Acute Myocardial Infarction. Echocardiography 28:5, 556-563

  502. 502

    Douglas L. Packer, Anne M. Gillis, Hugh Calkins, Thomas F. Deering, Richard I. Fogel, Bruce L. Wilkoff. (2011) ICDs: Evidence, guidelines and glitches. Heart Rhythm 8:5, 800-803

  503. 503

    Hajime Osawa, Toshihiro Fujimatsu, Fumie Takai, Hiroyuki Suzuki. (2011) Hypertrophic cardiomyopathy with apical aneurysm: left ventricular reconstruction and cryoablation for ventricular tachycardia. General Thoracic and Cardiovascular Surgery 59:5, 354-358

  504. 504

    Maria Teresa La Rovere. Evaluation of the Autonomic Nervous System: From Algorithms to Clinical Practice. In: Advanced Methods of Biomedical Signal Processing. John Wiley & Sons, Inc., 2011:83-97.

  505. 505

    Andrew D. Blaufox, Irfan Warsy, Marise D’Souza, Ronald Kanter. (2011) Transesophageal Electrophysiological Evaluation of Children with a History of Supraventricular Tachycardia in Infancy. Pediatric Cardiology

  506. 506

    Active Ventricular Arrhythmias. In: Clinical Arrhythmology. Wiley-Blackwell, 2011:181-229.

  507. 507

    Daniel B. Kramer, Aaron S. Kesselheim, Lisa Salberg, Dan W. Brock, William H. Maisel. (2011) Ethical and Legal Views Regarding Deactivation of Cardiac Implantable Electrical Devices in Patients With Hypertrophic Cardiomyopathy. The American Journal of Cardiology 107:7, 1071-1075.e5

  508. 508

    Jaya Mallidi, Girish N. Nadkarni, Ronald D. Berger, Hugh Calkins, Saman Nazarian. (2011) Meta-analysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease. Heart Rhythm 8:4, 503-510

  509. 509

    Cameron J. Holloway, Lindsay M. Edwards, Oliver J. Rider, Angela Fast, Kieran Clarke, Jane M. Francis, Saul G. Myerson, Stefan Neubauer. (2011) A comparison of visual and quantitative assessment of left ventricular ejection fraction by cardiac magnetic resonance. The International Journal of Cardiovascular Imaging 27:4, 563-569

  510. 510

    Mahmoud Houmsse, Veronica Franco, William T. Abraham. (2011) Epidemiology of Sudden Cardiac Death in Patients with Heart Failure. Heart Failure Clinics 7:2, 147-155

  511. 511

    Andrea M. Russo. (2011) Risk stratification early post-MI after percutaneous coronary intervention: Should programmed ventricular stimulation be revisited?. Heart Rhythm 8:4, 500-502

  512. 512

    Ayesha Hasan, Benjamin Sun. (2011) Defibrillators and Cardiac Resynchronization Therapy as a Bridge to Cardiac Transplantation. Heart Failure Clinics 7:2, 227-239

  513. 513

    H. Voller, W. Kamke, H. U. Klein, M. Block, R. Reibis, S. Treusch, K. Contzen, K. Wegscheider, . (2011) Clinical practice of defibrillator implantation after myocardial infarction: impact of implant time: results from the PreSCD II Registry. Europace 13:4, 499-508

  514. 514

    Melanie D. Everitt, Amy E. Donaldson, Josef Stehlik, Aditya K. Kaza, Deborah Budge, Rami Alharethi, Emily A. Bullock, Abdallah G. Kfoury, Anji T. Yetman. (2011) Would access to device therapies improve transplant outcomes for adults with congenital heart disease? Analysis of the United Network for Organ Sharing (UNOS). The Journal of Heart and Lung Transplantation 30:4, 395-401

  515. 515

    John A Dodson, Mathew S Maurer. (2011) Changing nature of cardiac interventions in older adults. Aging Health 7:2, 283-295

  516. 516

    Samir Saba. (2011) Sudden Cardiac Death Risk Stratification and Assessment: Primary Prevention Based on Ejection Fraction Criteria. Heart Failure Clinics 7:2, 175-183

  517. 517

    Anurag Gupta, Amin Al-Ahmad, Paul J. Wang. (2011) Subcutaneous Implantable Cardioverter-Defibrillator Technology. Heart Failure Clinics 7:2, 287-294

  518. 518

    M. Santini, C. Pignalberi. (2011) Timing of defibrillator implant after acute myocardial infarction: what's new?. Europace 13:4, 455-457

  519. 519

    Ragavendra R. Baliga, James B. Young. (2011) Editorial: Sudden Death in Heart Failure: An Ounce of Prediction is Worth a Pound of Prevention. Heart Failure Clinics 7:2, xiii-xviii

  520. 520

    Michael L. Bernard, Michael R. Gold. (2011) Economic Implications and Cost-effectiveness of Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy. Heart Failure Clinics 7:2, 241-250

  521. 521

    Naohiko Nakanishi, Shinya Nishizawa, Yohei Kitamura, Takeshi Nakamura, Akiyoshi Matsumuro, Takahisa Sawada, Hiroaki Matsubara. (2011) The Increased Mortality from Witnessed Out-of-Hospital Cardiac Arrest in the Home. Prehospital Emergency Care 15:2, 271-277

  522. 522

    Rod Passman, Charles A. Herzog. (2011) End-stage renal disease: Sudden cardiac death: stratifying risk in dialysis patients. Nature Reviews Nephrology 7:3, 133-135

  523. 523

    Ayumi Goda, Lars H. Lund, Donna Mancini. (2011) The Heart Failure Survival Score outperforms the peak oxygen consumption for heart transplantation selection in the era of device therapy. The Journal of Heart and Lung Transplantation 30:3, 315-325

  524. 524

    J. Camm, S. Nisam. (2011) Implantable cardioverter-defibrillator utilization. Europace 13:3, 448-448

  525. 525

    M. Falip, M. Codina. (2011) Epilepsia. Medicine - Programa de Formación Médica Continuada Acreditado 10:74, 4991-5001

  526. 526

    Brian Clarke, Jonathan Howlett, John Sapp, Pantelis Andreou, Ratika Parkash. (2011) The Effect of Comorbidity on the Competing Risk of Sudden and Nonsudden Death in an Ambulatory Heart Failure Population. Canadian Journal of Cardiology 27:2, 254-261

  527. 527

    Saurabh Malhotra, Mithilesh K Das. (2011) Delayed and indirect effects of antiarrhythmic drugs in reducing sudden cardiac death. Future Cardiology 7:2, 203-217

  528. 528

    G. H. van Welsenes, J. B. van Rees, C. J. W. Borleffs, S. C. Cannegieter, J. J. Bax, L. van Erven, M. J. Schalij. (2011) Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients. Europace 13:3, 389-394

  529. 529

    Teresa Bastante Valiente, María J. Ruiz Cano, Juan F. Delgado, María López Gil, Fernando Arribas, Miguel A. Gómez Sánchez, José Cortina, Carlos Sáenz de la Calzada. (2011) Implante de desfibrilador como prevención primaria de muerte súbita en pacientes en lista de espera de trasplante cardiaco: experiencia de un centro. Revista Española de Cardiología 64:3, 240-242

  530. 530

    C. Butter. (2011) Verbesserung der linksventrikulären Kontraktilität durch Stimulation in der absoluten Refraktärperiode. Herzschrittmachertherapie + Elektrophysiologie 22:1, 27-33

  531. 531

    Igor Diemberger, Mauro Biffi, Cristian Martignani, Giuseppe Boriani. (2011) From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter–defibrillator systems. Expert Review of Medical Devices 8:2, 235-255

  532. 532

    Jonathan P. Piccini, Sana M. Al-Khatib, Anne S. Hellkamp, Kevin J. Anstrom, Jeanne E. Poole, Daniel B. Mark, Kerry L. Lee, Gust H. Bardy. (2011) Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Heart Rhythm 8:3, 393-400

  533. 533

    GREGORY M. MARCUS, DERRICK W. CHAN, RITA F. REDBERG. (2011) Recollection of Pain Due to Inappropriate Versus Appropriate Implantable Cardioverter-Defibrillator Shocks. Pacing and Clinical Electrophysiology 34:3, 348-353

  534. 534

    Rachel C. Myles, Francis L. Burton, Stuart M. Cobbe, Godfrey L. Smith. (2011) Alternans of action potential duration and amplitude in rabbits with left ventricular dysfunction following myocardial infarction. Journal of Molecular and Cellular Cardiology 50:3, 510-521

  535. 535

    E. Brooke Lerner, David Persse, Chris M. Souders, Fritz Sterz, Reinhard Malzer, Michael Lozano, Mark Westfall, Marc A. Brouwer, Pierre M. van Grunsven, Anne Whitehead, Jan-Aage Olsen, Ulrich R. Herken, Lars Wik. (2011) Design of the Circulation Improving Resuscitation Care (CIRC) Trial: A new state of the art design for out-of-hospital cardiac arrest research. Resuscitation 82:3, 294-299

  536. 536

    D. M. Leistner, J. Schmitt, S. Palm, J. Klotsche, S. Estel, A. Fink, C. W. Israel, B. Assmus, G. Z. Duray, S. Dimmeler, S. H. Hohnloser, A. M. Zeiher. (2011) Intracoronary administration of bone marrow-derived mononuclear cells and arrhythmic events in patients with chronic heart failure. European Heart Journal 32:4, 485-491

  537. 537

    Alon Barsheshet, Arthur J. Moss, Scott McNitt, Christian Jons, Michael Glikson, Helmut U. Klein, David T. Huang, Jonathan S. Steinberg, Mary W. Brown, Wojciech Zareba, Ilan Goldenberg. (2011) Long-term implications of cumulative right ventricular pacing among patients with an implantable cardioverter-defibrillator. Heart Rhythm 8:2, 212-218

  538. 538

    Antti M. Kiviniemi, Mikko P. Tulppo, Arto J. Hautala, Timo H. Mäkikallio, Juha S. Perkiömäki, Tapio Seppänen, Heikki V. Huikuri. (2011) Long-term outcome of patients with chronotropic incompetence after an acute myocardial infarction. Annals of Medicine 43:1, 33-39

  539. 539

    Melissa H. Kong, Gregg C. Fonarow, Eric D. Peterson, Anne B. Curtis, Adrian F. Hernandez, Gillian D. Sanders, Kevin L. Thomas, David L. Hayes, Sana M. Al-Khatib. (2011) Systematic Review of the Incidence of Sudden Cardiac Death in the United States. Journal of the American College of Cardiology 57:7, 794-801

  540. 540

    William E. Sanders, Mark W. Richey, Robert A. Malkin, Stephen C. Masson, T.J. Ransbury, Mark W. Urtz, Raymond E. Ideker. (2011) Novel intravascular defibrillator: Defibrillation thresholds of intravascular cardioverter-defibrillator compared to conventional implantable cardioverter-defibrillator in a canine model. Heart Rhythm 8:2, 288-292

  541. 541

    William T Abraham, Philip B Adamson, Robert C Bourge, Mark F Aaron, Maria Rosa Costanzo, Lynne W Stevenson, Warren Strickland, Suresh Neelagaru, Nirav Raval, Steven Krueger, Stanislav Weiner, David Shavelle, Bradley Jeffries, Jay S Yadav. (2011) Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. The Lancet 377:9766, 658-666

  542. 542

    Biykem Bozkurt. Heart Failure as a Consequence of Dilated Cardiomyopathy. In: Heart Failure: A Companion to Braunwald's Heart Disease. Elsevier, 2011:372-394.

  543. 543

    Kristina Hermann Haugaa, Thor Edvardsen, Jan P. Amlie. (2011) Prediction of Life-Threatening Arrhythmias – Still an Unresolved Problem. Cardiology 118:2, 129-137

  544. 544

    Marc A. Rozner. Cardiac Pacing and Defibrillation. In: Kaplan's Cardiac Anesthesia: The Echo Era. Elsevier, 2011:790-806.

  545. 545

    Norbert M. van Hemel. (2011) The ECG: The old ally for a better selection of preventive ICD treatment?. Heart Rhythm 8:1, 46-47

  546. 546

    Pil Sang Song, June Soo Kim, Dae-Hee Shin, Jung Wae Park, Ki In Bae, Chang Hee Lee, Dong Chae Jung, Dong Ryeol Ryu, Young Keun On. (2011) Electrical Storms in Patients with an Implantable Cardioverter Defibrillator. Yonsei Medical Journal 52:1, 26

  547. 547

    Sana M. Al-Khatib, Gillian D. Sanders, Sean M. O’Brien, Daniel Matlock, Louise O. Zimmer, Frederick A. Masoudi, Eric Peterson. (2011) Do Physicians’ Attitudes toward Implantable Cardioverter Defibrillator Therapy Vary by Patient Age, Gender, or Race?. Annals of Noninvasive Electrocardiology 16:1, 77-84

  548. 548

    D. A. M. J. Theuns, B. A. Schaer, O. I. I. Soliman, D. Altmann, C. Sticherling, M. L. Geleijnse, S. Osswald, L. Jordaens. (2011) The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality. Europace 13:1, 62-69

  549. 549

    Arnold Pinter, Paul Dorian. (2011) Device therapy: Who may and who may not benefit from an ICD?. Nature Reviews Cardiology 8:1, 10-12

  550. 550

    Kristin M. Burns, Frank Evans, Jonathan R. Kaltman. (2011) Pediatric ICD utilization in the United States from 1997 to 2006. Heart Rhythm 8:1, 23-28

  551. 551

    Subramaniam C. Krishnan. The Electrophysiology Laboratory and Electrophysiologic Procedures. In: Cardiac Catheterization Handbook. Elsevier, 2011:243-288.

  552. 552

    Jonathan P. Piccini, Jason N. Katz, Christopher B. Granger, L. Kristin Newby. The Modern Cardiac Care Unit. In: Acute Coronary Syndromes: A Companion to Braunwald's Heart Disease. Elsevier, 2011:405-416.

  553. 553

    David G. Strauss, Jeanne E. Poole, Galen S. Wagner, Ronald H. Selvester, Julie M. Miller, Jill Anderson, George Johnson, Steven E. McNulty, Daniel B. Mark, Kerry L. Lee, Gust H. Bardy, Katherine C. Wu. (2011) An ECG index of myocardial scar enhances prediction of defibrillator shocks: An analysis of the Sudden Cardiac Death in Heart Failure Trial. Heart Rhythm 8:1, 38-45

  554. 554

    Shuo-Tsan Lee, Anthony J. White, Satoshi Matsushita, Konstantinos Malliaras, Charles Steenbergen, Yiqiang Zhang, Tao-Sheng Li, John Terrovitis, Kristine Yee, Sinan Simsir, Raj Makkar, Eduardo Marbán. (2011) Intramyocardial Injection of Autologous Cardiospheres or Cardiosphere-Derived Cells Preserves Function and Minimizes Adverse Ventricular Remodeling in Pigs With Heart Failure Post-Myocardial Infarction. Journal of the American College of Cardiology 57:4, 455-465

  555. 555

    James D. Flaherty, Robert O. Bonow, Mihai Gheorghiade. Heart Failure as a Consequence of Ischemic Heart Disease. In: Heart Failure: A Companion to Braunwald's Heart Disease. Elsevier, 2011:355-371.

  556. 556

    David Bello, Arnold Einhorn, Rishi Kaushal, Satish Kenchaiah, Aidan Raney, David Fieno, Jagat Narula, Jeffrey Goldberger, Kalyanam Shivkumar, Haris Subacius, Alan Kadish. (2011) Cardiac magnetic resonance imaging: infarct size is an independent predictor of mortality in patients with coronary artery disease. Magnetic Resonance Imaging 29:1, 50-56

  557. 557

    Sandeep Talwar, Leslie A. Saxon. Clinical Trials of Cardiac Resynchronization Therapy. In: Clinical Cardiac Pacing, Defibrillation and Resynchronization Therapy. Elsevier, 2011:279-299.

  558. 558

    JÉRÔME SCHWARTZ, HUGUES BLANGY, PIERRE YVES ZINZIUS, LUC FREYSZ, ETIENNE ALIOT, NICOLAS SADOUL. (2011) Recall Alerts in Implantable Cardioverter-Defibrillator Recipients: Implications for Patients and Physicians. Pacing and Clinical Electrophysiology 34:1, 96-103

  559. 559

    Revenco Diana, Morgan James P, Tsao Lana. (2011) <![CDATA[The dilemma of implantable cardioverter-defibrillator therapy in the geriatric population]]> : The dilemma of implantable cardioverter-defibrillator therapy in the geriatric population. Journal of Geriatric Cardiology 8:3, 195

  560. 560

    Philip J. Podrid. Management of Arrhythmias in Heart Failure. In: Heart Failure: A Companion to Braunwald's Heart Disease. Elsevier, 2011:765-786.

  561. 561

    P. Santangeli, A. Dello Russo, M. Casella, G. Pelargonio, L. Di Biase, A. Natale. (2011) Left ventricular ejection fraction for the risk stratification of sudden cardiac death: friend or foe?. Internal Medicine Journal 41:1a, 55-60

  562. 562

    Bruce L. Wilkoff, Daniel J. Cantillon. Device Therapy in Heart Failure. In: Heart Failure: A Companion to Braunwald's Heart Disease. Elsevier, 2011:694-703.

  563. 563

    Derek V. Exner. Clinical Trials of Defibrillator Therapy. In: Clinical Cardiac Pacing, Defibrillation and Resynchronization Therapy. Elsevier, 2011:257-278.

  564. 564

    Marc E. Stone, Koray Arica, Masao Hayashi, Gregory W. Fischer. New Approaches to the Surgical Treatment of End-Stage Heart Failure. In: Kaplan's Cardiac Anesthesia: The Echo Era. Elsevier, 2011:814-835.

  565. 565

    Akihiko Shimizu. (2011) Indication of Implantable Devices for the Prevention of Sudden Cardiac Death. Journal of Arrhythmia 27:1, 87-90

  566. 566

    G. H. Welsenes, C. J. W. Borleffs, J. B. Rees, J. Z. Atary, J. Thijssen, E. E. Wall, M. J. Schalij. (2011) Improvements in 25 Years of Implantable Cardioverter Defibrillator Therapy. Netherlands Heart Journal 19:1, 24

  567. 567

    MAREK MALIK. (2011) Autonomic Tests to Detect Cardiac Risk and Their Clinical Practicality. Journal of Cardiovascular Electrophysiologyno-no

  568. 568

    J. Dizon, K. Chen, S. Dizon, A. Biviano, W. Whang, F. Ehlert, J. Vazquez, T. Nazif, H. Garan. (2011) A comparison of long-standing implantable cardioverter-defibrillator patients with and without appropriate therapy for ventricular arrhythmias: impact of a widening QRS. Europace 13:1, 77-81

  569. 569

    Hisham Dokainish, Matthias Friedrich, Maria C. Ziadi, Rob S. Beanlands. Use of Cardiac Imaging in the Evaluation of Heart Failure. In: Heart Failure: A Companion to Braunwald's Heart Disease. Elsevier, 2011:526-544.

  570. 570

    Takashi Kurita. (2011) Japanese Journal of Electrocardiology 31:4, 376-386

  571. 571

    Enrico Ammirati, Ornella E. Rimoldi, Paolo G. Camici. (2011) Is There Evidence Supporting Coronary Revascularization in Patients With Left Ventricular Systolic Dysfunction?. Circulation Journal 75:1, 3-10

  572. 572

    Frédéric L. Paulin, Derek V. Exner. Sudden Cardiac Death. In: Textbook of Critical Care. Elsevier, 2011:594-603.

  573. 573

    Haris M. Haqqani, Laurence M. Epstein, Joshua M. Cooper. Engineering and Construction of Pacemaker and ICD Leads. In: Clinical Cardiac Pacing, Defibrillation and Resynchronization Therapy. Elsevier, 2011:127-143.

  574. 574

    Roman Laszlo, Mathias C. Busch, Jüergen Schreieck. (2011) Genetic Polymorphisms as Risk Stratification Tool in Primary Preventive ICD Therapy. ISRN Cardiology 2011, 1-5

  575. 575

    Mathew Maurer, Eileen M. Hsich, Ileana L. Piña, Anne L. Taylor. Heart Failure in Special Populations. In: Heart Failure: A Companion to Braunwald's Heart Disease. Elsevier, 2011:716-727.

  576. 576

    Mark Kozak, Charles E. Chambers. Cardiac Catheterization Laboratory. In: Kaplan's Cardiac Anesthesia: The Echo Era. Elsevier, 2011:33-73.

  577. 577

    Dragan Kovacevic, Anastazija Stojisic-Milosavljevic, Vasilije Topalov, Bogoljub Mihajlovic, Dejan Sakac, Ziva Kozlovacki. (2011) Prevention of sudden cardiac death by the implantable cardioverter defibrilator. Medicinski pregled 64:5-6, 291-294

  578. 578

    Leonardo Calò, Tiziana De Santo, Francesca Nuccio, Luigi Sciarra, Lucia De Luca, Lorenza Mangoni di S. Stefano, Enrico Piroli, Lorenzo Zuccaro, Marco Rebecchi, Ermenegildo de Ruvo. (2011) Predictive Value of Microvolt T-Wave Alternans for Cardiac Death or Ventricular Tachyarrhythmic Events in Ischemic and Nonischemic Cardiomyopathy Patients: A Meta-Analysis : Microvolt T-Wave Alternans. Annals of Noninvasive Electrocardiology 16:4, 388

  579. 579

    M. F. Nageh, J. J. Kim, J. Chung, J. F. Yao. (2011) The role of implantable cardioverter defibrillators in high-risk CABG patients identified early post-cardiac surgery. Europace 13:1, 70-76

  580. 580

    Ilan Goldenberg, Arthur J. Moss. Implantable cardioverter defibrillators in patients with coronary artery disease. In: Coronary Care Manual. Elsevier, 2011:417-427.

  581. 581

    Harvey D. White, Derek P. Chew. Management of ST-elevation myocardial infarction. In: Coronary Care Manual. Elsevier, 2011:474-484.

  582. 582

    Nabil El-Sherif. Pathophysiology of ventricular arrhythmias in myocardial infarction and sudden cardiac death. In: Coronary Care Manual. Elsevier, 2011:79-88.

  583. 583

    David A. Richards, David L. Ross. Ventricular tachycardia. In: Coronary Care Manual. Elsevier, 2011:543-547.

  584. 584

    Michael V. Jelinek. Driving, flying, and sport after a coronary event. In: Coronary Care Manual. Elsevier, 2011:678-680.

  585. 585

    Tang , Anthony S.L. , Wells , George A. , Talajic , Mario , Arnold , Malcolm O. , Sheldon , Robert , Connolly , Stuart , Hohnloser , Stefan H. , Nichol , Graham , Birnie , David H. , Sapp , John L. , Yee , Raymond , Healey , Jeffrey S. , Rouleau , Jean L. , . (2010) Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure. New England Journal of Medicine 363:25, 2385-2395
    Free Full Text

  586. 586

    Deepak Bhakta, Miriam R. Groh, Changyu Shen, Robert M. Pascuzzi, William J. Groh. (2010) Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1. American Heart Journal 160:6, 1137-1141.e1

  587. 587

    Anthony P. Redhead, Douglas Turkington, Sanjay Rao, Margaret M. Tynan, John P. Bourke. (2010) Psychopathology in postinfarction patients implanted with cardioverter-defibrillators for secondary prevention. A cross-sectional, case-controlled study. Journal of Psychosomatic Research 69:6, 555-563

  588. 588

    CHARLES D. SWERDLOW, MICHAEL SHEHATA. (2010) Antitachycardia Pacing in Primary-Prevention ICDs. Journal of Cardiovascular Electrophysiology 21:12, 1355-1357

  589. 589

    MOHAMMAD SAEED, CURTIS G. NEASON, MEHDI RAZAVI, SHANKER CHANDIRAMANI, JOSEPH ALONSO, SENTHIL NATARAJAN, JOHN H. IP, DARREN F. PERESS, SUMATI RAMADAS, ALI MASSUMI. (2010) Programming Antitachycardia Pacing for Primary Prevention in Patients With Implantable Cardioverter Defibrillators: Results From the PROVE Trial. Journal of Cardiovascular Electrophysiology 21:12, 1349-1354

  590. 590

    U.C. Hoppe, E. Erdmann. (2010) Herzinsuffizienz Update 2010 und aktuelle ESC-Leitlinien. Herz 35:8, 535-541

  591. 591

    J. S. HEALEY, D. H. BIRNIE, D. S. LEE, A. D. Krahn, E. Crystal, C. S. Simpson, P. Dorian, Z. Chen, D. Cameron, A. Verma, S. J. Connolly, L. J. Gula, E. Lockwood, G. Nair, J. V. Tu, . (2010) Defibrillation Testing at the Time of ICD Insertion: An Analysis From the Ontario ICD Registry. Journal of Cardiovascular Electrophysiology 21:12, 1344-1348

  592. 592

    G.C. Grönefeld, D. Bänsch. (2010) Antiarrhythmische Therapie mit β-Rezeptor-Antagonisten. Herzschrittmachertherapie + Elektrophysiologie 21:4, 222-227

  593. 593

    I. Battipaglia, L. Barone, L. Mariani, F. Infusino, R. Remoli, G. Careri, G. Pinnacchio, P. Tarzia, G. A. Lanza, F. Crea. (2010) Relationship between cardiac autonomic function and sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillators. Europace 12:12, 1725-1731

  594. 594

    SUSANNE S. PEDERSEN, KRISTA C. VAN DEN BROEK, MARTHA VAN DEN BERG, DOMINIC A. M. J. THEUNS. (2010) Shock as a Determinant of Poor Patient-Centered Outcomes in Implantable Cardioverter Defibrillator Patients: Is There More to It Than Meets the Eye?. Pacing and Clinical Electrophysiology 33:12, 1430-1436

  595. 595

    H.H. Klein, A. Krämer, B.M. Pieske, H.-J. Trappe, H. Vries. (2010) Fahreignung bei kardiovaskulären Erkrankungen. Der Kardiologe 4:6, 441-473

  596. 596

    Javier Alzueta, Antonio Linde, Alberto Barrera, Jose Peña, Rafael Peinado. (2010) Registro Español de Desfibrilador Automático Implantable. VI Informe Oficial del Grupo de Trabajo de Desfibrilador Automático Implantable de la Sociedad Española de Cardiología (2009). Revista Española de Cardiología 63:12, 1468-1481

  597. 597

    Zeliha Koyak, Joris R de Groot, Barbara JM Mulder. (2010) Interventional and surgical treatment of cardiac arrhythmias in adults with congenital heart disease. Expert Review of Cardiovascular Therapy 8:12, 1753-1766

  598. 598

    Arnold C.T. Ng, Matteo Bertini, C. Jan Willem Borleffs, Victoria Delgado, Eric Boersma, Sebastiaan R.D. Piers, Joep Thijssen, Gaetano Nucifora, Miriam Shanks, See Hooi Ewe, Mauro Biffi, Nico R.L. van de Veire, Dominic Y. Leung, Martin J. Schalij, Jeroen J. Bax. (2010) Predictors of Death and Occurrence of Appropriate Implantable Defibrillator Therapies in Patients With Ischemic Cardiomyopathy. The American Journal of Cardiology 106:11, 1566-1573

  599. 599

    Penchala S. Mittadodla, Philip N. Salen, Darren M. Traub. (2010) Isoproterenol as an adjunct for treatment of idiopathic ventricular fibrillation storm in a pregnant woman. The American Journal of Emergency Medicine

  600. 600

    Casey S. Hager, Sunil Jain, Jeffry Blackwell, Benjamin Culp, Juhee Song, Christopher D. Chiles. (2010) Effect of Renal Function on Survival After Implantable Cardioverter Defibrillator Placement. The American Journal of Cardiology 106:9, 1297-1300

  601. 601

    Massimo Volpe, Pietro Francia, Giuliano Tocci, Speranza Rubattu, Sara Cangianiello, Maria Assunta Elena Rao, Bruno Trimarco, Mario Condorelli. (2010) Prediction of Long-Term Survival in Chronic Heart Failure by Multiple Biomarker Assessment: A 15-Year Prospective Follow-Up Study. Clinical Cardiology 33:11, 700-707

  602. 602

    E. Claver, R. Leta, S. Pujadas, A. Hidalgo, F. Carreras, G. Pons-Lladó. (2010) Evaluación del ventrículo izquierdo por ecocardiografia tridimensional. Comparación con la Cardio-RM. Radiología 52:6, 534-540

  603. 603

    Wilbert S Aronow. (2010) Implantable Cardioverter-Defibrillators. American Journal of Therapeutics 17:6, e208-e220

  604. 604

    Saurabh Kumar, Gopal Sivagangabalan, Sarah Zaman, Elizabeth B. West, Arun Narayan, Aravinda Thiagalingam, Pramesh Kovoor. (2010) Electrophysiology-guided defibrillator implantation early after ST-elevation myocardial infarction. Heart Rhythm 7:11, 1589-1597

  605. 605

    Eric C. Stecker. (2010) Is there new hope for sudden cardiac death prevention early after myocardial infarction?. Heart Rhythm 7:11, 1598-1599

  606. 606

    Larisa G. Tereshchenko, Lichy Han, Alan Cheng, Joseph E. Marine, David D. Spragg, Sunil Sinha, Darshan Dalal, Hugh Calkins, Gordon F. Tomaselli, Ronald D. Berger. (2010) Beat-to-beat three-dimensional ECG variability predicts ventricular arrhythmia in ICD recipients. Heart Rhythm 7:11, 1606-1613

  607. 607

    EDWARD SZE, ARTHUR J. MOSS, SCOTT MCNITT, ALON BARSHESHET, MARK L. ANDREWS, WOJCIECH ZAREBA, ILAN GOLDENBERG, . (2010) Risk Factors for Recurrent Heart Failure Events in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). Journal of Cardiovascular Electrophysiology 21:11, 1217-1223

  608. 608

    Shibaji Shome, Dan Li, Julie Thompson, Aaron McCabe. (2010) Improving contemporary algorithms for implantable cardioverter-defibrillator function. Journal of Electrocardiology 43:6, 503-508

  609. 609

    EDWARD DUNCAN, GLYN THOMAS, NEVILLE JOHNS, CAMERON PFEFFER, GAUTHAM APPANNA, NIRAV SHAH, ROSS HUNTER, MALCOLM FINLAY, RICHARD J. SCHILLING, SIMON SPORTON. (2010) Do Traditional VT Zones Improve Outcome in Primary Prevention ICD Patients?. Pacing and Clinical Electrophysiology 33:11, 1353-1358

  610. 610

    J. Z. Atary, C. J. W. Borleffs, J. G. van der Bom, S. A. I. P. Trines, M. Bootsma, K. Zeppenfeld, L. van Erven, M. J. Schalij. (2010) Right ventricular stimulation threshold at ICD implant predicts device therapy in primary prevention patients with ischaemic heart disease. Europace 12:11, 1581-1588

  611. 611

    Arend F.L. Schinkel, Jeroen J. Bax, Victoria Delgado, Don Poldermans, Shahbudin H. Rahimtoola. (2010) Clinical Relevance of Hibernating Myocardium in Ischemic Left Ventricular Dysfunction. The American Journal of Medicine 123:11, 978-986

  612. 612

    Larisa G. Tereshchenko, Alan Cheng, Barry J. Fetics, Joseph E. Marine, David D. Spragg, Sunil Sinha, Hugh Calkins, Gordon F. Tomaselli, Ronald D. Berger. (2010) Ventricular arrhythmia is predicted by sum absolute QRST integralbut not by QRS width. Journal of Electrocardiology 43:6, 548-552

  613. 613

    Arthur E. Fass. (2010) Chronic Coronary Disease in the Post-COURAGE Era. Cardiology in Review 18:6, 292-297

  614. 614

    Alan Cheng, Yongfei Wang, Jeptha P. Curtis, Paul D. Varosy. (2010) Acute Lead Dislodgements and In-Hospital Mortality in Patients Enrolled in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry. Journal of the American College of Cardiology 56:20, 1651-1656

  615. 615

    Wilbert S Aronow. (2010) Use of implantable cardioverter-defibrillators. Future Cardiology 6:6, 859-870

  616. 616

    D. A. M. J. Theuns, T. Smith, M. G. M. Hunink, G. H. Bardy, L. Jordaens. (2010) Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis. Europace 12:11, 1564-1570

  617. 617

    Daniel B. Kramer, Aaron S. Kesselheim, Dan W. Brock, William H. Maisel. (2010) Ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: A quantitative assessment. Heart Rhythm 7:11, 1537-1542

  618. 618

    Fadi A. Saab, Philippe Gabriel Steg, Álvaro Avezum, José López-Sendón, Frederick A. Anderson, Wei Huang, Kim A. Eagle. (2010) Can an elderly woman's heart be too strong?. American Heart Journal 160:5, 849-854

  619. 619

    Nico R. Van de Veire, Jeroen J. Bax. Imaging the Failing Heart. In: Management of Heart Failure. John Wiley & Sons, Ltd, 2010:45-81.

  620. 620

    Sanjiv M. Narayan. Preventing Sudden Cardiac Arrest in the Heart Failure Patient. In: Management of Heart Failure. John Wiley & Sons, Ltd, 2010:177-195.

  621. 621

    Philip B. Adamson. Devices for Following Heart Failure Patients. In: Management of Heart Failure. John Wiley & Sons, Ltd, 2010:235-254.

  622. 622

    Vijay U. Rao, John R. Teerlink. Treating Systolic Heart Failure. In: Management of Heart Failure. John Wiley & Sons, Ltd, 2010:287-326.

  623. 623

    E. Maffei, G. Messalli, A. Palumbo, C. Martini, S. Seitun, A. Aldrovandi, A. Cuttone, E. Emiliano, R. Malagò, A. Weustink, N. Mollet, F. Cademartiri. (2010) Left ventricular ejection fraction: real-world comparison between cardiac computed tomography and echocardiography in a large population. La radiologia medica 115:7, 1015-1027

  624. 624

    J. Kreuz, O. Balta, M. Linhart, R. Fimmers, L. Lickfett, F. Mellert, G. Nickenig, J. O. Schwab. (2010) An impaired renal function and advanced heart failure represent independent predictors of the incidence of malignant ventricular arrhythmias in patients with an implantable cardioverter/defibrillator for primary prevention. Europace 12:10, 1439-1445

  625. 625

    Palaniappan Saravanan, Gavin Freeman, Neil C. Davidson. (2010) Risk assessment for sudden cardiac death in dialysis patients: How relevant are conventional cardiac risk factors?. International Journal of Cardiology 144:3, 431-432

  626. 626

    Alon Barsheshet, Ilan Goldenberg, Craig R. Narins, Arthur J. Moss, Scott McNitt, Paul J. Wang, David T. Huang, W. Jackson Hall, Wojciech Zareba, Michael Eldar, Victor Guetta. (2010) Time dependence of life-threatening ventricular tachyarrhythmias after coronary revascularization in MADIT-CRT. Heart Rhythm 7:10, 1421-1427

  627. 627

    M. Juhani Junttila, Petra Barthel, Robert J. Myerburg, Timo H. Mäkikallio, Axel Bauer, Kurt Ulm, Antti Kiviniemi, Mikko Tulppo, Juha S. Perkiömäki, Georg Schmidt, Heikki V. Huikuri. (2010) Sudden cardiac death after myocardial infarction in patients with type 2 diabetes. Heart Rhythm 7:10, 1396-1403

  628. 628

    Kei Nishiyama, Satoshi Shizuta, Takahiro Doi, Takeshi Morimoto, Takeshi Kimura. (2010) Sudden cardiac death after PCI and CABG in the bare-metal stent era: Incidence, prevalence, and predictors. International Journal of Cardiology 144:2, 263-266

  629. 629

    Niels F. Otani, Stefan Luther, Rupinder Singh, Robert F. Gilmour. (2010) Transmural Ultrasound-based Visualization of Patterns of Action Potential Wave Propagation in Cardiac Tissue. Annals of Biomedical Engineering 38:10, 3112-3123

  630. 630

    Melissa H. Kong, Eric D. Peterson, Gregg C. Fonarow, Gillian D. Sanders, Clyde W. Yancy, Andrea M. Russo, Anne B. Curtis, Samuel F. Sears, Kevin L. Thomas, Susan Campbell, Mark D. Carlson, Chris Chiames, Nakela L. Cook, David L. Hayes, Michelle LaRue, Adrian F. Hernandez, Edward L. Lyons, Sana M. Al-Khatib. (2010) Addressing disparities in sudden cardiac arrest care and the underutilization of effective therapies. American Heart Journal 160:4, 605-618.e1

  631. 631

    S. S. Pedersen, K. C. van den Broek, R. A. M. Erdman, L. Jordaens, D. A. M. J. Theuns. (2010) Pre-implantation implantable cardioverter defibrillator concerns and Type D personality increase the risk of mortality in patients with an implantable cardioverter defibrillator. Europace 12:10, 1446-1452

  632. 632

    Matthew J. O'Connor, David N. Rosenthal, Robert E. Shaddy. (2010) Outpatient Management of Pediatric Heart Failure. Heart Failure Clinics 6:4, 515-529

  633. 633

    Timm-Michael L. Dickfeld. Image-Guided Electrophysiology Mapping and Ablation. In: Cardiac CT, PET and MR. Wiley-Blackwell, 2010:334-353.

  634. 634

    Jason T. Jacobson, Justin B. Weiner. (2010) REVIEW: Management of Ventricular Tachycardia in Patients with Structural Heart Disease. Cardiovascular Therapeutics 28:5, 255-263

  635. 635

    Giuseppe Boriani, Igor Diemberger, Cinzia Valzania, Mauro Biffi, Cristian Martignani, Emanuel Raschi, Valentina Mantovani, Matteo Ziacchi, Matteo Bertini, Fabrizio De Ponti, Angelo Branzi. (2010) Role of drugs and devices in patients at risk of sudden cardiac death. Fundamental & Clinical Pharmacology 24:5, 575-594

  636. 636

    Fernando Hornero, Jesús Almendral. (2010) Arritmias ventriculares. Aspectos generales. Cirugía Cardiovascular 17:3, 219-229

  637. 637

    Stephen C. Hammill, Mark S. Kremers, Lynne Warner Stevenson, Paul A. Heidenreich, Christine M. Lang, Jeptha P. Curtis, Yongfei Wang, Charles I. Berul, Alan H. Kadish, Sana M. Al-Khatib, Ileana L. Pina, Mary Norine Walsh, Michael J. Mirro, Bruce D. Lindsay, Matthew R. Reynolds, Kathryn Pontzer, Laura Blum, Frederick Masoudi, John Rumsfeld, Ralph G. Brindis. (2010) Review of the Registry's Fourth Year, Incorporating Lead Data and Pediatric ICD Procedures, and Use as a National Performance Measure. Heart Rhythm 7:9, 1340-1345

  638. 638

    Anoop K Shetty, Miles WH Behan, Julian Bostock, C Aldo Rinaldi. (2010) Device therapy for the management of cardiac tachyarrhythmias. Expert Review of Cardiovascular Therapy 8:9, 1257-1266

  639. 639

    PAUL S. CHAN, MICHAEL R. GOLD, BRAHMAJEE K. NALLAMOTHU. (2010) Do Beta-Blockers Impact Microvolt T-Wave Alternans Testing in Patients at Risk for Ventricular Arrhythmias? A Meta-Analysis. Journal of Cardiovascular Electrophysiology 21:9, 1009-1014

  640. 640

    Cara N. Pellegrini, Melvin M. Scheinman. (2010) Clinical Management of Ventricular Tachycardia. Current Problems in Cardiology 35:9, 453-504

  641. 641

    Sony Jacob, Prasad K. Cherian, Waqas S. Ghumman, Mithilesh K. Das. (2010) “Pseudo” Faraday cage: a solution for telemetry link interaction between a left ventricular assist device and an implantable cardioverter defibrillator. Journal of Interventional Cardiac Electrophysiology 28:3, 221-225

  642. 642

    Ann Marie P. Mauro. (2010) Long-term follow-up study of uncertainty and psychosocial adjustment among implantable cardioverter defibrillator recipients. International Journal of Nursing Studies 47:9, 1080-1088

  643. 643

    EATHAR RAZAK, SWAPNA KAMIREDDY, SAMIR SABA. (2010) Implantable Cardioverter-Defibrillators Confer Survival Benefit in Patients with Chronic Obstructive Pulmonary Disease. Pacing and Clinical Electrophysiology 33:9, 1125-1130

  644. 644

    Francisco J. Pastor-Pérez, Sergio Manzano-Fernández, Rebeca Goya-Esteban, Domingo A. Pascual-Figal, Oscar Barquero-Pérez, Jose Luis Rojo-Álvarez, Maria Dolores Martinez Martinez-Espejo, Mariano Valdés Chavarri, Arcadio García-Alberola. (2010) Comparison of Detection of Arrhythmias in Patients With Chronic Heart Failure Secondary to Non-Ischemic Versus Ischemic Cardiomyopathy by 1 Versus 7-Day Holter Monitoring. The American Journal of Cardiology 106:5, 677-681

  645. 645

    Javed Butler, Inder S. Anand, Michael A. Kuskowski, Thomas Rector, Peter Carson, Jay N. Cohn, . (2010) Digoxin Use and Heart Failure Outcomes: Results from the Valsartan Heart Failure Trial (Val-HeFT). Congestive Heart Failure 16:5, 191-195

  646. 646

    MASSIMO BARAVELLI, PAOLO CATTANEO, ANDREA ROSSI, MARIA CRISTINA ROSSI, CECILIA FANTONI, ANNA PICOZZI, DANIELA IMPERIALE, MELANIA ROMANO, LUCIA SAPORITI, ALDA BREGASI, LORENZO MENICANTI, CLAUDIO ANZÀ. (2010) Low-Risk Profile for Malignant Ventricular Arrhythmias and Sudden Cardiac Death after Surgical Ventricular Reconstruction. Pacing and Clinical Electrophysiology 33:9, 1054-1062

  647. 647

    Niloufar Tabatabaei, Stephen C. Hammill. (2010) Role of the Automatic Implantable Cardioverter Defibrillator in the Post-myocardial Infarction Patient. Current Cardiovascular Risk Reports 4:5, 321-326

  648. 648

    J. Jimenez-Candil, J. Hernandez, A. Martin, M. Ruiz-Olgado, J. Herrero, C. Ledesma, J. Morinigo, C. Martin-Luengo. (2010) Influence of beta-blocker therapy on antitachycardia pacing effectiveness for monomorphic ventricular tachycardias occurring in implantable cardioverter-defibrillator patients: a dose-dependent effect. Europace 12:9, 1231-1238

  649. 649

    Peter Nordbeck, Bernhard Seidl, Beatrix Fey, Wolfgang R. Bauer, Oliver Ritter. (2010) Effect of cardiac resynchronization therapy on the incidence of electrical storm. International Journal of Cardiology 143:3, 330-336

  650. 650

    Yuri B. Pride, Jennifer L. Giuseffi, Satishkumar Mohanavelu, Caitlin J. Harrigan, Warren J. Manning, C. Michael Gibson, Evan Appelbaum. (2010) Relation Between Infarct Size in ST-Segment Elevation Myocardial Infarction Treated Successfully by Percutaneous Coronary Intervention and Left Ventricular Ejection Fraction Three Months After the Infarct. The American Journal of Cardiology 106:5, 635-640

  651. 651

    Brian Feingold, Gaurav Arora, Steven A. Webber, Kenneth J. Smith. (2010) Cost-Effectiveness of Implantable Cardioverter-Defibrillators in Children With Dilated Cardiomyopathy. Journal of Cardiac Failure 16:9, 734-741

  652. 652

    Shane F. Tsai, David P. Chan, Pamela S. Ro, Bethany Boettner, Curt J. Daniels. (2010) Rate of Inducible Ventricular Arrhythmia in Adults With Congenital Heart Disease. The American Journal of Cardiology 106:5, 730-736

  653. 653

    Mauricio Arruda, Tamer Fahmy, Luciana Armaganijan, Luigi Biase, Dimpi Patel, Andrea Natale. (2010) Endocardial and epicardial mapping and catheter ablation of post myocardial infarction ventricular tachycardia. Journal of Interventional Cardiac Electrophysiology 28:2, 137-145

  654. 654

    Gianluca Di Bella, Concetta Zito, Michele Gaeta, Maurizio Cusmà Piccione, Fabio Minutoli, Rocco Donato, Antonino Recupero, Antonio Madaffari, Sebastiano Coglitore, Scipione Carerj. (2010) Semiautomatic Quantification of Left Ventricular Function by Two-Dimensional Feature Tracking Imaging Echocardiography. A Comparison Study with Cardiac Magnetic Resonance Imaging. Echocardiography 27:7, 791-797

  655. 655

    P. Omoumi, J.P. Métais, P. Bertrand, D. Alison. (2010) Volumétrie et fraction d’éjection ventriculaires gauches et droites en IRM : critères de contourage et reproductibilité interobservateur. Journal de Radiologie 91:7-8, 769-778

  656. 656

    R. F. E. Pedretti, A. Curnis, R. Massa, F. Morandi, M. Tritto, L. Manca, E. Occhetta, G. Molon, G. M. De Ferrari, S. Sarzi Braga, G. Raciti, C. Klersy, J. A. Salerno-Uriarte, . (2010) Proportion of patients needing an implantable cardioverter defibrillator on the basis of current guidelines: impact on healthcare resources in Italy and the USA. Data from the ALPHA study registry. Europace 12:8, 1105-1111

  657. 657

    S. M. Al-Khatib, G. Hafley, K. L. Lee, A. E. Buxton. (2010) Relation between time from myocardial infarction to enrolment and patient outcomes in the Multicenter UnSustained Tachycardia Trial. Europace 12:8, 1112-1118

  658. 658

    PREETHAM REDDY, DAVID G. BENDITT, SELCUK ADABAG. (2010) CASE REPORT: Electromagnetic Device-Device Interaction between a New Generation Implantable Pacemaker and Left Ventricular Assist Device: Recognition and Potential Solutions. Pacing and Clinical Electrophysiologyno-no

  659. 659

    Faris Khan, Evan Adelstein, Samir Saba. (2010) Implantable cardioverter defibrillators confer survival benefit in patients with renal insufficiency but not in dialysis-dependent patients. Journal of Interventional Cardiac Electrophysiology 28:2, 117-123

  660. 660

    KENT R. NILSSON, KEVIN P. JACKSON. (2010) CASE REPORT: Hemiazygous Coil Placement for High-Defibrillation Thresholds in a Patient with a Right-Sided Implantable Cardioverter Defibrillator. Pacing and Clinical Electrophysiologyno-no

  661. 661

    H. V. Huikuri. (2010) Timing of implantation of cardioverter-defibrillator after acute myocardial infarction. Europace 12:8, 1057-1058

  662. 662

    S. I. Chrysostomakis, P. E. Vardas. (2010) 'Shocking' discrepancies. Europace 12:8, 1055-1056

  663. 663

    Bardy , Gust H. , Smith , Warren M. , Hood , Margaret A. , Crozier , Ian G. , Melton , Iain C. , Jordaens , Luc , Theuns , Dominic , Park , Robert E. , Wright , David J. , Connelly , Derek T. , Fynn , Simon P. , Murgatroyd , Francis D. , Sperzel , Johannes , Neuzner , Jörg , Spitzer , Stefan G. , Ardashev , Andrey V. , Oduro , Amo , Boersma , Lucas , Maass , Alexander H. , Van Gelder , Isabelle C. , Wilde , Arthur A. , van Dessel , Pascal F. , Knops , Reinoud E. , Barr , Craig S. , Lupo , Pierpaolo , Cappato , Riccardo , Grace , Andrew A. , . (2010) An Entirely Subcutaneous Implantable Cardioverter–Defibrillator. New England Journal of Medicine 363:1, 36-44
    Free Full Text

  664. 664

    Roger A. Winkle. (2010) The Effectiveness and Cost Effectiveness of Public-Access Defibrillation. Clinical Cardiology 33:7, 396-399

  665. 665

    Janine Pöss, Claudius Jacobshagen, Christian Ukena, Michael Böhm. (2010) Hotlines and clinical trial updates presented at the German Cardiac Society Meeting 2010: FAIR-HF, CIPAMI, LIPSIA-NSTEMI, Handheld-BNP, PEPCAD III, remote ischaemic conditioning, CERTIFY, PreSCD-II, German Myocardial Infarction Registry, DiaRegis. Clinical Research in Cardiology 99:7, 411-417

  666. 666

    Yvan Le Dolley, Franck Thuny, Julien Mancini, Jean-Paul Casalta, Alberto Riberi, Frédérique Gouriet, Emilie Bastard, Sebastien Ansaldi, Frederic Franceschi, Sebastien Renard, Sebastien Prevot, Roch Giorgi, Laurence Tafanelli, Jean-François Avierinos, Didier Raoult, Jean-Claude Deharo, Gilbert Habib. (2010) Diagnosis of Cardiac Device–Related Infective Endocarditis After Device Removal. JACC: Cardiovascular Imaging 3:7, 673-681

  667. 667

    Badri Chandrasekaran, Peter J Cowburn. (2010) Heart failure: the challenge of selecting patients for implantable cardioverter defibrillator therapy. Expert Review of Medical Devices 7:4, 461-467

  668. 668

    Sanders H. Chae, Todd M. Koelling. (2010) Patient and Physician Determinants of Implantable Cardioverter Defibrillator Use in the Heart Failure Population. Congestive Heart Failure 16:4, 141-146

  669. 669

    M. R. Cowie. (2010) Response to Editorial: Pitfalls in economic analysis. Europace 12:7, 1044-1046

  670. 670

    Norman C Wang, Jonathan P Piccini, Marvin A Konstam, Aldo P Maggioni, Brian Traver, Karl Swedberg, James E Udelson, Faiez Zannad, Thomas Cook, Christopher M OʼConnor, Alan B Miller, Liliana Grinfeld, Mihai Gheorghiade. (2010) Implantable Cardioverter-Defibrillators in Patients Hospitalized for Heart Failure With Chronically Reduced Left Ventricular Ejection Fraction. American Journal of Therapeutics 17:4, e78-e87

  671. 671

    EVAN C. ADELSTEIN, ALAA SHALABY, SAMIR SABA. (2010) Response to Cardiac Resynchronization Therapy in Patients with Heart Failure and Renal Insufficiency. Pacing and Clinical Electrophysiology 33:7, 850-859

  672. 672

    Pasquale Santangeli, Gemma Pelargonio, Antonio Dello Russo, Michela Casella, Caterina Bisceglia, Stefano Bartoletti, Pietro Santarelli, Luigi Di Biase, Andrea Natale. (2010) Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: A systematic review and meta-analysis. Heart Rhythm 7:7, 876-882

  673. 673

    Hamid Ghanbari, Christian Machado. (2010) ICD therapy in women: Are men from Mars and women from Venus?. Heart Rhythm 7:7, 883-884

  674. 674

    Jonathan P. Piccini, Aijing Z. Starr, John R. Horton, Linda K. Shaw, Kerry L. Lee, Sana M. Al-Khatib, Ami E. Iskandrian, Christopher M. O'Connor, Salvador Borges-Neto. (2010) Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging and the Risk of Sudden Cardiac Death in Patients With Coronary Disease and Left Ventricular Ejection Fraction >35%. Journal of the American College of Cardiology 56:3, 206-214

  675. 675

    Mohammad Reza Movahed, Sudhakar Sattur. (2010) Low ejection fraction documented during cardiac catheterization is significantly associated with long-term, all-cause mortality. Cardiovascular Revascularization Medicine 11:3, 163-166

  676. 676

    Sandra L. Carroll, Heather M. Arthur. (2010) A comparative study of uncertainty, optimism and anxiety in patients receiving their first implantable defibrillator for primary or secondary prevention of sudden cardiac death. International Journal of Nursing Studies 47:7, 836-845

  677. 677

    Mina K. Chung, Steven J. Szymkiewicz, Mingyuan Shao, Edwin Zishiri, Mark J. Niebauer, Bruce D. Lindsay, Patrick J. Tchou. (2010) Aggregate National Experience With the Wearable Cardioverter-Defibrillator. Journal of the American College of Cardiology 56:3, 194-203

  678. 678

    Wilbert S. Aronow. (2010) Office Management after Myocardial Infarction. The American Journal of Medicine 123:7, 593-595

  679. 679

    Jo-Jo Hai, Chung-Wah Siu, Hee-Hwa Ho, Sheung-Wai Li, Stephen Lee, Hung-Fat Tse. (2010) Relationship between changes in heart rate recovery after cardiac rehabilitation on cardiovascular mortality in patients with myocardial infarction. Heart Rhythm 7:7, 929-936

  680. 680

    Gillian D. Sanders, Melissa H. Kong, Sana M. Al-Khatib, Eric D. Peterson. (2010) Cost-effectiveness of implantable cardioverter defibrillators in patients ≥65 years of age. American Heart Journal 160:1, 122-131

  681. 681

    Guy Amit, David S. Rosenbaum, Dennis M. Super, Otto Costantini. (2010) Microvolt T-wave alternans and electrophysiologic testing predict distinct arrhythmia substrates: Implications for identifying patients at risk for sudden cardiac death. Heart Rhythm 7:6, 763-768

  682. 682

    MANOJ N. OBEYESEKERE, WILLIAM CHAN, DION STUB, S PRABHU, ELIZA P TEO, GEOFF TOOGOOD, JUSTIN MARIANI, ARCHER BROUGHTON, PETER M KISTLER. (2010) Left Ventricular Ejection Fraction and Absence of ACE Inhibitor/Angiotensin II Receptor Blocker Predicts Appropriate Defibrillator Therapy in the Primary Prevention Population. Pacing and Clinical Electrophysiology 33:6, 696-704

  683. 683

    Sanjeev P. Bhavnani, Jeffrey Kluger, Craig I. Coleman, C. Michael White, Danette Guertin, Nabil A. Shafi, Ravi K. Yarlagadda, Christopher A. Clyne. (2010) The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators. Heart Rhythm 7:6, 755-760

  684. 684

    Mark J. Boogers, Martin J. Schalij, Jeroen J. Bax. (2010) Should mechanical dyssynchrony be assessed in patients with implantable cardioverter-defibrillators?. Journal of Nuclear Cardiology 17:3, 354-358

  685. 685

    Mark J. Boogers, C. Jan Willem Borleffs, Maureen M. Henneman, Rutger J. van Bommel, Jan van Ramshorst, Eric Boersma, Petra Dibbets-Schneider, Marcel P. Stokkel, Ernst E. van der Wall, Martin J. Schalij, Jeroen J. Bax. (2010) Cardiac Sympathetic Denervation Assessed With 123-Iodine Metaiodobenzylguanidine Imaging Predicts Ventricular Arrhythmias in Implantable Cardioverter-Defibrillator Patients. Journal of the American College of Cardiology 55:24, 2769-2777

  686. 686

    Guido Ritscher, Helge Simon, Georg Nölker, Johannes Brachmann, Anil-Martin Sinha. (2010) Elektrophysiologische Diagnostik und Therapie. Medizinische Klinik 105:6, 416-430

  687. 687

    Wael A. AlJaroudi, Fadi G. Hage, Daniel Hermann, Harish Doppalapudi, Rajesh Venkataraman, Jaekyeong Heo, Ami E. Iskandrian. (2010) Relation of left-ventricular dyssynchrony by phase analysis of gated SPECT images and cardiovascular events in patients with implantable cardiac defibrillators. Journal of Nuclear Cardiology 17:3, 398-404

  688. 688

    BRETT D. ATWATER, JAMES P. DAUBERT. (2010) Can We Improve the Identification of Ventricular Scar to Guide Substrate-Based Ventricular Tachycardia Ablation?. Journal of Cardiovascular Electrophysiology 21:6, 685-687

  689. 689

    Scott M. Berry, K. Jack Ishak, Bryan R. Luce, Donald A. Berry. (2010) Bayesian Meta-Analyses for Comparative Effectiveness and Informing Coverage Decisions. Medical Care 48, S137-S144

  690. 690

    D. Bänsch, G. Grönefeld. (2010) Der Patient mit chronischer Herzinsuffizienz. Herzschrittmachertherapie + Elektrophysiologie 21:2, 112-116

  691. 691

    N.C. Ewertsen, G. Steinbeck, J. Senges, D. Andresen. (2010) ICD-Therapie zur Primärprävention. Herzschrittmachertherapie + Elektrophysiologie 21:2, 109-111

  692. 692

    T. BEN MORRISON, ROBERT F. REA, DAVID O. HODGE, DANIEL CRUSAN, CELESTE KOESTLER, SAMUEL J. ASIRVATHAM, DAVID BRADLEY, WIN K. SHEN, THOMAS M. MUNGER, STEPHEN C. HAMMILL, PAUL A. FRIEDMAN. (2010) Risk Factors for Implantable Defibrillator Lead Fracture in a Recalled and a Nonrecalled Lead. Journal of Cardiovascular Electrophysiology 21:6, 671-677

  693. 693

    Sumeet S. Chugh. (2010) Early identification of risk factors for sudden cardiac death. Nature Reviews Cardiology 7:6, 318-326

  694. 694

    Keiichi Inada, Kurt C. Roberts-Thomson, Jens Seiler, Daniel Steven, Usha B. Tedrow, Bruce A. Koplan, William G. Stevenson. (2010) Mortality and safety of catheter ablation for antiarrhythmic drug-refractory ventricular tachycardia in elderly patients with coronary artery disease. Heart Rhythm 7:6, 740-744

  695. 695

    C.W. Israel. (2010) ICD-Therapie zur Primärprävention des plötzlichen Herztods. Herzschrittmachertherapie + Elektrophysiologie 21:2, 102-108

  696. 696

    Gautham Kalahasty, Kenneth A. Ellenbogen. (2010) Selection of Ventricular Pacing Sites Guided by Echocardiography: An Electrophysiologist's Perspective. Journal of the American Society of Echocardiography 23:6, 608-610

  697. 697

    (2010) Section 9: Electrophysiology Testing and the Use of Devices in Heart Failure. Journal of Cardiac Failure 16:6, e115-e121

  698. 698

    JERRY M. JOHN, AHMED HUSSEIN, NASER IMRAN, SAMUEL J. DURHAM, BLAIR P. GRUBB, YOUSUF KANJWAL. (2010) Underutilization of Implantable Cardioverter Defibrillators Post Coronary Artery Bypass Grafting in Patients with Systolic Dysfunction. Pacing and Clinical Electrophysiology 33:6, 727-733

  699. 699

    Eric Larose, Josep Rodés-Cabau, Philippe Pibarot, Stéphane Rinfret, Guy Proulx, Can M. Nguyen, Jean-Pierre Déry, Onil Gleeton, Louis Roy, Bernard Noël, Gérald Barbeau, Jacques Rouleau, Jean-Rock Boudreault, Marc Amyot, Robert De Larochellière, Olivier F. Bertrand. (2010) Predicting Late Myocardial Recovery and Outcomes in the Early Hours of ST-Segment Elevation Myocardial Infarction. Journal of the American College of Cardiology 55:22, 2459-2469

  700. 700

    P. Tassani-Prell, G. Juchem. (2010) Erfahrene Anästhesisten unverzichtbar. Der Anaesthesist 59:6, 505-506

  701. 701

    T. Sellmann, M. Winterhalter, U. Herold, P. Kienbaum. (2010) Implantation von Kardioverter-Defibrillatoren. Der Anaesthesist 59:6, 507-518

  702. 702

    F. Duru, P. Dorian, S. Favale, C. Perings, S. S. Pedersen, V. Willems, . (2010) Effects of an alert system on implantable cardioverter defibrillator-related anxiety: rationale, design, and endpoints of the PANORAMIC multicentre trial. Europace 12:5, 726-730

  703. 703

    JAVIER JIMÉNEZ-CANDIL, MARÍA RUIZ, JESÚS HERRERO, VÍCTOR LEÓN, ANA MARTÍN, JOSÉ MORIÑIGO, CLAUDIO LEDESMA, CÁNDIDO MARTÍN-LUENGO. (2010) Relationship between the Duration of the Basal QRS Complex and Electrical Therapies for Ventricular Tachycardias among ICD Patients. Pacing and Clinical Electrophysiology 33:5, 596-604

  704. 704

    Richard N Vest, Michael R Gold. (2010) Risk stratification of ventricular arrhythmias in patients with systolic heart failure. Current Opinion in Cardiology 25:3, 268-275

  705. 705

    Darren Green, Paul R. Roberts. (2010) VENTRICULAR ARRHYTHMIAS AND SUDDEN DEATH IN PATIENTS WITH CHRONIC KIDNEY DISEASE. Journal of Renal Care 36, 54-60

  706. 706

    Dawood Darbar. (2010) Genomics, heart failure and sudden cardiac death. Heart Failure Reviews 15:3, 229-238

  707. 707

    H. Van Herendael, A. Pinter, K. Ahmad, V. Korley, I. Mangat, P. Dorian. (2010) Role of antiarrhythmic drugs in patients with implantable cardioverter defibrillators. Europace 12:5, 618-625

  708. 708

    SANA M. AL-KHATIB, JONATHAN P. PICCINI, DAVID KNIGHT, MARGARET STEWART, NANCY CLAPP-CHANNING, GILLIAN D. SANDERS. (2010) Remote Monitoring of Implantable Cardioverter Defibrillators versus Quarterly Device Interrogations in Clinic: Results from a Randomized Pilot Clinical Trial. Journal of Cardiovascular Electrophysiology 21:5, 545-550

  709. 709

    GIANNI PASTORE, FRANCESCO ZANON, FRANCO NOVENTA, ENRICO BARACCA, SILVIO AGGIO, GIORGIO CORBUCCI, ROBERTO CAZZIN, LORIS RONCON, SERGE S. BAROLD. (2010) Variability of Left Ventricular Electromechanical Activation during Right Ventricular Pacing: Implications for the Selection of the Optimal Pacing Site. Pacing and Clinical Electrophysiology 33:5, 566-574

  710. 710

    Bodh I Jugdutt. (2010) Heart failure in the elderly: advances and challenges. Expert Review of Cardiovascular Therapy 8:5, 695-715

  711. 711

    JOHN RICKARD, DHARAM J. KUMBHANI, EIRAN Z. GORODESKI, BRYAN BARANOWSKI, OUSSAMA WAZNI, DAVID O. MARTIN, RICHARD GRIMM, BRUCE L. WILKOFF. (2010) Cardiac Resynchronization Therapy in Non-Left Bundle Branch Block Morphologies. Pacing and Clinical Electrophysiology 33:5, 590-595

  712. 712

    Beata Sredniawa, Michal Mazurek, Radoslaw Lenarczyk, Oskar Kowalski, Jacek Kowalczyk, Zbigniew Kalarus. (2010) Early therapy following myocardial infarction: arguments for and against implantable cardioverter-defibrillators. Future Cardiology 6:3, 315-323

  713. 713

    J. Becher, S. G. Kaufmann, S. Paule, B. Fahn, O. Skerl, W. R. Bauer, G. Ertl, S. K. G. Maier. (2010) Device-based impedance measurement is a useful and accurate tool for direct assessment of intrathoracic fluid accumulation in heart failure. Europace 12:5, 731-740

  714. 714

    S. L. Kopecky, S. C. Litin. (2010) Clinical Pearls in Cardiology. Mayo Clinic Proceedings 85:5, 473-478

  715. 715

    A. Selcuk Adabag, Russell V. Luepker, Véronique L. Roger, Bernard J. Gersh. (2010) Sudden cardiac death: epidemiology and risk factors. Nature Reviews Cardiology 7:4, 216-225

  716. 716

    C. JAN WILLEM BORLEFFS, JOEP THIJSSEN, MIHÁLY K. De BIE, JOHANNES B. Van REES, GUIDO H. Van WELSENES, LIESELOT Van ERVEN, JEROEN J. BAX, SUZANNE C. CANNEGIETER, MARTIN J. SCHALIJ. (2010) Recurrent Implantable Cardioverter-Defibrillator Replacement Is Associated with an Increasing Risk of Pocket-Related Complications. Pacing and Clinical Electrophysiologyno-no

  717. 717

    Martino Martinelli Filho, Sérgio Freitas de Siqueira, Roberto Costa, Oswaldo T. Greco, Luiz Felipe Moreira, Andre D'avila, E. Kevin Heist. (2010) Conventional Versus Biventricular Pacing in Heart Failure and Bradyarrhythmia: The COMBAT Study. Journal of Cardiac Failure 16:4, 293-300

  718. 718

    ANDREW VOIGT, ALAA SHALABY, SAMIR SABA. (2010) Continued Rise in Rates of Cardiovascular Implantable Electronic Device Infections in the United States: Temporal Trends and Causative Insights. Pacing and Clinical Electrophysiology 33:4, 414-419

  719. 719

    Massimo Giammaria, Claudio Bruna, Roberto Gnavi. (2010) Trend in implantable cardioverter defibrillators and relation to need. Journal of Cardiovascular Medicine 11:4, 265-270

  720. 720

    J. Malcolm O. Arnold, Lorne J. Gula. (2010) The Art and Science of Heart Failure. Journal of the American College of Cardiology 55:17, 1811-1813

  721. 721

    S. A. Lubitz, P. Leong-Sit, N. Fine, D. B. Kramer, J. Singh, P. T. Ellinor. (2010) Effectiveness of cardiac resynchronization therapy in mild congestive heart failure: systematic review and meta-analysis of randomized trials. European Journal of Heart Failure 12:4, 360-366

  722. 722

    Noel C.F. Codella, Matthew D. Cham, Richard Wong, Christopher Chu, James K. Min, Martin R. Prince, Yi Wang, Jonathan W. Weinsaft. (2010) Rapid and accurate left ventricular chamber quantification using a novel CMR segmentation algorithm: A clinical validation study. Journal of Magnetic Resonance Imaging 31:4, 845-853

  723. 723

    R. Cáceres, J. Richter, K. G. Säfström, A. M. Landtblom. (2010) Increased need for combinated nervus vagus-stimulators and electronic cardiac devices: aspects on methods and safety. Acta Neurologica Scandinavica 121:4, 287-288

  724. 724

    Emile G Daoud, John D Hummel, Troy E Rhodes. (2010) Management of sudden cardiac death risk in the very early postmyocardial infarction period. Current Opinion in Cardiology1

  725. 725

    S. de Haan, P. Knaapen, A. M. Beek, C. C. de Cock, A. A. Lammertsma, A. C. van Rossum, C. P. Allaart. (2010) Risk stratification for ventricular arrhythmias in ischaemic cardiomyopathy: the value of non-invasive imaging. Europace 12:4, 468-474

  726. 726

    Jenny Tagney. (2010) A literature review comparing the experiences and emergent needs of adult patients with permanent pacemakers (PPMs) and implantable cardioverter defibrillators (ICDs). Journal of Clinical Nursingno-no

  727. 727

    DAVID D. SPRAGG, JOSEPH E. MARINE. (2010) Inappropriate Biventricular Implantable Cardioverter Defibrillator Firing Due to Cryptogenic Double Counting. Pacing and Clinical Electrophysiology 33:4, 486-490

  728. 728

    SERGIO THAL, TALAL MOUKABARY, RAVICHANDRA BOYELLA, MADHAN SHANMUGASUNDARAM, MARY K. PIERCE, HOANG THAI, STEVEN GOLDMAN. (2010) The Relationship between Warfarin, Aspirin, and Clopidogrel Continuation in the Peri-procedural Period and the Incidence of Hematoma Formation after Device Implantation. Pacing and Clinical Electrophysiology 33:4, 385-388

  729. 729

    Mario Castaño, Juan Miguel Gil-Jaurena, Lourdes Conejo, Javier Gualis. (2010) Epidemiología de las taquiarritmias preoperatorias en la cirugía cardíaca. Cirugía Cardiovascular 17:2, 131-141

  730. 730

    HELMUT U. KLEIN, ULF MELTENDORF, SVEN REEK, JAN SMID, SEBASTIAN KUSS, IWONA CYGANKIEWICZ, CHRISTIAN JONS, STEVEN SZYMKIEWICZ, FRANK BUHTZ, ANKE WOLLBRUECK, WOJCIECH ZAREBA, ARTHUR J. MOSS. (2010) Bridging a Temporary High Risk of Sudden Arrhythmic Death. Experience with the Wearable Cardioverter Defibrillator (WCD). Pacing and Clinical Electrophysiology 33:3, 353-367

  731. 731

    Kristina H. Haugaa, Marit Kristine Smedsrud, Torkel Steen, Erik Kongsgaard, Jan Pål Loennechen, Terje Skjaerpe, Jens-Uwe Voigt, Rik Willems, Gunnar Smith, Otto A. Smiseth, Jan P. Amlie, Thor Edvardsen. (2010) Mechanical Dispersion Assessed by Myocardial Strain in Patients After Myocardial Infarction for Risk Prediction of Ventricular Arrhythmia. JACC: Cardiovascular Imaging 3:3, 247-256

  732. 732

    HANS J. MOORE, MATTHEW N. PETERS, MICHAEL R. FRANZ, PAMELA E. KARASIK, STEVEN N. SINGH, ROSS D. FLETCHER. (2010) Intrathoracic Impedance Preceding Ventricular Tachyarrhythmia Episodes. Pacing and Clinical Electrophysiology

  733. 733

    CHUNG-WAH SIU, VINCENT PONG, HEE-HWA HO, SHASHA LIU, CHU-PAK LAU, SHEUNG-WAI LI, HUNG-FAT TSE. (2010) Are MADIT II Criteria for Implantable Cardioverter Defibrillator Implantation Appropriate for Chinese Patients?. Journal of Cardiovascular Electrophysiology 21:3, 231-235

  734. 734

    J. E. Val-Mejias, A. Oza. (2010) Does defibrillation threshold increase as left ventricular ejection fraction decreases?. Europace 12:3, 385-388

  735. 735

    INDIRESHA RAMACHANDRA. (2010) Impact of ICD Battery Longevity on Need for Device Replacements-Insights from a Veterans Affairs Database. Pacing and Clinical Electrophysiology 33:3, 314-319

  736. 736

    Pablo B. Nery, Nisha D’Mello, Rob Beanlands. (2010) Screening patients for primary prophylaxis implantable cardioverter defibrillators: Insights into current practices. Canadian Journal of Cardiology 26:3, e125-e127

  737. 737

    Richard L Verrier, Mark E Josephson. (2010) “Noninvasive Arrhythmia Risk Assessment in Guiding Pharmacologic Therapy for Prevention of Sudden Cardiac Death—Where do we stand? Where do we go?”. Journal of Cardiovascular Pharmacology1

  738. 738

    Christopher Lane, Paul Dorian, Nina Ghosh, Maria Radina, Suzan O’Donnell, Kevin Thorpe, Iqwal Mangat, Victoria Korley, Arnold Pinter. (2010) Limitations in the current screening practice of assessing left ventricular ejection fraction for a primary prophylactic implantable defibrillator in southern Ontario. Canadian Journal of Cardiology 26:3, e118-e124

  739. 739

    JAMES D. DANIELS, JUSTIN SAUNDERS, SUNTHOSH PARVATHANENI, AMANDA BYRD, JOSE A. JOGLAR, OWEN OBEL. (2010) Electrocardiographic Findings, Device Therapies, and Comorbidities in Octogenarian Implantable Defibrillator Recipients. Journal of Cardiovascular Electrophysiology 21:3, 236-241

  740. 740

    DANIEL B. SIMS, LUIS I. GARCIA, ANDREA MIGNATTI, PAOLO C. COLOMBO, MARGARET JONES, NIR URIEL, DONNA M. MANCINI, ULRICH P. JORDE. (2010) Utilization of Defibrillators and Resynchronization Therapy at the Time of Evaluation at a Heart Failure and Cardiac Transplantation Center. Pacing and Clinical Electrophysiology

  741. 741

    Hannah Asghar, Peter S. Rahko. (2010) Quality of Heart Failure Management: A Comparison of Care Between a Comprehensive Heart Failure Program and a General Cardiology Practice. Congestive Heart Failure 16:2, 65-70

  742. 742

    Eva R. Serber, Nancy J. Finch, Lawrence B. Afrin, W. James Greenland. (2010) Using a webcast support service: Experiences of in-person attendees of an implantable cardioverter defibrillator support group. Heart & Lung: The Journal of Acute and Critical Care 39:2, 94-104

  743. 743

    OSMAN FAHEEM, ARUN PADALA, JEFFREY KLUGER, STEVEN ZWEIBEL, CHRISTOPHER A. CLYNE. (2010) Coronary Sinus Shocking Lead As Salvage In Patients with Advanced CHF and High Defibrillation Thresholds. Pacing and Clinical Electrophysiology

  744. 744

    J. Z. Atary, C. J. W. Borleffs, S. S. Liem, J. J. Bax, B. L. van der Hoeven, M. Bootsma, E. E. van der Wall, L. van Erven, M. J. Schalij. (2010) Structured care for patients after acute myocardial infarction: sudden cardiac death prevention--data from the Leiden MISSION! AMI study. Europace 12:3, 378-384

  745. 745

    N. Valli. (2010) Évaluation de l’innervation sympathique cardiaque par la scintigraphie myocardique à la 123I-métaiodobenzylguanidine. Médecine Nucléaire 34:3, 184-190

  746. 746

    Jason Bradfield, Noel G. Boyle. (2010) The paradox of ICD shocks: Sudden cardiac death prevention—Heart failure death acceleration. Heart Rhythm 7:3, 361-362

  747. 747

    C. Jan Willem Borleffs, Johannes B. van Rees, Guido H. van Welsenes, Enno T. van der Velde, Lieselot van Erven, Jeroen J. Bax, Martin J. Schalij. (2010) Prognostic Importance of Atrial Fibrillation in Implantable Cardioverter-Defibrillator Patients. Journal of the American College of Cardiology 55:9, 879-885

  748. 748

    STEVEN M. MARKOWITZ. (2010) Defibrillator Implantation in the Elderly: Patients Are Older, But Are Physicians Wiser?. Journal of Cardiovascular Electrophysiology 21:3, 242-244

  749. 749

    Massimo Santini, Maurizio Lunati, Pascal Defaye, Johann Mermi, Alessandro Proclemer, Silvia Castillo-Arroys, Giulio Molon, Elisabetta Santi, Tiziana Santo, Xavier Navarro, Axel Kloppe. (2010) Prospective multicenter randomized trial of fast ventricular tachycardia termination by prolonged versus conventional anti-tachyarrhythmia burst pacing in implantable cardioverter-defibrillator patients-Atp DeliVery for pAiNless ICD thErapy (ADVANCE-D) Trial results. Journal of Interventional Cardiac Electrophysiology 27:2, 127-135

  750. 750

    Jon A. Grammes, Christopher M. Schulze, Mohammad Al-Bataineh, George A. Yesenosky, Christine S. Saari, Michelle J. Vrabel, Jay Horrow, Mashiul Chowdhury, John M. Fontaine, Steven P. Kutalek. (2010) Percutaneous Pacemaker and Implantable Cardioverter-Defibrillator Lead Extraction in 100 Patients With Intracardiac Vegetations Defined by Transesophageal Echocardiogram. Journal of the American College of Cardiology 55:9, 886-894

  751. 751

    Barry J. Maron. (2010) Muerte súbita cardiaca en cardiopatías genéticas y esperanzas de prevención. Revista Española de Cardiología 63:3, 257-260

  752. 752

    DREW ERTEL, KAVITA PHATAK, KEVIN MAKATI, MARIAN HOLLAND, SARA BAIG, MICHAEL H. KIM, MARK LINK, ROD PASSMAN. (2010) Predictors of Early Mortality in Patients Age 80 and Older Receiving Implantable Defibrillators. Pacing and Clinical Electrophysiology

  753. 753

    Jennifer NA Silva, Charles E Canter. (2010) Current management of pediatric dilated cardiomyopathy. Current Opinion in Cardiology 25:2, 80-87

  754. 754

    Rodrigo Antonini Ribeiro, Steffan Frosi Stella, Suzi Alves Camey, Leandro Ioschpe Zimerman, Maurício Pimentel, Luis Eduardo Rohde, Carísi Anne Polanczyk. (2010) Cost-Effectiveness of Implantable Cardioverter-Defibrillators in Brazil: Primary Prevention Analysis in the Public Sector. Value in Health 13:2, 160-168

  755. 755

    DARWIN JEYARAJ, MAHI ASHWATH, DAVID S. ROSENBAUM. (2010) Pathophysiology and Clinical Implications of Cardiac Memory. Pacing and Clinical Electrophysiology 33:3, 346-352

  756. 756

    Joel Landzberg, Julius M. Gardin. (2010) Risk Factors for Heart Failure in Young Adults. Current Cardiovascular Risk Reports 4:2, 128-135

  757. 757

    CYNTHIA M. DOUGHERTY, ROBB W. GLENNY, PETER J. KUDENCHUK, TODD E. MALINICK, GAYLE L. FLO. (2010) Testing an Exercise Intervention to Improve Aerobic Conditioning and Autonomic Function after an Implantable Cardioverter Defibrillator (ICD). Pacing and Clinical Electrophysiology

  758. 758

    ATUL VERMA, BRADLEY SARAK, ALEXANDER J. KAPLAN, RICHARD OOSTHUIZEN, MARIANNE BEARDSALL, ZAEV WULFFHART, JANET HIGENBOTTAM, YAARIV KHAYKIN. (2010) Predictors of Appropriate Implantable Cardioverter Defibrillator (ICD) Therapy in Primary Prevention Patients with Ischemic and Nonischemic Cardiomyopathy. Pacing and Clinical Electrophysiology 33:3, 320-329

  759. 759

    Bonnie Choy, Eric Hansen, Arthur J. Moss, Scott McNitt, Wojciech Zareba, Ilan Goldenberg. (2010) Relation of Body Mass Index to Sudden Cardiac Death and the Benefit of Implantable Cardioverter–Defibrillator in Patients With Left Ventricular Dysfunction After Healing of Myocardial Infarction. The American Journal of Cardiology 105:5, 581-586

  760. 760

    JOGIEN H.M. HEERSCHE, NICO A. BLOM, FREEK VAN DE HEUVEL, CHRISTIAAN BLANK, ANNETTE G. REIMER, SALLY-ANN CLUR, MAARTEN WITSENBURG, A. DERK JAN TEN HARKEL. (2010) Implantable Cardioverter Defibrillator Therapy for Prevention of Sudden Cardiac Death in Children in The Netherlands. Pacing and Clinical Electrophysiology 33:2, 179-185

  761. 761

    Giuseppe Boriani, Claudio Rapezzi, Igor Diemberger, Lucio Gonzini, Marco Gorini, Donata Lucci, Gianfranco Sinagra, Robin M. T. Cooke, Giuseppe Di Pasquale, Luigi Tavazzi, Aldo P. Maggioni. (2010) Trial-generated profiles for implantation of electrical devices in outpatients with heart failure: real-world prevalence and 1-year outcome. Journal of Evaluation in Clinical Practice 16:1, 82-91

  762. 762

    MAYURKUMAR BHAKTA, CHEDOZIE C. OBIOHA, DAN SORAJJA, KOMADOOR SRIVATHSAN, FRANCISCO A. ARABIA, PATRICK A. DEVALERIA, DAWN E. JAROSZEWSKI, LUIS R. SCOTT, GREGORY T. ALTEMOSE. (2010) Nontraditional Implantable Cardioverter Defibrillator Placement in Adult Patients with Limited Venous Access: A Case Series. Pacing and Clinical Electrophysiology 33:2, 217-225

  763. 763

    Mithilesh K Das, Douglas P Zipes. (2010) Antiarrhythmic and Nonantiarrhythmic Drugs for Sudden Cardiac Death Prevention. Journal of Cardiovascular Pharmacology1

  764. 764

    Gautam V. Ramani, Patricia A. Uber, Mandeep R. Mehra. (2010) Chronic Heart Failure: Contemporary Diagnosis and Management. Mayo Clinic Proceedings 85:2, 180-195

  765. 765

    Alfred E Buxton, Kristin E Ellison, Peem Lorvidhaya, Ohad Ziv. (2010) Left Ventricular Ejection Fraction for Sudden Death Risk Stratification and Guiding ICD Implantation. Journal of Cardiovascular Pharmacology1

  766. 766

    Miia K. Hyytinen-Oinas, Kari Ylitalo, Mari Karsikas, Tapio Seppänen, M. J. Pekka Raatikainen, Paavo Uusimaa, Heikki V. Huikuri, Juha S. Perkiömäki. (2010) Electrocardiographic abnormalities and ventricular tachyarrhythmias after myocardial infarction. Scandinavian Cardiovascular Journal 44:1, 15-23

  767. 767

    Bharat K Kantharia. (2010) Cardiac arrhythmias in congestive heart failure. Expert Review of Cardiovascular Therapy 8:2, 137-140

  768. 768

    Douglas S. Lee, Andrew D. Krahn, Jeffrey S. Healey, David Birnie, Eugene Crystal, Paul Dorian, Christopher S. Simpson, Yaariv Khaykin, Douglas Cameron, Amir Janmohamed, Raymond Yee, Peter C. Austin, Zhongliang Chen, Judy Hardy, Jack V. Tu. (2010) Evaluation of Early Complications Related to De Novo Cardioverter Defibrillator Implantation. Journal of the American College of Cardiology 55:8, 774-782

  769. 769

    H.-J. Trappe. (2010) Kardiale Resynchronisationstherapie bei Hochrisikopatienten mit Herzinsuffizienz der NYHA-Stadien I–II. Der Kardiologe 4:1, 23-26

  770. 770

    John Lynn Jefferies, Jeffrey A Towbin. (2010) Dilated cardiomyopathy. The Lancet 375:9716, 752-762

  771. 771

    Michael V. Orlov, Julius M. Gardin, Mara Slawsky, Renee L. Bess, Gerald Cohen, William Bailey, Vance Plumb, Horst Flathmann, Katerina de Metz. (2010) Biventricular pacing improves cardiac function and prevents further left atrial remodeling in patients with symptomatic atrial fibrillation after atrioventricular node ablation. American Heart Journal 159:2, 264-270

  772. 772

    Garrick C. Stewart, Joanne R. Weintraub, Parakash P. Pratibhu, Marc J. Semigran, Janice M. Camuso, Kimberly Brooks, Sui W. Tsang, Mary Susan Anello, Viviane T. Nguyen, Eldrin F. Lewis, Anju Nohria, Akshay S. Desai, Michael M. Givertz, Lynne W. Stevenson. (2010) Patient Expectations From Implantable Defibrillators to Prevent Death in Heart Failure. Journal of Cardiac Failure 16:2, 106-113

  773. 773

    J. P. Piccini, M. Zhang, K. Pieper, S. D. Solomon, S. M. Al-Khatib, F. Van de Werf, M. A. Pfeffer, J. J.V. McMurray, R. M. Califf, E. J. Velazquez. (2010) Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial. European Heart Journal 31:2, 211-221

  774. 774

    Marcus L. Koller, Burghard Schumacher. (2010) Medikamentöse Therapie von Herzrhythmusstörungen. Medizinische Klinik 105:1, 26-40

  775. 775

    Barry L. Zaret. Cardiac Performance. In: Clinical Nuclear Cardiology: State of the Art and Future Directions. Elsevier, 2010:183-193.

  776. 776

    Aamir Cheema, Tejwant Singh, Manreet Kanwar, Karuna Chilukuri, Viqar Maria, Fareena Saleem, Katrina Johnson, John Frank, Luis Pires, Sohail Hassan. (2010) Chronic Kidney Disease and Mortality in Implantable Cardioverter-Defibrillator Recipients. Cardiology Research and Practice 2010, 1-6

  777. 777

    David A. Philips, Terry D. Bauch. (2010) Rapid Correction of Hypokalemia in a Patient with an Implantable Cardioverter-Defibrillator and Recurrent Ventricular Tachycardia. Journal of Emergency Medicine 38:3, 308

  778. 778

    Venkata M. Alla, Kishlay Anand, Mandeep Hundal, Aimin Chen, Showri Karnam, Tom Hee, Claire Hunter, Aryan N. Mooss, Dennis Esterbrooks, Syed M. Mohiuddin. (2010) Impact of Moderate to Severe Renal Impairment on Mortality and Appropriate Shocks in Patients with Implantable Cardioverter Defibrillators. Cardiology Research and Practice 2010, 1-6

  779. 779

    Lilian P. Joventino, Peter J. Zimetbaum. Cardiac Devices for the Treatment of Bradyarrhythmias and Tachyarrhythmias. In: Sabiston and Spencer's Surgery of the Chest. Elsevier, 2010:1305-1327.

  780. 780

    Anil K. Gehi, J. Paul Mounsey. Cardiac Pacemakers and Defibrillators. In: Netter's Cardiology. Elsevier, 2010:271-277.

  781. 781

    B. Brembilla-Perrot, O. Claudon, O. Marçon, J.-M. Sellal, P.-Y. Zinzius, N. Sadoul, H. Blangy, L. Muresan, S. Magalhes. (2010) Une étude électrophysiologique complète reste nécessaire dans une cardiopathie évoluée symptomatique. Annales de Cardiologie et d Angéiologie 59:2, 93

  782. 782

    Valeria Calvi, Daniela Dugo, Davide Capodanno, Rocco Arancio, Angelo Di Grazia, Claudio Liotta, Euglena Puzzangara, Antonio Ragusa, Alberto Arestia, Corrado Tamburino. (2010) Intraoperative defibrillation threshold testing during implantable cardioverter-defibrillator insertion: Do we really need it?. American Heart Journal 159:1, 98-102

  783. 783

    Nam-Ho Kim, Kyeong Ho Yun, Seok Kyu Oh. (2010) Sudden Cardiac Death. Journal of Korean Medical Association 53:3, 214

  784. 784

    M.D. Cheitlin. (2010) Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events. Yearbook of Cardiology 2010, 441-442

  785. 785

    Fredrik Holmqvist, Pyotr G. Platonov, Scott McNitt, Slava Polonsky, Jonas Carlson, Wojciech Zareba, Arthur J. Moss, . (2010) Abnormal P-Wave Morphology Is a Predictor of Atrial Fibrillation Development and Cardiac Death in MADIT II Patients. Annals of Noninvasive Electrocardiology 15:1, 63-72

  786. 786

    N. Sadoul, H. Blangy, E. Aliot. (2010) Le suivi d’un patient implanté d’un défibrillateur. Archives des Maladies du Coeur et des Vaisseaux - Pratique 2010:184, 16-24

  787. 787

    Yasushi Oginosawa, Haruhiko Abe, Ritsuko Kohno, Hitoshi Minamiguchi. (2010) Resume Driving After a Refueling Pit Stop. Circulation Journal 74:11, 2283-2284

  788. 788

    Myron C. Gerson, Mouhamad Abdallah, James N. Muth, Alexandru I. Costea. (2010) Will Imaging Assist in the Selection of Patients With Heart Failure for an ICD?. JACC: Cardiovascular Imaging 3:1, 101-110

  789. 789

    Shepard D. Weiner, LeRoy E. Rabbani. (2010) Secondary prevention strategies for coronary heart disease. Journal of Thrombosis and Thrombolysis 29:1, 8-24

  790. 790

    Prem Soman. Radionuclide Imaging in Heart Failure. In: Clinical Nuclear Cardiology: State of the Art and Future Directions. Elsevier, 2010:468-482.

  791. 791

    Arthur J. Moss. (2010) What We Have Learned From the Family of Multicenter Automatic Defibrillator Implantation Trials. Circulation Journal 74:6, 1038-1041

  792. 792

    Gaetano Thiene, Cristina Basso. (2010) Myocardial infarction: a paradigm of success in modern medicine. Cardiovascular Pathology 19:1, 1-5

  793. 793

    JONATHAN P. PICCINI, SANA M. AL-KHATIB, EVAN R. MYERS, KEVIN J. ANSTROM, ALFRED E. BUXTON, ERIC D. PETERSON, GILLIAN D. SANDERS. (2010) Optimal Timing of Implantable Cardioverter-Defibrillator Implantation After Myocardial Infarction: A Decision Analysis. Journal of Cardiovascular Electrophysiology

  794. 794

    Jan Willem Haveman, Susan J. J. Logtenberg, Nanne Kleefstra, Klaas H. Groenier, Henk J. G. Bilo, Adri M. Blomme. (2010) Surgical aspects and complications of continuous intraperitoneal insulin infusion with an implantable pump. Langenbeck's Archives of Surgery 395:1, 65-71

  795. 795

    Takayuki Nagai, Kazuhiro Satomi, Takashi Noda, Hideo Okamura, Yuko Yamada, Wataru Shimizu, Kazuhiro Suyama, Naohiko Aihara, Shiro Kamakura, Takashi Kurita. (2010) Relationship Between Oral Amiodarone and Inappropriate Therapy From an Implantable Cardioverter Defibrillator. Circulation Journal 74:7, 1302-1307

  796. 796

    Marc A. Rozner. Implantable Cardiac Pulse Generators: Pacemakers and Cardioverter-Defibrillators. In: Miller's Anesthesia. Elsevier, 2010:1387-1409.

  797. 797

    Wilbert S. Aronow. Cardiac Arrhythmias. In: Brocklehurst's Textbook of Geriatric Medicine and Gerontology. Elsevier, 2010:327-337.

  798. 798

    Fredrick J. Jaeger. Cardiac Arrhythmias. In: Current Clinical Medicine. Elsevier, 2010:114-128.

  799. 799

    Karl-Heinz Kuck, Anselm Schaumann, Lars Eckardt, Stephan Willems, Rodolfo Ventura, Etienne Delacrétaz, Heinz-Friedrich Pitschner, Josef Kautzner, Burghard Schumacher, Peter S Hansen. (2010) Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. The Lancet 375:9708, 31-40

  800. 800

    PABLO B. NERY, RUSSELL FERNANDES, GIRISH M. NAIR, GLEN L. SUMNER, CARLOS S. RIBAS, SYAMKUMAR M. DIVAKARA MENON, XIAOYIN WANG, ANDREW D. KRAHN, CARLOS A. MORILLO, STUART J. CONNOLLY, JEFF S. HEALEY. (2010) Device-Related Infection Among Patients With Pacemakers and Implantable Defibrillators: Incidence, Risk Factors, and Consequences. Journal of Cardiovascular Electrophysiology

  801. 801

    H. Michael Bolooki, Arman Askari. Acute Myocardial Infarction. In: Current Clinical Medicine. Elsevier, 2010:65-71.

  802. 802

    C. Kouakam, N. Saoudi, S. Kacet. (2010) DAI : quel est le bon nombre d’implantations ?. Archives des Maladies du Coeur et des Vaisseaux - Pratique 2010:184, 7-15

  803. 803

    Robert Hobbs, Andrew Boyle. Heart Failure. In: Current Clinical Medicine. Elsevier, 2010:171-179.

  804. 804

    Gianluca Di Bella, Claudio Passino, Giovanni Donato Aquaro, Daniele Rovai, Elisabetta Strata, Francesco Arrigo, Michele Emdin, Massimo Lombardi, Alessandro Pingitore. (2010) Different Substrates of Non-Sustained Ventricular Tachycardia in Post-infarction Patients With and Without Left Ventricular Dilatation. Journal of Cardiac Failure 16:1, 61-68

  805. 805

    Albert Flotats, Ignasi Carrió. Cardiac Neurotransmission Imaging. In: Clinical Nuclear Cardiology: State of the Art and Future Directions. Elsevier, 2010:657-673.

  806. 806

    Eugene H. Chung, J. Paul Mounsey. Sudden Cardiac Death. In: Netter's Cardiology. Elsevier, 2010:251-260.

  807. 807

    Eugene H. Chung, Richard G. Sheahan, J. Paul Mounsey. Ventricular Tachycardia. In: Netter's Cardiology. Elsevier, 2010:241-249.

  808. 808

    Adam W. Grasso, Sorin J. Brener. Complications of Acute Myocardial Infarction. In: Current Clinical Medicine. Elsevier, 2010:72-80.

  809. 809

    E. Claver, R. Leta, S. Pujadas, A. Hidalgo, F. Carreras, G. Pons-Lladó. (2010) Evaluation of the left ventricle with three-dimensional echocardiography: Comparison with cardiac magnetic resonance. Radiología (English Edition) 52:6, 534-540

  810. 810

    Michiro Kiryu, Shinichi Niwano, Jun Kishihara, Yuya Aoyama, Shoko Ishikawa, Masami Murakami, Sayaka Kurokawa, Yoshihiro Yumoto, Ryuta Imaki, Hidehira Fukaya, Hiroe Niwano, Tohru Izumi. (2010) Preventive Effect of Amiodarone on VT/VF Events in ICD Patients with Structural Heart Diseases. Journal of Arrhythmia 26:4, 250-258

  811. 811

    Wilbert S. Aronow. Diagnosis and Management of Coronary Artery Disease. In: Brocklehurst's Textbook of Geriatric Medicine and Gerontology. Elsevier, 2010:286-294.

  812. 812

    William H. Sauer, Erica Zado, Edward P. Gerstenfeld, Francis E. Marchlinski, David J. Callans. (2010) Incidence and predictors of mortality following ablation of ventricular tachycardia in patients with an implantable cardioverter-defibrillator. Heart Rhythm 7:1, 9-14

  813. 813

    Slaughter , Mark S. , Rogers , Joseph G. , Milano , Carmelo A. , Russell , Stuart D. , Conte , John V. , Feldman , David , Sun , Benjamin , Tatooles , Antone J. , Delgado , Reynolds M. III , Long , James W. , Wozniak , Thomas C. , Ghumman , Waqas , Farrar , David J. , Frazier , O. Howard , . (2009) Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device. New England Journal of Medicine 361:23, 2241-2251
    Free Full Text

  814. 814

    Ernest Matthew Quin, Michael R. Gold. (2009) Implantable device use in systolic heart failure: Lessons learned from IMPROVE HF. Heart Rhythm 6:12, 1735-1736

  815. 815

    Janet D. Pierce, Kathleen Dalton, Katherine Duke, Joseph R. Spaniol. (2009) Heart Failure Guidelines and Implications for Surgically Treating Heart Failure. AORN Journal 90:6, 874-892

  816. 816

    P. Pascale, J. Schlaepfer, M. Oddo, M.-D. Schaller, P. Vogt, M. Fromer. (2009) Ventricular arrhythmia in coronary artery disease: limits of a risk stratification strategy based on the ejection fraction alone and impact of infarct localization. Europace 11:12, 1639-1646

  817. 817

    Corinna Lenz, Thomas Dietze, Michael Möller, Wolfgang Schöbel, Jens Wicke, Hans-Jörg Kellner, Rainer Gradaus, Jörg Neuzner. (2009) Incessant ventricular tachycardia, refractory to catheter ablation, in an ICD patient terminated by ICD lead extraction: a case report. Clinical Research in Cardiology 98:12, 803-805

  818. 818

    Philip B. Adamson. (2009) Pathophysiology of the transition from chronic compensated and acute decompensated heart failure: New insights from continuous monitoring devices. Current Heart Failure Reports 6:4, 287-292

  819. 819

    Sing-Chien Yap, Louise Harris. (2009) Sudden cardiac death in adults with congenital heart disease. Expert Review of Cardiovascular Therapy 7:12, 1605-1620

  820. 820

    C. Adlbrecht, M. Hlsmann, M. Gwechenberger, G. Strunk, C. Khazen, F. Wiesbauer, M. Elhenicky, S. Neuhold, T. Binder, G. Maurer, I. M. Lang, R. Pacher. (2009) Outcome after device implantation in chronic heart failure is dependent on concomitant medical treatment. European Journal of Clinical Investigation 39:12, 1073-1081

  821. 821

    Rafael Peinado, Esteban G. Torrecilla, José Ormaetxe, Miguel Álvarez, Rocío Cózar, Javier Alzueta. (2009) Registro Español de Desfibrilador Automático Implantable. V Informe Oficial del Grupo de Trabajo de Desfibrilador Automático Implantable de la Sociedad Española de Cardiología (2008). Revista Española de Cardiología 62:12, 1435-1449

  822. 822

    Stavros Mountantonakis, Mathew D. Hutchinson. (2009) Who should receive an implantable cardioverter-defibrillator after myocardial infarction?. Current Heart Failure Reports 6:4, 236-244

  823. 823

    Katia Noyes, Ethan Corona, Peter Veazie, Andrew W. Dick, Hongwei Zhao, Arthur J. Moss. (2009) Examination of the Effect of Implantable Cardioverter-Defibrillators on Health-Related Quality of Life. American Journal Cardiovascular Drugs 9:6, 393-400

  824. 824

    MEHMET K. AKTAS, DAVID D. KIM, SCOTT MCNITT, DAVID T. HUANG, SPENCER Z. ROSERO, BURR W. HALL, WOJCIECH ZAREBA, JAMES P. DAUBERT. (2009) Right Ventricular Dysfunction and the Incidence of Implantable Cardioverter-Defibrillator Therapies. Pacing and Clinical Electrophysiology 32:12, 1501-1508

  825. 825

    Mandeep R. Mehra, Clyde W. Yancy, Nancy M. Albert, Anne B. Curtis, Wendy Gattis Stough, Mihai Gheorghiade, J. Thomas Heywood, Mark L. McBride, Christopher M. O'Connor, Dwight Reynolds, Mary Norine Walsh, Gregg C. Fonarow. (2009) Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post–myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF. Heart Rhythm 6:12, 1727-1734

  826. 826

    D. J. van Veldhuisen, A. H. Maass, S. G. Priori, P. Stolt, I. C. van Gelder, K. Dickstein, K. Swedberg. (2009) Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. European Journal of Heart Failure 11:12, 1143-1151

  827. 827

    D. P. Morin, L. Oikarinen, M. Viitasalo, L. Toivonen, M. S. Nieminen, S. E. Kjeldsen, B. Dahlof, M. John, R. B. Devereux, P. M. Okin. (2009) QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study. European Heart Journal 30:23, 2908-2914

  828. 828

    Jennifer L. Dorosz, Keith D. Aaronson, Eric D. Good, Theodore J. Kolias. (2009) A Restrictive Inflow Pattern Does Not Predict Implantable Cardioverter-Defibrillator Therapy in Primary Prevention. Clinical Cardiology 32:12, E32-E35

  829. 829

    Carsten Stoepel, Jean Boland, Rachele Busca, Gauri Saal, Mário Oliveira. (2009) Usefulness of Remote Monitoring in Cardiac Implantable Device Follow-Up. Telemedicine and e-Health 15:10, 1026-1030

  830. 830

    Nathaniel Hall, T Jared Bunch. (2009) Defining new risk factors for out-of-hospital cardiac arrest: A hot opportunity for discovery*. Critical Care Medicine 37:12, 3178-3179

  831. 831

    Beat Andreas Schaer, Michael Theodor Koller, Christian Sticherling, David Altmann, Lucas Joerg, Stefan Osswald. (2009) Longevity of implantable cardioverter-defibrillators, influencing factors, and comparison to industry-projected longevity. Heart Rhythm 6:12, 1737-1743

  832. 832

    A. E. Belevych, D. Terentyev, S. Viatchenko-Karpinski, R. Terentyeva, A. Sridhar, Y. Nishijima, L. D. Wilson, A. J. Cardounel, K. R. Laurita, C. A. Carnes, G. E. Billman, S. Gyorke. (2009) Redox modification of ryanodine receptors underlies calcium alternans in a canine model of sudden cardiac death. Cardiovascular Research 84:3, 387-395

  833. 833

    C. J. W. Borleffs, G. H. van Welsenes, R. J. van Bommel, E. T. van der Velde, J. J. Bax, L. van Erven, H. Putter, J. G. van der Bom, F. R. Rosendaal, M. J. Schalij. (2009) Mortality risk score in primary prevention implantable cardioverter defibrillator recipients with non-ischaemic or ischaemic heart disease. European Heart Journal

  834. 834

    Atul Aggarwal, Yongfei Wang, John S. Rumsfeld, Jeptha P. Curtis, Paul A. Heidenreich. (2009) Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation. Heart Rhythm 6:11, 1565-1571

  835. 835

    Arash Arya, Christopher Piorkowski, Simon Kircher, Philipp Sommer, Andreas Bollmann, Thomas Gaspar, Gerhard Hindricks. (2009) Results of Recent Studies in Catheter Ablation of Ventricular Tachycardias. Herz 34:7, 539-544

  836. 836

    E. M. Kanoupakis, E. G. Manios, P. E. Vardas. (2009) Predicting future shocks in implantable cardioverter defibrillator recipients: the role of biomarkers. Europace 11:11, 1434-1439

  837. 837

    G. Breithardt. (2009) MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy): cardiac resynchronization therapy towards early management of heart failure. European Heart Journal 30:21, 2551-2553

  838. 838

    JORGE E. SCHLIAMSER, MOEEN A. SALEEM, JEFFREY J. GOLDBERGER. (2009) Use of a Custom-Designed Adapter to Manage ICD Lead Fracture. Journal of Cardiovascular Electrophysiology 20:11, 1284-1286

  839. 839

    Sascha Rolf, Wilhelm Haverkamp. (2009) Grenzen und Möglichkeiten der invasiven Risikostratifikation. Herz 34:7, 528-538

  840. 840

    Giuseppe Stabile, Assunta Iuliano, Pietro Turco, Carmine Ciardiello, Antonio De Simone. (2009) Cardiac resynchronization therapy: a review of CRT-D versus CRT-P. Future Cardiology 5:6, 567-572

  841. 841

    SAMIR SABA, LAKSHMI PRASAD RAVIPATI, ANDREW VOIGT. (2009) Recent Trends in Utilization of Implantable Cardioverter-Defibrillators in Survivors of Cardiac Arrest in the United States. Pacing and Clinical Electrophysiology 32:11, 1444-1449

  842. 842

    Corrado Carbucicchio, Paolo Della Bella, Gaetano Fassini, Nicola Trevisi, Stefania Riva, Francesco Giraldi, Francesca Baratto, Giancarlo Marenzi, Erminio Sisillo, Antonio Bartorelli, Francesco Alamanni. (2009) Percutaneous Cardiopulmonary Support for Catheter Ablation of Unstable Ventricular Arrhythmias in High-Risk Patients. Herz 34:7, 545-552

  843. 843

    Jeffrey J. Goldberger, Rod Passman. (2009) Implantable Cardioverter-Defibrillator Therapy After Acute Myocardial Infarction. Journal of the American College of Cardiology 54:22, 2001-2005

  844. 844

    G. Z. Duray, J. Schmitt, S. Richter, C. W. Israel, S. H. Hohnloser. (2009) Arrhythmic death in implantable cardioverter defibrillator patients: a long-term study over a 10 year implantation period. Europace 11:11, 1462-1468

  845. 845

    Joseph D. Mishkin, Sherry J. Saxonhouse, Gregory W. Woo, Thomas A. Burkart, William M. Miles, Jamie B. Conti, Richard S. Schofield, Samuel F. Sears, Juan M. Aranda. (2009) Appropriate Evaluation and Treatment of Heart Failure Patients After Implantable Cardioverter-Defibrillator Discharge. Journal of the American College of Cardiology 54:22, 1993-2000

  846. 846

    Benthe Sjøli, Stein Ørn, Bjørnar Grenne, Trond Vartdal, Otto A. Smiseth, Thor Edvardsen, Harald Brunvand. (2009) Comparison of Left Ventricular Ejection Fraction and Left Ventricular Global Strain as Determinants of Infarct Size in Patients with Acute Myocardial Infarction. Journal of the American Society of Echocardiography 22:11, 1232-1238

  847. 847

    Lee A. Fleisher, Joshua A. Beckman, Kenneth A. Brown, Hugh Calkins, Elliot L. Chaikof, Kirsten E. Fleischmann, William K. Freeman, James B. Froehlich, Edward K. Kasper, Judy R. Kersten, Barbara Riegel, John F. Robb. (2009) 2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery. Journal of the American College of Cardiology 54:22, e13-e118

  848. 848

    Axel Bauer, Petra Barthel, Alexander Müller, Kurt Ulm, Heikki Huikuri, Marek Malik, Georg Schmidt. (2009) Risk prediction by heart rate turbulence and deceleration capacity in postinfarction patients with preserved left ventricular function retrospective analysis of 4 independent trials. Journal of Electrocardiology 42:6, 597-601

  849. 849

    Tobias Tönnis, Karl-Heinz Kuck. (2009) Grenzen und Möglichkeiten der nichtinvasiven Risikostratifikation für den plötzlichen Herztod. Herz 34:7, 506-516

  850. 850

    M. Rodríguez-Mañero, A. Macías Gallego, I. García-Bolao. (2009) Muerte súbita. Medicine - Programa de Formación Médica Continuada Acreditado 10:44, 2934-2941

  851. 851

    Steinbeck , Gerhard , Andresen , Dietrich , Seidl , Karlheinz , Brachmann , Johannes , Hoffmann , Ellen , Wojciechowski , Dariusz , Kornacewicz-Jach , Zdzisława , Sredniawa , Beata , Lupkovics , Géza , Hofgärtner , Franz , Lubinski , Andrzej , Rosenqvist , Mårten , Habets , Alphonsus , Wegscheider , Karl , Senges , Jochen , . (2009) Defibrillator Implantation Early after Myocardial Infarction. New England Journal of Medicine 361:15, 1427-1436
    Free Full Text

  852. 852

    Moss , Arthur J. , Hall , W. Jackson , Cannom , David S. , Klein , Helmut , Brown , Mary W. , Daubert , James P. , Estes , N.A. Mark III , Foster , Elyse , Greenberg , Henry , Higgins , Steven L. , Pfeffer , Marc A. , Solomon , Scott D. , Wilber , David , Zareba , Wojciech , . (2009) Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events. New England Journal of Medicine 361:14, 1329-1338
    Free Full Text

  853. 853

    S. Thavapalachandran, D. P. Leong, M. K. Stiles, B. John, H. Dimitri, D. H. Lau, P. J. Psaltis, A. G. Brooks, M. Alasady, H. S. Lim, G. D. Young, P. Sanders. (2009) Evidence-based management of heart failure in clinical practice: a review of device-based therapy use. Internal Medicine Journal 39:10, 669-675

  854. 854

    Steven J. Keteyian, Debra Isaac, Udho Thadani, Brad A. Roy, Daniel R. Bensimhon, Robert McKelvie, Stuart D. Russell, Anne S. Hellkamp, William E. Kraus. (2009) Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction. American Heart Journal 158:4, S72-S77

  855. 855

    H.-J. Trappe. (2009) 25 Jahre Defibrillatortherapie in Deutschland. Der Kardiologe 3:5, 413-424

  856. 856

    M. Meine, T. Smith, R. N.W. Hauer. (2009) The economical challenge in the treatment of chronic heart failure: is primary prophylactic ICD therapy cost-effective in Europe? Reply. Europace 11:10, 1408-1410

  857. 857

    Arthur J. Moss. (2009) QRS Duration in the Selection of Patients for Cardiac Resynchronization Therapy. Annals of Noninvasive Electrocardiology 14:4, 317-318

  858. 858

    Nina Ghosh, Iqwal Mangat, Suzan S O’Donnell, Arnold Pinter, Victoria Korley, Chris Lane, Paul Dorian. (2009) Outcomes in heart failure patients referred for consideration of implantable cardioverter defibrillator for primary prophylaxis of sudden cardiac death: What are the risks of waiting?. Canadian Journal of Cardiology 25:10, e342-e346

  859. 859

    Byron K. Lee, Jeffery E. Olgin. (2009) Role of wearable and automatic external defibrillators in improving survival in patients at risk for sudden cardiac death. Current Treatment Options in Cardiovascular Medicine 11:5, 360-365

  860. 860

    EMILY C. SIMONS, DAVID Y. FEIGENBLUM, DMITRY NEMIROVSKY, GRANT R. SIMONS. (2009) Alert Tones Are Frequently Inaudible among Patients with Implantable Cardioverter-Defibrillators. Pacing and Clinical Electrophysiology 32:10, 1272-1275

  861. 861

    HARIS M. HAQQANI, HARRY G. MOND. (2009) The Implantable Cardioverter-Defibrillator Lead: Principles, Progress, and Promises. Pacing and Clinical Electrophysiology 32:10, 1336-1353

  862. 862

    J. M. McComb, C. J. Plummer, M. W. Cunningham, D. Cunningham. (2009) Inequity of access to implantable cardioverter defibrillator therapy in England: possible causes of geographical variation in implantation rates. Europace 11:10, 1308-1312

  863. 863

    PAUL KNOPS, DOMINIC A. M. J. THEUNS, JAN C. J. RES, LUC JORDAENS. (2009) Analysis of Implantable Defibrillator Longevity Under Clinical Circumstances: Implications for Device Selection. Pacing and Clinical Electrophysiology 32:10, 1276-1285

  864. 864

    M. R. Cowie, . (2009) Editorial: The economical challenge in the treatment of chronic heart failure: is primary prophylactic implantable cardioverter defibrillator therapy cost-effective in Europe?. Europace 11:10, 1407-1408

  865. 865

    SANDRA B. DUNBAR, JONATHAN J. LANGBERG, CAROLYN M. REILLY, BINDU VISWANATHAN, FRANCES MCCARTY, STEVEN D. CULLER, MARIAN C. O’BRIEN, WILLIAM S. WEINTRAUB. (2009) Effect of a Psychoeducational Intervention on Depression, Anxiety, and Health Resource Use in Implantable Cardioverter Defibrillator Patients. Pacing and Clinical Electrophysiology 32:10, 1259-1271

  866. 866

    B. McHale, S. A. Harding, N. A. Lever, P. D. Larsen. (2009) A national survey of clinician's knowledge of and attitudes towards implantable cardioverter defibrillators. Europace 11:10, 1313-1316

  867. 867

    Brenda S. Thompson. (2009) Sudden Cardiac Death and Heart Failure. AACN Advanced Critical Care 20:4, 356-365

  868. 868

    Matteo Anselmino, Melissa Vinci, Chiara Comoglio, Mauro Rinaldi, Maria Grazia Bongiorni, Gian Paolo Trevi, Pier Giorgio Golzio. (2009) Bacteriology of infected extracted pacemaker and ICD leads. Journal of Cardiovascular Medicine 10:9, 693-698

  869. 869

    Hubertus Degen, Thomas Lickfeld, Carsten Stoepel, Michael Haude. (2009) Perkutane Mitralklappenanulorrhaphie mit dem Carillon™ XE2 Mitral Contour System™ von Cardiac Dimensions™. Herz 34:6, 451-457

  870. 870

    ANDREA M. RUSSO, JOHN D. DAY, KIRA STOLEN, CHRISTOPHER M. MULLIN, VINAYAK DORAISWAMY, DARIN L. LEREW, BRIAN OLSHANSKY. (2009) Implantable Cardioverter Defibrillators: Do Women Fare Worse Than Men? Gender Comparison in the INTRINSIC RV Trial. Journal of Cardiovascular Electrophysiology 20:9, 973-978

  871. 871

    J.M. Segura Saint-Gerons, F. Mazuelos Bellido, M. Anguita Sánchez, J. Súarez de Lezo Cruz-Conde. (2009) Indicaciones de estudio electrofisiológico cardiaco. Medicine - Programa de Formación Médica Continuada Acreditado 10:38, 2582-2583

  872. 872

    M. Kullmer, M. Albanese, W. Schöls. (2009) Kardiale Resynchronisationstherapie. Herzschrittmachertherapie + Elektrophysiologie 20:3, 143-147

  873. 873

    Saman Rasoul, Jan Paul Ottervanger, Menko-Jan de Boer, Jan-Henk E. Dambrink, Jan C.A. Hoorntje, A.T. Marcel Gosselink, Felix Zijlstra, Harry Suryapranata, Arnoud W.J. van ʼt Hof. (2009) Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarction. Coronary Artery Disease 20:6, 415-421

  874. 874

    Krista C. van den Broek, Ivan Nyklíĉek, Johan Denollet. (2009) Anxiety Predicts Poor Perceived Health in Patients With an Implantable Defibrillator. Psychosomatics 50:5, 483-492

  875. 875

    Sanjiv Kaul. (2009) Man Must Measure. JACC: Cardiovascular Imaging 2:9, 1111-1113

  876. 876

    Weiwei Li, Brian Olshansky. (2009) Electrophysiological device therapy (implantable defibrillators) in older adults. Current Cardiovascular Risk Reports 3:5, 347-354

  877. 877

    Deborah Meyers. (2009) Medical therapies for the management of cardiomyopathy and chronic congestive heart failure. Current Cardiovascular Risk Reports 3:5, 315-322

  878. 878

    Derek R. MacFadden, Jack V. Tu, Alice Chong, Peter C. Austin, Douglas S. Lee. (2009) Evaluating sex differences in population-based utilization of implantable cardioverter-defibrillators: Role of cardiac conditions and noncardiac comorbidities. Heart Rhythm 6:9, 1289-1296

  879. 879

    Aneta Aleksova, Gastone Sabbadini, Marco Merlo, Bruno Pinamonti, Giulia Barbati, Massimo Zecchin, Rossana Bussani, Furio Silvestri, Anna M Iorio, Davide Stolfo, Matteo Dal Ferro, Andreea M Dragos, Gennaro Meringolo, Stelios Pyxaras, Francesco Lo Giudice, Andrea Perkan, Andrea di Lenarda, Gianfranco Sinagra. (2009) Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure – a subgroup analysis from the Trieste Cardiomyopathy Registry. Journal of Cardiovascular Medicine 10:9, 699-705

  880. 880

    PIETRO FRANCIA, CRISTINA BALLA, ARIANNA UCCELLINI, RICCARDO CAPPATO. (2009) Arrhythmia Detection in Single- and Dual-Chamber Implantable Cardioverter Defibrillators: The More Leads, the Better?. Journal of Cardiovascular Electrophysiology 20:9, 1077-1082

  881. 881

    M. Brignole. (2009) Are complications of implantable defibrillators under-estimated and benefits over-estimated?. Europace 11:9, 1129-1133

  882. 882

    Florian Streitner, Juergen Kuschyk, Christian Veltmann, Desiree Ratay, Nina Schoene, Ines Streitner, Martina Brueckmann, Burghard Schumacher, Martin Borggrefe, Christian Wolpert. (2009) Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical storm. Cytokine 47:3, 166-172

  883. 883

    WENJIE XU, HANS J. MOORE, PAMELA E. KARASIK, MICHAEL R. FRANZ, STEVE N. SINGH, ROSS D. FLETCHER. (2009) Management Strategies When Implanted Cardioverter Defibrillator Leads Fail: Survey Findings. Pacing and Clinical Electrophysiology 32:9, 1130-1141

  884. 884

    Andrew E. Epstein. (2009) Update on primary prevention implantable cardioverter-defibrillator therapy. Current Cardiology Reports 11:5, 335-342

  885. 885

    Zian H. Tseng. (2009) Genetic association studies of sudden cardiac death/arrest: The importance of context. Heart Rhythm 6:9, 1315-1317

  886. 886

    YEN-HUNG LIN, LIAN-YU LIN, YING-SHREN CHEN, HUI-CHUN HUANG, JEN-KUANG LEE, YI-LWUN HO, LIN-CHU LIAO, WEN-JONE CHEN. (2009) The Association between T-Wave Morphology and Life-Threatening Ventricular Tachyarrhythmias in Patients with Congestive Heart Failure. Pacing and Clinical Electrophysiology 32:9, 1173-1177

  887. 887

    J.M. Segura Saint-Gerons, F. Mazuelos Bellido, M. Anguita Sánchez, J. Suárez de Lezo Cruz-Conde. (2009) Tratamiento de las taquiarritmias por métodos no farmacológicos. Ablaciones. Desfibriladores. Medicine - Programa de Formación Médica Continuada Acreditado 10:38, 2563-2569

  888. 888

    J. Marti-Almor, M. Cladellas, V. Bazan, C. Altaba, M. Guijo, J. Delclos, J. Bruguera-Cortada. (2009) Long-term mortality predictors in patients with chronic bifascicular block. Europace 11:9, 1201-1207

  889. 889

    Ilknur Can, Venkatakrishna N. Tholakanahalli. (2009) Current status of implantable cardioverter-defibrillator therapy in heart failure. Current Heart Failure Reports 6:3, 199-209

  890. 890

    Robert C. Sheppard, Jason C. Levine, Joshua Rovin, Hugh M. van Gelder. (2009) A novel way an implantable cardioverter-defibrillator prevents death: Protection from a gunshot. Heart Rhythm 6:9, 1390

  891. 891

    ALAN H. KADISH, DAVID BELLO, J. PAUL FINN, ROBERT O. BONOW, ANDI SCHAECHTER, HARIS SUBACIUS, CHRISTINE ALBERT, JAMES P. DAUBERT, CARISSA G. FONSECA, JEFFREY J. GOLDBERGER. (2009) Rationale and Design for the Defibrillators to Reduce Risk by Magnetic Resonance Imaging Evaluation (DETERMINE) Trial. Journal of Cardiovascular Electrophysiology 20:9, 982-987

  892. 892

    Yuri B. Pride, Evan Appelbaum, Erin E. Lord, Sarah Sloan, Christopher P. Cannon, Marc S. Sabatine, C. Michael Gibson. (2009) Relation Between Myocardial Infarct Size and Ventricular Tachyarrhythmia Among Patients With Preserved Left Ventricular Ejection Fraction Following Fibrinolytic Therapy for ST-Segment Elevation Myocardial Infarction. The American Journal of Cardiology 104:4, 475-479

  893. 893

    Haris M. Haqqani, Francis E. Marchlinski. (2009) Electrophysiologic substrate underlying postinfarction ventricular tachycardia: Characterization and role in catheter ablation. Heart Rhythm 6:8, S70-S76

  894. 894

    DAVID J. WILBER. (2009) Electrophysiologic Testing for Risk Stratification Following Myocardial Infarction: Dead or Alive?. Journal of Cardiovascular Electrophysiology 20:8, 856-858

  895. 895

    Ken Matsuoka, Masami Nishino, Hiroyasu Kato, Yasuyuki Egami, Ryu Shutta, Hitoshi Yamaguchi, Kenjiro Tanaka, Jun Tanouchi, Yoshio Yamada. (2009) Right Ventricular Apical Pacing Impairs Left Ventricular Twist as Well as Synchrony: Acute Effects of Right Ventricular Apical Pacing. Journal of the American Society of Echocardiography 22:8, 914-919

  896. 896

    Michael J. Cutler, David S. Rosenbaum. (2009) Risk stratification for sudden cardiac death: Is there a clinical role for T wave alternans?. Heart Rhythm 6:8, S56-S61

  897. 897

    Deryk L. McDowell, Paul J. Hauptman. (2009) Implantable Defibrillators and Cardiac Resynchronization Therapy in Heart Transplant Recipients: Results of a National Survey. The Journal of Heart and Lung Transplantation 28:8, 847-850

  898. 898

    SUSANNE S. PEDERSEN, MARTHA VAN DEN BERG, DOMINIC A. M. J. THEUNS. (2009) A Viewpoint on the Impact of Device Advisories on Patient-Centered Outcomes. Pacing and Clinical Electrophysiology 32:8, 1006-1011

  899. 899

    Sebastian Haas, Hans Peter Richter, Jens C Kubitz. (2009) Anesthesia during cardiologic procedures. Current Opinion in Anaesthesiology 22:4, 519-523

  900. 900

    Robert J. Myerburg, Vivek Reddy, Agustin Castellanos. (2009) Indications for Implantable Cardioverter-Defibrillators Based on Evidence and Judgment. Journal of the American College of Cardiology 54:9, 747-763

  901. 901

    Giovanni Lucignani. (2009) Metaiodobenzylguanidine (mIBG) molecular imaging in implantable cardioverter defibrillator (ICD) therapy planning: a health technology assessment issue. European Journal of Nuclear Medicine and Molecular Imaging 36:8, 1346-1350

  902. 902

    Clemens von Schacky. (2009) Cardiovascular disease prevention and treatment. Prostaglandins, Leukotrienes and Essential Fatty Acids 81:2-3, 193-198

  903. 903

    S. Genovesi, M. G. Valsecchi, E. Rossi, D. Pogliani, I. Acquistapace, V. De Cristofaro, A. Stella, A. Vincenti. (2009) Sudden death and associated factors in a historical cohort of chronic haemodialysis patients. Nephrology Dialysis Transplantation 24:8, 2529-2536

  904. 904

    Akli Otmani, Ludovic Trinquart, Eloi Marijon, Thomas Lavergne, Xavier Waintraub, Antoine Lepillier, Gilles Chatellier, Jean-Yves Le Heuzey. (2009) Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: Results from the EVADEF cohort study. American Heart Journal 158:2, 230-237.e1

  905. 905

    Mintu P. Turakhia, Paul J. Wang. (2009) “Low ejection fraction prophylaxis” with implantable defibrillators in the elderly: Call for a randomized trial?. Heart Rhythm 6:8, 1144-1145

  906. 906

    Larisa G. Tereshchenko, Mitchell N. Faddis, Barry J. Fetics, Karl E. Zelik, Igor R. Efimov, Ronald D. Berger. (2009) Transient Local Injury Current in Right Ventricular Electrogram After Implantable Cardioverter-Defibrillator Shock Predicts Heart Failure Progression. Journal of the American College of Cardiology 54:9, 822-828

  907. 907

    C. W. Israel. (2009) Do some implant too many defibrillators or others too few?. Europace 11:8, 982-984

  908. 908

    , J. Vijgen, G. Botto, J. Camm, C.-J. Hoijer, W. Jung, J.-Y. Le Heuzey, A. Lubinski, T. M. Norekval, M. Santomauro, M. Schalij, J.-P. Schmid, P. Vardas. (2009) Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators. Europace 11:8, 1097-1107

  909. 909

    Sébastien Knecht, Frédéric Sacher, Matthew Wright, Mélèze Hocini, Akihiko Nogami, Thomas Arentz, Bertrand Petit, Robert Franck, Christian De Chillou, Dominique Lamaison, Jéronimo Farré, Thomas Lavergne, Thierry Verbeet, Isabelle Nault, Seiichiro Matsuo, Lionel Leroux, Rukshen Weerasooriya, Bruno Cauchemez, Nicolas Lellouche, Nicolas Derval, Sanjiv M. Narayan, Pierre Jaïs, Jacques Clementy, Michel Haïssaguerre. (2009) Long-Term Follow-Up of Idiopathic Ventricular Fibrillation Ablation. Journal of the American College of Cardiology 54:6, 522-528

  910. 910

    H. S. Lim, G. Y.H. Lip. (2009) Defibrillation testing in patients with atrial fibrillation. Europace 11:8, 1108-1109

  911. 911

    Randy Wexler, Adam Pleister, David Feldman. (2009) Sociology meets genetics: Sociogenetic implications for future management of hypertension and heart failure. Current Treatment Options in Cardiovascular Medicine 11:4, 305-315

  912. 912

    Geoffrey S Pitt. (2009) Channeling a New Focus for Heart Failure: Insights Into Ion Channels. Journal of Cardiovascular Pharmacology 54:2, 95-97

  913. 913

    Stacie L. Daugherty, Pamela N. Peterson, Yongfei Wang, Jeptha P. Curtis, Paul A. Heidenreich, JoAnn Lindenfeld, Humberto J. Vidaillet, Frederick A. Masoudi. (2009) Use of implantable cardioverter defibrillators for primary prevention in the community: Do women and men equally meet trial enrollment criteria?. American Heart Journal 158:2, 224-229

  914. 914

    P. A. Scott, N. G. Turner, A. Chungh, J. M. Morgan, P. R. Roberts. (2009) Varying implantable cardioverter defibrillator referral patterns from implanting and non-implanting hospitals. Europace 11:8, 1048-1051

  915. 915

    DAVID FOO, BRUCE D. WALKER, DENNIS L. KUCHAR, CHARLES W. THORBURN, ANDRE TAY, CHRISTOPHER S. HAYWARD, PETER MACDONALD, ANNE KEOGH, EUGENE KOTLYAR, PHILIP SPRATT, PAUL JANSZ. (2009) Left Ventricular Mechanical Assist Devices and Cardiac Device Interactions: An Observational Case Series. Pacing and Clinical Electrophysiology 32:7, 879-887

  916. 916

    Paul Khairy, Annie Dore, Nancy Poirier, François Marcotte, Reda Ibrahim, François-Pierre Mongeon, Lise-Andrée Mercier. (2009) Risk stratification in surgically repaired tetralogy of Fallot. Expert Review of Cardiovascular Therapy 7:7, 755-762

  917. 917

    M. Stockburger, O. Celebi, A. Krebs, T. Knaus, A. Nitardy, D. Habedank, R. Dietz. (2009) Right ventricular pacing is associated with impaired overall survival, but not with an increased incidence of ventricular tachyarrhythmias in routine cardioverter/defibrillator recipients with reservedly programmed pacing. Europace 11:7, 924-930

  918. 918

    Komandoor Srivathsan, Daniel WC Ng, Farouk Mookadam. (2009) Ventricular tachycardia and ventricular fibrillation. Expert Review of Cardiovascular Therapy 7:7, 801-809

  919. 919

    Erlinda C. Wheeler, Ingrid Pretzer-Aboff, Thomas Hardie, Angela DiSabatino, Jennifer Saylor, Rita Lucey. (2009) Psychological Impact of Implantable Cardioverter Defibrillator on Their Recipients. Dimensions of Critical Care Nursing 28:4, 176-181

  920. 920

    G. C. Digby, M. E. Daubney, J. Baggs, D. Campbell, C. S. Simpson, D. P. Redfearn, F. J. Brennan, H. Abdollah, A. Baranchuk. (2009) Physiotherapy and cardiac rhythm devices: a review of the current scope of practice. Europace 11:7, 850-859

  921. 921

    Frank Grothues, Ruediger Braun-Dullaeus. (2009) Serial Assessment of Ventricular Morphology and Function. Heart Failure Clinics 5:3, 301-314

  922. 922

    Andreas Wolfgang Schoenenberger, Richard Kobza, Peiman Jamshidi, Michel Zuber, Antonio Abbate, Andreas Ernst Stuck, Matthias Pfisterer, Paul Erne. (2009) Sudden Cardiac Death in Patients With Silent Myocardial Ischemia After Myocardial Infarction (from the Swiss Interventional Study on Silent Ischemia Type II [SWISSI II]). The American Journal of Cardiology 104:2, 158-163

  923. 923

    Fredrik Holmqvist, Pyotr G. Platonov, Jonas Carlson, Wojciech Zareba, Arthur J. Moss, . (2009) Altered Interatrial Conduction Detected in MADIT II Patients Bound to Develop Atrial Fibrillation. Annals of Noninvasive Electrocardiology 14:3, 268-275

  924. 924

    M. K. de Bie, B. van Dam, A. Gaasbeek, M. van Buren, L. van Erven, J. J. Bax, M. J. Schalij, T. J. Rabelink, J. W. Jukema. (2009) The current status of interventions aiming at reducing sudden cardiac death in dialysis patients. European Heart Journal 30:13, 1559-1564

  925. 925

    Carlo Briguori, Tiziana Claudia Aranzulla, Flavio Airoldi, John Cosgrave, Davide Tavano, Iassen Michev, Matteo Montorfano, Mauro Carlino, Alfredo Castelli, Massimo Giuseppe Sangiorgi, Antonio Colombo. (2009) Stent implantation in patients with severe left ventricular systolic dysfunction. International Journal of Cardiology 135:3, 376-384

  926. 926

    SJOERD A. MOLLEMA, PATRICK KLEIN, JOGIEN HEERSCHE, MARTIN J. SCHALIJ, ERNST E. VAN DER WALL, MICHEL I.M. VERSTEEGH, ROBERT J.M. KLAUTZ, LIESELOT VAN ERVEN, JEROEN J. BAX. (2009) Left Ventricular Ejection Fraction as Criterion for Implantation of an Implantable Cardioverter-Defibrillator in Heart Failure Patients Undergoing Surgical Left Ventricular Reconstruction. Pacing and Clinical Electrophysiology 32:7, 913-917

  927. 927

    ANGELO BIVIANO, DONNA MANCINI, YOSHIFUMI NAKA, JERRY ARELLANO, HASAN GARAN. (2009) Overcoming Electromagnetic Interference by LVADs on ICD Function by Shielding the ICD Programmer Wand and Extension Cable. Pacing and Clinical Electrophysiology 32:7, 945-948

  928. 928

    JING TIAN, MARK F. SMITH, PONRAJ CHINNADURAI, VASKEN DILSIZIAN, Aharon TURGEMAN, AHARON ABBO, KALPITKUMAR GAJERA, CHENYANG XU, DANIEL PLOTNICK, ROBERT PETERS, MAGDI SABA, STEPHEN SHOROFSKY, TIMM DICKFELD. (2009) Clinical Application of PET/CT Fusion Imaging for Three-Dimensional Myocardial Scar and Left Ventricular Anatomy during Ventricular Tachycardia Ablation. Journal of Cardiovascular Electrophysiology 20:6, 597-604

  929. 929

    M. Meine, T. Smith, R. N.W. Hauer. (2009) The economical challenge in the treatment of chronic heart failure: is primary prophylactic ICD therapy cost-effective in Europe?. Europace 11:6, 689-691

  930. 930

    E. M. Aliot, W. G. Stevenson, J. M. Almendral-Garrote, F. Bogun, C. H. Calkins, E. Delacretaz, P. D. Bella, G. Hindricks, P. Jais, M. E. Josephson, J. Kautzner, G. N. Kay, K.-H. Kuck, B. B. Lerman, F. Marchlinski, V. Reddy, M.-J. Schalij, R. Schilling, K. Soejima, D. Wilber. (2009) EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Europace 11:6, 771-817

  931. 931

    K. M. Stein, S. Mittal, F. R. Gilliam, D. M. Gilligan, Q. Zhong, S. M. Kraus, T. E. Meyer. (2009) Predictors of early mortality in implantable cardioverter-defibrillator recipients. Europace 11:6, 734-740

  932. 932

    William H. Maisel, Robert G. Hauser, Stephen C. Hammill, Robert G. Hauser, Kenneth A. Ellenbogen, Andrew E. Epstein, David L. Hayes, Joseph S. Alpert, Ronald D. Berger, Anne B. Curtis, Anne M. Dubin, N.A. Mark Estes, Melanie T. Gura, Andrew D. Krahn, Rachel Lampert, Bruce D. Lindsay, Bruce L. Wilkoff. (2009) Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines. Heart Rhythm 6:6, 869-885

  933. 933

    M. R. Cowie, D. Marshall, M. Drummond, N. Ferko, M. Maschio, M. Ekman, L. de Roy, H. Heidbuchel, Y. Verboven, F. Braunschweig, C. Linde, G. Boriani. (2009) Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population. Europace 11:6, 716-726

  934. 934

    C. Cevik, A. Perez-Verdia, K. Nugent. (2009) Implantable cardioverter defibrillators and their role in heart failure progression. Europace 11:6, 710-715

  935. 935

    ARABINDRA B. KATWAL, CRAIG J. McCOTTER. (2009) Use of a Wireless Implantable Cardioverter Defibrillator in a Patient with a Preexisting Neurostimulator. Pacing and Clinical Electrophysiology 32:6, 822-824

  936. 936

    MOHAMAD A. ALAITI, ANJLI MAROO, THOMAS B. EDEL. (2009) Troponin Levels after Cardiac Electrophysiology Procedures: Review of the Literature. Pacing and Clinical Electrophysiology 32:6, 800-810

  937. 937

    Derek V. Exner. (2009) Noninvasive risk stratification after myocardial infarction: Rationale, current evidence and the need for definitive trials. Canadian Journal of Cardiology 25, 21A-27A

  938. 938

    W. Röll, P. Sasse, M. Breitbach, D. Wenzel, A.M. Klein, T. Bostani, B.K. Fleischmann, A. Welz. (2009) Zellersatztherapie am Herzen: Fiktion oder reale Möglichkeit. Zeitschrift für Herz-,Thorax- und Gefäßchirurgie 23:3, 170-176

  939. 939

    BRETT GIDNEY, DAVID S. CANNOM. (2009) The Role of Electrophysiologic Studies in Dilated Cardiomyopathy: Definitive Results from the DEFINITE Trial. Pacing and Clinical Electrophysiology 32:6, 753-754

  940. 940

    Etienne M. Aliot, William G. Stevenson, Jesus Ma Almendral-Garrote, Frank Bogun, C. Hugh Calkins, Etienne Delacretaz, Paolo Della Bella, Gerhard Hindricks, Pierre Jaïs, Mark E. Josephson, Josef Kautzner, G. Neal Kay, Karl-Heinz Kuck, Bruce B. Lerman, Francis Marchlinski, Vivek Reddy, Martin-Jan Schalij, Richard Schilling, Kyoko Soejima, David Wilber. (2009) EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias. Heart Rhythm 6:6, 886-933

  941. 941

    Alfred E. Buxton. (2009) Risk stratification for sudden death in patients with coronary artery disease. Heart Rhythm 6:6, 836-847

  942. 942

    Hein J. Verberne, G. Aernout Somsen, Berthe L.F. van Eck-Smit. (2009) 123I-meta-iodobenzylguanidine in patients with chronic heart failure: technical aspects, conceptual issues, and future prospects. Nuclear Medicine Communications 30:6, 411-414

  943. 943

    E. Agricola, A. Ielasi, M. Oppizzi, P. Faggiano, L. Ferri, A. Calabrese, E. Vizzardi, O. Alfieri, A. Margonato. (2009) Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction. European Journal of Heart Failure 11:6, 581-587

  944. 944

    SAMIR SABA, SANDEEP JAIN, RAVEEN BAZAZ, DAVID SCHWARTZMAN. (2009) Time Shift of Marker Legend in Stored Intracardiac Events in Three Patients with the Vitality 2 EL DR (Model T167) and Prizm 2DR (Model 1861) Dual-Chamber Defibrillators. Journal of Cardiovascular Electrophysiology 20:5, 564-567

  945. 945

    Joseph C. Lee, Laurence M. Epstein, Linda L. Huffer, William G. Stevenson, Bruce A. Koplan, Usha B. Tedrow. (2009) ICD lead proarrhythmia cured by lead extraction. Heart Rhythm 6:5, 613-618

  946. 946

    Christopher R. Ellis, Jeffrey N. Rottman. (2009) Increased rate of subacute lead complications with small-caliber implantable cardioverter-defibrillator leads. Heart Rhythm 6:5, 619-624

  947. 947

    Wilbert S. Aronow. (2009) Treatment of Ventricular Arrhythmias in the Elderly. Cardiology in Review 17:3, 136-146

  948. 948

    Paolo Nardi, Antonio Pellegrino, Antonio Scafuri, Dionisio Colella, Carlo Bassano, Patrizio Polisca, Luigi Chiariello. (2009) Long-Term Outcome of Coronary Artery Bypass Grafting in Patients With Left Ventricular Dysfunction. The Annals of Thoracic Surgery 87:5, 1401-1407

  949. 949

    Maria A. Castel, Herbert Nägele. (2009) Sudden Cardiac Arrest in Patients With Severe Nonischemic Heart Failure: Risk Stratification With the Heart Failure Survival Score. Congestive Heart Failure 15:3, 112-116

  950. 950

    Jean-Marc Raymond, Frederic Sacher, Robert Winslow, Usha Tedrow, William G. Stevenson. (2009) Catheter Ablation for Scar-related Ventricular Tachycardias. Current Problems in Cardiology 34:5, 225-270

  951. 951

    STEFANO BIANCHI, RENATO P. RICCI, FRANCESCO BISCIONE, FABRIZIO SGRECCIA, NATALE DI BELARDINO, PIETRO ROSSI, SILVIA GIULI, ANDREA GRAMMATICO, TIZIANA DE SANTO, ELISABETTA SANTI, MONICA MERICO, GIANFRANCO PICCIRILLO, PAOLO AZZOLINI, MASSIMO SANTINI, ANDREA PUGLISI. (2009) Primary Prevention Implantation of Cardioverter Defibrillator without Defibrillation Threshold Testing: 2-Year Follow-up. Pacing and Clinical Electrophysiology 32:5, 573-578

  952. 952

    Robbert H.J. Crusio, Yisachar J. Greenberg. (2009) An unusual presentation of implantable cardioverter-defibrillator lead perforation. Journal of Electrocardiology 42:3, 265-266

  953. 953

    D. R. Tomlinson, Y. Bashir, T. R. Betts, K. Rajappan. (2009) Accuracy of manual QRS duration assessment: its importance in patient selection for cardiac resynchronization and implantable cardioverter defibrillator therapy. Europace 11:5, 638-642

  954. 954

    Daniel R. Frisch, Evaldas Giedrimas, Satishkumar Mohanavelu, Amy Shui, Kalon K.L. Ho, C. Michael Gibson, Mark E. Josephson, Peter J. Zimetbaum. (2009) Predicting Irreversible Left Ventricular Dysfunction After Acute Myocardial Infarction. The American Journal of Cardiology 103:9, 1206-1209

  955. 955

    Gilbert H.L. Tang, Stephen Fremes. (2009) Invited Commentary. The Annals of Thoracic Surgery 87:5, 1407-1408

  956. 956

    R. P. Ricci, A. Quesada, J. Almendral, F. Arribas, C. Wolpert, P. Adragao, M. Zoni-Berisso, X. Navarro, T. DeSanto, A. Grammatico, M. Santini, . (2009) Dual-chamber implantable cardioverter defibrillators reduce clinical adverse events related to atrial fibrillation when compared with single-chamber defibrillators: a subanalysis of the DATAS trial. Europace 11:5, 587-593

  957. 957

    ALESSANDRO PROCLEMER, MARCO GHIDINA, DOMENICO FACCHIN, LUCA REBELLATO, DOMENICO CORRADO, MAURIZIO GASPARINI, DARIO GREGORI. (2009) Use of Implantable Cardioverter-Defibrillator in Inherited Arrhythmogenic Diseases: Data from Italian ICD Registry for the Years 2001-6. Pacing and Clinical Electrophysiology 32:4, 434-445

  958. 958

    Manuel Martínez-Sellés, María Teresa Vidán, Ramón López-Palop, Lourdes Rexach, Elisabet Sánchez, Tomás Datino, María Cornide, Pilar Carrillo, José M. Ribera, Óscar Díaz-Castro, Camino Bañuelos. (2009) El anciano con cardiopatía terminal. Revista Española de Cardiología 62:4, 409-421

  959. 959

    Katherine C. Wu. (2009) MRI with late gadolinium enhancement as a predictor of ventricular arrhythmias. Current Cardiovascular Imaging Reports 2:2, 116-123

  960. 960

    GRZEGORZ PIETRASIK, ILAN GOLDENBERG, SCOTT McNITT, BRONISLAVA POLONSKY, ARTHUR J. MOSS, WOJCIECH ZAREBA. (2009) Efficacy of Medical Therapy for the Reduction of Heart Failure Events in Patients with Implanted Cardioverter Defibrillators. Journal of Cardiovascular Electrophysiology 20:4, 395-400

  961. 961

    Mariell Jessup, William T. Abraham, Donald E. Casey, Arthur M. Feldman, Gary S. Francis, Theodore G. Ganiats, Marvin A. Konstam, Donna M. Mancini, Peter S. Rahko, Marc A. Silver, Lynne Warner Stevenson, Clyde W. Yancy. (2009) 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults. Journal of the American College of Cardiology 53:15, 1343-1382

  962. 962

    Richard D. Lane, Harry T. Reis, Derick R. Peterson, Wojciech Zareba, Arthur J. Moss. (2009) Happiness and Stress Alter Susceptibility to Cardiac Events in Long QT Syndrome. Annals of Noninvasive Electrocardiology 14:2, 193-200

  963. 963

    D.T. Connelly. (2009) Current controversies in using electrical devices. European Journal of Heart Failure Supplements 8:Supplement 1, i21-i24

  964. 964

    Kristian B. Filion, Xuanqian Xie, Charlotte J. van der Avoort, Nandini Dendukuri, James M. Brophy. (2009) Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: A cost-effectiveness study. International Journal of Technology Assessment in Health Care 25:02, 151

  965. 965

    Amy S. Kelley, M. Carrington Reid, David H. Miller, Joseph J. Fins, Mark S. Lachs. (2009) Implantable cardioverter-defibrillator deactivation at the end of life: A physician survey. American Heart Journal 157:4, 702-708.e1

  966. 966

    Judith L. Meadows, David Carballo, Raymond Y. Kwong. (2009) The prognostic value of cardiac MRI. Current Cardiovascular Imaging Reports 2:2, 145-156

  967. 967

    Iwona Cygankiewicz, John Gillespie, Wojciech Zareba, Mary W. Brown, Ilan Goldenberg, Helmut Klein, Scott McNitt, Slava Polonsky, Mark Andrews, Edward M. Dwyer, W. Jackson Hall, Arthur J. Moss. (2009) Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators. Heart Rhythm 6:4, 468-473

  968. 968

    T. Buck, O.-A. Breithardt, L. Faber, W. Fehske, F. A. Flachskampf, A. Franke, A. Hagendorff, R. Hoffmann, I. Kruck, H. Kücherer, T. Menzel, K. Pethig, K. Tiemann, J.-U. Voigt, F. Weidemann, U. Nixdorff. (2009) Manual zur Indikation und Durchführung der Echokardiographie. Clinical Research in Cardiology Supplements 4:S1, 3-51

  969. 969

    Sharon Ann Hunt, William T. Abraham, Marshall H. Chin, Arthur M. Feldman, Gary S. Francis, Theodore G. Ganiats, Mariell Jessup, Marvin A. Konstam, Donna M. Mancini, Keith Michl, John A. Oates, Peter S. Rahko, Marc A. Silver, Lynne Warner Stevenson, Clyde W. Yancy. (2009) 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults. Journal of the American College of Cardiology 53:15, e1-e90

  970. 970

    N. Schulz, K. Puschel, E. E. Turk. (2009) Fatal complications of pacemaker and implantable cardioverter-defibrillator implantation: medical malpractice?. Interactive CardioVascular and Thoracic Surgery 8:4, 444-448

  971. 971

    JERNEJA TASIČ, IGOR ZUPAN. (2009) T-Wave Variability as a Risk Stratifier in Patients with Dilated Cardiomyopathy. Pacing and Clinical Electrophysiology 32, S155-S157

  972. 972

    Jeffrey J. Goldberger. (2009) Evidence-based analysis of risk factors for sudden cardiac death. Heart Rhythm 6:3, S2-S7

  973. 973

    Christina M. Holmgren, Britta M. Nyström, Thomas K. Karlsson, Johan D. Herlitz, Nils G. Edvardsson. (2009) Presumed arrhythmic death in consecutive survivors of acute myocardial infarction – implications for primary implantable cardioverter defibrillator implantation. Coronary Artery Disease 20:2, 155-162

  974. 974

    Guy Amit, Otto Costantini, David S. Rosenbaum. (2009) Can we alternate between T-wave alternans testing methods?. Heart Rhythm 6:3, 338-340

  975. 975

    DOMINIC A.M.J. THEUNS, MAXIMO RIVERO-AYERZA, PAUL KNOPS, JAN C.J. RES, LUC JORDAENS. (2009) Analysis of 57,148 Transmissions by Remote Monitoring of Implantable Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 32, S63-S65

  976. 976

    Christina Salazar, William T. Abraham. (2009) Biventricular and novel pacing mechanisms in heart failure. Current Heart Failure Reports 6:1, 14-18

  977. 977

    Bruce A. Koplan, William G. Stevenson. (2009) Ventricular Tachycardia and Sudden Cardiac Death. Mayo Clinic Proceedings 84:3, 289-297

  978. 978

    Douglas C. Shook, Robert M. Savage. (2009) Anesthesia in the Cardiac Catheterization Laboratory and Electrophysiology Laboratory. Anesthesiology Clinics 27:1, 47-56

  979. 979

    Henry Krum, William T Abraham. (2009) Heart failure. The Lancet 373:9667, 941-955

  980. 980

    Stefan H. Hohnloser, Takanori Ikeda, Richard J. Cohen. (2009) Evidence regarding clinical use of microvolt T-wave alternans. Heart Rhythm 6:3, S36-S44

  981. 981

    Axel Müller, T. M. Helms, J. Neuzner, J. Schweizer, H. Korb. (2009) Schrittmacher und interne Defibrillatoren mit kardiotelemedizinischer Unterstützung. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 52:3, 306-315

  982. 982

    Bruce L. Wilkoff, Peter J. Kudenchuk, Alfred E. Buxton, Arjun Sharma, James R. Cook, Anil K. Bhandari, Michael Biehl, Gery Tomassoni, Anna Leonen, Linette R. Klevan, Alfred P. Hallstrom. (2009) The DAVID (Dual Chamber and VVI Implantable Defibrillator) II Trial. Journal of the American College of Cardiology 53:10, 872-880

  983. 983

    MARTIN STOCKBURGER, ALICE KREBS, AISCHA NITARDY, DIRK HABEDANK, ÖZLEM CELEBI, THOMAS KNAUS, RAINER DIETZ. (2009) Survival and Appropriate Device Interventions in Recipients of Cardioverter Defibrillators Implanted for the Primary Versus Secondary Prevention of Sudden Cardiac Death. Pacing and Clinical Electrophysiology 32, S16-S20

  984. 984

    Paul S. Chan, John D. Birkmeyer, Harlan M. Krumholz, John A. Spertus, Brahmajee K. Nallamothu. (2009) Racial and Gender Trends in the Use of Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries Between 1997 and 2003. Congestive Heart Failure 15:2, 51-57

  985. 985

    PAUL W.X. FOLEY, CLARA E. ADDISON, STEPHANIE B. WHINNEY, KIRAN PATEL, DAVID CUNNINGHAM, MICHAEL P. FRENNEAUX, FRANCISCO LEYVA. (2009) Implantable Cardioverter Defibrillator Therapy for Primary Prevention of Sudden Cardiac Death after Myocardial Infarction:. Pacing and Clinical Electrophysiology 32, S131-S134

  986. 986

    Maulik D. Majmudar, Christine Tompkins, Justin M. Bachmann, Roger S. Blumenthal, Joseph E. Marine. (2009) Effects of Lipid-Altering Therapies on Ventricular Arrhythmias and Sudden Cardiac Death. Cardiology in Review 17:2, 60-69

  987. 987

    Rahul Sakhuja, Mary Keebler, Tai-Shuan Lai, Cara McLaughlin Gavin, Ranjan Thakur, Deepak L. Bhatt. (2009) Meta-Analysis of Mortality in Dialysis Patients With an Implantable Cardioverter Defibrillator. The American Journal of Cardiology 103:5, 735-741

  988. 988

    JASON BRADFIELD, ALBERTA WARNER, MALCOLM M. BERSOHN. (2009) Low Referral Rate for Prophylactic Implantation of Cardioverter-Defibrillators in a Tertiary Care Medical Center. Pacing and Clinical Electrophysiology 32, S194-S197

  989. 989

    Gaetano M. De Ferrari, Antonio Sanzo. (2009) T-wave alternans in risk stratification of patients with nonischemic dilated cardiomyopathy: Can it help to better select candidates for ICD implantation?. Heart Rhythm 6:3, S29-S35

  990. 990

    David G. Strauss, Katherine C. Wu. (2009) Imaging myocardial scar and arrhythmic risk prediction—a role for the electrocardiogram?. Journal of Electrocardiology 42:2, 138.e1-138.e8

  991. 991

    Eyal Herzog, Emad F. Aziz, Marrick Kukin, Jonathan S. Steinberg, Suneet Mittal. (2009) Novel Pathway for Sudden Cardiac Death Prevention. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 8:1, 1-6

  992. 992

    (2009) Guías de Práctica Clínica de la Sociedad Europea de Cardiología (ESC). Manejo del infarto agudo de miocardio en pacientes con elevación persistente del segmento ST. Revista Española de Cardiología 62:3, 293.e1-293.e47

  993. 993

    Eric J. Rashba. (2009) Anger Management May Save Your Life. Journal of the American College of Cardiology 53:9, 779-781

  994. 994

    Michael J. Mirro. (2009) Strategies for reducing sudden cardiac death: Application of microvolt T-wave alternans testing in clinical practice. Heart Rhythm 6:3, S45-S48

  995. 995

    (2009) Implantable Cardioverter–Defibrillators. New England Journal of Medicine 360:9, 937-938
    Free Full Text

  996. 996

    A. Bauer, P. Barthel, R. Schneider, K. Ulm, A. Muller, A. Joeinig, R. Stich, A. Kiviniemi, K. Hnatkova, H. Huikuri, A. Schomig, M. Malik, G. Schmidt. (2009) Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk). European Heart Journal 30:5, 576-583

  997. 997

    Mithilesh Das. (2009) Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death. Expert Review of Cardiovascular Therapy 7:2, 181-195

  998. 998

    Gregory K. Feld, Paul Clopton. (2009) Comparability of Noninvasive Microvolt T-Wave Alternans Versus Invasive Ventricular Programmed Stimulation to Guide Implantable Cardioverter-Defibrillator Implantation in Patients at Risk of Sudden DeathEditorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.. Journal of the American College of Cardiology 53:6, 480-482

  999. 999

    Jaydutt B. Patel, Bruce A. Koplan. (2009) ICD implantation in patients with ischemic left ventricular dysfunction. Current Treatment Options in Cardiovascular Medicine 11:1, 3-9

  1000. 1000

    Bimal Shah, Adrian F. Hernandez, Li Liang, Sana M. Al-Khatib, Clyde W. Yancy, Gregg C. Fonarow, Eric D. Peterson. (2009) Hospital Variation and Characteristics of Implantable Cardioverter-Defibrillator Use in Patients With Heart Failure. Journal of the American College of Cardiology 53:5, 416-422

  1001. 1001

    CAROLINE MEDI, HARRY G. MOND. (2009) Right Ventricular Outflow Tract Septal Pacing: Long-Term Follow-Up of Ventricular Lead Performance. Pacing and Clinical Electrophysiology 32:2, 172-176

  1002. 1002

    Otto Costantini, Stefan H. Hohnloser, Malcolm M. Kirk, Bruce B. Lerman, James H. Baker, Barathi Sethuraman, Mary M. Dettmer, David S. Rosenbaum. (2009) The ABCD (Alternans Before Cardioverter Defibrillator) Trial. Journal of the American College of Cardiology 53:6, 471-479

  1003. 1003

    SUSANNE S. PEDERSEN, SAMUEL F. SEARS, MATTHEW M. BURG, KRISTA C. VAN DEN BROEK. (2009) Does ICD Indication Affect Quality of Life and Levels of Distress?. Pacing and Clinical Electrophysiology 32:2, 153-156

  1004. 1004

    U.C. Hoppe, M. Böhm, H. Drexler, G. Hasenfuß, B. Lemke, A. Osterspey, M. Pauschinger. (2009) Kommentar zu den ESC-Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008. Der Kardiologe 3:1, 16-23

  1005. 1005

    Jeff S. Healey, Andrew D. Krahn. (2009) Bad lead? Good lead? What should we believe?. Heart Rhythm 6:2, 210-211

  1006. 1006

    Amer Alshekhlee, Win-Kuang Shen, Judith Mackall, Thomas C. Chelimsky. (2009) Incidence and Mortality Rates of Syncope in the United States. The American Journal of Medicine 122:2, 181-188

  1007. 1007

    Eloi Marijon, Ludovic Trinquart, Akli Otmani, Xavier Waintraub, Salem Kacet, Jacques Clémenty, Gilles Chatellier, Jean-Yves Le Heuzey. (2009) Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study. American Heart Journal 157:2, 391-397.e1

  1008. 1008

    Sanjiv M. Narayan. (2009) From nonuniform repolarization to abnormal calcium dynamics: The elusive culprit for ventricular arrhythmias in heart failure. Heart Rhythm 6:2, 260-262

  1009. 1009

    Vikas Kuriachan, Derek V. Exner. (2009) Role of risk stratification after myocardial infarction. Current Treatment Options in Cardiovascular Medicine 11:1, 10-21

  1010. 1010

    Mark C. Haigney, Wojciech Zareba, Javed M. Nasir, Scott McNitt, Douglas McAdams, Philip J. Gentlesk, Robert E. Goldstein, Arthur J. Moss. (2009) Gender differences and risk of ventricular tachycardia or ventricular fibrillation. Heart Rhythm 6:2, 180-186

  1011. 1011

    Edward Duncan, Ajay Shah, Mark Kearney. End-stage congestive heart failure. In: Textbook of Palliative Medicine. CRC Press, 2009:918-924.

  1012. 1012

    M. Rivero-Ayerza, B. Schaer. (2009) Device therapy in heart failure: do all treatment goals apply to all patients?. Europace 11:3, 280-282

  1013. 1013

    W. C. Levy, D. Mozaffarian, D. T. Linker, K. W. Kenyon, J. G.F. Cleland, M. Komajda, W. J. Remme, C. Torp-Pedersen, M. Metra, P. A. Poole-Wilson, . (2009) Years-needed-to-treat to add 1 year of life: a new metric to estimate treatment effects in randomized trials. European Journal of Heart Failure 11:3, 256-263

  1014. 1014

    E. Marijon, S. Boveda, N. Combes, J.-P. Albenque, J.-Y. Le Heuzey. (2009) Comment évaluer le risque de mort subite dans les suites d’un infarctus du myocarde ?. Annales de Cardiologie et d Angéiologie 58:4, 220

  1015. 1015

    Iwona Cygankiewicz, Wojciech Zareba, Rafael Vazquez, Antoni Bayes-Genis, Domingo Pascual, Carlos Macaya, Jesus Almendral, Miquel Fiol, Alfredo Bardaji, Jose R. Gonzalez-Juanatey. (2009) Risk Stratification of Mortality in Patients With Heart Failure and Left Ventricular Ejection Fraction >35%. The American Journal of Cardiology 103:7, 1003

  1016. 1016

    Johannes Blumer, Thomas Wolber, Jens Hellermann, Johannes Holzmeister, Christian Binggeli, Firat Duru, Corinna Brunckhorst. (2009) Predictors of Appropriate Implantable Cardioverter-Defibrillator Therapy During Long-Term Follow-up of Patients With Coronary Artery Disease. International Heart Journal 50:3, 313-321

  1017. 1017

    Mark C. Haigney, Willem J. Kop, Shama Alam, David S. Krantz, Pamela Karasik, Albert A. DelNegro, John S. Gottdiener. (2009) QT Variability during Rest and Exercise in Patients with Implantable Cardioverter Defibrillators and Healthy Controls. Annals of Noninvasive Electrocardiology 14:1, 40-49

  1018. 1018

    Jon  W. Schrock, Charles L. Emerman. (2009) Observation Unit Management of Acute Decompensated Heart Failure. Heart Failure Clinics 5:1, 85-100

  1019. 1019

    Massimo Santini, Renato P. Ricci, Maurizio Lunati, Maurizio Landolina, Giovanni B. Perego, Maurizio Marzegalli, Milena Schirru, Chiara Belvito, Roberto Brambilla, Giuseppe Guenzati, Serena Gilardi, Sergio Valsecchi. (2009) Remote monitoring of patients with biventricular defibrillators through the CareLink system improves clinical management of arrhythmias and heart failure episodes. Journal of Interventional Cardiac Electrophysiology 24:1, 53-61

  1020. 1020

    Nabil El-Sherif, Abdullah Khan, Joseph Savarese, Gioia Turitto. (2009) Sudden Cardiac Death and Coronary Artery Disease-Pathophysiology and Risk Stratification. Journal of Arrhythmia 25:3, 122-129

  1021. 1021

    Martin Stockburger. (2009) Ein- und Zweikammer-ICD: Sind die Unterschiede zum Schrittmacher in Implantation und Nachsorge heutzutage noch bedeutsam?. Herzschrittmachertherapie + Elektrophysiologie 19:S1, 6

  1022. 1022

    Henry Greenberg. (2009) The Future of Sudden Cardiac Death. Annals of Noninvasive Electrocardiology 14:1, 1-3

  1023. 1023

    Eric L. Bloomfield. (2009) The Ethics of Rationing of Critical Care Services: Should Technology Assessment Play a Role?. Anesthesiology Research and Practice 2009, 1-8

  1024. 1024

    Yoshio Uetsuka. (2009) Iryo To Shakai 19:1, 97-106

  1025. 1025

    M.D. Cheitlin. (2009) Prognostic Importance of Defibrillator Shocks in Patients with Heart Failure. Yearbook of Cardiology 2009, 362-364

  1026. 1026

    Akihiko Shimizu. (2009) Cardiac Resynchronization Therapy With and Without Implantable Cardioverter-Defibrillator. Circulation Journal 73:SupplementA, A29-A35

  1027. 1027

    Melanie Hauck, Alexander Bauer, Frederik Voss, Slawomir Weretka, Hugo A. Katus, Ruediger Becker. (2009) “Home monitoring” for early detection of implantable cardioverter-defibrillator failure. Clinical Research in Cardiology 98:1, 19-24

  1028. 1028

    Dawood Darbar, Dan M. Roden. RHYTHM DISORDERS. In: Pharmacology and Therapeutics. Elsevier, 2009:367-387.

  1029. 1029

    Derek V Exner. (2009) Implantable cardioverter defibrillator therapy for patients with less severe left ventricular dysfunction. Current Opinion in Cardiology 24:1, 61-67

  1030. 1030

    Samer H. Sayyed, Mark M. Cassidy, M. Azam Hadi. (2009) Use of multidetector computed tomography for evaluation of global and regional left ventricular function. Journal of Cardiovascular Computed Tomography 3:1, S23-S34

  1031. 1031

    Fabian J. Arnaldo, Nikolaos Anatoliotakis, Carlos Palacio, David R. Nabert, Steve S. Hsu. (2009) Increased N-terminal-pro-B-type natriuretic peptide levels in patients with appropriate implantable defibrillator therapies. Heart & Lung: The Journal of Acute and Critical Care 38:1, 10-16

  1032. 1032

    Andrew Holt. Management of cardiac arrhythmias. In: Oh's Intensive Care Manual. Elsevier, 2009:189-243.

  1033. 1033

    LIONEL H. OPIE, JOHN P. DIMARCO, BERNARD J. GERSH. Antiarrhythmic Drugs and Strategies. In: Drugs for the Heart. Elsevier, 2009:235-292.

  1034. 1034

    Thomas Dresing. Cardiac Defibrillators. In: Neuromodulation. Elsevier, 2009:817-821.

  1035. 1035

    D TZIVONI, J BALKIN, F BAR, M HIBBERD, J REIBER, G COWING. (2009) Effect of Caldaret on the Incidence of Severe Left Ventricular Dysfunction in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Coronary Intervention. The American Journal of Cardiology 103:1, 1-4

  1036. 1036

    Melissa Matchett, Samuel F Sears, Garrett Hazelton, Kari Kirian, Elynor Wilson, Rajasekhar Nekkanti. (2009) The implantable cardioverter defibrillator: its history, current psychological impact and future. Expert Review of Medical Devices 6:1, 43-50

  1037. 1037

    John W. Albarran, Pam Moule. . 2009:141.

  1038. 1038

    James F. Neuenschwander. (2009) Cardiac Devices in Emergency Department Heart Failure Patients. Heart Failure Clinics 5:1, 63-73

  1039. 1039

    Tsuyoshi SHIGA. (2009) Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 40:3, 113S-114S

  1040. 1040

    Marc A. Rozner. How Should We Prepare the Patient with a Pacemaker/Implantable Cardioverter-Defibrillator?. In: Evidence-Based Practice of Anesthesiology. Elsevier, 2009:87-94.

  1041. 1041

    Hiroshige Murata, Toshihiko Ohara, Yoshinori Kobayashi, Yasushi Miyauchi, Takao Katoh, Kyoichi Mizuno. (2009) Detection of Arrhythmogenic Substrates in Prior Myocardial Infarction Patients with Complete Right Bundle Branch Block QRS Using Wavelet-Transformed ECG. Journal of Nippon Medical School 76:6, 291-299

  1042. 1042

    Anthony S Tang, George A Wells, Malcolm Arnold, Stuart Connolly, Stefan Hohnloser, Graham Nichol, Jean Rouleau, Robert Sheldon, Mario Talajic. (2009) Resynchronization/defibrillation for ambulatory heart failure trial: rationale and trial design. Current Opinion in Cardiology 24:1, 1-8

  1043. 1043

    A. Lepillier, O. Paziaud, G. Lascault, X. Copie, O. Piot. (2009) Prise en charge d’une tachycardie ventriculaire récidivante sur cardiopathie non ischémique chez un patient implanté d’un défibrillateur. Annales de Cardiologie et d Angéiologie 58:1, 34

  1044. 1044

    KALYANAM SHIVKUMAR, JOSEPH K. PERLOFF. Electrophysiologic Abnormalities: Unoperated Occurrence and Postoperative Residua and Sequelae. In: Congenital Heart Disease in Adults. Elsevier, 2009:418-459.

  1045. 1045

    BERNARD J. GERSH, LIONEL H. OPIE. Which Therapy for Which Condition?. In: Drugs for the Heart. Elsevier, 2009:388-458.

  1046. 1046

    Jessica S. Kim, Marc A. Judson, Robert Donnino, Michael Gold, Leslie T. Cooper, Eric N. Prystowsky, Stephen Prystowsky. (2009) Cardiac sarcoidosis. American Heart Journal 157:1, 9-21

  1047. 1047

    Karl D Donovan, Bernard EF Hockings. Cardiac pacing and implantable cardioverter/defibrillators. In: Oh's Intensive Care Manual. Elsevier, 2009:245-258.

  1048. 1048

    Nabil EI-Sherif, Abdullah Khan, Joseph Savarese, Gioia Turitto. (2009) Sudden Cardiac Death and Coronary Artery Disease —Pathophysiology and Risk Stratification. Journal of Arrhythmia 25:3, 122-129

  1049. 1049

    B. Gal, D. Lacroix, F. Brigadeau. (2009) Exploration électrophysiologique. EMC - Cardiologie 4:1, 1-13

  1050. 1050

    S. Spencker, N. Coban, L. Koch, A. Schirdewan, D. Muller. (2008) Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure. Europace 11:4, 483-488

  1051. 1051

    A. Proclemer, M. Ghidina, D. Gregori, D. Facchin, L. Rebellato, P. Fioretti, M. Brignole. (2008) Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07. Europace 11:4, 465-475

  1052. 1052

    S. Valk, L. Jordaens. (2008) Primary prevention: a necessity after myocardial infarction with left ventricular dysfunction. Europace 11:4, 407-408

  1053. 1053

    M. Santini, M. Russo, G. Botto, M. Lunati, A. Proclemer, B. Schmidt, A. Erdogan, E. Helmling, W. Rauhe, M. Desaga, E. Santi, M. Messier, G. Boriani. (2008) Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI). Europace 11:4, 476-482

  1054. 1054

    RONG BAI, LUIGI DI BIASE, CLAUDE ELAYI, CHI KEONG CHING, CONOR BARRETT, KAREN PHILIPPS, PASCAL LIM, DIMPI PATEL, TOM CALLAHAN, DAVID O. MARTIN, MAURICIO ARRUDA, ROBERT A. SCHWEIKERT, WALID I. SALIBA, BRUCE WILKOFF, ANDREA NATALE. (2008) Mortality of Heart Failure Patients After Cardiac Resynchronization Therapy: Identification of Predictors. Journal of Cardiovascular Electrophysiology 19:12, 1259-1265

  1055. 1055

    Michael J. Root. (2008) Implantable Cardiac Rhythm Device Batteries. Journal of Cardiovascular Translational Research 1:4, 254-257

  1056. 1056

    Alfred P. Hallstrom, D. George Wyse, John McAnulty, . (2008) Clinical criteria for predicting benefit of ICD/PM in post myocardial infarction patients: an AVID and CAST analysis. Journal of Interventional Cardiac Electrophysiology 23:3, 159-166

  1057. 1057

    Jerry P. Nolan, Robert W. Neumar, Christophe Adrie, Mayuki Aibiki, Robert A. Berg, Bernd W. Böttiger, Clifton Callaway, Robert S.B. Clark, Romergryko G. Geocadin, Edward C. Jauch, Karl B. Kern, Ivan Laurent, W.T. Longstreth, Raina M. Merchant, Peter Morley, Laurie J. Morrison, Vinay Nadkarni, Mary Ann Peberdy, Emanuel P. Rivers, Antonio Rodriguez-Nunez, Frank W. Sellke, Christian Spaulding, Kjetil Sunde, Terry Vanden Hoek. (2008) Post-cardiac arrest syndrome: Epidemiology, pathophysiology, treatment, and prognostication. Resuscitation 79:3, 350-379

  1058. 1058

    Ori Galante, Guy Amit, Doron Zahger, Abraham Wagshal, Reuben Ilia, Amos Katz. (2008) B-type Natruiretic Peptide Levels Stratify the Risk for Arrhythmia Among Implantable Cardioverter Defibrillator Patients. Clinical Cardiology 31:12, 586-589

  1059. 1059

    MITESH S. AMIN, AARON D. FOX, GAUTHAM KALAHASTY, RICHARD K. SHEPARD, MARK A. WOOD, KENNETH A. ELLENBOGEN. (2008) Benefit of Primary Prevention Implantable Cardioverter-Defibrillators in the Setting of Chronic Kidney Disease: A Decision Model Analysis. Journal of Cardiovascular Electrophysiology 19:12, 1275-1280

  1060. 1060

    Christian G. Wollmann, Dirk Böcker, Andreas Löher, Hans H. Scheld, Günter Breithardt, Rainer Gradaus. (2008) Diagnostik und Therapie von ICD-Elektrodendefekten. Herzschrittmachertherapie + Elektrophysiologie 19:4, 169-180

  1061. 1061

    James N. Kirkpatrick, Bradley P. Knight. (2008) The management of implantable cardiac devices at the end of life. Progress in Palliative Care 16:5, 250-256

  1062. 1062

    J.D. Schipke, G. Heusch, A. Fritzsche, K. Meyer, E. Gams, J. Winter. (2008) Blood pressure and heart rate immediately after termination of short-term ventricular fibrillation. Resuscitation 79:3, 404-409

  1063. 1063

    Martin Seifert, Jana Hoffmann, Jürgen Meyhöfer, Christian Butter. (2008) Verbesserung der linksventrikulären Kontraktilität durch Stimulation in der absoluten Refraktärperiode –. Herzschrittmachertherapie + Elektrophysiologie 19:S1, 69-76

  1064. 1064

    Antonio Curnis, Giosue Mascioli, Luca Bontempi, Manuel Cerini, Tommaso Bignotti, Gabriele Bonetti, Livio Dei Cas. (2008) Is it safe to allow patients with implantable cardioverter-defibrillators to drive? Learnings from a single center experience. Journal of Cardiovascular Medicine 9:12, 1241-1245

  1065. 1065

    (2008) Guía de práctica clínica de la Sociedad Europea de Cardiología (ESC) para el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica (2008). Revista Española de Cardiología 61:12, 1329.e1-1329.e70

  1066. 1066

    George V. Moukarbel, Scott D. Solomon. (2008) Treatment of asymptomatic left ventricular dysfunction. Current Treatment Options in Cardiovascular Medicine 10:6, 476-485

  1067. 1067

    Ali Erdogan, Michael Coch, Mehmet Bilgin, Mariana Parahuleva, Harald Tillmanns, Bernd Waldecker, Nedim Soydan. (2008) Prognostic value of heart rate variability after acute myocardial infarction in the era of immediate reperfusion. Herzschrittmachertherapie + Elektrophysiologie 19:4, 161-168

  1068. 1068

    Alessia Gimelli, Patrizia Landi, Paolo Marraccini, Rosa Sicari, Paolo Frumento, Antonio L’Abbate, Daniele Rovai. (2008) Left ventricular ejection fraction measurements: accuracy and prognostic implications in a large population of patients with known or suspected ischemic heart disease. The International Journal of Cardiovascular Imaging 24:8, 793-801

  1069. 1069

    Lorne J. Gula, George J. Klein, Anne S. Hellkamp, David Massel, Andrew D. Krahn, Allan C. Skanes, Raymond Yee, Jill Anderson, George W. Johnson, Jeanne E. Poole, Daniel B. Mark, Kerry L. Lee, Gust H. Bardy. (2008) Ejection fraction assessment and survival: An analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). American Heart Journal 156:6, 1196-1200

  1070. 1070

    Giovanni B. Perego, Maurizio Landolina, Giuseppe Vergara, Maurizio Lunati, Gabriele Zanotto, Alessia Pappone, Gabriele Lonardi, Giancarlo Speca, Saverio Iacopino, Annamaria Varbaro, Shantanu Sarkar, Doug A. Hettrick, Alessandra Denaro, . (2008) Implantable CRT device diagnostics identify patients with increased risk for heart failure hospitalization. Journal of Interventional Cardiac Electrophysiology 23:3, 235-242

  1071. 1071

    ILAN GOLDENBERG, ARTHUR J. MOSS. (2008) Implantable Cardioverter Defibrillator Efficacy and Chronic Kidney Disease: Competing Risks of Arrhythmic and Nonarrhythmic Mortality. Journal of Cardiovascular Electrophysiology 19:12, 1281-1283

  1072. 1072

    Myerburg , Robert J. , . (2008) Implantable Cardioverter–Defibrillators after Myocardial Infarction. New England Journal of Medicine 359:21, 2245-2253
    Full Text

  1073. 1073

    U. Bildirici, A. Vural, A. Agacdiken, T. Sahin, U. Celikyurt, T. Kilic, D. Ural. (2008) Comparison of the effects of left vs. right ventricular pacing on left ventricular remodelling. Europace 10:12, 1387-1391

  1074. 1074

    C. A. Muratore, L. A. Batista Sa, P. A. Chiale, R. Eloy, M. C. Tentori, J. Escudero, A. M. C. Lima, L. E. Medina, R. Garillo, J. Maloney. (2008) Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America. Europace 11:2, 164-168

  1075. 1075

    Yasushi Akutsu, Kyouichi Kaneko, Yusuke Kodama, Hui-Ling Li, Mitsuharu Kawamura, Taku Asano, Kaoru Tanno, Akira Shinozuka, Takehiko Gokan, Youichi Kobayashi. (2008) Cardiac sympathetic nerve abnormality predicts ventricular tachyarrhythmic events in patients without conventional risk of sudden death. European Journal of Nuclear Medicine and Molecular Imaging 35:11, 2066-2073

  1076. 1076

    MICHAEL O SWEENEY, ANNE S HELLKAMP, KENNETH A ELLENBOGEN, GERVASIO A LAMAS. (2008) Reduced Ejection Fraction, Sudden Cardiac Death, and Heart Failure Death in the Mode Selection Trial (MOST): Implications for Device Selection in Elderly Patients with Sinus Node Disease. Journal of Cardiovascular Electrophysiology 19:11, 1160-1166

  1077. 1077

    Theodore Chow, Dean J. Kereiakes, John Onufer, Alan Woelfel, Sinan Gursoy, Brett J. Peterson, Mark L. Brown, Wenji Pu, David G. Benditt. (2008) Does Microvolt T-Wave Alternans Testing Predict Ventricular Tachyarrhythmias in Patients With Ischemic Cardiomyopathy and Prophylactic Defibrillators?. Journal of the American College of Cardiology 52:20, 1607-1615

  1078. 1078

    Jeffrey S. Berger, C. Noel Bairey-Merz, Rita F. Redberg, Pamela S. Douglas. (2008) Improving the quality of care for women with cardiovascular disease. American Heart Journal 156:5, 816-825.e1

  1079. 1079

    FELIX YANG, BINDI SHAH, SEI IWAI, STEVEN M. MARKOWITZ, BRUCE B. LERMAN, KENNETH M. STEIN. (2008) ICD Implantation and Arrhythmia-Free Survival in Patients with Depressed LV Function Following Surgery for Valvular Heart Disease. Pacing and Clinical Electrophysiology 31:11, 1419-1424

  1080. 1080

    Mark V. Sherrid, James P. Daubert. (2008) Risks and Challenges of Implantable Cardioverter-Defibrillators in Young Adults. Progress in Cardiovascular Diseases 51:3, 237-263

  1081. 1081

    D. A. Taylor, A. G. Zenovich. (2008) Cardiovascular cell therapy and endogenous repair. Diabetes, Obesity and Metabolism 10, 5-15

  1082. 1082

    RITUPARNA S. SHINDE, YASH LOKHANDWALA, SUNIL V. SATHE, CHANDRASHEKAR N. MAKHALE, PURVEZ K. GRANT, MANUEL DURAIRAJ. (2008) Last Ditch CRT: Right Is Not Always Wrong!. Pacing and Clinical Electrophysiology 31:11, 1500-1502

  1083. 1083

    George Crossley, Andrew Boyle, Holly Vitense, Lou Sherfesee, R. Hardwin Mead. (2008) Trial design of the clinical evaluation of remote notification to reduce time to clinical decision: The Clinical evaluation Of remote NotificatioN to rEduCe Time to clinical decision (CONNECT) study. American Heart Journal 156:5, 840-846

  1084. 1084

    Maurizio Gasparini, Maurizio Lunati, Maurizio Landolina, Massimo Santini, Luigi Padeletti, Gianni Perego, Antonio Vincenti, Antonio Curnis, Angelo Carboni, Alessandra Denaro, Alessia Spotti, Andrea Grammatico, François Regoli, Giuseppe Boriani. (2008) Electrical storm in patients with biventricular implantable cardioverter defibrillator: Incidence, predictors, and prognostic implications. American Heart Journal 156:5, 847-854

  1085. 1085

    GIANNI PASTORE, FRANCO NOVENTA, PIERGIUSEPPE PIOVESANA, ROBERTO CAZZIN, SILVIO AGGIO, ROBERTO VERLATO, FRANCESCO ZANON, ENRICO BARACCA, LORIS RONCON, LUIGI PADELETTI, S. SERGE BAROLD. (2008) Left Ventricular Dyssynchrony Resulting from Right Ventricular Apical Pacing: Relevance of Baseline Assessment. Pacing and Clinical Electrophysiology 31:11, 1456-1462

  1086. 1086

    DAVID SCHWARTZMAN. (2008) Getting the Most Out of Life. Journal of Cardiovascular Electrophysiology 19:11, 1167-1168

  1087. 1087

    John P. Boehmer, Mark D. Carlson, Teresa Marco, Brian E. Jaski, Steven L. Higgins, Charles Kennergren, Andrew E. Epstein. (2008) Adjudication of mortality events in a heart failure–arrhythmia trial by a multiparameter descriptive method: Comparison with methods used in heart failure trials and methods used in arrhythmia trials. Journal of Interventional Cardiac Electrophysiology 23:2, 101-110

  1088. 1088

    Rajesh Subbiah, Lorne J. Gula, George J. Klein, Allan C. Skanes, James White, Raymond Yee, Andrew D. Krahn. (2008) Workup of the Cardiac Arrest Survivor. Progress in Cardiovascular Diseases 51:3, 195-203

  1089. 1089

    Stefan Brunner, Markus G Engelmann, Wolfgang-Michael Franz. (2008) Stem cell mobilisation for myocardial repair. Expert Opinion on Biological Therapy 8:11, 1675-1690

  1090. 1090

    Vera M.L. Gimenes, Marcelo L.C. Vieira, Mercedes M. Andrade, Jairo Pinheiro, Viviane T. Hotta, Wilson Mathias. (2008) Standard Values for Real-Time Transthoracic Three-Dimensional Echocardiographic Dyssynchrony Indexes in a Normal Population. Journal of the American Society of Echocardiography 21:11, 1229-1235

  1091. 1091

    MANISH UNDAVIA, NATHAN E. GOLDSTEIN, PILAR COHEN, KAMOLTIP SINTHAWANARONG, MAGDALENA SINGSON, DIVAYA BHUTANI, TRACEY MUNSON, JOSEPH ANTHONY GOMES, AVI FISCHER, DAVENDRA MEHTA. (2008) Impact of Implantable Cardioverter-Defibrillator Recalls on Patients' Anxiety, Depression, and Quality of Life. Pacing and Clinical Electrophysiology 31:11, 1411-1418

  1092. 1092

    Rüdiger Dissmann, Wolfram Kamke, Rona Reibis, Joachim Herbstleb, Karl Wegscheider, Heinz Völler. (2008) Prognostic impact of left bundle-branch block in the early stable phase after acute myocardial infarction. International Journal of Cardiology 130:3, 438-443

  1093. 1093

    Sumeet S. Chugh, Kyndaron Reinier, Carmen Teodorescu, Audrey Evanado, Elizabeth Kehr, Mershed Al Samara, Ronald Mariani, Karen Gunson, Jonathan Jui. (2008) Epidemiology of Sudden Cardiac Death: Clinical and Research Implications. Progress in Cardiovascular Diseases 51:3, 213-228

  1094. 1094

    Mark M. Gallagher, Giovanni B. Forleo, Elijah R. Behr, Giulia Magliano, Lucia De Luca, Valeria Morgia, Fabio De Liberato, Francesco Romeo. (2008) Prevalence and significance of Brugada-type ECG in 12,012 apparently healthy European subjects. International Journal of Cardiology 130:1, 44-48

  1095. 1095

    , F. Van de Werf, J. Bax, A. Betriu, C. Blomstrom-Lundqvist, F. Crea, V. Falk, G. Filippatos, K. Fox, K. Huber, A. Kastrati, A. Rosengren, P. G. Steg, M. Tubaro, F. Verheugt, F. Weidinger, M. Weis, , A. Vahanian, J. Camm, R. De Caterina, V. Dean, K. Dickstein, G. Filippatos, C. Funck-Brentano, I. Hellemans, S. D. Kristensen, K. McGregor, U. Sechtem, S. Silber, M. Tendera, P. Widimsky, J. L. Zamorano, , S. Silber, F. V. Aguirre, N. Al-Attar, E. Alegria, F. Andreotti, W. Benzer, O. Breithardt, N. Danchin, C. D. Mario, D. Dudek, D. Gulba, S. Halvorsen, P. Kaufmann, R. Kornowski, G. Y. H. Lip, F. Rutten. (2008) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:. European Heart Journal 29:23, 2909-2945

  1096. 1096

    J. Kreuz, L. M. Lickfett, J. O. Schwab. (2008) Modern noninvasive risk stratification in primary prevention of sudden cardiac death. Journal of Interventional Cardiac Electrophysiology 23:1, 23-28

  1097. 1097

    CHRISTOPHER R. ELLIS, KATHERINE T. MURRAY. (2008) When an ICD is Not the Answer… Hypothyroidism-Induced Cardiomyopathy and Torsades de Pointes. Journal of Cardiovascular Electrophysiology 19:10, 1105-1107

  1098. 1098

    BARRY J. MARON, PAOLO SPIRITO. (2008) Implantable Defibrillators and Prevention of Sudden Death in Hypertrophic Cardiomyopathy. Journal of Cardiovascular Electrophysiology 19:10, 1118-1126

  1099. 1099

    , K. Dickstein, A. Cohen-Solal, G. Filippatos, J. J.V. McMurray, P. Ponikowski, P. A. Poole-Wilson, A. Stromberg, D. J. van Veldhuisen, D. Atar, A. W. Hoes, A. Keren, A. Mebazaa, M. Nieminen, S. G. Priori, K. Swedberg, , A. Vahanian, J. Camm, R. De Caterina, V. Dean, K. Dickstein, G. Filippatos, C. Funck-Brentano, I. Hellemans, S. D. Kristensen, K. McGregor, U. Sechtem, S. Silber, M. Tendera, P. Widimsky, J. L. Zamorano, , M. Tendera, A. Auricchio, J. Bax, M. Bohm, U. Corra, P. della Bella, P. M. Elliott, F. Follath, M. Gheorghiade, Y. Hasin, A. Hernborg, T. Jaarsma, M. Komajda, R. Kornowski, M. Piepoli, B. Prendergast, L. Tavazzi, J.-L. Vachiery, F. W. A. Verheugt, J. L. Zamorano, F. Zannad. (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). European Heart Journal 29:19, 2388-2442

  1100. 1100

    Margit Strauß, Anselm Kai Gitt, Torsten Becker, Thomas Kleemann, Rudolf Schiele, Harald Darius, Claus Jünger, Jochen Senges, Karlheinz Seidl, . (2008) Prehospital cardiac arrest: a marker for higher mortality in patients with acute myocardial infarction and moderately reduced left ventricular function: results from the MITRA plus registry. Clinical Research in Cardiology 97:10, 748-752

  1101. 1101

    Naoki Serizawa, Dai Yumino, Katsuya Kajimoto, Yoshimi Tagawa, Atsushi Takagi, Morio Shoda, Hiroshi Kasanuki, Nobuhisa Hagiwara. (2008) Impact of Sleep-Disordered Breathing on Life-Threatening Ventricular Arrhythmia in Heart Failure Patients With Implantable Cardioverter-Defibrillator. The American Journal of Cardiology 102:8, 1064-1068

  1102. 1102

    Sana M. Al-Khatib, Gillian D. Sanders, Mark Carlson, Aida Cicic, Anne Curtis, Gregg C. Fonarow, Peter W. Groeneveld, David Hayes, Paul Heidenreich, Daniel Mark, Eric Peterson, Eric N. Prystowsky, Philip Sager, Marcel E. Salive, Kevin Thomas, Clyde W. Yancy, Wojciech Zareba, Douglas Zipes. (2008) Preventing tomorrow's sudden cardiac death today. American Heart Journal 156:4, 613-622

  1103. 1103

    Yaariv Khaykin, Allan Skanes, Bonnie Whaley, Carol Hill, Marianne Beardsall, Catherine Seabrook, Zaev Wulffhart, Richard Oosthuizen, Lorne Gula, Atul Verma. (2008) Real-time integration of 2D intracardiac echocardiography and 3D electroanatomical mapping to guide ventricular tachycardia ablation. Heart Rhythm 5:10, 1396-1402

  1104. 1104

    Ashraf M. Anwar, Youssef F. M. Nosir. (2008) Role of Real Time Three-Dimensional Echocardiography in Heart Failure. Echocardiography 25:9, 983-992

  1105. 1105

    DAVID S. CANNOM, JOHN FISHER. (2008) The Fidelis Recall: How Much Pressure Can the ICD World Bear?. Pacing and Clinical Electrophysiology 31:10, 1233-1235

  1106. 1106

    Sanjeev Saksena, Rangadham Nagarakanti. (2008) The future of implantable defibrillator and cardiac resynchronization therapy trials. Journal of Interventional Cardiac Electrophysiology 23:1, 29-39

  1107. 1107

    H.-J. Trappe. (2008) Kardiale Resynchronisationstherapie. Der Kardiologe 2:5, 407-416

  1108. 1108

    J. Tebbenjohanns, S. Willems, M. Antz, D. Pfeiffer, K.-H. Seidl, T. Lewalter. (2008) Kommentar zu den „ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death – executive summary“. Der Kardiologe 2:5, 363-388

  1109. 1109

    Saadia Sherazi, James P. Daubert, Robert C. Block, Vinodh Jeevanantham, Khalid Abdel-Gadir, Michael R. DiSalle, James M. Haley, Abrar H. Shah. (2008) Physicians' Preferences and Attitudes About End-of-Life Care in Patients With an Implantable Cardioverter-Defibrillator. Mayo Clinic Proceedings 83:10, 1139-1141

  1110. 1110

    SANA M AL-KHATIB, ANNE S. HELLKAMP, KERRY L LEE, JILL ANDERSON, JEANNE E. POOLE, DANIEL B. MARK, GUST H. BARDY, . (2008) Implantable Cardioverter Defibrillator Therapy in Patients with Prior Coronary Revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Journal of Cardiovascular Electrophysiology 19:10, 1059-1065

  1111. 1111

    P. Peter Borek, Bruce L. Wilkoff. (2008) Pacemaker and ICD leads: Strategies for long-term management. Journal of Interventional Cardiac Electrophysiology 23:1, 59-72

  1112. 1112

    Jeffrey J. Goldberger, Michael E. Cain, Stefan H. Hohnloser, Alan H. Kadish, Bradley P. Knight, Michael S. Lauer, Barry J. Maron, Richard L. Page, Rod S. Passman, David Siscovick, William G. Stevenson, Douglas P. Zipes. (2008) American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. Heart Rhythm 5:10, e1-e21

  1113. 1113

    Ian N. Sabir, Juliet A. Usher-Smith, Christopher L.-H. Huang, Andrew A. Grace. (2008) Risk stratification for sudden cardiac death. Progress in Biophysics and Molecular Biology 98:2-3, 340-346

  1114. 1114

    Healey , Jeff , Connolly , Stuart , . (2008) Life and Death after ICD Implantation. New England Journal of Medicine 359:10, 1058-1059
    Full Text

  1115. 1115

    Poole , Jeanne E. , Johnson , George W. , Hellkamp , Anne S. , Anderson , Jill , Callans , David J. , Raitt , Merritt H. , Reddy , Ramakota K. , Marchlinski , Francis E. , Yee , Raymond , Guarnieri , Thomas , Talajic , Mario , Wilber , David J. , Fishbein , Daniel P. , Packer , Douglas L. , Mark , Daniel B. , Lee , Kerry L. , Bardy , Gust H. , . (2008) Prognostic Importance of Defibrillator Shocks in Patients with Heart Failure. New England Journal of Medicine 359:10, 1009-1017
    Free Full Text

  1116. 1116

    Scott W Ferreira, Paul J Hauptman. (2008) Implantation of cardiac defibrillators for primary prevention: a pendulum too far?. Expert Review of Cardiovascular Therapy 6:8, 1047-1050

  1117. 1117

    Sanjiv M. Narayan. (2008) T-Wave Alternans Testing for Ventricular Arrhythmias. Progress in Cardiovascular Diseases 51:2, 118-127

  1118. 1118

    Alexander R. Lyon, Sian E. Harding, Nicholas S. Peters. (2008) Cardiac Stem Cell Therapy and Arrhythmogenicity: Prometheus and the arrows of Apollo and Artemis. Journal of Cardiovascular Translational Research 1:3, 207-216

  1119. 1119

    Alan H. Kadish, James A. Reiffel, Gerald V. Naccarelli, John P. DiMarco. (2008) Device Therapies in the Post-Myocardial Infarction Patient with Left Ventricular Dysfunction. The American Journal of Cardiology 102:5, 29G-37G

  1120. 1120

    Andrew E. Epstein. (2008) Benefits of the Implantable Cardioverter-Defibrillator. Journal of the American College of Cardiology 52:14, 1122-1127

  1121. 1121

    Roderick Tung, Peter Zimetbaum, Mark E. Josephson. (2008) A Critical Appraisal of Implantable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death. Journal of the American College of Cardiology 52:14, 1111-1121

  1122. 1122

    Paul Dorian, Hussein R. Al-Khalidi, Stefan H. Hohnloser, Jose M. Brum, Preston M. Dunnmon, Craig M. Pratt, Michael J. Holroyde, Peter Kowey. (2008) Azimilide Reduces Emergency Department Visits and Hospitalizations in Patients With an Implantable Cardioverter-Defibrillator in a Placebo-Controlled Clinical Trial. Journal of the American College of Cardiology 52:13, 1076-1083

  1123. 1123

    Matthew E. Harinstein, James D. Flaherty, Gregg C. Fonarow, Mihai Gheorghiade. (2008) Directions for Research in the Post-Myocardial Infarction Patient with Left Ventricular Dysfunction. The American Journal of Cardiology 102:5, 57G-61G

  1124. 1124

    Lutz Frankenstein, Christian Zugck, Manfred Nelles, Dieter Schellberg, Andrew Remppis, Hugo Katus. (2008) Primary ICD-therapy in patients with advanced heart failure: selection strategies and future trials. Clinical Research in Cardiology 97:9, 594-600

  1125. 1125

    Andrew D. Krahn, Jeffrey S. Hoch, Marie Antoinette Rockx, Peter Leong-Sit, Lorne J. Gula, Raymond Yee, Allan C. Skanes, George J. Klein. (2008) Cost of Preimplantation Cardiac Imaging in Patients Referred for a Primary-Prevention Implantable Cardioverter-Defibrillator. The American Journal of Cardiology 102:5, 588-592

  1126. 1126

    David S. Cannom, Brett Gidney. (2008) Azimilide: Another Effort to Prevent Implantable Cardioverter-Defibrillator Shocks and Their Sequelae. Journal of the American College of Cardiology 52:13, 1084-1085

  1127. 1127

    Suhny Abbara, Benjamin J.W. Chow, Antonio J. Pena, Ricardo C. Cury, Udo Hoffmann, Koen Nieman, Thomas J. Brady. (2008) Assessment of left ventricular function with 16- and 64-slice multi-detector computed tomography. European Journal of Radiology 67:3, 481-486

  1128. 1128

    Douglas S. Lee, David Birnie, Douglas Cameron, Eugene Crystal, Paul Dorian, Lorne J. Gula, Jeffrey S. Healey, Amir Janmohammed, Yaariv Khaykin, Andrew D. Krahn, Catherine LeFeuvre, Christopher S. Simpson, Raymond Yee, Judy Hardy, Pamela M. Slaughter, Zhongliang Chen, David A. Alter, Andreas Laupacis, Jack V. Tu. (2008) Design and implementation of a population-based registry of implantable cardioverter defibrillators (ICDs) in Ontario. Heart Rhythm 5:9, 1250-1256

  1129. 1129

    Kenneth M. Stein. (2008) Noninvasive Risk Stratification for Sudden Death: Signal-Averaged Electrocardiography, Nonsustained Ventricular Tachycardia, Heart Rate Variability, Baroreflex Sensitivity, and QRS Duration. Progress in Cardiovascular Diseases 51:2, 106-117

  1130. 1130

    Jeffrey J. Goldberger, Michael E. Cain, Stefan H. Hohnloser, Alan H. Kadish, Bradley P. Knight, Michael S. Lauer, Barry J. Maron, Richard L. Page, Rod S. Passman, David Siscovick, William G. Stevenson, Douglas P. Zipes. (2008) American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. Journal of the American College of Cardiology 52:14, 1179-1199

  1131. 1131

    Sameer Parekh, Kenneth M. Stein. (2008) Selective site pacing: Rationale and practical application. Current Cardiology Reports 10:5, 351-359

  1132. 1132

    Karen E. Thomas, Mark E. Josephson. (2008) The Role of Electrophysiology Study in Risk Stratification of Sudden Cardiac Death. Progress in Cardiovascular Diseases 51:2, 97-105

  1133. 1133

    H. V. Huikuri, M.J. P. Raatikainen, R. Moerch-Joergensen, J. Hartikainen, V. Virtanen, J. Boland, O. Anttonen, N. Hoest, L. V.A. Boersma, E. S. Platou, M. D. Messier, P.-E. Bloch-Thomsen, . (2008) Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction. European Heart Journal 30:6, 689-698

  1134. 1134

    M. Biffi, M. Ziacchi, M. Bertini, D. Sangiorgi, D. Corsini, C. Martignani, I. Diemberger, G. Boriani. (2008) Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems. Europace 10:11, 1288-1295

  1135. 1135

    C. N. Pellegrini, K. Lee, J. E. Olgin, M. P. Turakhia, Z. H. Tseng, R. Lee, N. Badhwar, B. Lee, P. D. Varosy. (2008) Impact of advanced age on survival in patients with implantable cardioverter defibrillators. Europace 10:11, 1296-1301

  1136. 1136

    M. Fatemi, Y. Etienne, P. Castellant, J.-J. Blanc. (2008) Primary failure of cardiac resynchronization therapy: what are the causes and is it worth considering a second attempt? A single-centre experience. Europace 10:11, 1308-1312

  1137. 1137

    S. Tzeis, G. Andrikopoulos, C. Kolb, P. E. Vardas. (2008) Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks. Europace 10:11, 1256-1265

  1138. 1138

    D. A.M.J. Theuns, M. Rivero-Ayerza, D. M. Goedhart, M. Miltenburg, L. J. Jordaens. (2008) Morphology discrimination in implantable cardioverter-defibrillators: consistency of template match percentage during atrial tachyarrhythmias at different heart rates. Europace 10:9, 1060-1066

  1139. 1139

    L. Ding, W. Hua, H. Niu, K. Chen, S. Zhang. (2008) Primary prevention of sudden cardiac death using implantable cardioverter defibrillators. Europace 10:9, 1034-1041

  1140. 1140

    Iwona Cygankiewicz, Wojciech Zareba, Rafael Vazquez, Montserrat Vallverdu, Jose R. Gonzalez-Juanatey, Mariano Valdes, Jesus Almendral, Juan Cinca, Pere Caminal, Antoni Bayes de Luna. (2008) Heart rate turbulence predicts all-cause mortality and sudden death in congestive heart failure patients. Heart Rhythm 5:8, 1095-1102

  1141. 1141

    Deepak Bhakta, Lynne D. Foreman. (2008) Cosmic radiation: Not science fiction, but clinical reality. Heart Rhythm 5:8, 1204-1205

  1142. 1142

    Hongkun Wang, Hongwei Zhao. (2008) A Study on Confidence Intervals for Incremental Cost-Effectiveness Ratios. Biometrical Journal 50:4, 505-514

  1143. 1143

    Michael R. Rosen, Peter R. Brink, Ira S. Cohen, Peter Danilo, Richard B. Robinson, Amy B. Rosen, Matthias J. Szabolcs. (2008) Regenerative therapies in electrophysiology and pacing. Journal of Interventional Cardiac Electrophysiology 22:2, 87-98

  1144. 1144

    NAHUM A. FREEDBERG. (2008) Passive Ventricular Restraint Device with Defibrillation Capabilities: Is There a Panacea for Heart Failure on the Horizon?. Journal of Cardiovascular Electrophysiology 19:8, 858-860

  1145. 1145

    BRETT FAULKNIER, DAVID T. HUANG, JAMES P. DAUBERT. (2008) Time Dependence of Arrhythmias in ICD Patients. Journal of Cardiovascular Electrophysiology 19:8, 790-793

  1146. 1146

    Paul S. Chan, Dean J. Kereiakes, Cheryl Bartone, Theodore Chow. (2008) Usefulness of Microvolt T-Wave Alternans to Predict Outcomes in Patients With Ischemic Cardiomyopathy Beyond One Year. The American Journal of Cardiology 102:3, 280-284

  1147. 1147

    Marc A. Simon, John Watson, J. Timothy Baldwin, William R. Wagner, Harvey S. Borovetz. (2008) Current and Future Considerations in the Use of Mechanical Circulatory Support Devices*. Annual Review of Biomedical Engineering 10:1, 59-84

  1148. 1148

    Joseph A. Blatt, Jeanne E. Poole, George W. Johnson, David J. Callans, Merritt H. Raitt, Ramakota K. Reddy, Francis E. Marchlinski, Raymond Yee, Thomas Guarnieri, Mario Talajic, David J. Wilber, Jill Anderson, Kiyon Chung, Wai Shun Wong, Daniel B. Mark, Kerry L. Lee, Gust H. Bardy. (2008) No Benefit From Defibrillation Threshold Testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). Journal of the American College of Cardiology 52:7, 551-556

  1149. 1149

    Christine M. Albert, Rebecca Quigg, Samir Saba, N.A. Mark Estes, Andi Shaechter, Haris Subacius, Adam Howard, Joseph Levine, Alan Kadish. (2008) Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy. American Heart Journal 156:2, 367-372

  1150. 1150

    ALAWI A. ALSHEIKH-ALI, MICHAEL HOMER, PRASAD V. MADDUKURI, BENJAMIN KALSMITH, N. A. MARK ESTES, MARK S. LINK. (2008) Time-Dependence of Appropriate Implantable Defibrillator Therapy in Patients with Ischemic Cardiomyopathy. Journal of Cardiovascular Electrophysiology 19:8, 784-789

  1151. 1151

    Bruce L. Wilkoff, Brian D. Williamson, Richard S. Stern, Stephen L. Moore, Fei Lu, Sung W. Lee, Ulrika M. Birgersdotter-Green, Mark S. Wathen, Isabelle C. Van Gelder, Brooke M. Heubner, Mark L. Brown, Keith K. Holloman. (2008) Strategic Programming of Detection and Therapy Parameters in Implantable Cardioverter-Defibrillators Reduces Shocks in Primary Prevention Patients. Journal of the American College of Cardiology 52:7, 541-550

  1152. 1152

    Jason Swindle, Thomas E. Burroughs, Mark A. Schnitzler, Paul J. Hauptman. (2008) Short-term mortality and cost associated with cardiac device implantation in patients hospitalized with heart failure. American Heart Journal 156:2, 322-328

  1153. 1153

    Harvey D White, Derek P Chew. (2008) Acute myocardial infarction. The Lancet 372:9638, 570-584

  1154. 1154

    Leonardo Calo, Ermenegildo de Ruvo. (2008) A turbulent era for congestive heart failure patients?. Heart Rhythm 5:8, 1103-1104

  1155. 1155

    A. Chieffo, S.-J. Park, E. Meliga, I. Sheiban, M. S. Lee, A. Latib, Y.-H. Kim, M. Valgimigli, D. Sillano, V. Magni, G. Biondi-Zoccai, M. Montorfano, F. Airoldi, R. Rogacka, M. Carlino, I. Michev, C.-W. Lee, M.-K. Hong, S.-W. Park, C. Moretti, E. Bonizzoni, G. M. Sangiorgi, J. Tobis, P. W. Serruys, A. Colombo. (2008) Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registry. European Heart Journal 29:17, 2108-2115

  1156. 1156

    Julia H. Indik, Craig M. Peters, Richard L. Donnerstein, Peter Ott, Karl B. Kern, Robert A. Berg. (2008) Direction of signal recording affects waveform characteristics of ventricular fibrillation in humans undergoing defibrillation testing during ICD implantation. Resuscitation 78:1, 38-45

  1157. 1157

    ANDREA M. RUSSO, JEANNE E. POOLE, DANIEL B. MARK, JILL ANDERSON, ANNE S. HELLKAMP, KERRY L. LEE, GEORGE W. JOHNSON, MICHAEL DOMANSKI, GUST H. BARDY. (2008) Primary Prevention with Defibrillator Therapy in Women: Results from the Sudden Cardiac Death in Heart Failure Trial. Journal of Cardiovascular Electrophysiology 19:7, 720-724

  1158. 1158

    Rik Hermanides, Jan Paul Ottervanger. (2008) Treatment of ST-elevation myocardial infarction. Future Cardiology 4:4, 391-397

  1159. 1159

    Charles A. Herzog, J. Michael Mangrum, Rod Passman. (2008) NON-CORONARY HEART DISEASE IN DIALYSIS PATIENTS: Sudden Cardiac Death and Dialysis Patients. Seminars in Dialysis 21:4, 300-307

  1160. 1160

    Theodore Chow, Deepak Joshi. (2008) Microvolt T-wave alternans testing for ventricular arrhythmia risk stratification. Expert Review of Cardiovascular Therapy 6:6, 833-842

  1161. 1161

    P. M. Spooner. (2008) Sudden cardiac death: influence of diabetes. Diabetes, Obesity and Metabolism 10:7, 523-532

  1162. 1162

    Jonathan W. Weinsaft, Matthew D. Cham, Matthew Janik, James K. Min, Claudia I. Henschke, David F. Yankelevitz, Richard B. Devereux. (2008) Left ventricular papillary muscles and trabeculae are significant determinants of cardiac MRI volumetric measurements: Effects on clinical standards in patients with advanced systolic dysfunction. International Journal of Cardiology 126:3, 359-365

  1163. 1163

    Andrew E. Epstein, John P. DiMarco, Kenneth A. Ellenbogen, N.A. Mark Estes, Roger A. Freedman, Leonard S. Gettes, A. Marc Gillinov, Gabriel Gregoratos, Stephen C. Hammill, David L. Hayes, Mark A. Hlatky, L. Kristin Newby, Richard L. Page, Mark H. Schoenfeld, Michael J. Silka, Lynne Warner Stevenson, Michael O. Sweeney, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Jeffrey L. Anderson, Christopher E. Buller, Mark A. Creager, Steven M. Ettinger, David P. Faxon, Jonathan L. Halperin, Loren F. Hiratzka, Sharon A. Hunt, Harlan M. Krumholz, Frederick G. Kushner, Bruce W. Lytle, Rick A. Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel, Lynn G. Tarkington, Clyde W. Yancy. (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary. Heart Rhythm 5:6, 934-955

  1164. 1164

    Matthias Wilhelm, Rueth Tobias, Fatima Asskali, Robert Kraehner, Simone Kuly, Lutz Klinghammer, Hansjosef Boehles, Werner Guenther Daniel. (2008) Red blood cell omega-3 fatty acids and the risk of ventricular arrhythmias in patients with heart failure. American Heart Journal 155:6, 971-977

  1165. 1165

    Bao C. Huynh, Aleksandr Rovner, Michael W. Rich. (2008) Identification of Older Patients with Heart Failure Who May Be Candidates for Hospice Care: Development of a Simple Four-Item Risk Score. Journal of the American Geriatrics Society 56:6, 1111-1115

  1166. 1166

    Ronni Levy, Andrea DellaValle, A. Serdar Atav, Afazal ur Rehman, Allan H. Sklar, Nicolas J. Stamato. (2008) The Relationship Between Glomerular Filtration Rate and Survival in Patients Treated with an Implantable Cardioverter Defibrillator. Clinical Cardiology 31:6, 265-269

  1167. 1167

    Tetsuo Sasano, M. Roselle Abraham, Kuan-Cheng Chang, Hiroshi Ashikaga, Kevin J. Mills, Daniel P. Holt, John Hilton, Stephan G. Nekolla, Jun Dong, Albert C. Lardo, Henry Halperin, Robert F. Dannals, Eduardo Marbán, Frank M. Bengel. (2008) Abnormal Sympathetic Innervation of Viable Myocardium and the Substrate of Ventricular Tachycardia After Myocardial Infarction. Journal of the American College of Cardiology 51:23, 2266-2275

  1168. 1168

    Andrew E. Epstein, John P. DiMarco, Kenneth A. Ellenbogen, N. A. Mark Estes, Roger A. Freedman, Leonard S. Gettes, A. Marc Gillinov, Gabriel Gregoratos, Stephen C. Hammill, David L. Hayes, Mark A. Hlatky, L. Kristin Newby, Richard L. Page, Mark H. Schoenfeld, Michael J. Silka, Lynne Warner Stevenson, Michael O. Sweeney, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Jeffrey L. Anderson, Christopher E. Buller, Mark A. Creager, Steven M. Ettinger, David P. Faxon, Jonathan L. Halperin, Loren F. Hiratzka, Sharon A. Hunt, Harlan M. Krumholz, Frederick G. Kushner, Bruce W. Lytle, Rick A. Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel, Lynn G. Tarkington, Clyde W. Yancy. (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. Heart Rhythm 5:6, e1-e62

  1169. 1169

    Grace Lin, Ryan A. Meverden, David O. Hodge, Daniel Z. Uslan, David L. Hayes, Peter A. Brady. (2008) Age and gender trends in implantable cardioverter defibrillator utilization: A population based study. Journal of Interventional Cardiac Electrophysiology 22:1, 65-70

  1170. 1170

    Ritesh Dhar, Alawi A. Alsheikh-Ali, N.A. Mark Estes, Arthur J. Moss, Wojciech Zareba, James P. Daubert, Henry Greenberg, Robert B. Case, David M. Kent. (2008) Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). Heart Rhythm 5:6, 807-813

  1171. 1171

    J. Philip Saul, Andrew E. Epstein, Michael J. Silka, Charles I. Berul, MacDonald Dick, John P. DiMarco, Richard A. Friedman, Eric Rosenthal, Elizabeth A. Stephenson, Victoria L. Vetter. (2008) Heart Rhythm Society/Pediatric and Congenital Electrophysiology Society Clinical Competency Statement: Training pathways for implantation of cardioverter-defibrillators and cardiac resynchronization therapy devices in pediatric and congenital heart patients. Heart Rhythm 5:6, 926-933

  1172. 1172

    S. P. Bhavnani, C. I. Coleman, C. M. White, C. A. Clyne, R. Yarlagadda, D. Guertin, J. Kluger. (2008) Association between statin therapy and reductions in atrial fibrillation or flutter and inappropriate shock therapy. Europace 10:7, 854-859

  1173. 1173

    Arthur J. Moss. (2008) What is the real world for analyzing outcomes and costs of ICD therapy?. Heart Rhythm 5:5, 654-655

  1174. 1174

    Yee Guan Yap, Trinh Duong, Martin Bland, Marek Malik, Christian Torp-Pedersen, Lars Køber, Stuart J. Connolly, Mark M. Gallagher, A. John Camm. (2008) Potential demographic and baselines variables for risk stratification of high-risk post-myocardial infarction patients in the era of implantable cardioverter-defibrillator — A prognostic indicator. International Journal of Cardiology 126:1, 101-107

  1175. 1175

    Melvin M. Scheinman, Edmund Keung. (2008) The Year in Review of Clinical Cardiac Electrophysiology. Journal of the American College of Cardiology 51:21, 2075-2081

  1176. 1176

    Andrew E. Epstein, John P. DiMarco, Kenneth A. Ellenbogen, N.A. Mark Estes, Roger A. Freedman, Leonard S. Gettes, A. Marc Gillinov, Gabriel Gregoratos, Stephen C. Hammill, David L. Hayes, Mark A. Hlatky, L. Kristin Newby, Richard L. Page, Mark H. Schoenfeld, Michael J. Silka, Lynne Warner Stevenson, Michael O. Sweeney. (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. Journal of the American College of Cardiology 51:21, e1-e62

  1177. 1177

    Ilan Goldenberg, Arthur J. Moss. (2008) Implantable Device Therapy. Progress in Cardiovascular Diseases 50:6, 449-474

  1178. 1178

    Aysha Arshad, Anisha Mandava, Ganesh Kamath, Dan Musat. (2008) Sudden Cardiac Death and the Role of Medical Therapy. Progress in Cardiovascular Diseases 50:6, 420-438

  1179. 1179

    Peter W. Groeneveld, Steven A. Farmer, Janice J. Suh, Mary Anne Matta, Feifei Yang. (2008) Outcomes and costs of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death among the elderly. Heart Rhythm 5:5, 646-653

  1180. 1180

    Henry Greenberg. (2008) Sudden Cardiac Death. An Essay for 2008. Progress in Cardiovascular Diseases 50:6, 384-389

  1181. 1181

    Andreas Brieke, Joseph Cleveland, JoAnn Lindenfeld. (2008) Mechanical support in acute and chronic heart failure. Current Cardiology Reports 10:3, 168-175

  1182. 1182

    Andrew E. Epstein, John P. DiMarco, Kenneth A. Ellenbogen, N.A. Mark Estes, Roger A. Freedman, Leonard S. Gettes, A. Marc Gillinov, Gabriel Gregoratos, Stephen C. Hammill, David L. Hayes, Mark A. Hlatky, L. Kristin Newby, Richard L. Page, Mark H. Schoenfeld, Michael J. Silka, Lynne Warner Stevenson, Michael O. Sweeney. (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary. Journal of the American College of Cardiology 51:21, 2085-2105

  1183. 1183

    Bardy , Gust H. , Lee , Kerry L. , Mark , Daniel B. , Poole , Jeanne E. , Toff , William D. , Tonkin , Andrew M. , Smith , Warren , Dorian , Paul , Packer , Douglas L. , White , Roger D. , Longstreth , W.T. Jr. , Anderson , Jill , Johnson , George , Bischoff , Eric , Yallop , Julie J. , McNulty , Steven , Ray , Linda Davidson , Clapp-Channing , Nancy E. , Rosenberg , Yves , Schron , Eleanor B. , . (2008) Home Use of Automated External Defibrillators for Sudden Cardiac Arrest. New England Journal of Medicine 358:17, 1793-1804
    Free Full Text

  1184. 1184

    Wolfram Grimm. (2008) Outcomes of elderly heart failure recipients of ICD and CRT. International Journal of Cardiology 125:2, 154-160

  1185. 1185

    Samuel O. Jones, Robert E. Eckart, Christine M. Albert, Laurence M. Epstein. (2008) Large, single-center, single-operator experience with transvenous lead extraction: Outcomes and changing indications. Heart Rhythm 5:4, 520-525

  1186. 1186

    John A. Chiladakis, Nikolaos Koutsogiannis, Andreas Kalogeropoulos, Panagiotis Arvanitis, Dimitrios Alexopoulos. (2008) Adverse Effects of Continuous Ventricular Pacing in Patients with Slower Atrial Fibrillation and Normal Left Ventricular Systolic Function. Annals of Noninvasive Electrocardiology 13:2, 130-136

  1187. 1187

    Michael T. Koller, Theo Stijnen, Ewout W. Steyerberg, Jacobus Lubsen. (2008) Meta-analyses of chronic disease trials with competing causes of death may yield biased odds ratios. Journal of Clinical Epidemiology 61:4, 365-372

  1188. 1188

    LORNE J. GULA, DAVID MASSEL, ANDREW D. KRAHN, RAYMOND YEE, ALLAN C. SKANES, GEORGE J. KLEIN. (2008) Is Defibrillation Testing Still Necessary? A Decision Analysis and Markov Model. Journal of Cardiovascular Electrophysiology 19:4, 400-405

  1189. 1189

    Juha S. Perkiömäki, Vesa Jokinen, Jari Tapanainen, K.E. Juhani Airaksinen, Heikki V. Huikuri. (2008) Autonomic Markers as Predictors of Nonfatal Acute Coronary Events after Myocardial Infarction. Annals of Noninvasive Electrocardiology 13:2, 120-129

  1190. 1190

    Rohit Mehta, Amit A. Doshi, Ayesha K. Hasan, Charles J. Love, Marg Pizzuto, Chittoor Sai-Sudhakar, David P. Chan. (2008) Device Interactions in Patients With Advanced Cardiomyopathy. Journal of the American College of Cardiology 51:16, 1613-1614

  1191. 1191

    Merritt H. Raitt. (2008) Implantable Cardioverter-Defibrillator Shocks. Journal of the American College of Cardiology 51:14, 1366-1368

  1192. 1192

    Maria Teresa La Rovere, Gian Domenico Pinna, Grzegorz Raczak. (2008) Baroreflex Sensitivity: Measurement and Clinical Implications. Annals of Noninvasive Electrocardiology 13:2, 191-207

  1193. 1193

    B. Hesse, T. B. Lindhardt, W. Acampa, C. Anagnostopoulos, J. Ballinger, J. J. Bax, L. Edenbrandt, A. Flotats, G. Germano, T. Gmeiner Stopar, P. Franken, A. Kelion, A. Kjaer, D. Le Guludec, M. Ljungberg, A. F. Maenhout, C. Marcassa, J. Marving, F. McKiddie, W. M. Schaefer, L. Stegger, R. Underwood. (2008) EANM/ESC guidelines for radionuclide imaging of cardiac function. European Journal of Nuclear Medicine and Molecular Imaging 35:4, 851-885

  1194. 1194

    Christiana O. Adesanya, Kabir A. Yousuf, Carter Co, Shobhana Gaur, Sameer Ahmed, Anthony Pothoulakis, Agaram Suryaprasad, Satyendra Gupta. (2008) Is Wider Worse? QRS Duration Predicts Cardiac Mortality in Patients with Right Bundle Branch Block. Annals of Noninvasive Electrocardiology 13:2, 165-170

  1195. 1195

    James P. Daubert, Wojciech Zareba, David S. Cannom, Scott McNitt, Spencer Z. Rosero, Paul Wang, Claudio Schuger, Jonathan S. Steinberg, Steven L. Higgins, David J. Wilber, Helmut Klein, Mark L. Andrews, W. Jackson Hall, Arthur J. Moss. (2008) Inappropriate Implantable Cardioverter-Defibrillator Shocks in MADIT II. Journal of the American College of Cardiology 51:14, 1357-1365

  1196. 1196

    Dominic A.M.J. Theuns, Maximo Rivero-Ayerza, Erik Boersma, Luc Jordaens. (2008) Prevention of inappropriate therapy in implantable defibrillators: A meta-analysis of clinical trials comparing single-chamber and dual-chamber arrhythmia discrimination algorithms. International Journal of Cardiology 125:3, 352-357

  1197. 1197

    Hind W. Rahmouni, James N. Kirkpatrick, Martin G. St. John Sutton. (2008) Effects of cardiac resynchronization therapy on ventricular remodeling. Current Heart Failure Reports 5:1, 25-30

  1198. 1198

    Timm Dickfeld, Christopher Kocher. (2008) The role of integrated PET-CT scar maps for guiding ventricular tachycardia ablations. Current Cardiology Reports 10:2, 149-157

  1199. 1199

    Juyong B. Kim, Daniel M. Spevack, Paul A. Tunick, John R. Bullinga, Itzhak Kronzon, Larry A. Chinitz, Harmony R. Reynolds. (2008) The Effect of Transvenous Pacemaker and Implantable Cardioverter Defibrillator Lead Placement on Tricuspid Valve Function: An Observational Study. Journal of the American Society of Echocardiography 21:3, 284-287

  1200. 1200

    Robert L. McNamara, Bethany A. Austin, Yongfei Wang, Grace L. Smith, Viola Vaccarine, Harlan M. Krumholz. (2008) Systolic Function as a Predictor of Mortality and Quality of Life in Long-term Survivors with Heart Failure. Clinical Cardiology 31:3, 119-124

  1201. 1201

    Gust H. Bardy, Kerry L. Lee, Daniel B. Mark, Jeanne E. Poole, William D. Toff, Andrew M. Tonkin, Warren Smith, Paul Dorian, Julie J. Yallop, Douglas L. Packer, Roger D. White, Will Longstreth, Jill Anderson, George Johnson, Eric Bischoff, Crystal D. Munkers, Amanda Brown, Steven McNulty, Linda Davidson Ray, Nancy E. Clapp-Channing, Yves Rosenberg, Marcel Salive, Eleanor B. Schron. (2008) Rationale and design of the Home Automatic External Defibrillator Trial (HAT). American Heart Journal 155:3, 445-454

  1202. 1202

    Denis Agostini, Hein J. Verberne, Wolfgang Burchert, Juhani Knuuti, Pavol Povinec, Gianmario Sambuceti, Mustafa Unlu, Montserrat Estorch, Gopa Banerjee, Arnold F. Jacobson. (2008) I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study. European Journal of Nuclear Medicine and Molecular Imaging 35:3, 535-546

  1203. 1203

    Sunil K. Sinha. (2008) AVID revisited: Quality of life is important too. Heart Rhythm 5:3, 366

  1204. 1204

    Ayman El-Menyar, Nidal Asaad. (2008) T-Wave Alternans and Sudden Cardiac Death. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 7:1, 21-28

  1205. 1205

    Joseph B. Thibodeau, Jayasree Pillarisetti, Taiyeb M. Khumri, Philip G. Jones, Michael L. Main. (2008) Mortality Rates and Clinical Predictors of Reduced Survival After Cardioverter Defibrillator Implantation. The American Journal of Cardiology 101:6, 861-864

  1206. 1206

    Paul A. Santolucito, Dennis A. Tighe, Darleen Lessard, Rovshan M. Ismailov, Joel M. Gore, Jorge Yarzebski, Robert J. Goldberg. (2008) Changing trends in the evaluation of ejection fraction in patients hospitalized with acute myocardial infarction: The Worcester Heart Attack Study. American Heart Journal 155:3, 485-493

  1207. 1207

    Steven M Hollenberg. Management of Complications. Informa Healthcare, 2008:280-299.

  1208. 1208

    James O. Mudd, David A. Kass. (2008) Tackling heart failure in the twenty-first century. Nature 451:7181, 919-928

  1209. 1209

    Björn C. Knollmann, Dan M. Roden. (2008) A genetic framework for improving arrhythmia therapy. Nature 451:7181, 929-936

  1210. 1210

    Arnt V. Kristen, Thomas J. Dengler, Ute Hegenbart, Stefan O. Schonland, Hartmut Goldschmidt, Falk-Udo Sack, Frederik Voss, Rüdiger Becker, Hugo A. Katus, Alexander Bauer. (2008) Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death. Heart Rhythm 5:2, 235-240

  1211. 1211

    Michael W. Rich. Therapy of Acute Myocardial Infarction. Informa Healthcare, 2008:293-326.

  1212. 1212

    Kapil Kumar, Kevin F. Kwaku, Richard L. Verrier. (2008) Treatment options for patients with coronary artery disease identified as high risk by T-wave alternans testing. Current Treatment Options in Cardiovascular Medicine 10:1, 39-48

  1213. 1213

    Dalane W. Kitzman, Jerome L. Fleg. Heart Failure. Informa Healthcare, 2008:542-576.

  1214. 1214

    Dennis T. Ko, David A. Alter, Peter C. Austin, John J. You, Douglas S. Lee, Feng Qiu, Therese A. Stukel, Jack V. Tu. (2008) Life expectancy after an index hospitalization for patients with heart failure: A population-based study. American Heart Journal 155:2, 324-331

  1215. 1215

    ANDREAS W. SCHOENENBERGER, PAUL ERNE, STEPHAN AMMANN, GERHARD GILLMANN, RICHARD KOBZA, ANDREAS E. STUCK. (2008) Prediction of Arrhythmic Events after Myocardial Infarction Based on Signal-Averaged Electrocardiogram and Ejection Fraction. Pacing and Clinical Electrophysiology 31:2, 221-228

  1216. 1216

    Wilbert S. Aronow. Management of the Older Patient After Myocardial Infarction. Informa Healthcare, 2008:327-350.

  1217. 1217

    Damian P. Redfearn. (2008) Non-Gaussian index: Hope yet for the grail seekers?. Heart Rhythm 5:2, 269-270

  1218. 1218

    Maria R. Costanzo, Roger M. Mills, Janet Wynne. (2008) Characteristics of “Stage D” heart failure: Insights from the Acute Decompensated Heart Failure National Registry Longitudinal Module (ADHERE LM). American Heart Journal 155:2, 339-347

  1219. 1219

    Frederik Voss, Henning Steen, Alexander Bauer, Evangelos Giannitsis, Hugo A. Katus, Ruediger Becker. (2008) Determination of myocardial infarct size by noncontact mapping. Heart Rhythm 5:2, 308-314

  1220. 1220

    Augusto Achilli, Massimo Sassara, Daniele Pontillo, Federico Turreni, Pietro Rossi, Rosanna De Luca, Catherine Klersy, Nicolino Patruno, Paola Achilli, Luciano Sallusti, Paolo Spadaccia, Luigi Cricco, Francesco Serra. (2008) Effectiveness of cardiac resynchronisation therapy in patients with echocardiographic evidence of mechanical dyssynchrony. Journal of Cardiovascular Medicine 9:2, 131-136

  1221. 1221

    RYAN ANTHONY, JAMES P. DAUBERT, WOJCIECH ZAREBA, MARK L. ANDREWS, SCOTT McNITT, ETHAN LEVINE, DAVID T. HUANG, W. JACKSON HALL, ARTHUR J. MOSS, . (2008) Mechanisms of Ventricular Fibrillation Initiation in MADIT II Patients with Implantable Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 31:2, 144-150

  1222. 1222

    Wilbert S. Aronow, Carmine Sorbera. Ventricular Arrhythmias in the Elderly. Informa Healthcare, 2008:605-626.

  1223. 1223

    Suneet Mittal. (2008) Selecting Patients for an Implantable Cardioverter-Defibrillator. Journal of the American College of Cardiology 51:3, 297-299

  1224. 1224

    Carsten W Israel. (2008) How to avoid inappropriate therapy. Current Opinion in Cardiology 23:1, 65-71

  1225. 1225

    Esteban González-Torrecilla. (2008) Indicaciones actuales del desfibrilador automático implantable. Revista Española de Cardiología Suplementos 8:1, 3A-8A

  1226. 1226

    Akihiko Shimizu, Takashi Nitta, Takashi Kurita, Katsuhiko Imai, Takeshi Kimura, Yoshinori Kobayashi, Kyoko Soejima, Shinichi Niwano, Shigeyuki Watanabe, Haruhiko Abe. (2008) Current status of implantable defibrillator devices in patients with left ventricular dysfunction-The first report from the online registry database. Journal of Arrhythmia 24:3, 133-140

  1227. 1227

    Arthur L. Riba. (2008) Evidence-Based Performance and Quality Improvement in the Acute Cardiac Care Setting. Critical Care Clinics 24:1, 201-229

  1228. 1228

    Jeffrey J. Goldberger, Robert O. Bonow, Michael Cuffe, Alan Dyer, Philip Greenland, Yves Rosenberg, Robert O'Rourke, Prediman K. Shah, Sidney Smith. (2008) Postmyocardial infarction ?-blocker therapy: The bradycardia conundrum. Rationale and design for the Pacemaker & ?-blocker therapy post-MI (PACE-MI) trial. American Heart Journal 155:3, 455

  1229. 1229

    Rafael Peinado-Peinado, José Luis Merino-Llorens, José Hernán Roa-Rad, Ester Macía-Palafox, Óscar Quintero-Henson. (2008) Calidad de vida y estado psicológico de los pacientes portadores de desfibrilador automático implantable. Revista Española de Cardiología Suplementos 8:1, 40A-50A

  1230. 1230

    William H. Sauer, Michael R. Bristow. (2008) The Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial in perspective. Journal of Interventional Cardiac Electrophysiology 21:1, 3-11

  1231. 1231

    Nathan E. Goldstein, Davendra Mehta, Saima Siddiqui, Ezra Teitelbaum, Jessica Zeidman, Magdelena Singson, Elena Pe, Elizabeth H. Bradley, R. Sean Morrison. (2008) “That’s Like an Act of Suicide” Patients’ Attitudes Toward Deactivation of Implantable Defibrillators. Journal of General Internal Medicine 23:S1, 7-12

  1232. 1232

    Randy Lieberman, William J. Havel, Eric Rashba, Paul J. DeGroot, Kurt Stromberg, Stephen R. Shorofsky. (2008) Acute defibrillation performance of a novel, non-transvenous shock pathway in adult ICD indicated patients. Heart Rhythm 5:1, 28-34

  1233. 1233

    Ilan Goldenberg, Anant K. Vyas, W. Jackson Hall, Arthur J. Moss, Hongyue Wang, Hua He, Wojciech Zareba, Scott McNitt, Mark L. Andrews. (2008) Risk Stratification for Primary Implantation of a Cardioverter-Defibrillator in Patients With Ischemic Left Ventricular Dysfunction. Journal of the American College of Cardiology 51:3, 288-296

  1234. 1234

    M.D. Cheitlin. (2008) Long-Term Survival of Patients With Heart Failure and Ventricular Conduction Delay Treated With Cardiac Resynchronization Therapy. Yearbook of Cardiology 2008, 395-398

  1235. 1235

    M.D. Cheitlin. (2008) Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction. Yearbook of Cardiology 2008, 446-448

  1236. 1236

    Christer Gottfridsson, Britta Nyström, Thomas Karlsson, Johan Herlitz, Nils Edvardsson. (2008) Sex difference and factors associated with outcome in patients with sustained ventricular arrhythmias. Scandinavian Cardiovascular Journal 42:3, 182-191

  1237. 1237

    Ulrik Sartipy, Anders Löfving, Anders Albåge, Dan Lindblom. (2008) Surgery for ventricular tachycardia and left ventricular aneurysm provides arrhythmia control. Scandinavian Cardiovascular Journal 42:3, 226-232

  1238. 1238

    Hillel A Steiner, John M Miller. (2008) Disparity in utilization of implantable cardioverter-defibrillators in treatment of heart failure based on sex and race. Women's Health 4:1, 23-25

  1239. 1239

    Young Soo Lee, Seong Wook Han, Yoon Nyun Kim, Chang Wook Nam, Hyung Sub Kim, Kee Sik Kim, Robert W. Rho. (2008) Similar Degree in Mechanical Left Ventricular Dyssynchrony Between Right Ventricular Outflow Tract and Right Ventricular Apical Pacing: A Strain Doppler Imaging Study. Korean Circulation Journal 38:11, 590

  1240. 1240

    James J.H. Chong, Anand N. Ganesan, Vicki Eipper, Pramesh Kovoor. (2008) Comparison of Left Ventricular Ejection Fraction and Inducible Ventricular Tachycardia in ST-Elevation Myocardial Infarction Treated by Primary Angioplasty Versus Thrombolysis. The American Journal of Cardiology 101:2, 153-157

  1241. 1241

    Anthony N. DeMaria, Jeroen J. Bax, Ori Ben-Yehuda, Paul Clopton, Gregory K. Feld, Geoffrey S. Ginsburg, Barry H. Greenberg, James D. Knoke, Wilbur Y.W. Lew, João A.C. Lima, Alan S. Maisel, Sanjiv M. Narayan, Jagat Narula, David J. Sahn, Sotirios Tsimikas. (2008) Highlights of the Year in JACC 2007. Journal of the American College of Cardiology 51:4, 490-512

  1242. 1242

    Spinar Jindrich, Ludka Ondrej, Musil Viktor, Pozdisek Zbynek, Pavlik Tomas, Dusek Ladislav, Vitovec Jiri, Spinarova Lenka, Soucek Miroslav. (2008) The Profile and Prognosis of Patients Hospitalised With Heart Failure. International Heart Journal 49:6, 691-705

  1243. 1243

    Lawrence J. Gessman, Richard Trohman. Cardiac Arrhythmias. In: Critical Care Medicine. Elsevier, 2008:647-675.

  1244. 1244

    SUSANNE S PEDERSEN, DOMINIC AMJ THEUNS, RUUD AM ERDMAN, LUC JORDAENS. (2008) Clustering of Device-Related Concerns and Type D Personality Predicts Increased Distress in ICD Patients Independent of Shocks1. Pacing and Clinical Electrophysiology 31:1, 20-27

  1245. 1245

    Paul A. Gould, George J. Klein, Raymond Yee, Allan C. Skanes, Lorne J. Gula, Andrew D. Krahn. Syncope. Elsevier, 2008:247-263.

  1246. 1246

    Gautham Kalahasty, Kenneth Ellenbogen. (2008) The Role of Pacemakers in the Management of Patients with Atrial Fibrillation. Medical Clinics of North America 92:1, 161-178

  1247. 1247

    Fernando Arribas, María López-Gil, Rafael Salguero, Javier Chimeno. (2008) Algunos aspectos relacionados con la implantación del desfibrilador automático implantable. Revista Española de Cardiología Suplementos 8:1, 51A-64A

  1248. 1248

    MAURIZIO LUNATI, MAURIZIO GASPARINI, MASSIMO SANTINI, MAURIZIO LANDOLINA, GIOVANNI B. PEREGO, CARLO PAPPONE, MAURIZIO MARZEGALLI, CARLO ARGIOLAS, ANANT MURTHY, SERGIO VALSECCHI, . (2008) Follow-Up of CRT-ICD: Implications for the Use of Remote Follow-Up Systems. Data from the InSync ICD Italian Registry. Pacing and Clinical Electrophysiology 31:1, 38-46

  1249. 1249

    Chang Hoon Lee, Gi-Byoung Nam, Hyun-Gu Park, Hyung Yong Kim, Kyoung-Min Park, Jun Kim, Kee-Joon Choi, You-Ho Kim. (2008) Effects of Antiarrhythmic Drugs on Inappropriate Shocks in Patients With Implantable Cardioverter Defibrillators. Circulation Journal 72:1, 102-105

  1250. 1250

    Muhammad R. Sohail, Daniel Z. Uslan, Akbar H. Khan, Paul A. Friedman, David L. Hayes, Walter R. Wilson, James M. Steckelberg, Sarah M. Jenkins, Larry M. Baddour. (2008) Infective Endocarditis Complicating Permanent Pacemaker and Implantable Cardioverter-Defibrillator Infection. Mayo Clinic Proceedings 83:1, 46-53

  1251. 1251

    Nathan E. Goldstein, Davendra Mehta, Ezra Teitelbaum, Elizabeth H. Bradley, R. Sean Morrison. (2008) “It’s Like Crossing a Bridge” Complexities Preventing Physicians from Discussing Deactivation of Implantable Defibrillators at the End of Life. Journal of General Internal Medicine 23:S1, 2-6

  1252. 1252

    Steven Werns. Acute Coronary Syndromes and Acute Myocardial Infarction. In: Critical Care Medicine. Elsevier, 2008:589-646.

  1253. 1253

    SANJAY KUMAR, RICHARD A. GRIMM. Pacing and Diastolic Heart Failure. In: Diastology. Elsevier, 2008:373-384.

  1254. 1254

    M.D. Cheitlin. (2008) Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction. Yearbook of Medicine 2008, 406-408

  1255. 1255

    Mattias Neyt, Nancy Thiry, Dirk Ramaekers, Hans Van Brabandt. (2008) Cost Effectiveness of Implantable Cardioverter-Defibrillators for Primary Prevention in a Belgian Context. Applied Health Economics and Health Policy 6:1, 67-80

  1256. 1256

    Timm Dickfeld, Peng Lei, Vasken Dilsizian, Jean Jeudy, Jun Dong, Apostolos Voudouris, Robert Peters, Magdi Saba, Raj Shekhar, Stephen Shorofsky. (2008) Integration of Three-Dimensional Scar Maps for Ventricular Tachycardia Ablation With Positron Emission Tomography-Computed Tomography. JACC: Cardiovascular Imaging 1:1, 73-82

  1257. 1257

    Hiroto Takamatsu, Hiroshi Tada, Hiroki Okaniwa, Hiroyuki Toide, Hiroko Maruyama, Rumi Higuchi, Kenichi Kaseno, Shigeto Naito, Masahiko Kurabayashi, Shigeru Oshima, Koichi Taniguchi. (2008) Right Bundle Branch Block and Impaired Left Ventricular Function as Evidence of a Left Ventricular Conduction Delay. Circulation Journal 72:1, 120-126

  1258. 1258

    Katherine J. Hoercher, Edward R. Nowicki, Eugene H. Blackstone, Gurmeet Singh, Joan M. Alster, Gonzalo V. Gonzalez-Stawinski, Randall C. Starling, James B. Young, Nicholas G. Smedira. (2008) Prognosis of patients removed from a transplant waiting list for medical improvement: Implications for organ allocation and transplantation for status 2 patients. Journal of Thoracic and Cardiovascular Surgery 135:5, 1159

  1259. 1259

    Darwin Jeyaraj, Lance D. Wilson, Isabelle Deschênes. (2008) Stretch the heart: Get memory. Heart Rhythm 5:1, 114-115

  1260. 1260

    Akihiko Shimizu, Takashi Nitta, Takashi Kurita, Katsuhiko Imai, Takeshi Kimura, Yoshinori Kobayashi, Kyoko Soejima, Shinichi Niwano, Shigeyuki Watanabe, Haruhiko Abe. (2008) Current status of implantable defibrillator devices in patients with left ventricular dysfunction — The first report from the online registry database. Journal of Arrhythmia 24:3, 133-140

  1261. 1261

    B. Brembilla-Perrot. (2008) Tachycardies ventriculaires. EMC - Cardiologie 3:4, 1-17

  1262. 1262

    P. Djiane, J.-C. Deharo. (2008) Blocs auriculoventriculaires. EMC - Cardiologie 3:3, 1-15

  1263. 1263

    S. Boveda, E. Marijon, J.-P. Albenque, A. Bortone, J. Najjar, N. Combes. (2008) Arythmies ventriculaires postinfarctus : identification des patients à risque. EMC - Cardiologie 3:3, 1-8

  1264. 1264

    J.-J. Dujardin, O. Fabre. (2008) Complications de l'infarctus du myocarde. Évolution et pronostic. EMC - Cardiologie 3:1, 1-13

  1265. 1265

    Derek V. Exner, Katherine M. Kavanagh, Michael P. Slawnych, L. Brent Mitchell, Darlene Ramadan, Sandeep G. Aggarwal, Catherine Noullett, Allie Van Schaik, Ryan T. Mitchell, Mariko A. Shibata, Sajad Gulamhussein, James McMeekin, Wayne Tymchak, Gregory Schnell, Anne M. Gillis, Robert S. Sheldon, Gordon H. Fick, Henry J. Duff. (2007) Noninvasive Risk Assessment Early After a Myocardial Infarction. Journal of the American College of Cardiology 50:24, 2275-2284

  1266. 1266

    Dalibor Heřman, Světlana Převorovská, František Maršík. (2007) Determination of myocardial energetic output for cardiac rhythm pacing. Cardiovascular Engineering 7:4, 156-161

  1267. 1267

    Chiung-Zuan Chiu, Jun-Jack Cheng. (2007) Congestive Heart Failure in the Elderly. International Journal of Gerontology 1:4, 143-152

  1268. 1268

    H.-J. Trappe. (2007) Plötzlicher Herztod. Der Kardiologe 1:4, 261-271

  1269. 1269

    SUSANNE S. PEDERSEN, KRISTA C. VAN DEN BROEK, SAMUEL F. SEARS. (2007) Psychological Intervention Following Implantation of an Implantable Defibrillator: A Review and Future Recommendations. Pacing and Clinical Electrophysiology 30:12, 1546-1554

  1270. 1270

    Michael R. Da Rosa, John L. Sapp, Jonathan G. Howlett, Alec Falkenham, Jean-Francois Légaré. (2007) Implantable Cardioverter-Defibrillator Implantation as a Bridge to Cardiac Transplantation. The Journal of Heart and Lung Transplantation 26:12, 1336-1339

  1271. 1271

    Arthur M. Feldman, Ron M. Oren, William T. Abraham, John P. Boehmer, Peter E. Carson, Eric Eichhorn, Edward M. Gilbert, Andrew Kao, Carl V. Leier, Brian D. Lowes, Michael A. Mathier, Frank A. McGrew, Marco Metra, Lawrence S. Zisman, Simon F. Shakar, Steven K. Krueger, Alastair D. Robertson, Bill G. White, Michael J. Gerber, Gwyn E. Wold, Michael R. Bristow. (2007) Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: Results of the oral enoximone in intravenous inotrope-dependent subjects trial. American Heart Journal 154:5, 861-869

  1272. 1272

    Kurt Fritzsche, Florian Forster, Axel Schweickhardt, Hartmut Kanwischer, Arno Drinkmann, Sven Rabung, Günter Bergmann, Annette Geibel, Christoph Herrmann-Lingen. (2007) Depressive coping is a predictor for emotional distress and poor quality of life in a German–Austrian sample of cardioverter-defibrillator implant recipients at 3 months and 1 year after implantation. General Hospital Psychiatry 29:6, 526-536

  1273. 1273

    Rachel Lampert. (2007) Implantable Cardioverter-Defibrillator Use and Benefit in Women. Cardiology in Review 15:6, 298-303

  1274. 1274

    Henry W. Sesselberg, Arthur J. Moss, Scott McNitt, Wojciech Zareba, James P. Daubert, Mark L. Andrews, W. Jackson Hall, Benjamin McClinitic, David T. Huang. (2007) Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: A MADIT-II substudy. Heart Rhythm 4:11, 1395-1402

  1275. 1275

    Michael Kindermann, Oliver Adam, Nikos Werner, Michael Böhm. (2007) Clinical Trial Updates and Hotline Sessions presented at the European Society of Cardiology Congress 2007. Clinical Research in Cardiology 96:11, 767-786

  1276. 1276

    V PONTIERI, A NETO, A DEFRANCACAMARGO, M KOIKE, I VELASCO. (2007) The herbal drug Catuama reverts and prevents ventricular fibrillation in the isolated rabbit heart. Journal of Electrocardiology 40:6, 534.e1-534.e8

  1277. 1277

    Philip B. Adamson, Jamie B. Conti, Andrew L. Smith, William T. Abraham, Mark F. Aaron, Juan M. Aranda, Jr., James Baker, Robert C. Bourge, Lynne Warner-Stevenson, Brandon Sparks. (2007) Reducing Events in Patients with Chronic Heart Failure (REDUCEhf ) Study Design: Continuous Hemodynamic Monitoring with an Implantable Defibrillator. Clinical Cardiology 30:11, 567-575

  1278. 1278

    Mikhael F. El-Chami, Ibrahim R. Hanna, Heather Bush, Jonathan J. Langberg. (2007) Impact of race and gender on cardiac device implantations. Heart Rhythm 4:11, 1420-1426

  1279. 1279

    ALESSIO LILLI, GIUSEPPE RICCIARDI, MARIA CRISTINA PORCIANI, ALESSANDRO PAOLETTI PERINI, PAOLO PIERAGNOLI, NICOLA MUSILLI, ANDREA COLELLA, STEFANO DEL PACE, ANTONIO MICHELUCCI, FEDERICO TURRENI, MASSIMO SASSARA, AUGUSTO ACHILLI, S. SERGE BAROLD, LUIGI PADELETTI. (2007) Cardiac Resynchronization Therapy:. Gender Related Differences in Left Ventricular Reverse Remodeling. Pacing and Clinical Electrophysiology 30:11, 1349-1355

  1280. 1280

    Hongwei Zhao, Heejung Bang, Hongkun Wang, Phillip E. Pfeifer. (2007) On the equivalence of some medical cost estimators with censored data. Statistics in Medicine 26:24, 4520-4530

  1281. 1281

    Param P. Sharma, Robert T. Greenlee, Kelley P. Anderson, Po-Huang Chyou, Hector J. Osorio, Peter N. Smith, John H. Hayes, Humberto Vidaillet. (2007) Prevalence and mortality of patients with myocardial infarction and reduced left ventricular ejection fraction in a defined community: Relation to the second multicenter automatic defibrillator implantation trial. Journal of Interventional Cardiac Electrophysiology 19:3, 157-164

  1282. 1282

    Ulrik Sartipy, Anders Albåge, Per Insulander, Dan Lindblom. (2007) Surgery for ventricular tachycardia in patients undergoing surgical ventricular restoration: The Karolinska approach. Journal of Interventional Cardiac Electrophysiology 19:3, 171-178

  1283. 1283

    Guy Amit, Otto Costantini. (2007) SCD in patients with cardiomyopathy: Use of microvolt T-wave alternans and other noninvasive tests for risk stratification and prevention of SCD. Current Treatment Options in Cardiovascular Medicine 9:5, 345-355

  1284. 1284

    Jordana Kron, Jamie B. Conti. (2007) Cardiac Resynchronization Therapy for Treatment of Heart Failure in the Elderly. Heart Failure Clinics 3:4, 511-518

  1285. 1285

    Ilan Goldenberg, Arthur J. Moss. (2007) Treatment of Arrhythmias and Use of Implantable Cardioverter-Defibrillators to Improve Survival in Elderly Patients with Cardiac Disease. Heart Failure Clinics 3:4, 519-528

  1286. 1286

    JENNIFER COWGER MATTHEWS, DAPHNE BETLEY, FRED MORADY, FRANK PELOSI. (2007) Adverse Interaction Between a Left Ventricular Assist Device and an Implantable Cardioverter Defibrillator. Journal of Cardiovascular Electrophysiology 18:10, 1107-1108

  1287. 1287

    Lee A. Fleisher, Joshua A. Beckman, Kenneth A. Brown, Hugh Calkins, Elliott L. Chaikof, Kirsten E. Fleischmann, William K. Freeman, James B. Froehlich, Edward K. Kasper, Judy R. Kersten, Barbara Riegel, John F. Robb, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Jeffrey L. Anderson, Elliott M. Antman, Christopher E. Buller, Mark A. Creager, Steven M. Ettinger, David P. Faxon, Valentin Fuster, Jonathan L. Halperin, Loren F. Hiratzka, Sharon A. Hunt, Bruce W. Lytle, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel, Lynn G. Tarkington, Clyde W. Yancy. (2007) ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery. Journal of the American College of Cardiology 50:17, e159-e242

  1288. 1288

    VENKU JAYANTI, MENEKHEM M. ZVIMAN, SAMAN NAZARIAN, HENRY R. HALPERIN, RONALD D. BERGER. (2007) Novel Electrode Design for Potentially Painless Internal Defibrillation Also Allows for Successful External Defibrillation. Journal of Cardiovascular Electrophysiology 18:10, 1095-1100

  1289. 1289

    Indranill Basu Ray, Lahn Fendelander, Jagmeet P. Singh. (2007) Cardiac Resynchronization Therapy and its Potential Proarrhythmic Effect. Clinical Cardiology 30:10, 498-502

  1290. 1290

    David Rosen, Matthew V. Decaro, Mark G. Graham. (2007) Evidence-based Treatment of Chronic Heart Failure. Comprehensive Therapy 33:1, 2-17

  1291. 1291

    Wilbert S. Aronow. (2007) Treatment After Myocardial Infarction. Comprehensive Therapy 33:1, 39-47

  1292. 1292

    Mintu Turakhia, Zian H. Tseng. (2007) Sudden Cardiac Death: Epidemiology, Mechanisms, and Therapy. Current Problems in Cardiology 32:9, 501-546

  1293. 1293

    Alfred E. Buxton, Kerry L. Lee, Gail E. Hafley, Luis A. Pires, John D. Fisher, Michael R. Gold, Mark E. Josephson, Michael H. Lehmann, Eric N. Prystowsky. (2007) Limitations of Ejection Fraction for Prediction of Sudden Death Risk in Patients With Coronary Artery Disease. Journal of the American College of Cardiology 50:12, 1150-1157

  1294. 1294

    Nora Goldschlager, Andrew E. Epstein, Gerald V. Naccarelli, Brian Olshansky, Bramah Singh, Harold R. Collard, Elizabeth Murphy. (2007) A Practical Guide for Clinicians Who Treat Patients with Amiodarone: 2007. Heart Rhythm 4:9, 1250-1259

  1295. 1295

    Gaetano Antonio Lanza. (2007) The Electrocardiogram as a Prognostic Tool for Predicting Major Cardiac Events. Progress in Cardiovascular Diseases 50:2, 87-111

  1296. 1296

    HAITHAM HREYBE, EATHAR RAZAK, SAMIR SABA. (2007) Effect of End-Stage Renal Failure and Hemodialysis on Mortality Rates in Implantable Cardioverter-Defibrillator Recipients. Pacing and Clinical Electrophysiology 30:9, 1091-1095

  1297. 1297

    Gudula Christ, Ruediger Becker, Frederik Voss, Kamilla Kelemen, Julia Senges-Becker, Melanie Hauck, Wolfgang Schoels, Ingo Bald, Hugo A. Katus, Alexander Bauer. (2007) Indications for predismissal testing with arrhythmia-induction in patients receiving an implantable cardioverter defibrillator. Clinical Research in Cardiology 96:9, 613-620

  1298. 1298

    Stephan Willems, Lars Eckardt, Ellen Hoffmann, Hanno Klemm, Heinz Friedrich Pitschner, Christopher Reithmann, Jürgen Tebbenjohanns, Bernhard Zrenner. (2007) Leitlinie invasive elektrophysiologische Diagnostik. Clinical Research in Cardiology 96:9, 634-651

  1299. 1299

    C. Stellbrink. (2007) Elektrotherapie der Herzinsuffizienz. Der Internist 48:9, 961-970

  1300. 1300

    Dwight W. Reynolds, Christina M. Murray. (2007) New concepts in physiologic cardiac pacing. Current Cardiology Reports 9:5, 351-357

  1301. 1301

    Kevin L. Thomas, Sana M. Al-Khatib, Richard C. Kelsey, Heather Bush, Lynne Brosius, Eric J. Velazquez, Eric D. Peterson, F. Roosevelt Gilliam. (2007) Racial Disparity in the Utilization of Implantable-Cardioverter Defibrillators Among Patients With Prior Myocardial Infarction and an Ejection Fraction of ≤35%. The American Journal of Cardiology 100:6, 924-929

  1302. 1302

    Kelley P. Anderson. (2007) Risk Assessment for Defibrillator Therapy. Journal of the American College of Cardiology 50:12, 1158-1160

  1303. 1303

    Jan Paul Ottervanger, Anand R. Ramdat Misier, Jan-Henk E. Dambrink, Menko-Jan de Boer, Jan C.A. Hoorntje, A.T. Marcel Gosselink, Harry Suryapranata, Stoffer Reiffers, Arnoud W.J. van ‘t Hof. (2007) Mortality in Patients With Left Ventricular Ejection Fraction ≤30% After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction. The American Journal of Cardiology 100:5, 793-797

  1304. 1304

    Mithilesh K. Das, Rajdeep Gaitonde, John M. Miller. (2007) Indications for implantable cardioverter defibrillator use for primary prevention of sudden cardiac death. Current Cardiology Reports 9:5, 371-380

  1305. 1305

    U.C. Hoppe. (2007) Leitliniengerechte Therapie der chronischen Herzinsuffizienz. Der Internist 48:9, 929-937

  1306. 1306

    Ramanna Merla, Nischita K. Reddy, Sanjay Kunapuli, Ernst Schwarz, Antonio Vitarelli, Salvatore Rosanio. (2007) Late Right Ventricular Perforation and Hemothorax After Transvenous Defibrillator Lead Implantation. The American Journal of the Medical Sciences 334:3, 209-211

  1307. 1307

    Deepak Natarajan. (2007) Cardiac Resynchronization Therapy for Severe Drug Refractory Systolic Heart Failure. Apollo Medicine 4:3, 184-188

  1308. 1308

    Theodore Chow, Sayed Saghir, Cheryl Bartone, Megan Goebel, Julia Schneider, Terri Booth, Paul S. Chan. (2007) Usefulness of Microvolt T-Wave Alternans on Predicting Outcome in Patients With Ischemic Cardiomyopathy With and Without Defibrillators. The American Journal of Cardiology 100:4, 598-604

  1309. 1309

    DAVID T. HUANG, HENRY W. SESSELBERG, SCOTT McNITT, KATIA NOYES, MARK L. ANDREWS, W. JACKSON HALL, ANDREW DICK, JAMES P. DAUBERT, WOJCIECH ZAREBA, ARTHUR J. MOSS, . (2007) Improved Survival Associated with Prophylactic Implantable Defibrillators in Elderly Patients with Prior Myocardial Infarction and Depressed Ventricular Function: A MADIT-II Substudy. Journal of Cardiovascular Electrophysiology 18:8, 833-838

  1310. 1310

    Aasha S. Gopal, Ebere O. Chukwu, Dennis G. Mihalatos, Alan S. Katz, Sunil T. Mathew, Justine S. Lachmann, Rena S. Toole, William Schapiro, Nathaniel Reichek. (2007) Left Ventricular Structure and Function for Postmyocardial Infarction and Heart Failure Risk Stratification by Three-dimensional Echocardiography. Journal of the American Society of Echocardiography 20:8, 949-958

  1311. 1311

    Mark S. Link, N.A. Mark Estes. (2007) How to Manage Athletes with Syncope. Cardiology Clinics 25:3, 457-466

  1312. 1312

    DAVID J. FOX, NEIL C. DAVIDSON, DAVID H. BENNETT, BERNARD CLARKE, CLIFFORD J. GARRATT, MARK C.S. HALL, AMIR M. ZAIDI, KAY PATTERSON, ADAM P. FITZPATRICK. (2007) Safety and Acceptability of Implantation of Internal Cardioverter-Defibrillators Under Local Anesthetic and Conscious Sedation. Pacing and Clinical Electrophysiology 30:8, 992-997

  1313. 1313

    M. Roser, S. Götze. (2007) ICD-Therapie. Der Kardiologe 1:2, 149-164

  1314. 1314

    Douglas C Shook, Wendy Gross. (2007) Offsite anesthesiology in the cardiac catheterization lab. Current Opinion in Anaesthesiology 20:4, 352-358

  1315. 1315

    Nicolas Shammas. Congestive Heart Failure. In: Comprehensive Management of High Risk Cardiovascular Patients. CRC Press, 2007:525-544.

  1316. 1316

    Leslie Levin, Ron Goeree, Nancy Sikich, Birthe Jorgensen, Melissa C. Brouwers, Tony Easty, Catherine Zahn. (2007) Establishing a comprehensive continuum from an evidentiary base to policy development for health technologies: The Ontario experience. International Journal of Technology Assessment in Health Care 23:03,

  1317. 1317

    Martin Cadeiras, Manuel Prinz von Bayern, Mario C. Deng. (2007) Cardiac Transplantation: Any Role Left?. Heart Failure Clinics 3:3, 321-347

  1318. 1318

    Michael R. Gold, Hue-Teh Shih, John Herre, David Breiter, Yunlong Zhang, Mark Schwartz. (2007) Comparison of Defibrillation Efficacy and Survival Associated With Right Versus Left Pectoral Placement for Implantable Defibrillators. The American Journal of Cardiology 100:2, 243-246

  1319. 1319

    ALI F. SONEL, ALAA SHALABY, JOSEPH P. MCCONNELL, TAMMY CZARNECKI, SCOTT HOGEN, MALIHA ZAHID, MORTEZA AMIDI. (2007) Detectable Troponin Levels Predict Poor Prognosis in Patients With Left Ventricular Dysfunction Undergoing Internal Defibrillator Implantation. Pacing and Clinical Electrophysiology 30:7, 839-844

  1320. 1320

    Thomas Klingenheben. (2007) Microvolt T-Wave Alternans for Arrhythmia Risk Stratification in Left Ventricular Dysfunction. Journal of the American College of Cardiology 50:2, 174-175

  1321. 1321

    Sanjiv M. Narayan. (2007) Is T-wave alternans as good or better than programmed ventricular stimulation?. Heart Rhythm 4:7, 913-915

  1322. 1322

    Brian Olshansky, John D. Day, Darin R. Lerew, Scott Brown, Kira Q. Stolen. (2007) Eliminating right ventricular pacing may not be best for patients requiring implantable cardioverter-defibrillators. Heart Rhythm 4:7, 886-891

  1323. 1323

    Gregg C. Fonarow, Clyde W. Yancy, Nancy M. Albert, Anne B. Curtis, Wendy Gattis Stough, Mihai Gheorghiade, J. Thomas Heywood, Mandeep Mehra, Christopher M. O'Connor, Dwight Reynolds, Mary Norine Walsh. (2007) Improving the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting: The IMPROVE HF performance improvement registry. American Heart Journal 154:1, 12-38

  1324. 1324

    Daniel J. Cantillon, Kenneth M. Stein, Steven M. Markowitz, Suneet Mittal, Bindi K. Shah, Daniel P. Morin, Eran S. Zacks, Matthew Janik, Shaun Ageno, Andreas C. Mauer, Bruce B. Lerman, Sei Iwai. (2007) Predictive Value of Microvolt T-Wave Alternans in Patients With Left Ventricular Dysfunction. Journal of the American College of Cardiology 50:2, 166-173

  1325. 1325

    Giuseppe Gioia, William Matthai, Karen Gillin, James Dralle, Alberto Benassi, Maria Francesca Gioia, Jacqueline White. (2007) Revascularization in severe left ventricular dysfunction: Outcome comparison of drug-eluting stent implantation versus coronary artery by-pass grafting. Catheterization and Cardiovascular Interventions 70:1, 26-33

  1326. 1326

    Daniel P. Morin, Eran S. Zacks, Andreas C. Mauer, Shaun Ageno, Matthew Janik, Steven M. Markowitz, Suneet Mittal, Sei Iwai, Bindi K. Shah, Bruce B. Lerman, Kenneth M. Stein. (2007) Effect of bundle branch block on microvolt T-wave alternans and electrophysiologic testing in patients with ischemic cardiomyopathy. Heart Rhythm 4:7, 904-912

  1327. 1327

    Ayesha Hasan, Clyde W. Yancy. (2007) Treatment of Ventricular Dysrhythmias and Sudden Cardiac Death: A Guideline-Based Approach for Patients With Chronic Left Ventricular Dysfunction. Congestive Heart Failure 13:4, 228-235

  1328. 1328

    James N. Kirkpatrick, Mani A. Vannan, Jagat Narula, Roberto M. Lang. (2007) Echocardiography in Heart Failure. Journal of the American College of Cardiology 50:5, 381-396

  1329. 1329

    J.O. Schwab, B. Lüderitz. (2007) Indikationen für den implantierbaren Cardioverter/Defibrillator (ICD). Der Internist 48:7, 715-726

  1330. 1330

    Salvatore Rosanio, Ernst R. Schwarz, Antonio Vitarelli, Ignatius Gerardo E. Zarraga, Sanjay Kunapuli, David L. Ware, Yochai Birnbaum, Enrique Tuero, Barry F. Uretsky. (2007) Sudden death prophylaxis in heart failure. International Journal of Cardiology 119:3, 291-296

  1331. 1331

    JAY CHEN, R. HARIS NASEEM, OWEN OBEL, JOSE A. JOGLAR. (2007) Habitual Cocaine Use Is Associated with High Defibrillation Threshold During ICD Implantation. Journal of Cardiovascular Electrophysiology 18:7, 722-725

  1332. 1332

    Jacob A. Udell, David N. Juurlink, Alexander Kopp, Douglas S. Lee, Jack V. Tu, Muhammad M. Mamdani. (2007) Inequitable distribution of implantable cardioverter defibrillators in Ontario. International Journal of Technology Assessment in Health Care 23:03,

  1333. 1333

    Frieder Braunschweig. (2007) Therapeutic and diagnostic role of electrical devices in acute heart failure. Heart Failure Reviews 12:2, 157-166

  1334. 1334

    Massimo Baravelli, Cecilia Fantoni, Claudio Anzà. (2007) The novel role of Micro T-Wave alternans in arrhythmic risk stratification of patients with left ventricular dysfunction. International Journal of Cardiology 119:1, 129-130

  1335. 1335

    Gillian D. Sanders, Sana M. Al-Khatib, Elise Berliner, J. Thomas Bigger, Alfred E. Buxton, Robert M. Califf, Mark Carlson, Anne B. Curtis, Jeptha P. Curtis, Michael Domanski, Eric Fain, Bernard J. Gersh, Michael R. Gold, Jeffrey Goldberger, Ali Haghighi-Mood, Stephen C. Hammill, Joel Harder, Jeffrey Healey, Mark A. Hlatky, Stefan H. Hohnloser, Kerry L. Lee, Daniel B. Mark, Brent Mitchell, Steve Phurrough, Eric Prystowsky, Joseph M. Smith, Norman Stockbridge, Robert Temple. (2007) Preventing tomorrow's sudden cardiac death today. American Heart Journal 153:6, 951-959

  1336. 1336

    Jean-Pierre Monassier, Laurent Monassier. (2007) Prise en charge du post-infarctus. La Presse Médicale 36:6, 999-1006

  1337. 1337

    David A.B. Richards, A. Robert Denniss. (2007) Assessment, Significance and Mechanism of Ventricular Electrical Instability after Myocardial Infarction. Heart, Lung and Circulation 16:3, 149-155

  1338. 1338

    Marc A Rozner. (2007) The patient with a cardiac pacemaker or implanted defibrillator and management during anaesthesia. Current Opinion in Anaesthesiology 20:3, 261-268

  1339. 1339

    Sumeet S. Chugh, Kyndaron Reinier, Eric C. Stecker. (2007) Learning From a Real-World Analysis of Implantable Cardioverter-Defibrillator Recipients. Journal of the American College of Cardiology 49:25, 2416-2418

  1340. 1340

    Sana M. Al-Khatib, Gillian D. Sanders, J. Thomas Bigger, Alfred E. Buxton, Robert M. Califf, Mark Carlson, Anne Curtis, Jeptha Curtis, Eric Fain, Bernard J. Gersh, Michael R. Gold, Ali Haghighi-Mood, Stephen C. Hammill, Jeff Healey, Mark Hlatky, Stefan Hohnloser, Raymond J. Kim, Kerry Lee, Daniel Mark, Marcus Mianulli, Brent Mitchell, Eric N. Prystowsky, Joseph Smith, David Steinhaus, Wojciech Zareba. (2007) Preventing tomorrow's sudden cardiac death today. American Heart Journal 153:6, 941-950

  1341. 1341

    PANAYOTA FLEVARI, PANAGIOTA GEORGIADOU, DIONYSSIOS LEFTHERIOTIS, EFTHIMIOS LIVANIS, GEORGE THEODORAKIS, DIMITRIOS TH KREMASTINOS. (2007) Heart Rate Turbulence After Short Runs of Nonsustained Ventricular Tachycardia in Chronic Heart Failure. Pacing and Clinical Electrophysiology 30:6, 787-795

  1342. 1342

    A. Robert Denniss, David A.B. Richards. (2007) Mechanisms, Prediction and Treatment of Ventricular Tachyarrhythmias Occurring Late After Myocardial Infarction. Heart, Lung and Circulation 16:3, 156-161

  1343. 1343

    Juan M. Aranda, Stephen E. McIntyre, Charles T. Klodell, Kaki M. York, Carl A. Dragstedt, Peter J. Chaille, Jamie B. Conti, Daniel F. Pauly, James A. Hill, Richard S. Schofield. (2007) Initial Heart Rate and Systolic Blood Pressure Predict Outcomes in Chronic Heart Failure Patients who are Evaluated for Cardiac Transplant. Clinical Cardiology 30:6, 282-287

  1344. 1344

    Douglas S. Lee, Jack V. Tu, Peter C. Austin, Paul Dorian, Raymond Yee, Alice Chong, David A. Alter, Andreas Laupacis. (2007) Effect of Cardiac and Noncardiac Conditions on Survival After Defibrillator Implantation. Journal of the American College of Cardiology 49:25, 2408-2415

  1345. 1345

    Timothy Mahoney, Mauricio Arruda, Patrick Tchou, Robert Schweikert. Catheter ablation of ventricular fibrillation and polymorphic ventricular tachycardia. In: Handbook of Cardiac Electrophysiology. CRC Press, 2007:317-326.

  1346. 1346

    Mauricio Arruda, Marketa Kozeluhova, Tamer Fahmy, Dimpi Patel, Luigi Biase. Mapping and catheter ablation of postmyocardial infarction ventricular tachycardia. In: Handbook of Cardiac Electrophysiology. CRC Press, 2007:327-339.

  1347. 1347

    Alessandro Proclemer, Marco Ghidina. (2007) Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Journal of Cardiovascular Medicine 8:5, 320-323

  1348. 1348

    Gregory de Lissovoy. (2007) The Implantable Cardiac Defibrillator. Medical Care 45:5, 371-373

  1349. 1349

    David J. Fox, Neil C. Davidson, Adam P. Fitzpatrick. (2007) How should we cost ICD therapy?. International Journal of Cardiology 118:1, 1-3

  1350. 1350

    Edward K. Rhee, Charles E. Canter, Susan Basile, Steven A. Webber, David C. Naftel. (2007) Sudden Death Prior to Pediatric Heart Transplantation: Would Implantable Defibrillators Improve Outcome?. The Journal of Heart and Lung Transplantation 26:5, 447-452

  1351. 1351

    Katia Noyes, Ethan Corona, Jack Zwanziger, W Jackson Hall, Hongwei Zhao, Hongkun Wang, Arthur J. Moss, Andrew W. Dick. (2007) Health-Related Quality of Life Consequences of Implantable Cardioverter Defibrillators. Medical Care 45:5, 377-385

  1352. 1352

    Makoto Imai, Sharad Rastogi, Ramesh C. Gupta, Sudhish Mishra, Victor G. Sharov, William C. Stanley, Yuval Mika, Benny Rousso, Daniel Burkhoff, Shlomo Ben-Haim, Hani N. Sabbah. (2007) Therapy With Cardiac Contractility Modulation Electrical Signals Improves Left Ventricular Function and Remodeling in Dogs With Chronic Heart Failure. Journal of the American College of Cardiology 49:21, 2120-2128

  1353. 1353

    Heather L. Bloom, Irfan Shukrullah, Jose R. Cuellar, Michael S. Lloyd, Samuel C. Dudley, A. Maziar Zafari. (2007) Long-term survival after successful inhospital cardiac arrest resuscitation. American Heart Journal 153:5, 831-836

  1354. 1354

    Arijit Dasgupta, Jessica Montalvo, Sara Medendorp, Donald M. Lloyd-Jones, Cybele Ghossein, Jeffrey Goldberger, Rod Passman. (2007) Increased Complication Rates of Cardiac Rhythm Management Devices in ESRD Patients. American Journal of Kidney Diseases 49:5, 656-663

  1355. 1355

    Mark E. Josephson. (2007) Electrophysiology at a crossroads. Heart Rhythm 4:5, 658-661

  1356. 1356

    George J. Klein. (2007) Electrophysiology at crossroads: A time of great opportunity. Heart Rhythm 4:5, 662-664

  1357. 1357

    Robin Germany, Christina Murray. (2007) Use of Device Diagnostics in the Outpatient Management of Heart Failure. The American Journal of Cardiology 99:10, S11-S16

  1358. 1358

    Heath E. Saltzman, Kumar Sharma, Paul J. Mather, Sharon Rubin, Suzanne Adams, David Joshua Whellan. (2007) Renal dysfunction in heart failure patients: what is the evidence?. Heart Failure Reviews 12:1, 37-47

  1359. 1359

    Michael E. Field, Michael O. Sweeney. (2007) Socio-economic analysis of cardiac resynchronization therapy. Journal of Interventional Cardiac Electrophysiology 17:3, 225-236

  1360. 1360

    Timothy W. Smith, Michael E. Cain. (2007) Sudden cardiac death: Epidemiologic and financial worldwide perspective. Journal of Interventional Cardiac Electrophysiology 17:3, 199-203

  1361. 1361

    Anne B. Curtis. (2007) Are women worldwide under-treated with regard to cardiac resynchronization and sudden death prevention?. Journal of Interventional Cardiac Electrophysiology 17:3, 169-175

  1362. 1362

    John G. F. Cleland, Periaswamy Velavan, Mansour Nasir. (2007) Fighting against sudden death: A single or multidisciplinary approach. Journal of Interventional Cardiac Electrophysiology 17:3, 205-210

  1363. 1363

    Fulvio Bellocci, Luigi M Biasucci, Gian Franco Gensini, Luigi Padeletti, Antonio Raviele, Massimo Santini, Giovanna Giubilato, Maurizio Landolina, Giuseppe Biondi-Zoccai, Giovanni Raciti, Massimo Sassara, Antonello Castro, Antoine Kheir, Filippo Crea. (2007) Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study. Journal of Cardiovascular Medicine 8:4, 293-299

  1364. 1364

    Ilan Goldenberg, Arthur J. Moss, Scott McNitt, Wojciech Zareba, W. Jackson Hall, Mark L. Andrews. (2007) Inverse Relationship of Blood Pressure Levels to Sudden Cardiac Mortality and Benefit of the Implantable Cardioverter-Defibrillator in Patients With Ischemic Left Ventricular Dysfunction. Journal of the American College of Cardiology 49:13, 1427-1433

  1365. 1365

    Javed Butler, Angel Leon. (2007) The Elusive Scourge of Sudden Cardiac Death. Journal of the American College of Cardiology 49:13, 1434-1435

  1366. 1366

    Paul S. Chan, Cheryl Bartone, Terri Booth, Dean Kereiakes, Theodore Chow. (2007) Prognostic implication of redefining indeterminate microvolt T-wave alternans studies as abnormal or normal. American Heart Journal 153:4, 523-529

  1367. 1367

    PETER W. GROENEVELD, MARY A. MATTA, JANICE J. SUH, FEIFEI YANG, JUDY A. SHEA. (2007) Quality of Life Among Implantable Cardioverter-Defibrillator Recipients in the Primary Prevention Therapeutic Era. Pacing and Clinical Electrophysiology 30:4, 463-471

  1368. 1368

    Stephan B. Danik, Moussa Mansour, Jagmeet Singh, Vivek Y. Reddy, Patrick T. Ellinor, David Milan, E. Kevin Heist, Andre d’Avila, Jeremy N. Ruskin, Theofanie Mela. (2007) Increased incidence of subacute lead perforation noted with one implantable cardioverter-defibrillator. Heart Rhythm 4:4, 439-442

  1369. 1369

    A. Selcuk Adabag, Barry J. Maron. (2007) Implications of Arrhythmias and Prevention of Sudden Death in Hypertrophic Cardiomyopathy. Annals of Noninvasive Electrocardiology 12:2, 171-180

  1370. 1370

    Bret T. Petersen, Nadeem Hussain, Joseph E. Marine, Richard G. Trohman, Steven Carpenter, Ram Chuttani, Joseph Croffie, James DiSario, Poonputt Chotiprasidhi, Julia Liu, Lehel Somogyi. (2007) Endoscopy in patients with implanted electronic devices. Gastrointestinal Endoscopy 65:4, 561-568

  1371. 1371

    Marc T. Silver. (2007) Implantable defibrillators and β-blockers in patients with left ventricular dysfunction: Economic, ethical, and legal considerations. American Heart Journal 153:4, 59-64

  1372. 1372

    S. Luke Kusmirek, Michael R. Gold. (2007) Sudden cardiac death: The role of risk stratification. American Heart Journal 153:4, 25-33

  1373. 1373

    Michael O. Sweeney. (2007) Minimizing right ventricular pacing: A new paradigm for cardiac pacing in sinus node dysfunction. American Heart Journal 153:4, 34-43

  1374. 1374

    T. Klingenheben, P. Ptaszynski. (2007) Clinical significance of microvolt T-wave alternans. Herzschrittmachertherapie & Elektrophysiologie 18:1, 39-44

  1375. 1375

    MINTU P. TURAKHIA, PAUL D VAROSY, KEANE LEE, ZIAN H. TSENG, RANDALL LEE, NITISH BADHWAR, MELVIN SCHEINMAN, BYRON K. LEE, JEFFREY E. OLGIN. (2007) Impact of Renal Function on Survival in Patients with Implantable Cardioverter-Defibrillators. Pacing and Clinical Electrophysiology 30:3, 377-384

  1376. 1376

    Andrew E. Epstein, Christina A. Baessler, Anne B. Curtis, N.A. Mark Estes, Bernard J. Gersh, Blair Grubb, L. Brent Mitchell. (2007) Addendum to “Personal and Public Safety Issues Related to Arrhythmias that May Affect Consciousness: Implications for Regulation and Physician Recommendations: A Medical/Scientific Statement from the American Heart Association and the North American Society of Pacing and Electrophysiology”. Heart Rhythm 4:3, 386-393

  1377. 1377

    S. M. Marcovina, F. Crea, J. Davignon, J. C. Kaski, W. Koenig, U. Landmesser, P. L. Pieri, J. Schulz-Menger, L. J. Shaw, J. Sobesky. (2007) Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic tools. Journal of Internal Medicine 261:3, 214-234

  1378. 1378

    VERONICA COX, MITUL PATEL, JASON KIM, TAYLOR LIU, GOWRI SIVARAMAN, SANJIV M. NARAYAN. (2007) Predicting Arrhythmia-Free Survival Using Spectral and Modified-Moving Average Analyses of T-Wave Alternans. Pacing and Clinical Electrophysiology 30:3, 352-358

  1379. 1379

    Christian Butter, Ernst Wellnhofer, Michael Schlegl, Georgia Winbeck, Eckart Fleck, Hani N. Sabbah. (2007) Enhanced Inotropic State of the Failing Left Ventricle by Cardiac Contractility Modulation Electrical Signals Is Not Associated With Increased Myocardial Oxygen Consumption. Journal of Cardiac Failure 13:2, 137-142

  1380. 1380

    Alexander Crössmann, Paul Pauli, Wilhelm Dengler, Volker Kühlkamp, Georg Wiedemann. (2007) Stability and cause of anxiety in patients with an implantable cardioverter-defibrillator: A longitudinal two-year follow-up. Heart & Lung: The Journal of Acute and Critical Care 36:2, 87-95

  1381. 1381

    Mitesh S. Amin, Kenneth A. Ellenbogen. (2007) Critical Pathway for Management of Pacemaker and Implantable Cardioverter-Defibrillator Advisories. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 6:1, 1-4

  1382. 1382

    K M Giacomini, C M Brett, R B Altman, N L Benowitz, M E Dolan, D A Flockhart, J A Johnson, D F Hayes, T Klein, R M Krauss, D L Kroetz, H L McLeod, A T Nguyen, M J Ratain, M V Relling, V Reus, D M Roden, C A Schaefer, A R Shuldiner, T Skaar, K Tantisira, R F Tyndale, L Wang, R M Weinshilboum, S T Weiss, I Zineh. (2007) The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response. Clinical Pharmacology &#38; Therapeutics 81:3, 328-345

  1383. 1383

    HAITHAM HREYBE, SAMIR SABA. (2007) A Clinical Risk Score to Predict the Time to First Appropriate Device Therapy in Recipients of Implantable Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 30:3, 385-389

  1384. 1384

    Eran S. Zacks, Daniel P. Morin, Shaun Ageno, Matthew Janik, Andreas C. Mauer, Steven M. Markowitz, Suneet Mittal, Sei Iwai, Bindi K. Shah, Bruce B. Lerman, Kenneth M. Stein. (2007) Effect of oral β-blocker therapy on microvolt T-wave alternans and electrophysiology testing in patients with ischemic cardiomyopathy. American Heart Journal 153:3, 392-397

  1385. 1385

    Theodore J. Iwashyna, Jason D. Christie. (2007) Low Use of Durable Medical Equipment By Chronically Disabled Elderly. Journal of Pain and Symptom Management 33:3, 324-330

  1386. 1386

    Doris A. Taylor, Andrey G. Zenovich. (2007) Cell therapy for left ventricular remodeling. Current Heart Failure Reports 4:1, 3-10

  1387. 1387

    Joseph F. Gomez, Wojciech Zareba, Arthur J. Moss, Scott McNitt, W. Jackson Hall. (2007) Prognostic Value of Location and Type of Myocardial Infarction in the Setting of Advanced Left Ventricular Dysfunction. The American Journal of Cardiology 99:5, 642-646

  1388. 1388

    Julien Laborderie, Pierre Bordachar, Mark D. O’Neill, Jacques Clémenty. (2007) Fluctuation of atrial and ventricular lead impedances heralding subtotal separation of device header and generator in a patient with an implantable cardioverter-defibrillator. Heart Rhythm 4:2, 218-220

  1389. 1389

    Brad Stuart. (2007) Palliative Care and Hospice in Advanced Heart Failure. Journal of Palliative Medicine 10:1, 210-228

  1390. 1390

    GRZEGORZ PIETRASIK, ILAN GOLDENBERG, SCOTT McNITT, ARTHUR J. MOSS, WOJCIECH ZAREBA. (2007) Obesity As a Risk Factor for Sustained Ventricular Tachyarrhythmias in MADIT II Patients. Journal of Cardiovascular Electrophysiology 18:2, 181-184

  1391. 1391

    Jordana Kron, Jamie B. Conti. (2007) Cardiac Resynchronization Therapy for Treatment of Heart Failure in the Elderly. Clinics in Geriatric Medicine 23:1, 193-203

  1392. 1392

    JOHN A. CHILADAKIS, NIKOLAOS KOUTSOGIANNIS, ANDREAS KALOGEROPOULOS, FANI ZAGLI, ILIAS SIHLIMIRIS, DIMITRIOS ALEXOPOULOS. (2007) Permanent and Atrial-Synchronized Ventricular Stimulation for Clinically Stable Patients with Normal or Impaired Left Ventricular Systolic Function. Pacing and Clinical Electrophysiology 30:2, 182-187

  1393. 1393

    John GF Cleland, Mansour Nasir, Ahmed Tageldien. (2007) Cardiac resynchronization therapy or atrio-biventricular pacing—what should it be called?. Nature Clinical Practice Cardiovascular Medicine 4:2, 90-101

  1394. 1394

    BRUCE D. GUNDERSON, ATHULA I. ABEYRATNE, WALTER H. OLSON, CHARLES D. SWERDLOW. (2007) Effect of Programmed Number of Intervals to Detect Ventricular Fibrillation on Implantable Cardioverter-Defibrillator Aborted and Unnecessary Shocks. Pacing and Clinical Electrophysiology 30:2, 157-165

  1395. 1395

    J. Kreuz, O. Balta, N. Liliegren, B. Ezmailzadeh, C. Schneider, A. Welz, G. Nickenig, J. O. Schwab. (2007) Inzidenz und Charakteristika von inadäquaten und adäquaten Therapieabgaben bei Patienten mit implantierbarem Cardioverter/Defibrillator zur Primärprophylaxe. Zeitschrift für Herz-,Thorax- und Gefäßchirurgie 21:1, 8-12

  1396. 1396

    PHILLIP S. CUCULICH, JOSÉ MAURICIO SÁNCHEZ, ROGER KERZNER, SCOTT L. GREENBERG, JAY SENGUPTA, JANE CHEN, MITCHELL N. FADDIS, MARYE J. GLEVA, TIMOTHY W. SMITH, BRUCE D. LINDSAY. (2007) Poor Prognosis for Patients with Chronic Kidney Disease Despite ICD Therapy for the Primary Prevention of Sudden Death. Pacing and Clinical Electrophysiology 30:2, 207-213

  1397. 1397

    Jacob R. Dutcher, Joel Kahn, Cindy Grines, Barry Franklin. (2007) Comparison of Left Ventricular Ejection Fraction and Exercise Capacity as Predictors of Two- and Five-Year Mortality Following Acute Myocardial Infarction. The American Journal of Cardiology 99:4, 436-441

  1398. 1398

    Ilan Goldenberg, Arthur J. Moss. (2007) Treatment of Arrhythmias and Use of Implantable Cardioverter-Defibrillators to Improve Survival in Elderly Patients with Cardiac Disease. Clinics in Geriatric Medicine 23:1, 205-219

  1399. 1399

    Kavitha M. Chinnaiyan, Justin Trivax, Barry A. Franklin, Brian Williamson, Joel K. Kahn. (2007) Stress Testing in Patients With Implantable Cardioverter-Defibrillators: A Preliminary Report. Preventive Cardiology 10:2, 92-95

  1400. 1400

    James O. O’Neill, Randall C. Starling, Mina K. Chung. (2007) Reply to Di Donato and colleagues. The Journal of Thoracic and Cardiovascular Surgery 133:2, 292-293

  1401. 1401

    Rainer Gradaus, Günter Breithardt. (2007) Should all patients with heart failure and left ventricular dysfunction receive combined CRT–ICD therapy?. Nature Clinical Practice Cardiovascular Medicine 4:2, 68-69

  1402. 1402

    Lauren A. Stutts, Natalie J. Cross, Jamie B. Conti, Samuel F. Sears. (2007) Examination of Research Trends on Patient Factors in Patients with Implantable Cardioverter Defibrillators. Clinical Cardiology 30:2, 64-68

  1403. 1403

    Mihai Gheorghiade, Gregg C. Fonarow. (2007) Management of Post-Myocardial Infarction Patients with Left Ventricular Systolic Dysfunction. The American Journal of Medicine 120:2, 109-120

  1404. 1404

    OLIVER R. SEGAL, ANTHONY W.C. CHOW, TOM WONG, NICOLA TREVISI, MARTIN D. LOWE, D. WYN DAVIES, PAOLO DELLA BELLA, DOUGLAS L. PACKER, NICHOLAS S. PETERS. (2007) A Novel Algorithm for Determining Endocardial VT Exit Site from 12-Lead Surface ECG Characteristics in Human, Infarct-Related Ventricular Tachycardia. Journal of Cardiovascular Electrophysiology 18:2, 161-168

  1405. 1405

    Ilan Goldenberg, Arthur J. Moss. (2007) Reply. Journal of the American College of Cardiology 49:1, 125

  1406. 1406

    Russell H. Greenfield. Heart Failure. In: Integrative Medicine. Elsevier, 2007:281-294.

  1407. 1407

    Takashi Kurita. (2007) Primary Prevention of Sudden Cardiac Death in Patients with Ischemic Heart Disease-Possible Role of the Shock Device in the Asia-. Journal of Arrhythmia 23:4, 264-268

  1408. 1408

    Jan W. Kantelhardt, Axel Bauer, Aicko Y. Schumann, Petra Barthel, Raphael Schneider, Marek Malik, Georg Schmidt. (2007) Phase-rectified signal averaging for the detection of quasi-periodicities and the prediction of cardiovascular risk. Chaos: An Interdisciplinary Journal of Nonlinear Science 17:1, 015112

  1409. 1409

    William T. Abraham. Implantable Devices for the Management of Heart Failure. In: Cardiovascular Therapeutics. Elsevier, 2007:363-372.

  1410. 1410

    Akira Ueno, Yoshinori Kobayashi, Kenji Yodogawa, Yasushi Miyauchi, Toshimi Yajima, Takashi Nitta, Takao Kato, Teruo Takano. (2007) A Prospective Study on the Risk-Stratification for Patients With Non-Sustained Ventricular Tachycardia Using a Novel Algorithm. Circulation Journal 71:7, 1107-1114

  1411. 1411

    Patrizio Pascale, Martin Fromer. (2007) Time Dependence of Defibrillator Benefit Postcoronary Revascularization. Journal of the American College of Cardiology 49:1, 124-125

  1412. 1412

    Giovanni Quarta, Laura Marino, Jasmine Passerini, Valentina Francione, Francesco Paneni, Camillo Autore. (2007) The Microvolt T-Wave Alternans Test. High Blood Pressure & Cardiovascular Prevention 14:4, 213-219

  1413. 1413

    LESLIE A. SAXON, TERESA DE MARCO, KENNETH A. ELLENBOGEN. Clinical Trials of Cardiac Resynchronization Therapy: Pacemakers and Defibrillators. In: Clinical Cardiac Pacing, Defibrillation, and Resynchronization Therapy. Elsevier, 2007:385-406.

  1414. 1414

    Rahul Mehra, Paul DeGroot. (2007) Where are we, and where are we heading in the device management of ventricular tachycardia/ventricular fibrillation?. Heart Rhythm 4:1, 99-103

  1415. 1415

    Rishi Sukhija, Vimal Mehta, Marino Leonardi, Jawahar L. Mehta. (2007) Implantable cardioverter defibrillators for prevention of sudden cardiac Death. Clinical Cardiology 30:1, 3-8

  1416. 1416

    Jackie Bryant, Hakan Brodin, Emma Loveman, Andrew Clegg. (2007) Clinical effectiveness and cost-effectiveness of implantable cardioverter defibrillators for arrhythmias: A systematic review and economic evaluation. International Journal of Technology Assessment in Health Care 23:01,

  1417. 1417

    M. In: Geriatric Clinical Advisor. Elsevier, 2007:125-137.

  1418. 1418

    Takanori Ikeda, Satoru Yusu, Kentaro Nakamura, Hideaki Yoshino. (2007) Risk Stratification for Sudden Cardiac Death. Circulation Journal 71:SupplementA, A106-A114

  1419. 1419

    Akiko Suyama-Chishaki, Mami Miyazono, Miyuki Tsuchihashi-Makaya, Hiroaki Chishaki, Syujiro Inoue, Yasushi Mukai, Masao Takemoto, Ryoichi Kaji, George Koike, Toru Maruyama, Kenji Sunagawa, Tatsuyuki Arimura, Chiharu Kubo. (2007) Quality of Life and Psychological Factors in Patients with Implantable Cardioverter Defibrillator. Journal of Arrhythmia 23:4, 269-276

  1420. 1420

    D. Karila-Cohen. (2007) Infarto de miocardio. Diagnóstico, tratamiento de la fase aguda y complicaciones. EMC - Tratado de Medicina 11:1, 1-13

  1421. 1421

    Takashi Kurita. (2007) Primary Prevention of Sudden Cardiac Death in Patients with Ischemic Heart Disease —Possible Role of the Shock Device in the Asia—. Journal of Arrhythmia 23:4, 264-268

  1422. 1422

    Sanjiv M. Narayan. (2007) T-Wave Alternans and Human Ventricular Arrhythmias. Journal of the American College of Cardiology 49:3, 347-349

  1423. 1423

    Eric R. Bates, Frederick G. Kushner. ST-Elevation Myocardial Infarction. In: Cardiovascular Therapeutics. Elsevier, 2007:246-289.

  1424. 1424

    Theodore Chow, Dean J. Kereiakes, Cheryl Bartone, Terri Booth, Edward J. Schloss, Theodore Waller, Eugene Chung, Santosh Menon, Brahmajee K. Nallamothu, Paul S. Chan. (2007) Microvolt T-Wave Alternans Identifies Patients With Ischemic Cardiomyopathy Who Benefit From Implantable Cardioverter-Defibrillator Therapy. Journal of the American College of Cardiology 49:1, 50-58

  1425. 1425

    MICHAEL O. SWEENEY. Programming and Follow-up of Cardiac Resynchronization Devices. In: Clinical Cardiac Pacing, Defibrillation, and Resynchronization Therapy. Elsevier, 2007:1087-1140.

  1426. 1426

    David Sidebotham, Robert Doughty. Heart Failure. In: Cardiothoracic Critical Care. Elsevier, 2007:278-292.

  1427. 1427

    Michael M. Givertz, Lynne W. Stevenson, Wilson S. Colucci. Strategies for Management of Decompensated Heart Failure. In: Cardiovascular Therapeutics. Elsevier, 2007:385-409.

  1428. 1428

    Vijay S Chauhan, Raja J Selvaraj. (2007) Utility of microvolt T-wave alternans to predict sudden cardiac death in patients with cardiomyopathy. Current Opinion in Cardiology 22:1, 25-32

  1429. 1429

    Angelo Auricchio, Marco Metra, Maurizio Gasparini, Barbara Lamp, Catherine Klersy, Antonio Curnis, Cecilia Fantoni, Edoardo Gronda, Juergen Vogt. (2007) Long-Term Survival of Patients With Heart Failure and Ventricular Conduction Delay Treated With Cardiac Resynchronization Therapy. The American Journal of Cardiology 99:2, 232-238

  1430. 1430

    Anne M Dubin, Charles I Berul. (2007) Electrophysiological interventions for treatment of congestive heart failure in pediatrics and congenital heart disease. Expert Review of Cardiovascular Therapy 5:1, 111-118

  1431. 1431

    DEREK V. EXNER. Clinical Trials of Defibrillator Therapy. In: Clinical Cardiac Pacing, Defibrillation, and Resynchronization Therapy. Elsevier, 2007:357-384.

  1432. 1432

    J.-C. Colavolpe, X. Assouan, M. Bonnet. (2007) Anestesia del paziente portatore di un pacemaker e/o di un defibrillatore impiantabile. EMC - Anestesia-Rianimazione 12:4, 1-17

  1433. 1433

    Emi Nakano, Tomoo Harada, Kiyoshi Nakazawa, Keizou Osada, Akihiko Takagi, Toshio Sasaki, Kihei Yoneyama, Hirofumi Wakimoto, Osamu Tanaka, Kouichi Mizuno, Nobuyuki Azuma, Ryouji Kishi, Fumihiko Miyake. (2007) Critical Slow Conduction Zone Located between the Tricuspid Annulus and a Myocardial Infarct Scar in a Patient with Multiple Ventricular Tachycardia Late after Myocardial Infarction. Journal of Arrhythmia 23:2, 157-163

  1434. 1434

    ANDREW D. KRAHN, GEORGE J. KLEIN, LORNE J. GULA, ALLAN C. SKANES, RAYMOND YEE. Follow-up and Interpretation of Implantable Syncope Monitors. In: Clinical Cardiac Pacing, Defibrillation, and Resynchronization Therapy. Elsevier, 2007:1141-1148.

  1435. 1435

    ANDREA M. RUSSO, FRANCIS E. MARCHLINSKI. Engineering and Construction of Pacemaker and Implantable Cardioverter-Defibrillator Leads. In: Clinical Cardiac Pacing, Defibrillation, and Resynchronization Therapy. Elsevier, 2007:161-200.

  1436. 1436

    Maxime Cannesson, Masaki Tanabe, Matthew S. Suffoletto, Dennis M. McNamara, Shobhit Madan, Joan M. Lacomis, John Gorcsan. (2007) A Novel Two-Dimensional Echocardiographic Image Analysis System Using Artificial Intelligence-Learned Pattern Recognition for Rapid Automated Ejection Fraction. Journal of the American College of Cardiology 49:2, 217-226

  1437. 1437

    Paveljit S. Bindra, David Lin, Susan Brozena, Francis Marchlinski, Sanjay Dixit. (2006) Placement of a coronary sinus lead in a patient with dextrocardia and situs inversus. Journal of Interventional Cardiac Electrophysiology 16:2, 93-95

  1438. 1438

    B. Brembilla-Perrot, O. Marçon, F. Chometon, J. Bertrand, A. Terrier de la Chaise, P. Louis, H. Belhakem, H. Blangy, O. Claudon, O. Selton, E. Khaldi, N. Sadoul, D. Beurrier, M. Abbas, M. Andronache, M. Abbas, N. Zhang. (2006) Supraventricular tachyarrhythmia as a cause of sudden cardiac arrest. Journal of Interventional Cardiac Electrophysiology 16:2, 97-104

  1439. 1439

    Takanori Ikeda, Hideaki Yoshino, Kaoru Sugi, Kaoru Tanno, Hiroki Shimizu, Jun Watanabe, Yuji Kasamaki, Akihiro Yoshida, Takao Kato. (2006) Predictive Value of Microvolt T-Wave Alternans for Sudden Cardiac Death in Patients With Preserved Cardiac Function After Acute Myocardial Infarction. Journal of the American College of Cardiology 48:11, 2268-2274

  1440. 1440

    Marcelle D. Smit, Pascal F.H.M. Van Dessel, Wybe Nieuwland, Ans C.P. Wiesfeld, Eng S. Tan, Rutger L. Anthonio, Lieselot Van Erven, Dirk J. Van Veldhuisen, Isabelle C. Van Gelder. (2006) Right ventricular pacing and the risk of heart failure in implantable cardioverter-defibrillator patients. Heart Rhythm 3:12, 1397-1403

  1441. 1441

    GIUSEPPE BORIANI, MAURO BIFFI, MAURIZIO RUSSO, MAURIZIO LUNATI, GIANLUCA BOTTO, ALESSANDRO PROCLEMER, GIUSEPPE VERGARA, WERNER RAHUE, CRISTIAN MARTIGNANI, RENATO RICCI, MASSIMO SANTINI, . (2006) Primary Prevention of Sudden Cardiac Death: Can We Afford the Cost of Cardioverter-Defibrillators? Data from the Search-MI Registry-Italian Sub-study. Pacing and Clinical Electrophysiology 29:s2, S29-S34

  1442. 1442

    STEFAN ASBACH, INGO WEISS, BEATE WENZEL, CHRISTOPH BODE, MANFRED ZEHENDER. (2006) Intrathoracic Far-Field Electrocardiogram Allows Continuous Monitoring of Ischemia After Total Coronary Occlusion. Pacing and Clinical Electrophysiology 29:12, 1334-1340

  1443. 1443

    Michael Colquhoun, Sue Jones, Thomas Clarke, Mark Cooke, Simon Brown, Janet McComb. (2006) Emergency management of arrhythmias and/or shocks in patients with implantable cardioverter defibrillators (ICDs). Resuscitation 71:3, 278-282

  1444. 1444

    Adnan Siddiqui, Peter R Kowey. (2006) Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies. Current Opinion in Internal Medicine 5:6, 544-552

  1445. 1445

    Rafael Peinado, Esteban G. Torrecilla, José Ormaetxe, Miguel Álvarez. (2006) Registro Español de Desfibrilador Automático Implantable. II Informe Oficial del Grupo de Trabajo de Desfibrilador Implantable de la Sociedad Española de Cardiología (2005). Revista Española de Cardiología 59:12, 1292-1302

  1446. 1446

    PAOLO DELLA BELLA, STEFANIA RIVA. (2006) Hybrid Therapies for Ventricular Arrhythmias. Pacing and Clinical Electrophysiology 29:s2, S40-S47

  1447. 1447

    Thomas Klingenheben. (2006) Arrhythmia Risk Prediction in Patients With Preserved Left Ventricular Function. Journal of the American College of Cardiology 48:11, 2275-2276

  1448. 1448

    , D.G. Benditt. (2006) The ACCF/AHA Scientific Statement on Syncope. Clinical Autonomic Research 16:6, 363-368

  1449. 1449

    MICHAEL O. SWEENEY, KENNETH A. ELLENBOGEN, ELAINE HOGAN MILLER, LOU SHERFESEE, TODD SHELDON, DAVID WHELLAN. (2006) The Managed Ventricular Pacing? Versus VVI 40 Pacing (MVP) Trial: Clinical Background, Rationale, Design, and Implementation. Journal of Cardiovascular Electrophysiology 17:12, 1295-1298

  1450. 1450

    (2006) Guías de Práctica Clínica del ACC/AHA/ESC 2006 sobre el manejo de pacientes con arritmias ventriculares y la prevención de la muerte cardiaca súbita.Versión resumida. Revista Española de Cardiología 59:12, 1328.e1-1328.e51

  1451. 1451

    , G. Breithardt. (2006) Empfehlungen zur Diagnostik und Behandlung von Patienten mit koronarer Herzkrankheit und Niereninsuffizienz. Clinical Research in Cardiology Supplements 1:2, 103-117

  1452. 1452

    Isaac Pourati, Lawrence Rosenthal. (2006) Indications for cardiac defibrillators in patients with congestive heart failure. Current Heart Failure Reports 3:4, 197-202

  1453. 1453

    Duncan W. Motherwell, Mark C. Petrie, William Martin, Stuart M. Cobbe. (2006) 123I- Metaiodobenzylguanidine in chronic heart failure: is there a clinical use?. Nuclear Medicine Communications 27:12, 927-931

  1454. 1454

    MAURIZIO GASPARINI, MAURIZIO LUNATI, MASSIMO SANTINI, MASSIMO TRITTO, ANTONIO CURNIS, MARIO BOCCHIARDO, ANTONIO VINCENTI, GIANFRANCO PISTIS, SERGIO VALSECCHI, ALESSANDRA DENARO, . (2006) Long-Term Survival in Patients Treated with Cardiac Resynchronization Therapy: A 3-Year Follow-Up Study from the InSync/InSync ICD Italian Registry. Pacing and Clinical Electrophysiology 29:s2, S2-S10

  1455. 1455

    Peter Leong-Sit, Lorne J. Gula, Pantelis Diamantouros, Andrew D. Krahn, Allan C. Skanes, Raymond Yee, George J. Klein. (2006) Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation. American Heart Journal 152:6, 1104-1108

  1456. 1456

    Kathy Hebert, James Mckinnie, Ron Horswell, Lee Arcement, Lynne Stevenson. (2006) Expansion of Heart Failure Device Therapy Into a Rural Indigent Population in Louisiana: Potential Economic and Health Policy Implications. Journal of Cardiac Failure 12:9, 689-693

  1457. 1457

    ALESSANDRO PROCLEMER, MARCO GHIDINA, GLORIA CICUTTINI, DARIO GREGORI, PAOLO MARIA FIORETTI. (2006) Impact of the Main Implantable Cardioverter-Defibrillator Trials for Primary and Secondary Prevention in Italy: A Survey of the National Activity During the Years 2001?2004. Pacing and Clinical Electrophysiology 29:s2, S20-S28

  1458. 1458

    George Hayashi, Kenichi Kurosaki, Shigeyuki Echigo, Hideki Kado, Norihide Fukushima, Michio Yokota, Kouichirou Niwa, Tokuko Shinohara, Makoto Nakazawa. (2006) Prevalence of Arrhythmias and Their Risk Factors Mid- and Long-Term After the Arterial Switch Operation. Pediatric Cardiology 27:6, 689-694

  1459. 1459

    Philip B. Adamson, Edward M. Gilbert. (2006) Reducing the Risk of Sudden Death in Heart Failure With β-Blockers. Journal of Cardiac Failure 12:9, 734-746

  1460. 1460

    GIOVANNI LUCA BOTTO, MARIO LUZI, FRANCO RUFFA, GIOVANNI RUSSO, GIOVANNI FERRARI. (2006) Atrial Tachyarrhythmias in Primary and Secondary Prevention ICD Recipients: Clinical and Prognostic Data. Pacing and Clinical Electrophysiology 29:s2, S48-S53

  1461. 1461

    Paul J. Hauptman, Peter Mikolajczak, Anil George, Clinton J. Mohr, Robert Hoover, Jason Swindle, Mark A. Schnitzler. (2006) Chronic inotropic therapy in end-stage heart failure. American Heart Journal 152:6, 1096.e1-1096.e8

  1462. 1462

    Leon Glass, Claudia Lerma. (2006) Risk stratification for arrhythmic sudden cardiac death. Heart Rhythm 3:12, 1497-1501

  1463. 1463

    Werner Jung, Dietrich Andresen, Michael Block, Dirk Böcker, Stefan H. Hohnloser, Karl-Heinz Kuck, Johannes Sperzel. (2006) Leitlinien zur Implantation von Defibrillatoren. Clinical Research in Cardiology 95:12, 696-708

  1464. 1464

    Syed Nasir Ghani, James N. Kirkpatrick, Kirk T. Spencer, Gwendolyn L. Smith, Martin C. Burke, Susan S. Kim, Aseem D. Desai, Bradley P. Knight. (2006) Rapid assessment of left ventricular systolic function in a pacemaker clinic using a hand-carried ultrasound device. Journal of Interventional Cardiac Electrophysiology 16:1, 39-43

  1465. 1465

    J. Thomas Bigger, Robert E. Kleiger. (2006) Individualizing Decisions for Patients With Prophylactic Implantable Cardiac Defibrillators Subject to Device Advisories: A Commentary. The American Journal of Cardiology 98:9, 1291-1293

  1466. 1466

    Francesco Grigioni, Giuseppe Boriani, Andrea Barbieri, Antonio Russo, Letizia Reggianini, Francesca Bursi, Luciano Potena, Caterina Ricci, Francesco Fallani, Fabio Coccolo, Gaia Magnani, Carlo Magelli, Maria G. Modena, Angelo Branzi. (2006) Relevance of cardioverter defibrillators for the prevention of sudden cardiac death on the timing of heart transplantation. Clinical Transplantation 20:6, 684-688

  1467. 1467

    Michael J. Yarnoz, Anne B. Curtis. (2006) Why Cardioverter-Defibrillator Implantation Might Not Be the Best Idea for Your Elderly Patient. The American Journal of Geriatric Cardiology 15:6, 367-371

  1468. 1468

    Sandeep Nathan, William Piccione, Arun Kumar, Steve Attanasio, Gary L. Schaer. (2006) Erosion of an Extrapericardial Implantable Cardioverter Defibrillator Patch Through the Gastric Fundus With Fistulous Tract Formation. Cardiology in Review 14:6, e21-e23

  1469. 1469

    Gabriel Vorobiof, Ilan Goldenberg, Arthur J. Moss, Wojciech Zareba, Scott McNitt. (2006) Effectiveness of the Implantable Cardioverter Defibrillator in Blacks Versus Whites (from MADIT-II). The American Journal of Cardiology 98:10, 1383-1386

  1470. 1470

    Timo H. Mäkikallio, Heikki V. Huikuri. (2006) Association Between Usage of Beta-Blocking Medication and Benefit from Implantable Cardioverter Therapy. The American Journal of Cardiology 98:9, 1245-1247

  1471. 1471

    Jo Mahenthiran, Mithilesh K. Das, Deepak Bhakta, Waqas Ghumman, Harvey Feigenbaum, Stephen G. Sawada. (2006) Prognostic Importance of Wall Motion Abnormalities in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator. The American Journal of Cardiology 98:10, 1301-1306

  1472. 1472

    Michael J. Yarnoz, Anne B. Curtis. (2006) Sex-Based Differences in Cardiac Resynchronization Therapy and Implantable Cardioverter Defibrillator Therapies. Cardiology in Review 14:6, 292-298

  1473. 1473

    Samuel F. Sears, Lauren A. Stutts, Juan M. Aranda, Eileen M. Handberg, Jamie B. Conti. (2006) Managing Congestive Heart Failure Patient Factors in the Device Era. Congestive Heart Failure 12:6, 335-340

  1474. 1474

    Michael A. Weber, Nanette K. Wenger, Stephen Scheidt. (2006) Who Should Be Treated With Implantable Cardioverter-Defibrillators?. The American Journal of Geriatric Cardiology 15:6, 336-337

  1475. 1475

    Nancy Kline Leidy, Kathleen Beusterien, Erin Sullivan, Randel Richner, Neal I. Muni. (2006) Integrating the Patient's Perspective into Device Evaluation Trials. Value in Health 9:6, 394-401

  1476. 1476

    Alfred E. Boxton. (2006) Implantable Cardioverter-Defibrillators Should Be Used Routinely in the Elderly. The American Journal of Geriatric Cardiology 15:6, 361-364

  1477. 1477

    N. N. HENYAN, C. M. WHITE, E. L. GILLESPIE, K. SMITH, C. I. COLEMAN, J. KLUGER. (2006) The impact of gender on survival amongst patients with implantable cardioverter defibrillators for primary prevention against sudden cardiac death. Journal of Internal Medicine 260:5, 467-473

  1478. 1478

    Post-Myocardial Infarction. In: Wiley Handbook of Current and Emerging Drug Therapies. John Wiley & Sons, Inc., 2006.

  1479. 1479

    Liza A. Prudente, Juanita Reigle, Cheryl Bourguignon, David E. Haines, John P. DiMarco. (2006) Psychological indices and phantom shocks in patients with ICD. Journal of Interventional Cardiac Electrophysiology 15:3, 185-190

  1480. 1480

    Elizabeth S. Kaufman, Daniel M. Bloomfield, Richard C. Steinman, Pearila B. Namerow, Ottorino Costantini, Richard J. Cohen, J. Thomas Bigger. (2006) “Indeterminate” Microvolt T-Wave Alternans Tests Predict High Risk of Death or Sustained Ventricular Arrhythmias in Patients With Left Ventricular Dysfunction. Journal of the American College of Cardiology 48:7, 1399-1404

  1481. 1481

    Nicolas W Shammas. Congestive Heart Failure: Epidemiology, Pathophysiology, and Current Therapies. Informa Healthcare, 2006:525-544.

  1482. 1482

    John J. Hayes, Arjun D. Sharma, John C. Love, John M. Herre, Anna O. Leonen, Peter J. Kudenchuk. (2006) Abnormal Conduction Increases Risk of Adverse Outcomes From Right Ventricular Pacing. Journal of the American College of Cardiology 48:8, 1628-1633

  1483. 1483

    Jan Paul Ottervanger, Anand R. Ramdat Misier, Felix Zijlstra, Martin J. Schalij, Eric Wever, Luc J.L.M. Jordaens, Jose P.S. Henriques, Menko-Jan de Boer, Hindrik W.J. Robbe, Hein J.J. Wellens. (2006) Implantable defibrillator early after primary percutaneous intervention for ST-elevation myocardial infarction: Rationale and design of the Defibrillator After Primary Angioplasty (DAPA) Trial. American Heart Journal 152:4, 636-640

  1484. 1484

    Michael G. McLaughlin, Peter J. Zimetbaum. (2006) Electrocardiographic Predictors of Arrhythmic Death. Annals of Noninvasive Electrocardiology 11:4, 327-337

  1485. 1485

    Karina W. Davidson, David J. Kupfer, J. Thomas Bigger, Robert M. Califf, Robert M. Carney, James C. Coyne, Susan M. Czajkowski, Ellen Frank, Nancy Frasure-Smith, Kenneth E. Freedland, Erika S. Froelicher, Alexander H. Glassman, Wayne J. Katon, Peter G. Kaufmann, Ronald C. Kessler, Helena C. Kraemer, K. Ranga R. Krishnan, François Lespérance, Nina Rieckmann, David S. Sheps, Jerry M. Suls. (2006) Assessment and treatment of depression in patients with cardiovascular disease: National heart, lung, and blood institute working group report. Annals of Behavioral Medicine 32:2, 121-126

  1486. 1486

    D. Steven, B. Lutomsky, T. Rostock, S. Willems. (2006) Moderne Pharmakotherapie bei supraventrikulären und ventrikulären Herzrhythmusstörungen. Der Internist 47:10, 1013-1023

  1487. 1487

    H. U. Klein. (2006) Prävention des plötzlichen Herztodes. Der Internist 47:10, 1040-1050

  1488. 1488

    William R. Lewis, Donna L. Luebke, Nancy J. Johnson, Michael D. Harrington, Ottorino Costantini, Mark P. Aulisio. (2006) Withdrawing Implantable Defibrillator Shock Therapy in Terminally Ill Patients. The American Journal of Medicine 119:10, 892-896

  1489. 1489

    Bruce A. Koplan, Laurence M. Epstein, Christine M. Albert, William G. Stevenson. (2006) Survival in octogenarians receiving implantable defibrillators. American Heart Journal 152:4, 714-719

  1490. 1490

    N. Klein, M. Klein, A. Salameh, D. Pfeiffer. (2006) Moderne Herzschrittmachertherapie. Der Internist 47:10, 1024-1033

  1491. 1491

    Stefan H Hohnloser. (2006) Can microvolt T-wave alternans predict mortality in patients with ischemic cardiomyopathy?. Nature Clinical Practice Cardiovascular Medicine 3:9, 470-471

  1492. 1492

    Harald C Ott, Doris A Taylor. (2006) From cardiac repair to cardiac regeneration – ready to translate?. Expert Opinion on Biological Therapy 6:9, 867-878

  1493. 1493

    Douglas P. Zipes, A. John Camm, Martin Borggrefe, Alfred E. Buxton, Bernard Chaitman, Martin Fromer, Gabriel Gregoratos, George Klein, Arthur J. Moss, Robert J. Myerburg, Silvia G. Priori, Miguel A. Quinones, Dan M. Roden, Michael J. Silka, Cynthia Tracy, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Elliott M. Antman, Jeffrey L. Anderson, Sharon A. Hunt, Jonathan L. Halperin, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel, Silvia G. Priori, Jean-Jacques Blanc, Andrzej Budaj, A. John Camm, Veronica Dean, Jaap W. Deckers, Catherine Despres, Kenneth Dickstein, John Lekakis, Keith McGregor, Marco Metra, Joao Morais, Ady Osterspey, Juan Luis Tamargo, José Luis Zamorano. (2006) ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death—Executive Summary. Journal of the American College of Cardiology 48:5, 1064-1108

  1494. 1494

    , G. Breithardt. (2006) Empfehlungen zur Diagnostik und Behandlung von Patienten mit koronarer Herzkrankheit und Niereninsuffizienz. Clinical Research in Cardiology Supplements 1:1, 8-30

  1495. 1495

    JEFFREY L. WILLIAMS, VLADIMIR SHUSTERMAN, SAMIR SABA. (2006) A Pilot Study Examining the Performance of Polynomial-Modeled Ventricular Shock Electrograms for Rhythm Discrimination in Implantable Devices. Pacing and Clinical Electrophysiology 29:9, 930-939

  1496. 1496

    ROBERT E. ECKART, LORNE J. GULA, MATTHEW R. REYNOLDS, ERIC A. SHRY, WILLIAM H. MAISEL. (2006) Mortality Following Defibrillator Implantation in Patients with Renal Insufficiency. Journal of Cardiovascular Electrophysiology 17:9, 940-943

  1497. 1497

    John E. Madias. (2006) Increase in the QRS Duration After Amelioration of Peripheral Edema and After Hemodialysis. Congestive Heart Failure 12:5, 265-270

  1498. 1498

    CHRISTOF KOLB, ISABEL DEISENHOFER, SEBASTIAN SCHMIEDER, PETRA BARTHEL, BERNHARD ZRENNER, MARTIN R. KARCH, CLAUS SCHMITT. (2006) Long-Term Follow-Up of Patients Supplied with Single-Chamber or Dual-Chamber Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 29:9, 946-952

  1499. 1499

    NEIL K. SANGHVI, PAUL LELORIER, ARJUN V. GURURAJ, KEVIN M. MONAHAN. (2006) Influence of Drive Cycle Length on Initiation of Ventricular Fibrillation During Implantable Cardioverter Defibrillator Threshold Testing. Pacing and Clinical Electrophysiology 29:9, 926-929

  1500. 1500

    Giuseppe Gioia, William Matthai, Alberto Benassi, Hamza Rana, Howard A. Levite, Lannae G. Ewing. (2006) Improved survival with drug-eluting stent implantation in comparison with bare metal stent in patients with severe left ventricular dysfunction. Catheterization and Cardiovascular Interventions 68:3, 392-398

  1501. 1501

    Andrew Ho, Ramin Assadi, Sudha M. Pai, Ramdas G. Pai. (2006) Is there a role for antiarrhythmic drugs in patients with implantable defibrillators?. Current Cardiology Reports 8:5, 365-369

  1502. 1502

    Roland R. van Kimmenade, James L. Januzzi, Patrick T. Ellinor, Umesh C. Sharma, Jaap A. Bakker, Adrian F. Low, Abelardo Martinez, Harry J. Crijns, Calum A. MacRae, Paul P. Menheere, Yigal M. Pinto. (2006) Utility of Amino-Terminal Pro-Brain Natriuretic Peptide, Galectin-3, and Apelin for the Evaluation of Patients With Acute Heart Failure. Journal of the American College of Cardiology 48:6, 1217-1224

  1503. 1503

    Heinrich Wieneke, Christoph N. Naber, Leon Piaszek, Stefan Sack, Ulrich H. Frey, Gerd Heusch, Raimund Erbel, Winfried Siffert. (2006) Better identification of patients who benefit from implantable cardioverter defibrillators by genotyping the G protein β3 subunit (GNB3) C825T polymorphism. Basic Research in Cardiology 101:5, 447-451

  1504. 1504

    Mitesh S. Amin, Kenneth A. Ellenbogen. (2006) Focus on management of pacemaker and ICD advisories, recalls, and alerts. Current Treatment Options in Cardiovascular Medicine 8:5, 347-352

  1505. 1505

    Michael W. Rich. (2006) Heart Failure in Older Adults. Medical Clinics of North America 90:5, 863-885

  1506. 1506

    Douglas P. Zipes, A. John Camm, Martin Borggrefe, Alfred E. Buxton, Bernard Chaitman, Martin Fromer, Gabriel Gregoratos, George Klein, Arthur J. Moss, Robert J. Myerburg, Silvia G. Priori, Miguel A. Quinones, Dan M. Roden, Michael J. Silka, Cynthia Tracy, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Elliott M. Antman, Jeffrey L. Anderson, Sharon A. Hunt, Jonathan L. Halperin, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel, Silvia G. Priori, Jean-Jacques Blanc, Andrzej Budaj, A. John Camm, Veronica Dean, Jaap W. Deckers, Catherine Despres, Kenneth Dickstein, John Lekakis, Keith McGregor, Marco Metra, Joao Morais, Ady Osterspey, Juan Luis Tamargo, José Luis Zamorano. (2006) ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Journal of the American College of Cardiology 48:5, e247-e346

  1507. 1507

    David R. Holmes, Douglas L. Wood. (2006) Medical Devices and Pharmaceuticals: Differences in Public Acceptance. The American Heart Hospital Journal 4:4, 269-272

  1508. 1508

    ILAN GOLDENBERG, ARTHUR J. MOSS, SCOTT McNITT, WOJCIECH ZAREBA, JAMES P. DAUBERT, W. JACKSON HALL, MARK L. ANDREWS, . (2006) Cigarette Smoking and the Risk of Supraventricular and Ventricular Tachyarrhythmias in High-Risk Cardiac Patients with Implantable Cardioverter Defibrillators. Journal of Cardiovascular Electrophysiology 17:9, 931-936

  1509. 1509

    Peter Cram, David Katz, Sandeep Vijan, David M. Kent, Kenneth M. Langa, A. Mark Fendrick. (2006) Implantable or External Defibrillators for Individuals at Increased Risk of Cardiac Arrest: Where Cost-Effectiveness Hits Fiscal Reality. Value in Health 9:5, 292-302

  1510. 1510

    Jeanne E. Poole. (2006) New indications for implantable defibrillator therapy. Current Cardiology Reports 8:5, 330-335

  1511. 1511

    PETRI KORHONEN, TERHI HUSA, ILKKA TIERALA, HEIKKI VAANANEN, MARKKU MAKIJARVI, TOIVO KATILA, LAURI TOIVONEN. (2006) QRS Duration in High-Resolution Methods and Standard ECG in Risk Assessment After First and Recurrent Myocardial Infarctions. Pacing and Clinical Electrophysiology 29:8, 830-836

  1512. 1512

    G PICCIRILLO. (2006) Age and QT variability index during free breathing, controlled breathing and tilt in patients with chronic heart failure and healthy control subjects. Translational Research 148:2, 72-78

  1513. 1513

    Ilan Goldenberg, Arthur J. Moss, Scott McNitt, Wojciech Zareba, Mark L. Andrews, W. Jackson Hall, Henry Greenberg, Robert B. Case. (2006) Relations Among Renal Function, Risk of Sudden Cardiac Death, and Benefit of the Implanted Cardiac Defibrillator in Patients With Ischemic Left Ventricular Dysfunction. The American Journal of Cardiology 98:4, 485-490

  1514. 1514

    Karthik Viswanathan, Justin Ghosh, Gerry C Kaye, John GF Cleland. (2006) Cardiac resynchronization therapy: redefining the role of device therapy in heart failure. Expert Review of Pharmacoeconomics & Outcomes Research 6:4, 455-469

  1515. 1515

    Daniel Z Uslan, Larry M Baddour. (2006) Cardiac device infections: getting to the heart of the matter. Current Opinion in Infectious Diseases 19:4, 346-348

  1516. 1516

    Lynne Warner Stevenson, Akshay S. Desai. (2006) Selecting Patients for Discussion of the ICD as Primary Prevention for Sudden Death in Heart Failure. Journal of Cardiac Failure 12:6, 407-412

  1517. 1517

    Claudia Ypenburg, Lieselot van Erven, Gabe B. Bleeker, Jeroen J. Bax, Marianne Bootsma, Maurits C. Wijffels, Ernst E. van der Wall, Martin J. Schalij. (2006) Benefit of Combined Resynchronization and Defibrillator Therapy in Heart Failure Patients With and Without Ventricular Arrhythmias. Journal of the American College of Cardiology 48:3, 464-470

  1518. 1518

    Jay N. Cohn. (2006) Efficacy and Safety in Clinical Trials in Cardiovascular Disease. Journal of the American College of Cardiology 48:3, 430-433

  1519. 1519

    Ivan C.K. Ho, David J. Milan, Moussa C. Mansour, Theofanie Mela, Mary L. Guy, Jeremy N. Ruskin, Patrick T. Ellinor. (2006) Fungal infection of implantable cardioverter-defibrillators: Case series of five patients managed over 22 years. Heart Rhythm 3:8, 919-923

  1520. 1520

    Leslie A. Saxon. (2006) Patient Selection for Primary Prevention ICDs—Are EPs Shocking Patients Into Consent?. Journal of Cardiac Failure 12:6, 413-415

  1521. 1521

    Jarcho , John A. , . (2006) Biventricular Pacing. New England Journal of Medicine 355:3, 288-294
    Full Text

  1522. 1522

    Christopher S. Simpson, Jeffrey S. Healey, Francois Philippon, Paul Dorian, L. Brent Mitchell, John L. Sapp, Blair J. O’Neill, Marcella M. Sholdice, Martin S. Green, Larry D. Sterns, Raymond Yee. (2006) Universal access – but when? Treating the right patient at the right time: Access to electrophysiology services in Canada. Canadian Journal of Cardiology 22:9, 741-746

  1523. 1523

    N. A. MARK ESTES. (2006) Discrimination When Dual-Chamber Termination Fails: A New Paradigm for ICDs?. Journal of Cardiovascular Electrophysiology 17:7, 702-704

  1524. 1524

    B. A. SCHAER, C. STICHERLING, S. OSSWALD. (2006) What are the professional and logistic demands to appropriately follow patients with an implantable cardioverter-defibrillator?. Journal of Internal Medicine 260:1, 88-92

  1525. 1525

    Aseem D. Desai, Tan Swee Yaw, Takuya Yamazaki, Amir Kaykha, Sung Chun, Victor F. Froelicher. (2006) Prognostic Significance of Quantitative QRS Duration. The American Journal of Medicine 119:7, 600-606

  1526. 1526

    Bruce L. Wilkoff, Kevin T. Ousdigian, Laurence D. Sterns, Zengri J. Wang, Ryan D. Wilson, John M. Morgan. (2006) A Comparison of Empiric to Physician-Tailored Programming of Implantable Cardioverter-Defibrillators. Journal of the American College of Cardiology 48:2, 330-339

  1527. 1527

    Charles I. Berul, Anne M. Dubin. (2006) Rhythm Management in Pediatric Heart Failure. Congenital Heart Disease 1:4, 140-147

  1528. 1528

    Amresh Raina, Thomas Pickering, Daichi Shimbo. (2006) Statin use in heart failure: A cause for concern?. American Heart Journal 152:1, 39-49

  1529. 1529

    Majid Haghjoo, Arash Arya, Mohammad Ali Sadr-Ameli. (2006) Value of Microvolt T-Wave Alternans for Predicting Patients Who Would Benefit from Implantable Cardioverter???Defibrillator Therapy. Cardiology in Review 14:4, 173-179

  1530. 1530

    F. TABRIZI, M. ROSENQVIST, L. BERGFELDT, A. ENGLUND. (2006) Long-term prognosis in patients with bifascicular block - the predictive value of noninvasive and invasive assessment. Journal of Internal Medicine 260:1, 31-38

  1531. 1531

    HIDEYUKI KAMOCHI, YOSHIO YAMANOUCHI, KEIJIRO SAKU. (2006) Effects of Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker on Ventricular Defibrillation Threshold. Pacing and Clinical Electrophysiology 29:7, 747-752

  1532. 1532

    MARK E. ALEXANDER, FRANK CECCHIN, KATHIE P. HUANG, CHARLES I. BERUL. (2006) Microvolt T-Wave Alternans with Exercise in Pediatrics and Congenital Heart Disease: Limitations and Predictive Value. Pacing and Clinical Electrophysiology 29:7, 733-741

  1533. 1533

    SAMIR SABA, LINDA BAKER, LEONARD GANZ, WILLIAM BARRINGTON, SANDEEP JAIN, OGUNDU NGWU, JILL CHRISTENSEN, MARK BROWN. (2006) Simultaneous Atrial and Ventricular Anti-Tachycardia Pacing as a Novel Method of Rhythm Discrimination. Journal of Cardiovascular Electrophysiology 17:7, 695-701

  1534. 1534

    David Seo, Geoffrey S. Ginsburg, Pascal J. Goldschmidt-Clermont. (2006) Gene Expression Analysis of Cardiovascular Diseases. Journal of the American College of Cardiology 48:2, 227-235

  1535. 1535

    Leslie W. Miller, Katherine Lietz. (2006) Candidate Selection for Long-term Left Ventricular Assist Device Therapy for Refractory Heart Failure. The Journal of Heart and Lung Transplantation 25:7, 756-764

  1536. 1536

    Robert G. Hauser, David L. Hayes, Andrew E. Epstein, David S. Cannom, Stephen C. Vlay, Susan L. Song, G. Frank O. Tyers. (2006) Multicenter experience with failed and recalled implantable cardioverter-defibrillator pulse generators. Heart Rhythm 3:6, 640-644

  1537. 1537

    Jack Zwanziger, W. Jackson Hall, Andrew W. Dick, Hongwei Zhao, Alvin I. Mushlin, Rebecca Marron Hahn, Hongkun Wang, Mark L. Andrews, Cathleen Mooney, Hongyue Wang, Arthur J. Moss. (2006) The Cost Effectiveness of Implantable Cardioverter-Defibrillators. Journal of the American College of Cardiology 47:11, 2310-2318

  1538. 1538

    Eric C. Stecker, Megan Sono, Erin Wallace, Karen Gunson, Jonathan Jui, Sumeet S. Chugh. (2006) Allelic variants of SCN5A and risk of sudden cardiac arrest in patients with coronary artery disease. Heart Rhythm 3:6, 697-700

  1539. 1539

    Wojciech Zareba, Jonathan S. Steinberg, Scott McNitt, James P. Daubert, Katarzyna Piotrowicz, Arthur J. Moss. (2006) Implantable cardioverter-defibrillator therapy and risk of congestive heart failure or death in MADIT II patients with atrial fibrillation. Heart Rhythm 3:6, 631-637

  1540. 1540

    Ezra A. Amsterdam. (2006) Cost Effectiveness of the Implantable Cardioverter-Defibrillator: Better in Higher-Risk Patients and Extended Duration. Preventive Cardiology 9:3, 131-132

  1541. 1541

    Eric J. Rashba, Stephen R. Shorofsky, Avram Scheiner, Robert W. Peters, Carol Ma, Michael R. Gold. (2006) Coronary sinus electrode does not reduce atrial defibrillation thresholds. Heart Rhythm 3:6, 647-652

  1542. 1542

    Hongkun Wang, Hongwei Zhao. (2006) Estimating Incremental Cost-Effectiveness Ratios and Their Confidence Intervals with Differentially Censored Data. Biometrics 62:2, 570-575

  1543. 1543

    Mrinal Saha, Albert Ferro. (2006) Cardiac stem cell therapy: present and future. British Journal of Clinical Pharmacology 61:6, 727-729

  1544. 1544

    Fred Kusumoto, Nora Goldschlager. (2006) Implantable cardiac arrhythmia devices-Part II: Implantable cardioverter defibrillators and implantable loop recorders. Clinical Cardiology 29:6, 237-242

  1545. 1545

    EMILY A. KUHL, NEHA K. DIXIT, ROBYN L. WALKER, JAMIE B. CONTI, SAMUEL F. SEARS. (2006) Measurement of Patient Fears About Implantable Cardioverter Defibrillator Shock: An Initial Evaluation of the Florida Shock Anxiety Scale. Pacing and Clinical Electrophysiology 29:6, 614-618

  1546. 1546

    AHMET KAYA BILGE, BESTE OZBEN, SABRI DEMIRCAN, MUTLU CINAR, ERCUMENT YILMAZ, KAMIL ADALET. (2006) Depression and Anxiety Status of Patients with Implantable Cardioverter Defibrillator and Precipitating Factors. Pacing and Clinical Electrophysiology 29:6, 619-626

  1547. 1547

    Barry J. Maron. (2006) Desfibrilador implantable para la prevención de la muerte súbita en la miocardiopatía hipertrófica. Revista Española de Cardiología 59:6, 527-530

  1548. 1548

    Adrienne H. Kovacs, Suzannef Eigofsky, J. Sean Goff, Arwa S. Saidi, Anne B. Curtis, Jamie B. Conti, Samuel F. Sears. (2006) Implantable cardioverter defibrillator implant-explant-implant case study: Addressing the psychological adjustment to multiple shocks. Clinical Cardiology 29:6, 274-276

  1549. 1549

    Oscar Bernal, Concepción Moro. (2006) Arritmias cardiacas en la mujer. Revista Española de Cardiología 59:6, 609-618

  1550. 1550

    Matthew R. Reynolds, David J. Cohen, Aaron D. Kugelmass, Phillip P. Brown, Edmund R. Becker, Steven D. Culler, April W. Simon. (2006) The Frequency and Incremental Cost of Major Complications Among Medicare Beneficiaries Receiving Implantable Cardioverter-Defibrillators. Journal of the American College of Cardiology 47:12, 2493-2497

  1551. 1551

    Joshua M. Stolker, Bastiaan Heere, Edward M. Geltman, Kenneth B. Schechtman, Linda R. Peterson. (2006) Prospective Comparison of Ventilatory Equivalent Versus Peak Oxygen Consumption in Predicting Outcomes of Patients With Heart Failure. The American Journal of Cardiology 97:11, 1607-1610

  1552. 1552

    Ilan Goldenberg, Arthur J. Moss, Scott McNitt, Wojciech Zareba, W. Jackson Hall, Mark L. Andrews, David J. Wilber, Helmut U. Klein. (2006) Time Dependence of Defibrillator Benefit After Coronary Revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. Journal of the American College of Cardiology 47:9, 1811-1817

  1553. 1553

    E. M. L. Wong, E. B. Wu, W. W. M. Chan, C. M. Yu. (2006) A review of the management of patients after percutaneous coronary intervention. International Journal of Clinical Practice 60:5, 582-589

  1554. 1554

    F. ROOSEVELT GILLIAM. (2006) T-Wave Oversensing in Implantable Cardiac Defibrillators Is Due to Technical Failure of Device Sensing. Journal of Cardiovascular Electrophysiology 17:5, 553-556

  1555. 1555

    Sami Viskin. (2006) Prediction versus prevention of sudden cardiac death. The Lancet 367:9523, 1639-1641

  1556. 1556

    Theodore Chow, Dean J. Kereiakes, Cheryl Bartone, Terri Booth, Edward J. Schloss, Theodore Waller, Eugene S. Chung, Santosh Menon, Brahmajee K. Nallamothu, Paul S. Chan. (2006) Prognostic Utility of Microvolt T-Wave Alternans in Risk Stratification of Patients With Ischemic Cardiomyopathy. Journal of the American College of Cardiology 47:9, 1820-1827

  1557. 1557

    Sheharyar Ali, Eduardo S. Antezano. (2006) Sudden Cardiac Death. Southern Medical Journal 99:5, 502-510

  1558. 1558

    Paul A. Friedman, Sohail Jalal, Scott Kaufman, Rollo Villareal, Scott Brown, Stephen J. Hahn, Darin R. Lerew. (2006) Effects of a rate smoothing algorithm for prevention of ventricular arrhythmias: Results of the Ventricular Arrhythmia Suppression Trial (VAST). Heart Rhythm 3:5, 573-580

  1559. 1559

    AUGUSTO CARDINALLI-NETO, OSVALDO T. GRECO, REINALDO B. BESTETTI. (2006) Automatic Implantable Cardioverter-Defibrillators in Chagas' Heart Disease Patients with Malignant Ventricular Arrhythmias. Pacing and Clinical Electrophysiology 29:5, 467-470

  1560. 1560

    Anne M. Gillis. (2006) Tincture of Time. Journal of the American College of Cardiology 47:9, 1818-1819

  1561. 1561

    MICHAEL H. LEHMANN, KEITH D. AARONSON. (2006) CRT-D Therapy in Heart Failure: How Much Do NYHA Class IV Patients Benefit?. Journal of Cardiovascular Electrophysiology 17:5, 491-494

  1562. 1562

    Axel Bauer, Jan W Kantelhardt, Petra Barthel, Raphael Schneider, Timo Mäkikallio, Kurt Ulm, Katerina Hnatkova, Albert Schömig, Heikki Huikuri, Armin Bunde, Marek Malik, Georg Schmidt. (2006) Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study. The Lancet 367:9523, 1674-1681

  1563. 1563

    Janet K. Shim, Ann J. Russ, Sharon R. Kaufman. (2006) Risk, life extension and the pursuit of medical possibility. Sociology of Health and Illness 28:4, 479-502

  1564. 1564

    Warren K. Laskey, William H. Maisel. (2006) Cardiac resynchronization therapy: A regulatory perspective. American Heart Journal 151:4, 757-761

  1565. 1565

    Joseph J. Germano, Matthew Reynolds, Vidal Essebag, Mark E. Josephson. (2006) Frequency and Causes of Implantable Cardioverter-Defibrillator Therapies: Is Device Therapy Proarrhythmic?. The American Journal of Cardiology 97:8, 1255-1261

  1566. 1566

    Paul A Gould, Andrew D Krahn, George J Klein, Raymond Yee, Allan C Skanes, Lorne J Gula. (2006) Investigating syncope: a review. Current Opinion in Internal Medicine 5:2, 159-166

  1567. 1567

    Kevin J. Makati, Airley E. Fish, Hannah H. England, Hocine Tighiouart, N.A. Mark Estes, Mark S. Link. (2006) Equivalent arrhythmic risk in patients recently diagnosed with dilated cardiomyopathy compared with patients diagnosed for 9 months or more. Heart Rhythm 3:4, 397-403

  1568. 1568

    S. Götze, C. Butter, E. Fleck. (2006) Kardiale Resynchronisation bei Herzinsuffizienz. Clinical Research in Cardiology 95:S4, 18-35

  1569. 1569

    JONATHAN S. STEINBERG, HOWARD LEVITT. (2006) Magnetocardiography Throws Its Hat in the Ring. Journal of Cardiovascular Electrophysiology 17:4, 402-404

  1570. 1570

    P. Brugada. (2006) What evidence do we have to replace in-hospital implantable cardioverter defibrillator follow-up?. Clinical Research in Cardiology 95:S3, iii3-iii9

  1571. 1571

    S. Jolly, P. Dorian, D. A. Alter. (2006) The impact of implantable cardiac defibrillators for primary prophylaxis in the community: baseline risk and clinically meaningful benefits. Journal of Evaluation in Clinical Practice 12:2, 190-195

  1572. 1572

    Gabor Duray, Carsten W Israel, Stefan H Hohnloser. (2006) Recent primary prevention implantable cardioverter defibrillator trials. Current Opinion in Internal Medicine 5:2, 154-158

  1573. 1573

    J. Herlitz, M. Castren, H. Friberg, J. Nolan, M. Skrifvars, K. Sunde, P.-A. Steen. (2006) Post resuscitation care. Resuscitation 69:1, 15-22

  1574. 1574

    David A. Cesario, G. William Dec. (2006) Implantable Cardioverter- Defibrillator Therapy in Clinical Practice. Journal of the American College of Cardiology 47:8, 1507-1517

  1575. 1575

    Stephen Hammill, Steve Phurrough, Ralph Brindis. (2006) The National ICD Registry: Now and into the future. Heart Rhythm 3:4, 470-473

  1576. 1576

    Gastone Sabbadini, Marco Metra, Andrea Di Lenarda, Savina Nodari, Gianfranco Sinagra, Livio Dei Cas. (2006) Managing heart failure in the very old. Aging Health 2:2, 253-275

  1577. 1577

    C. Perings, T. Korte, H.-J. Trappe, . (2006) IEGM-online based evaluation of implantable cardioverter defibrillator therapy appropriateness. Clinical Research in Cardiology 95:S3, iii22-iii28

  1578. 1578

    Jonathan Rosman, Sam Hanon, Michael Shapiro, Steven J Evans, Paul Schweitzer. (2006) Triggers of Sustained Monomorphic Ventricular Tachycardia Differ Among Patients with Varying Etiologies of Left Ventricular Dysfunction. Annals of Noninvasive Electrocardiology 11:2, 113-117

  1579. 1579

    PETRI KORHONEN, TERHI HUSA, ILKKA TIERALA, HEIKKI VAANANEN, MARKKU MAKIJARVI, TOIVO KATILA, LAURI TOIVONEN. (2006) Increased Intra-QRS Fragmentation in Magnetocardiography as a Predictor of Arrhythmic Events and Mortality in Patients with Cardiac Dysfunction After Myocardial Infarction. Journal of Cardiovascular Electrophysiology 17:4, 396-401

  1580. 1580

    M TOMA, F MCALISTER, J EZEKOWITZ, S KIMBER, S GULAMHUSEIN, A PANTANO, S SIVAKUMARAN, B CUJEC, I PATERSON, P ARMSTRONG. (2006) Proportion of Patients Followed in a Specialized Heart Failure Clinic Needing an Implantable Cardioverter Defibrillator as Determined by Applying Different Trial Eligibility Criteria. The American Journal of Cardiology 97:6, 882-885

  1581. 1581

    (2006) Sleep Apnea and Heart Disease. New England Journal of Medicine 354:10, 1086-1089
    Free Full Text

  1582. 1582

    Mario J. Garcia. (2006) Echocardiographic assessment of left ventricular function. Journal of Nuclear Cardiology 13:2, 280-293

  1583. 1583

    F. T. Wegener, G. C. Grönefeld, G. Duray, J. R. Ehrlich, S. H. Hohnloser. (2006) Pharmakotherapie der ventrikulären Rhythmusstörungen. Der Internist 47:3, 297-307

  1584. 1584

    William J. Groh. (2006) Lessons From a Population. Journal of the American College of Cardiology 47:6, 1167-1168

  1585. 1585

    S RAMAN, M SHAH, B MCCARTHY, A GARCIA, A FERKETICH. (2006) Multi–detector row cardiac computed tomography accurately quantifies right and left ventricular size and function compared with cardiac magnetic resonance. American Heart Journal 151:3, 736-744

  1586. 1586

    Imran S. Virk, John R. Ip, Rubinder S. Ruby, David Tepper. (2006) T-Wave Alternans: Is It an Appropriate Test for Primary Prevention Implantable Cardioverter-Defibrillator Risk Stratification?. The Role of Continuous Positive Airway Pressure in Heart Failure Patients With Central Sleep Apnea. Congestive Heart Failure 12:2, 116-118

  1587. 1587

    Christian Bruch, Michael Gotzmann, Jürgen Sindermann, Günter Breithardt, Thomas Wichter, Dirk Böcker, Rainer Gradaus. (2006) Prognostic Value of a Restrictive Mitral Filling Pattern in Patients With Systolic Heart Failure and an Implantable Cardioverter-Defibrillator. The American Journal of Cardiology 97:5, 676-680

  1588. 1588

    Claudia Martinez, Assaf Tzur, Hakop Hrachian, Joseph Zebede, Gervasio A. Lamas. (2006) Pacemakers and Defibrillators: Recent and Ongoing Studies That Impact the Elderly. The American Journal of Geriatric Cardiology 15:2, 82-87

  1589. 1589

    Lofty L. Basta. (2006) End-of-Life and Other Ethical Issues Related to Pacemaker and Defibrillator Use in the Elderly. The American Journal of Geriatric Cardiology 15:2, 114-117

  1590. 1590

    BRIAN OLSHANSKY, JOHN DAY, MAUREEN McGUIRE, STEPHEN HAHN, SCOTT BROWN, DARIN R. LEREW. (2006) Reduction of Right Ventricular Pacing in Patients with Dual-Chamber ICDs. Pacing and Clinical Electrophysiology 29:3, 237-243

  1591. 1591

    Stuart D. Russell. Acute Heart Failure. Informa Healthcare, 2006:203-226.

  1592. 1592

    James D. Allred, Andrew E. Epstein, Raymond E. Ideker. (2006) The Sign of Four and the SDNN of one of three. Heart Rhythm 3:3, 287-289

  1593. 1593

    Eric J. Rashba, N.A. Mark Estes, Paul Wang, Andi Schaechter, Adam Howard, Wojciech Zareba, Jean-Philippe Couderc, Juha Perkiomaki, Joseph Levine, Alan Kadish. (2006) Preserved heart rate variability identifies low-risk patients with nonischemic dilated cardiomyopathy: Results from the DEFINITE trial. Heart Rhythm 3:3, 281-286

  1594. 1594

    A. Bauer, J. Bauer, M. Bauer, K. Kelemen, F. Voss, J. Senges-Becker, S. Weretka, H. A. Katus, R. Becker. (2006) Effizienzpotential in der Nachsorge von Schrittmachern und implantierbaren Kardioverter Defibrillatoren. Herzschrittmachertherapie & Elektrophysiologie 17:1, 26-34

  1595. 1595

    Genevieve Smith, Sandra B. Dunbar, Amy L. Valderrama, Bindu Viswanathan. (2006) Gender Differences in Implantable Cardioverter-Defibrillator Patients at the Time of Insertion. Progress in Cardiovascular Nursing 21:2, 76-82

  1596. 1596

    Eric C. Stecker, Catherine Vickers, Justin Waltz, Carmen Socoteanu, Benjamin T. John, Ronald Mariani, John H. McAnulty, Karen Gunson, Jonathan Jui, Sumeet S. Chugh. (2006) Population-Based Analysis of Sudden Cardiac Death With and Without Left Ventricular Systolic Dysfunction. Journal of the American College of Cardiology 47:6, 1161-1166

  1597. 1597

    Michael O. Sweeney. Cardiac Resynchronization Therapy. Informa Healthcare, 2006:259-300.

  1598. 1598

    Akshay S. Desai, Bruce A Koplan. Device Therapy for Advanced Heart Disease: The Role of Implantable Defibrillators. Informa Healthcare, 2006:301-324.

  1599. 1599

    S. SERGE BAROLD, CHU-PAK LAU. (2006) Primary Prevention of Heart Failure in Cardiac Pacing. Pacing and Clinical Electrophysiology 29:3, 217-219

  1600. 1600

    Angelo Ramondo, Massimo Napodano, Giuseppe Tarantini, Diego Calzolari, Chiara Nalli, Luisa Cacciavillani, Sabino Iliceto. (2006) High-risk percutaneous coronary intervention using the intracardiac microaxial pump ‘Impella Recover’. Journal of Cardiovascular Medicine 7:2, 149-152

  1601. 1601

    J. A. Mariani, P. A. Gould, A. Broughton, D. M. Kaye. (2006) Cardiac resynchronisation therapy for heart failure. Internal Medicine Journal 36:2, 114-123

  1602. 1602

    Cecilia Linde, Michael Gold, William T. Abraham, Jean-Claude Daubert. (2006) Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure—the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. American Heart Journal 151:2, 288-294

  1603. 1603

    Andre J. Gauri, Andrew Davis, Thomas Hong, Martin C. Burke, Bradley P. Knight. (2006) Disparities in the Use of Primary Prevention and Defibrillator Therapy Among Blacks and Women. The American Journal of Medicine 119:2, 167.e17-167.e21

  1604. 1604

    R PHANG, D KANG, H TIGHIOUART, N ESTESIII, M LINK. (2006) High Risk of Ventricular Arrhythmias in Patients With Nonischemic Dilated Cardiomyopathy Presenting With Syncope. The American Journal of Cardiology 97:3, 416-420

  1605. 1605

    Daniel R. Wagner, Charles Delagardelle, Isabelle Ernens, Didier Rouy, Michel Vaillant, Jean Beissel. (2006) Matrix Metalloproteinase-9 Is a Marker of Heart Failure After Acute Myocardial Infarction. Journal of Cardiac Failure 12:1, 66-72

  1606. 1606

    HEATHER BLOOM, BRIAN HEEKE, ANGEL LEON, FERNANDO MERA, DAVID DELURGIO, JOHN BESHAI, JONATHAN LANGBERG. (2006) Renal Insufficiency and the Risk of Infection from Pacemaker or Defibrillator Surgery. Pacing and Clinical Electrophysiology 29:2, 142-145

  1607. 1607

    Andrew E. Epstein. (2006) Implantable cardioverter-defibrillators are still getting smarter: Now a way to identify lead failure and prevent resultant inappropriate shocks. Heart Rhythm 3:2, 163-164

  1608. 1608

    Haitham Hreybe, Rana Ezzeddine, William Barrington, Raveen Bazaz, Sandeep Jain, Ogundu Ngwu, Samir Saba. (2006) Relation of Advanced Heart Failure Symptoms to Risk of Inappropriate Defibrillator Shocks. The American Journal of Cardiology 97:4, 544-546

  1609. 1609

    Robert D Winslow, Sean Pinney, Valentin Fuster. (2006) Impact of implantable-cardioverter-defibrillator trials on clinical management of patients with heart failure. Nature Clinical Practice Cardiovascular Medicine 3:2, 86-93

  1610. 1610

    Heart Failure Society of America. (2006) Section 9: Electrophysiologic Testing and the Use of Devices in Heart Failure. Journal of Cardiac Failure 12:1, e70-e75

  1611. 1611

    Luis A. Pires. (2006) Implantable devices for management of chronic heart failure: defibrillators and biventricular pacing therapy. Current Opinion in Anaesthesiology 19:1, 69-74

  1612. 1612

    Bruce D. Gunderson, Jeffrey M. Gillberg, Mark A. Wood, Pugazhendhi Vijayaraman, Richard K. Shepard, Kenneth A. Ellenbogen. (2006) Development and testing of an algorithm to detect implantable cardioverter-defibrillator lead failure. Heart Rhythm 3:2, 155-162

  1613. 1613

    Timo H. Mäkikallio, Petra Barthel, Raphael Schneider, Axel Bauer, Jari M. Tapanainen, Mikko P. Tulppo, Juha S. Perkiömäki, Georg Schmidt, Heikki V. Huikuri. (2006) Frequency of Sudden Cardiac Death Among Acute Myocardial Infarction Survivors With Optimized Medical and Revascularization Therapy. The American Journal of Cardiology 97:4, 480-484

  1614. 1614

    Jeffrey J. Teuteberg, Eldrin F. Lewis, Anju Nohria, Sui W. Tsang, James C. Fang, Michael M. Givertz, John A. Jarcho, Gilbert H. Mudge, Kenneth L. Baughman, Lynne W. Stevenson. (2006) Characteristics of Patients Who Die With Heart Failure and a Low Ejection Fraction in the New Millennium. Journal of Cardiac Failure 12:1, 47-53

  1615. 1615

    Andrew McKeon, Carl Vaughan, Norman Delanty. (2006) Seizure versus syncope. The Lancet Neurology 5:2, 171-180

  1616. 1616

    Anant K. Vyas, Hongsheng Guo, Arthur J. Moss, Brian Olshansky, Scott A. McNitt, W. Jackson Hall, Wojciech Zareba, Jonathan S. Steinberg, Avi Fischer, Jeremy Ruskin, Mark L. Andrews. (2006) Reduction in Ventricular Tachyarrhythmias With Statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. Journal of the American College of Cardiology 47:4, 769-773

  1617. 1617

    BRYAN C. CANNON, RICHARD A. FRIEDMAN, ARNOLD L. FENRICH, CHARLES D. FRASER, E. DEAN McKENZIE, NAOMI J. KERTESZ. (2006) Innovative Techniques for Placement of Implantable Cardioverter-Defibrillator Leads in Patients with Limited Venous Access to the Heart. Pacing and Clinical Electrophysiology 29:2, 181-187

  1618. 1618

    Juha S. Perkiömäki, Miia Hyytinen-Oinas, Mari Karsikas, Tapio Seppänen, Katerina Hnatkova, Marek Malik, Heikki V. Huikuri. (2006) Usefulness of T-Wave Loop and QRS Complex Loop to Predict Mortality After Acute Myocardial Infarction. The American Journal of Cardiology 97:3, 353-360

  1619. 1619

    WOJCIECH ZAREBA, ARTHUR J. MOSS, W. JACKSON HALL, DAVID J. WILBER, JEREMY N. RUSKIN, SCOTT MCNITT, MARY BROWN, HONGYUE WANG, . (2006) Clinical Course and Implantable Cardioverter Defibrillator Therapy in Postinfarction Women with Severe Left Ventricular Dysfunction. Journal of Cardiovascular Electrophysiology 0:0, 060118052427054

  1620. 1620

    P. Bru, C. Duplantier, M. Fratu, M. Bourrat, B. Vaquette, C. Moreau, R. Lorillard. (2006) Suivi des défibrillateurs automatiques implantables en centre hospitalier général. Annales de Cardiologie et d Angéiologie 55:6, 342

  1621. 1621

    Kazuhiro Satomi, Takashi Kurita, Seiji Takatsuki, Yasuhiro Yokoyama, Masaomi Chinushi, Naoya Tsuboi, Takashi Nitta, Morio Shoda, Hideo Mitamura. (2006) Amiodarone Therapy in Patients Implanted With Cardioverter-Defibrillator for Life-Threatening Ventricular Arrhythmias. Circulation Journal 70:8, 977-984

  1622. 1622

    Pajman A Danai, Eric L Flenaugh. (2006) Bronchomediastinal Fistula. Journal of Bronchology 13:1, 37-38

  1623. 1623

    José Azpitarte. (2006) Profilaxis primaria con desfibrilador-cardioversor implantable en la insuficiencia cardiaca: un punto de vista clínico. Revista Española de Cardiología 59, 10-22

  1624. 1624

    N. Delarche, H. Bader. (2006) Resynchronisation ventriculaire et aspects pratiques. Annales de Cardiologie et d Angéiologie 55:6, 328

  1625. 1625

    Robert J. Myerburg, Agustin Castellanos. (2006) Clinical Research Designs and Implantable Defibrillator Indications. Journal of the American College of Cardiology 47:1, 108-111

  1626. 1626

    Michael L. Main, Marina N. Hannen, Lisa L. Kusnetzky, Justin L. Martin, Tina R. Coggins, Pam Lanza, Becky A. Morris, Anthony Magalski, Philip G. Jones. (2006) Myocardial Contrast Echocardiographic Estimates of Infarct Size Predict Likelihood of Left Ventricular Remodeling After Acute Anterior Wall Myocardial Infarction. Journal of the American Society of Echocardiography 19:1, 64-70

  1627. 1627

    Ulrik Sartipy, Anders Albåge, Eva Strååt, Per Insulander, Dan Lindblom. (2006) Surgery for Ventricular Tachycardia in Patients Undergoing Left Ventricular Reconstruction by the Dor Procedure. The Annals of Thoracic Surgery 81:1, 65-71

  1628. 1628

    Michael S Panutich, Bradley P Knight. (2006) Imaging techniques in cardiac electrophysiology. Expert Review of Cardiovascular Therapy 4:1, 59-70

  1629. 1629

    Gunnar H. Gislason, Niels Gadsboll, Miguel A. Quinones, Lars Kober, Marie Seibaek, Hans Burchardt, Christian Torp-Pedersen. (2006) The Reliability of Echocardiographic Left Ventricular Wall Motion Index to Identify High-Risk Patients for Multicenter Studies. Echocardiography 23:1, 1-6

  1630. 1630

    Margaret C. Herbst, William E. Sanders. Marcapasos y desfibriladores cardíacos. In: Netter. Cardiología. Elsevier, 2006:248-255.

  1631. 1631

    Michael H Gollob. (2006) Genetic profiling as a marker for risk of sudden cardiac death. Current Opinion in Cardiology 21:1, 42-46

  1632. 1632

    Ivan C.K. Ho, Jonathan J. Passeri, Mary L. Guy, Jeremy N. Ruskin, Patrick T. Ellinor. (2006) Impact of the Multicenter Automatic Defibrillator Implantation Trial on Clinical Practice. Annals of Noninvasive Electrocardiology 11:1, 20-27

  1633. 1633

    Satoko Kitamura, Kazuhiro Satomi, Takashi Kurita, Wataru Shimizu, Kazuhiro Suyama, Naohiko Aihara, Kazuo Niwaya, Junjiro Kobayashi, Shiro Kamakura. (2006) Long-Term Follow-up of Transvenous Defibrillation Leads. Circulation Journal 70:3, 273-277

  1634. 1634

    Harold L. Kennedy. (2006) The History, Science, and Innovation of Holter Technology. Annals of Noninvasive Electrocardiology 11:1, 85-94

  1635. 1635

    James P. Daubert, Wojciech Zareba, W. Jackson Hall, Claudio Schuger, Andrew Corsello, Angel R. Leon, Mark L. Andrews, Scott McNitt, David T. Huang, Arthur J. Moss. (2006) Predictive Value of Ventricular Arrhythmia Inducibility for Subsequent Ventricular Tachycardia or Ventricular Fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Patients. Journal of the American College of Cardiology 47:1, 98-107

  1636. 1636

    Richard G. Sheahan. Taquicardia ventricular. In: Netter. Cardiología. Elsevier, 2006:196-204.

  1637. 1637

    George J. Philippides. (2006) Managing the Post-Myocardial Infarction Patient with Asymptomatic Left Ventricular Dysfunction. Cardiology 105:2, 95-107

  1638. 1638

    Daniel M. Bloomfield, J. Thomas Bigger, Richard C. Steinman, Pearila B. Namerow, Michael K. Parides, Anne B. Curtis, Elizabeth S. Kaufman, Jorge M. Davidenko, Timothy S. Shinn, John M. Fontaine. (2006) Microvolt T-Wave Alternans and the Risk of Death or Sustained Ventricular Arrhythmias in Patients With Left Ventricular Dysfunction. Journal of the American College of Cardiology 47:2, 456-463

  1639. 1639

    Philippe Chevalier, Jean Cottraux, Evelyne Mollard, NanYao Sai, Sophie Brun, Haran Burri, Lioara Restier, Patrice Adeleine. (2006) Prevention of implantable defibrillator shocks by cognitive behavioral therapy: A pilot trial. American Heart Journal 151:1, 191.e1-191.e6

  1640. 1640

    Sanjiv M. Narayan. (2006) T-Wave Alternans and the Susceptibility to Ventricular Arrhythmias. Journal of the American College of Cardiology 47:2, 269-281

  1641. 1641

    J. Malcolm O. Arnold, Peter Liu, Catherine Demers, Paul Dorian, Nadia Giannetti, Haissam Haddad, George A. Heckman, Jonathan G. Howlett, Andrew Ignaszewski, David E. Johnstone, Philip Jong, Robert S. McKelvie, Gordon W. Moe, John D. Parker, Vivek Rao, Heather J. Ross, Errol J. Sequeira, Anna M. Svendsen, Koon Teo, Ross T. Tsuyuki, Michel White. (2006) Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: Diagnosis and management. Canadian Journal of Cardiology 22:1, 23-45

  1642. 1642

    Germanas Marinskis, Audrius Aidietis. (2006) Advances in nonpharmacologic therapies for ventricular arrhythmias. Therapy 3:1, 125-138

  1643. 1643

    Kathryn A. Glatter, J. Nilas Young, Matthew D. McElvany. (2006) Implantable Cardioverter?Defibrillators: A New Preventive Medical Option. Preventive Cardiology 9:1, 49-55

  1644. 1644

    S. Adam Strickberger, D. Woodrow Benson, Italo Biaggioni, David J. Callans, Mitchell I. Cohen, Kenneth A. Ellenbogen, Andrew E. Epstein, Paul Friedman, Jeffrey Goldberger, Paul A. Heidenreich, George J. Klein, Bradley P. Knight, Carlos A. Morillo, Robert J. Myerburg, Cathy A. Sila. (2006) AHA/ACCF Scientific Statement on the Evaluation of Syncope. Journal of the American College of Cardiology 47:2, 473-484

  1645. 1645

    HIROSHI KASANUKI. (2006) Present status and prospect of non-pharmacotherapy of arrhythmia.. Nihon Naika Gakkai Zasshi 95:9, 1912-1921

  1646. 1646

    D. Karila-Cohen. (2006) Infarctus du myocarde. Diagnostic, prise en charge à la phase aiguë et complications. EMC - Traité de médecine AKOS 1:4, 1-13

  1647. 1647

    P. Touboul. (2006) Fibrillation ventriculaire. EMC - Cardiologie 1:1, 1-7

  1648. 1648

    S. Dinanian. (2006) Traitement médical des troubles du rythme. EMC - Cardiologie 1:1, 1-7

  1649. 1649

    Stephen Minor, Toshio Akiyama. (2006) Ventricular Arrhythmias in the Elderly. Journal of Arrhythmia 22:1, 19-30

  1650. 1650

    Amir Kashani, S. Serge Barold. (2005) Significance of QRS Complex Duration in Patients With Heart Failure. Journal of the American College of Cardiology 46:12, 2183-2192

  1651. 1651

    Vijay K Verma, Steven M Hollenberg. (2005) Update on acute coronary syndromes and ST-elevation myocardial infarction. Current Opinion in Internal Medicine 4:6, 614-618

  1652. 1652

    WOJCIECH ZAREBA, ARTHUR J. MOSS, W. JACKSON HALL, DAVID J. WILBER, JEREMY N. RUSKIN, SCOTT MCNITT, MARY BROWN, HONGYUE WANG, . (2005) Clinical Course and Implantable Cardioverter Defibrillator Therapy in Postinfarction Women with Severe Left Ventricular Dysfunction. Journal of Cardiovascular Electrophysiology 16:12, 1265-1270

  1653. 1653

    Kenneth A. Ellenbogen, Mark A. Wood, Helmut U. Klein. (2005) Why Should We Care About CARE-HF?. Journal of the American College of Cardiology 46:12, 2199-2203

  1654. 1654

    H. Volkmann, C. Bergmann, M. Walter. (2005) Kardiale Resynchronisation: Wer ist geeignet?—. Zeitschrift für Kardiologie 94:S4, iv60-iv64

  1655. 1655

    Rafael Peinado, Ángel Arenal, Fernando Arribas, Esteban Torrecilla, Miguel Álvarez, José M. Ormaetxe, Nicasio Pérez-Castellano. (2005) Registro Español de Desfibrilador Automático Implantable. Primer Informe Oficial del Grupo de Trabajo de Desfibrilador Implantable de la Sociedad Española de Cardiología (años 2002-2004). Revista Española de Cardiología 58:12, 1435-1449

  1656. 1656

    Jeroen J. Bax, Theodore Abraham, S. Serge Barold, Ole A. Breithardt, Jeffrey W.H. Fung, Stephane Garrigue, John Gorcsan, David L. Hayes, David A. Kass, Juhani Knuuti, Christophe Leclercq, Cecilia Linde, Daniel B. Mark, Mark J. Monaghan, Petros Nihoyannopoulos, Martin J. Schalij, Christophe Stellbrink, Cheuk-Man Yu. (2005) Cardiac Resynchronization Therapy. Journal of the American College of Cardiology 46:12, 2168-2182

  1657. 1657

    Martin C. Burke, James A. Coman, Adam W. Cates, Curtis C. Lindstrom, David A. Sandler, Susan S. Kim, Bradley P. Knight. (2005) Defibrillation energy requirements using a left anterior chest cutaneous to subcutaneous shocking vector: Implications for a total subcutaneous implantable defibrillator. Heart Rhythm 2:12, 1332-1338

  1658. 1658

    Peter Carson, Inder Anand, Christopher O’Connor, Brian Jaski, Jonathan Steinberg, Amy Lwin, JoAnn Lindenfeld, Jalil Ghali, Jodi H. Barnet, Arthur M. Feldman, Michael R. Bristow. (2005) Mode of Death in Advanced Heart Failure. Journal of the American College of Cardiology 46:12, 2329-2334

  1659. 1659

    Harald C. Ott, Bryce H. Davis, Doris A. Taylor. (2005) Cell Therapy for Heart Failure—Muscle, Bone Marrow, Blood, and Cardiac-Derived Stem Cells. Seminars in Thoracic and Cardiovascular Surgery 17:4, 348-360

  1660. 1660

    Dhanunjaya Lakkireddy, Dimpi Patel, Kay Ryschon, Rohit Bhateja, Mihir Bhakru, Sergio Thal, Atul Verma, Oussama Wazni, Fethi Kilicaslan, Ashok Kondur, Subramanya Prasad, Jennifer Cummings, William Belden, David Burkhardt, Walid Saliba, Robert Schweikert, Mandeep Bhargava, Mina Chung, Bruce Wilkoff, Patrick Tchou, Andrea Natale. (2005) Safety and efficacy of radiofrequency energy catheter ablation of atrial fibrillation in patients with pacemakers and implantable cardiac defibrillators. Heart Rhythm 2:12, 1309-1316

  1661. 1661

    John D. Harding, Mariell Jessup. (2005) New Directions in the Medical Management of Heart Failure. Seminars in Thoracic and Cardiovascular Surgery 17:4, 334-342

  1662. 1662

    Gabor Duray, Sergio Richter, Johannes Manegold, Carsten W. Israel, Gerian Grönefeld, Stefan H. Hohnloser. (2005) Efficacy and Safety of ICD Therapy in a Population of Elderly Patients Treated with Optimal Background Medication. Journal of Interventional Cardiac Electrophysiology 14:3, 169-173

  1663. 1663

    Peter Spooner. Genetic factors underlying susceptibility to common arrhythmias. In: Molecular Mechanisms of Cardiac Hypertrophy and Failure. CRC Press, 2005:457-473.

  1664. 1664

    SANJEEV GOYAL, LAWRENCE ROSENTHAL. (2005) Persistent Left Superior Vena Cava-Inferior Vena Caval Communication Complicating Implantation of an Implantable Cardioverter Defibrillator. Pacing and Clinical Electrophysiology 28:11, 1245-1246

  1665. 1665

    CYNTHIA M. DOUGHERTY, ELAINE ADAMS THOMPSON, FRANCES MARCUS LEWIS. (2005) Long-Term Outcomes of a Telephone Intervention After an ICD. Pacing and Clinical Electrophysiology 28:11, 1157-1167

  1666. 1666

    Andrew E. Epstein. (2005) New insights into cardiac resynchronization therapy. Clinical Cardiology 28:S1, 45-50

  1667. 1667

    H. C. Ott, J. McCue, D. A. Taylor. (2005) Cell–based cardiovascular repair. Basic Research in Cardiology 100:6, 504-517

  1668. 1668

    Jonathan P. Piccini, Darshan Dalal, Ariel Roguin, Chandra Bomma, Alan Cheng, Kalpana Prakasa, Jun Dong, Crystal Tichnell, Cynthia James, Stuart Russell, Jane Crosson, Ronald D. Berger, Joseph E. Marine, Gordon Tomaselli, Hugh Calkins. (2005) Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. Heart Rhythm 2:11, 1188-1194

  1669. 1669

    James A. Reiffel. (2005) Practical algorithms for pharmacologic management of the post myocardial infarction patient. Clinical Cardiology 28:S1, 28-37

  1670. 1670

    Charles A. Herzog. (2005) Sudden Cardiac Death and Acute Myocardial Infarction in Dialysis Patients: Perspectives of a Cardiologist. Seminars in Nephrology 25:6, 363-366

  1671. 1671

    Gerald V. Naccarelli. (2005) Post myocardial infarction, left ventricular dysfunction, and the expanding role of cardiac implantable electrical devices. Clinical Cardiology 28:S1, 51-57

  1672. 1672

    James O. O’Neill, Randall C. Starling, Yaariv Khaykin, Patrick M. McCarthy, James B. Young, Melanie Hail, Nancy M. Albert, Nicholas Smedira, Mina K. Chung. (2005) Residual high incidence of ventricular arrhythmias after left ventricular reconstructive surgery. The Journal of Thoracic and Cardiovascular Surgery 130:5, 1250-1256

  1673. 1673

    Saman Nazarian, William H. Maisel, J. Shawn Miles, Sui Tsang, Lynne W. Stevenson, William G. Stevenson. (2005) Impact of implantable cardioverter defibrillators on survival and recurrent hospitalization in advanced heart failure. American Heart Journal 150:5, 955-960

  1674. 1674

    John D. Fisher. (2005) Who Needs a Defibrillator?. Journal of the American College of Cardiology 46:9, 1727-1728

  1675. 1675

    NICHOLAS S. PETERS. (2005) Arrhythmias After Cell Transplantation for Myocardial Regeneration: Natural History or Result of the Intervention?. Journal of Cardiovascular Electrophysiology 16:11, 1255-1257

  1676. 1676

    Robin AP Weir, Henry J Dargie. (2005) Carvedilol in chronic heart failure: past, present and future. Future Cardiology 1:6, 723-734

  1677. 1677

    Kelley P. Anderson. (2005) Sudden Cardiac Death Unresponsive to Implantable Defibrillator Therapy: An Urgent Target for Clinicians, Industry and Government. Journal of Interventional Cardiac Electrophysiology 14:2, 71-78

  1678. 1678

    Haitham Hreybe, Maninder Bedi, Rana Ezzeddine, William Barrington, Sandeep Jain, Ogundu Ngwu, Samir Saba. (2005) Indications for internal cardioverter defibrillator implantation predict time to first shock and the modulating effect of β-blockers. American Heart Journal 150:5, 1064.e1-1064.e5

  1679. 1679

    Jagmeet P. Singh, W. Jackson Hall, Scott McNitt, Hongyue Wang, James P. Daubert, Wojciech Zareba, Jeremy N. Ruskin, Arthur J. Moss. (2005) Factors Influencing Appropriate Firing of the Implanted Defibrillator for Ventricular Tachycardia/Fibrillation. Journal of the American College of Cardiology 46:9, 1712-1720

  1680. 1680

    Eric N. Prystowsky. (2005) Prevention of sudden cardiac death. Clinical Cardiology 28:S1, 12-18

  1681. 1681

    Todd J. Rudo, Peter R. Kowey. (2005) Real-world algorithms for the optimal use of drugs and devices in the patient post myocardial infarction and the future of post myocardial infarction management. Clinical Cardiology 28:S1, 58-63

  1682. 1682

    Sanders , Gillian D. , Hlatky , Mark A. , Owens , Douglas K. , . (2005) Cost-Effectiveness of Implantable Cardioverter–Defibrillators. New England Journal of Medicine 353:14, 1471-1480
    Free Full Text

  1683. 1683

    Jagmeet P. Singh, Jeremy N. Ruskin. (2005) Cardiac Resynchronization Therapy: The MGH Experience. Annals of Noninvasive Electrocardiology 10:s4, 44-54

  1684. 1684

    S. Sundar, R.P. Symonds, C. Deehan. (2005) Radiotherapy to patients with artificial cardiac pacemakers. Cancer Treatment Reviews 31:6, 474-486

  1685. 1685

    M.D. Harrington, D.L. Luebke, W.R. Lewis, M.P. Aulisio, N.J. Johnson. (2005) Cardiac Pacemakers at End of Life #111; Implantable Cardioverter Defibrillator (ICD) at End of Life #112. Journal of Palliative Medicine 8:5, 1055-1057

  1686. 1686

    Loren D. Berenbom, Brian C. Weiford, James L. Vacek, Martin P. Emert, W. Jackson Hall, Mark L. Andrews, Scott McNitt, Wojciech Zareba, Arthur J. Moss, . (2005) Differences in Outcomes Between Patients Treated with Single- versus Dual-Chamber Implantable Cardioverter Defibrillators: A Substudy of the Multicenter Automatic Defibrillator Implantation Trial II. Annals of Noninvasive Electrocardiology 10:4, 429-435

  1687. 1687

    Vinod Jayam, Menekhem Zviman, Venku Jayanti, Ariel Roguin, Henry Halperin, Ronald D. Berger. (2005) Internal defibrillation with minimal skeletal muscle activation: A new paradigm toward painless defibrillation. Heart Rhythm 2:10, 1108-1113

  1688. 1688

    Antonis A Armoundas, Stefan H Hohnloser, Takanori Ikeda, Richard J Cohen. (2005) Can microvolt T-wave alternans testing reduce unnecessary defibrillator implantation?. Nature Clinical Practice Cardiovascular Medicine 2:10, 522-528

  1689. 1689

    V. Dor, M. Sabatier, F. Montiglio, F. Civaia, M. Di Donato. (2005) Endoventricular Patch Reconstruction of Ischemic Failing Ventricle. A Single Center with 20 years Experience. Advantages of Magnetic Resonance Imaging Assessment. Heart Failure Reviews 9:4, 269-286

  1690. 1690

    Juan Fernández-Yáñez, Jesús Palomo, Esteban G. Torrecilla, David Pascual, Gregorio Garrido, José J. Gómez de Diego, Marta Domínguez, Jesús Almendral. (2005) Pronóstico de una población inicialmente candidata a trasplante cardíaco controlada con tratamiento médico. Revista Española de Cardiología 58:10, 1162-1170

  1691. 1691

    Sana M. Al-Khatib, F. Lee Lucas, James G. Jollis, David J. Malenka, David E. Wennberg. (2005) The Relation Between Patients’ Outcomes and the Volume of Cardioverter-Defibrillator Implantation Procedures Performed by Physicians Treating Medicare Beneficiaries. Journal of the American College of Cardiology 46:8, 1536-1540

  1692. 1692

    Dee Ann Rivera, Michael R. Bristow. (2005) Cardiac Resynchronization-A Heart Failure Perspective. Annals of Noninvasive Electrocardiology 10:s4, 16-23

  1693. 1693

    Arthur J. Moss, Mary W. Brown, David S. Cannom, James P. Daubert, Mark Estes, Elyse Foster, Henry M. Greenberg, W. Jackson Hall, Steven L. Higgins, Helmut Klein, Mark Pfeffer, David Wilber, Wojciech Zareba. (2005) Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT): Design and Clinical Protocol. Annals of Noninvasive Electrocardiology 10:s4, 34-43

  1694. 1694

    David S. Cannom, Morton Mower. (2005) Relationship of the Implantable Cardioverter Defibrillator and Chronic Resynchronization Therapy: The Perfect Marriage?. Annals of Noninvasive Electrocardiology 10:s4, 24-33

  1695. 1695

    PHILIPPINE KIES, ERIC BOERSMA, JEROEN J. BAX, ALIDA E. BORGER van der BURG, MARIANNE BOOTSMA, LIESELOT van ERVEN, ERNST E. van der WALL, MARTIN J. SCHALIJ. (2005) Determinants of Recurrent Ventricular Arrhythmia or Death in 300 Consecutive Patients with Ischemic Heart Disease Who Experienced Aborted Sudden Death: Data from the Leiden Out-of-Hospital Cardiac Arrest Study. Journal of Cardiovascular Electrophysiology 16:10, 1049-1056

  1696. 1696

    JOHN E. MADIAS, PETER W. MACFARLANE. (2005) Artificial Attenuation of ECG Voltage Produces Shortening of the Corresponding QRS Duration: Clinical Implications for Patients with Edema. Pacing and Clinical Electrophysiology 28:10, 1060-1065

  1697. 1697

    Ilan Goldenberg, Arthur J. Moss, Barry J. Maron, Andrew W. Dick, Wojciech Zareba. (2005) Cost-Effectiveness of Implanted Defibrillators in Young People with Inherited Cardiac Arrhythmias. Annals of Noninvasive Electrocardiology 10:s4, 67-83

  1698. 1698

    V. Suberviola Snchez-Caballero, R. Salguero Bodes, J.J. Parra Fuertes, C. Senz de la Calzada Campos. (2005) Infarto agudo de miocardio. Criterios diagn?sticos y pron?sticos. Cardiopat?a isqu?mica en la tercera edad. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 9:40, 2633-2642

  1699. 1699

    R. Mata Francs, V. Suberviola Snchez-Caballero, I. Snchez Prez, C. Senz de la Calzada Campos. (2005) Tratamiento de las complicaciones del infarto de miocardio. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 9:40, 2671-2681

  1700. 1700

    SANA M. AL-KHATIB. (2005) Does ICD Therapy Benefit Women with a History of Myocardial Infarction and Severe Left Ventricular Dysfunction?. Journal of Cardiovascular Electrophysiology 0:0, 050902082157002

  1701. 1701

    Karen Merchant, Ann LaBorde. (2005) Implementing a Cardiac Resynchronization Therapy Program in a County Hospital. JONA: The Journal of Nursing Administration 35:9, 404???409

  1702. 1702

    Sharon Ann Hunt, William T. Abraham, Marshall H. Chin, Arthur M. Feldman, Gary S. Francis, Theodore G. Ganiats, Mariell Jessup, Marvin A. Konstam, Donna M. Mancini, Keith Michl, John A. Oates, Peter S. Rahko, Marc A. Silver, Lynne Warner Stevenson, Clyde W. Yancy, Elliott M. Antman, Sidney C. Smith, Cynthia D. Adams, Jeffrey L. Anderson, David P. Faxon, Valentin Fuster, Jonathan L. Halperin, Loren F. Hiratzka, Sharon Ann Hunt, Alice K. Jacobs, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel. (2005) ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article. Journal of the American College of Cardiology 46:6, 1116-1143

  1703. 1703

    ALFRED E. BUXTON. (2005) Identifying the High Risk Patient with Coronary Artery Disease-Is Ejection Fraction All You Need?. Journal of Cardiovascular Electrophysiology 16:s1, S25-S27

  1704. 1704

    Sharon Ann Hunt. (2005) ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult. Journal of the American College of Cardiology 46:6, e1-e82

  1705. 1705

    GEORGE J. KLEIN, ANDREW D. KRAHN, ALLAN C. SKANES, RAYMOND YEE, LORNE J. GULA. (2005) Primary Prophylaxis of Sudden Death in Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy, and Dilated Cardiomyopathy. Journal of Cardiovascular Electrophysiology 16:s1, S28-S34

  1706. 1706

    (2005) Guías de Práctica Clínica sobre el diagnóstico y tratamiento de la insuficiencia cardíaca crónica. Versión resumida (actualización 2005). Revista Española de Cardiología 58:9, 1062-1092

  1707. 1707

    PETER ALTER, STEFAN WALDHANS, EVELINE PLACHTA, RAINER MOOSDORF, WOLFRAM GRIMM. (2005) Complications of Implantable Cardioverter Defibrillator Therapy in 440 Consecutive Patients. Pacing and Clinical Electrophysiology 28:9, 926-932

  1708. 1708

    Safwat Gassis, Angel R. Le. (2005) Cardiac Resynchronization Therapy: Strategies for Device Programming, Troubleshooting and Follow-Up. Journal of Interventional Cardiac Electrophysiology 13:3, 209-222

  1709. 1709

    Leon M. Ptaszek, Paul J. Wang, Sharon A. Hunt, Hannah Valantine, Mark Perlroth, Amin Al-Ahmad. (2005) Use of the implantable cardioverter-defibrillator in long-term survivors of orthotopic heart transplantation. Heart Rhythm 2:9, 931-933

  1710. 1710

    William N. Brodine, Robert T. Tung, John K. Lee, Eric S. Hockstad, Arthur J. Moss, Wojciech Zareba, W. Jackson Hall, Mark Andrews, Scott McNitt, James P. Daubert. (2005) Effects of Beta-Blockers on Implantable Cardioverter Defibrillator Therapy and Survival in the Patients with Ischemic Cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II). The American Journal of Cardiology 96:5, 691-695

  1711. 1711

    DAVID S. CANNOM. (2005) Prevention of Sudden Cardiac Death. Journal of Cardiovascular Electrophysiology 16:s1, S21-S24

  1712. 1712

    Brian T. Schuler, Angel R. León. (2005) Cardiac resynchronization therapy. Current Cardiology Reports 7:5, 321-328

  1713. 1713

    Prash Jayaraj, Kevin M. Monahan. (2005) Sudden cardiac death and the role of device therapy in dilated cardiomyopathy. Current Heart Failure Reports 2:3, 124-127

  1714. 1714

    Frank A. Cuoco, Steven N. Singh. (2005) Nonsustained ventricular tachycardia in dilated cardiomyopathy. Current Cardiology Reports 7:5, 368-375

  1715. 1715

    Wataru Shimizu, Kazuhiro Satomi. (2005) Implications and problems of the Sudden Cardiac Death in Heart Failure Trial. Future Cardiology 1:5, 599-603

  1716. 1716

    Anand Soni, Paul LeLorier. (2005) Sudden death in nondilated cardiomyopathies: Pathophysiology and prevention. Current Heart Failure Reports 2:3, 118-123

  1717. 1717

    Gregory K. Bruce, Paul A. Friedman. (2005) Device-based therapies for atrial fibrillation. Current Treatment Options in Cardiovascular Medicine 7:5, 359-370

  1718. 1718

    Zachary Goldberger, Brian Elbel, Craig A. McPherson, A. David Paltiel, Rachel Lampert. (2005) Cost Advantage of Dual-Chamber Versus Single-Chamber Cardioverter-Defibrillator Implantation. Journal of the American College of Cardiology 46:5, 850-857

  1719. 1719

    Arnold Pinter, Paul Dorian. (2005) Approach to antiarrhythmic therapy in patients with ICDs and frequent activations. Current Cardiology Reports 7:5, 376-381

  1720. 1720

    Philip B. Adamson. (2005) Ambulatory Hemodynamics in Patients With Chronic Heart Failure: Implications for Volume Management in Elderly Patients. The American Journal of Geriatric Cardiology 14:5, 236-241

  1721. 1721

    BEATRICE BREMBILLA-PERROT, CHRISTINE SUTY-SELTON, OLIVIER CLAUDON, ARNAUD TERRIER DE LA CHAISE, PIERRE LOUIS, MARC NIPPERT, BATRIC POPOVIC, HUGUES BLANGY, EMAD KHALDI, HADJ BELHAKEM, DANIEL BEURRIER, PIERRE HOURIEZ. (2005) Significance of Inducible Ventricular Flutter-Fibrillation After Myocardial Infarction. Pacing and Clinical Electrophysiology 28:9, 938-943

  1722. 1722

    W. Jung, R. Birkemeyer. (2005) Home Monitoring mit implantierbaren Defibrillatoren. Herzschrittmachertherapie & Elektrophysiologie 16:3, 183-190

  1723. 1723

    Matthew W. Ebinger, Subramaniam Krishnan, Claudio D. Schuger. (2005) Mechanisms of ventricular arrhythmias in heart failure. Current Heart Failure Reports 2:3, 111-117

  1724. 1724

    CRAIG J. McCOTTER, J. FRITZ ANGLE, LIZA A. PRUDENTE, J. PAUL MOUNSEY, JOHN D. FERGUSON, JOHN P. DiMARCO, JAMES P. HUMMEL, J. MICHAEL MANGRUM. (2005) Placement of Transvenous Pacemaker and ICD Leads Across Total Chronic Occlusions. Pacing and Clinical Electrophysiology 28:9, 921-925

  1725. 1725

    Jonathan A. Leighton, Komandoor Srivathsan, Elizabeth J. Carey, Virender K. Sharma, Russell I. Heigh, Janice K. Post, Paula J. Erickson, Sarah R. Robinson, Jane L. Bazzell, David E. Fleischer. (2005) Safety of Wireless Capsule Endoscopy in Patients with Implantable Cardiac Defibrillators. The American Journal of Gastroenterology 100:8, 1728-1731

  1726. 1726

    Eric C. Stecker, Katherine R. Strelich, Sumeet S. Chugh, Kathy Crispell, John H. McAnulty. (2005) Arrhythmias After Orthotopic Heart Transplantation. Journal of Cardiac Failure 11:6, 464-472

  1727. 1727

    Daniel J. Garry, Sean C. Goetsch, Amanda J. McGrath, Pradeep P.A. Mammen. (2005) Alternative Therapies for Orthotopic Heart Transplantation. The American Journal of the Medical Sciences 330:2, 88-101

  1728. 1728

    DAVID STEINHAUS, DWIGHT W. REYNOLDS, FREDRIK GADLER, G. NEAL KAY, MIKE F. HESS, TOM BENNETT, . (2005) Implant Experience with an Implantable Hemodynamic Monitor for the Management of Symptomatic Heart Failure. Pacing and Clinical Electrophysiology 28:8, 747-753

  1729. 1729

    ELIYAH STOUPEL, JAIRO KUSNIEC, ALEXANDER MAZUR, RONIT ZABARSKY, GREGORY GOLOVCHINER, EVGENY ABRAMSON, BORIS STRASBERG, ALEXANDER BATTLER. (2005) Temporal Relationship of Implantable Cardioverter Defibrillator Discharges and Environmental Physical Activity. Pacing and Clinical Electrophysiology 28:8, 777-781

  1730. 1730

    U. C. Hoppe, M. Böhm, R. Dietz, P. Hanrath, H. K. Kroemer, A. Osterspey, A. A. Schmaltz, E. Erdmann. (2005) Leitlinien zur Therapie der chronischen Herzinsuffizienz. Zeitschrift für Kardiologie 94:8, 488-509

  1731. 1731

    MICHAEL O. SWEENEY, KENNETH A. ELLENBOGEN, DAVID CASAVANT, ROBERT BETZOLD, TODD SHELDON, FENG TANG, MEGAN MUELLER, JOHN LINGLE, . (2005) Multicenter, Prospective, Randomized Safety and Efficacy Study of a New Atrial-Based Managed Ventricular Pacing Mode (MVP) in Dual Chamber ICDs. Journal of Cardiovascular Electrophysiology 16:8, 811-817

  1732. 1732

    Arjun D. Sharma, Carlos Rizo-Patron, Alfred P. Hallstrom, Gearoid P. O’Neill, Stephen Rothbart, James B. Martins, Marc Roelke, Jonathan S. Steinberg, H. Leon Greene. (2005) Percent right ventricular pacing predicts outcomes in the DAVID trial. Heart Rhythm 2:8, 830-834

  1733. 1733

    Robert D Winslow, Davendra Mehta, Valentin Fuster. (2005) Sudden cardiac death: mechanisms, therapies and challenges. Nature Clinical Practice Cardiovascular Medicine 2:7, 352-360

  1734. 1734

    A. Maybhate, S.C. Hao, S. Iwai, J.U. Lee, A.B. Guttigoli, K.M. Stein, B.B. Lerman, D.J. Christini. (2005) Detection of Repolarization Alternans With an Implantable Cardioverter Defibrillator Lead in a Porcine Model. IEEE Transactions on Biomedical Engineering 52:7, 1188-1194

  1735. 1735

    Brian Olshansky. (2005) Wide QRS, Narrow QRS. Journal of the American College of Cardiology 46:2, 317-319

  1736. 1736

    ANDREW T. HO, SUDHA M. PAI, PAM TIMOTHY, RAMDAS G. PAI. (2005) Effect of Concomitant Antiarrhythmic Therapy on Survival in Patients with Implantable Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 28:7, 647-653

  1737. 1737

    Glen Miske, Celso Acevedo, Thomas W. Goodlive, C. Michael Brown, T. Barry Levine. (2005) Cardiac Resynchronization Therapy and Tools to Identify Responders. Congestive Heart Failure 11:4, 199-206

  1738. 1738

    Arthur J. Moss. (2005) Heart Failure: A Central Factor in Progressive Mechanical and Electrical Cardiac Dysfunction. Annals of Noninvasive Electrocardiology 10:3, 279-279

  1739. 1739

    N. A. Mark Estes III. (2005) Primary Prevention of Sudden Cardiac Death: A Rational Approach to the Use of the Implantable Cardioverter Defibrillator. Journal of Interventional Cardiac Electrophysiology 13:2, 91-93

  1740. 1740

    Alfred E. Buxton, Michael O. Sweeney, Mark S. Wathen, Mark E. Josephson, Mary F. Otterness, Elaine Hogan-Miller, Alice J. Stark, Paul J. DeGroot. (2005) QRS Duration Does Not Predict Occurrence of Ventricular Tachyarrhythmias in Patients With Implanted Cardioverter-Defibrillators. Journal of the American College of Cardiology 46:2, 310-316

  1741. 1741

    LORNE J. GULA, ALYSON AMES, ASHLEY WOODBURN, JOHN MATKINS, MICHAEL McCORMICK, JEFFREY BELL, DEBORAH SINK, JAMES McCONVILLE, LAURENCE M. EPSTEIN. (2005) Central Venous Occlusion Is Not an Obstacle to Device Upgrade with the Assistance of Laser Extraction. Pacing and Clinical Electrophysiology 28:7, 661-666

  1742. 1742

    A. Derk Jan Harkel, Nico A. Blom, Annette G. Reimer, Raymond Tukkie, Narayanswami Sreeram, Margreet T. E. Bink-Boelkens. (2005) Implantable cardioverter defibrillator implantation in children in The Netherlands. European Journal of Pediatrics 164:7, 436-441

  1743. 1743

    C. Richard Conti. (2005) Ventricular arrhythmias: A general cardiologist's assessment of therapies in 2005. Clinical Cardiology 28:7, 314-316

  1744. 1744

    Cengiz Ermis, Alan X. Zhu, Laura Vanheel, Mary Jo Lemke, Scott Sakaguchi, Keith G. Lurie, Fei Lu, Joseph Lin, David G. Benditt. (2005) Comparison of Ventricular Arrhythmia Frequency in Patients With Ischemic Cardiomyopathy Versus Nonischemic Cardiomyopathy Treated With Implantable Cardioverter Defibrillators. The American Journal of Cardiology 96:2, 233-238

  1745. 1745

    Solomon , Scott D. , Zelenkofske , Steve , McMurray , John J.V. , Finn , Peter V. , Velazquez , Eric , Ertl , George , Harsanyi , Adam , Rouleau , Jean L. , Maggioni , Aldo , Kober , Lars , White , Harvey , Van de Werf , Frans , Pieper , Karen , Califf , Robert M. , Pfeffer , Marc A. , . (2005) Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both. New England Journal of Medicine 352:25, 2581-2588
    Free Full Text

  1746. 1746

    Buxton , Alfred E. , . (2005) Sudden Death after Myocardial Infarction — Who Needs Prophylaxis, and When?. New England Journal of Medicine 352:25, 2638-2640
    Full Text

  1747. 1747

    Anil V. Yadav, Mithilesh K. Das, Douglas P. Zipes. (2005) Selection of Patients for ICDs: ‘Where Are We in 2005?’. ACC Current Journal Review 14:6, 33-37

  1748. 1748

    Michael O. Sweeney. (2005) Wide right. Heart Rhythm 2:6, 616-618

  1749. 1749

    Robert G. Hauser. (2005) The Growing Mismatch Between Patient Longevity and the Service Life of Implantable Cardioverter-Defibrillators. Journal of the American College of Cardiology 45:12, 2022-2025

  1750. 1750

    Eduardo Vázquez Ruiz de Castroviejo, Juan Muñoz Bellido, Cristóbal Lozano Cabezas, Antonio Ramírez Moreno, Manuel Guzmán Herrera, Ada Tarabini Castellani, Antonio Fajardo Pineda, Blas Jiménez Araque, Juan B. Armenteros Lechuga, Carlos Pagola Vilardebó. (2005) Análisis de la frecuencia de las arritmias cardíacas y de los trastornos de conducción desde una perspectiva asistencial. Revista Española de Cardiología 58:6, 657-665

  1751. 1751

    S. Serge Barold, Bengt Herweg. (2005) Right Ventricular Outflow Tract Pacing: Not Ready for Prime-Time. Journal of Interventional Cardiac Electrophysiology 13:1, 39-46

  1752. 1752

    Douglass A. Morrison. (2005) What Is the Evidence for Percutaneous Coronary Intervention or Coronary Artery Bypass Graft in Ischemic Cardiomyopathy?. The American Heart Hospital Journal 3:3, 175-181

  1753. 1753

    S ALKHATIB, G SANDERS, D MARK, K LEE, G BARDY, J BIGGER, A BUXTON, S CONNOLLY, A KADISH, A MOSS. (2005) Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: Randomized trial evidence through 2004. American Heart Journal 149:6, 1020-1034

  1754. 1754

    Marc T. Silver. (2005) Primary Prevention Implantable Cardioverter-Defibrillators: Economics and Ethics. The American Heart Hospital Journal 3:3, 205-206

  1755. 1755

    T. Jared Bunch, Stephen C. Hammill, Roger D. White. (2005) Outcomes After Ventricular Fibrillation Out-of-Hospital Cardiac Arrest: Expanding the Chain of Survival. Mayo Clinic Proceedings 80:6, 774-782

  1756. 1756

    Shafie Fazel, Gilbert H.L. Tang, Denis Angoulvant, Massimo Cimini, Richard D. Weisel, Ren-Ke Li, Terrence M. Yau. (2005) Current Status of Cellular Therapy for Ischemic Heart Disease. The Annals of Thoracic Surgery 79:6, S2238-S2247

  1757. 1757

    H.-R Arntz, H.-J. Trappe. (2005) Frühdefibrillation: Perspektiven und Ausblick. Herzschrittmachertherapie & Elektrophysiologie 16:2, 112-117

  1758. 1758

    Wojciech Zareba, Katarzyna Piotrowicz, Scott McNitt, Arthur J. Moss. (2005) Implantable Cardioverter-Defibrillator Efficacy in Patients With Heart Failure and Left Ventricular Dysfunction (from the MADIT II Population). The American Journal of Cardiology 95:12, 1487-1491

  1759. 1759

    M.C. Viana Llamas, A. Hernndez Madrid, C. Moro Serrano. (2005) Tratamiento de las taquiarritmias por m?todos no farmacol?gicos. T?cnicas de ablaci?n. Desfibriladores. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 9:36, 2391-2399

  1760. 1760

    I.P. Garrido Bravo, J.. Rodrguez Fernndez, J. Garca de Lara, A. Castro Beiras. (2005) Tratamiento de la insuficiencia card?aca cr?nica. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 9:35, 2318-2326

  1761. 1761

    (2005) Implantable Cardioverter–Defibrillators. New England Journal of Medicine 352:19, 2022-2025
    Free Full Text

  1762. 1762

    Oliver R. Segal, Anthony W.C. Chow, Vias Markides, Richard J. Schilling, Nicholas S. Peters, D. Wyn Davies. (2005) Long-term results after ablation of infarct-related ventricular tachycardia. Heart Rhythm 2:5, 474-482

  1763. 1763

    Eric M. Crespo, Jane Kim, Kimberly A. Selzman. (2005) The Use of Implantable Cardioverter Defibrillators for the Prevention of Sudden Cardiac Death: A Review of the Evidence and Implications. The American Journal of the Medical Sciences 329:5, 238-246

  1764. 1764

    Amir Halkin, Mandeep Singh, Eugenia Nikolsky, Cindy L. Grines, James E. Tcheng, Eulogio Garcia, David A. Cox, Mark Turco, Thomas D. Stuckey, Yingo Na, Alexandra J. Lansky, Bernard J. Gersh, William W. O’Neill, Roxana Mehran, Gregg W. Stone. (2005) Prediction of Mortality After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction. Journal of the American College of Cardiology 45:9, 1397-1405

  1765. 1765

    Riccardo Fenici, Donatella Brisinda, Anna Maria Meloni. (2005) Clinical application of magnetocardiography. Expert Review of Molecular Diagnostics 5:3, 291-313

  1766. 1766

    ULRICH BACKENKOHLER, ALI ERDOGAN, MARY-KAY STEEN-MUELLER, CHRISTOPH KUHLMANN, ASTRID MOST, CHRISTIAN SCHAEFER, WILHELM STERTMANN, WOLFGANG WAAS, HARALD TILLMANNS, BERND WALDECKER. (2005) Long-Term Incidence of Malignant Ventricular Arrhythmia and Shock Therapy in Patients with Primary Defibrillator Implantation Does Not Differ from Event Rates in Patients Treated for Survived Cardiac Arrest. Journal of Cardiovascular Electrophysiology 16:5, 478-482

  1767. 1767

    MICHAEL O. SWEENEY. (2005) The Nature of the Game. Journal of Cardiovascular Electrophysiology 16:5, 483-485

  1768. 1768

    ATUL VERMA, NASSIR F MARROUCHE, ROBERT A. SCHWEIKERT, WALID SALIBA, OUSSAMA WAZNI, JENNIFER CUMMINGS, AHMAD ABDUL-KARIM, MANDEEP BHARGAVA, J. DAVID BURKHARDT, FETHI KILICASLAN, DAVID O. MARTIN, ANDREA NATALE. (2005) Relationship Between Successful Ablation Sites and the Scar Border Zone Defined by Substrate Mapping for Ventricular Tachycardia Post-Myocardial Infarction. Journal of Cardiovascular Electrophysiology 16:5, 465-471

  1769. 1769

    Isaac Pourati, Michael Hyder, Lawrence Rosenthal. (2005) Indications for implantable cardiac defibrillators in patients with congestive heart failure: Implications of the sudden cardiac death in heart failure trial. Current Cardiology Reports 7:3, 223-228

  1770. 1770

    George Ritter. (2005) Technology at the Crossroads with Care and Costs: The Implantation of the Automatic Internal Cardiac Defibrillator. Southern Medical Journal 98:5, 502-503

  1771. 1771

    R. Sukhija, W. S. Aronow, C. Sorbera, K. Yalamanchili, M. Cohen. (2005) Patients, Mean Age 70 Years, With Automatic Implantable Cardioverter-Defibrillators Treated With Dual-Chamber Rate Responsive Pacing (DDDR-70) Have a Higher Mortality Than Patients With Backup Ventricular Pacing (VVI-40) at 3.7-Year Follow-Up. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 60:5, 603-604

  1772. 1772

    LI WANG, STUART LAHTINEN, LINNEA LENTZ, NANCY RAKOW, CAMERON KASZAS, LINDA RUETZ, LEE STYLOS, WALTER H. OLSON. (2005) Feasibility of Using an Implantable System to Measure Thoracic Congestion in an Ambulatory Chronic Heart Failure Canine Model. Pacing and Clinical Electrophysiology 28:5, 404-411

  1773. 1773

    Mahi Lakshmi Ashwath, Felix O. Sogade. (2005) Ejection Fraction and QRS Width as Predictors of Event Rates in Patients with Implantable Cardioverter Defibrillators. Southern Medical Journal 98:5, 513-517

  1774. 1774

    Aslan T. Turer, Sunil V. Rao. (2005) Device Therapy in the Management of Congestive Heart Failure. Cardiology in Review 13:3, 130-138

  1775. 1775

    John JV McMurray, Marc A Pfeffer. (2005) Heart failure. The Lancet 365:9474, 1877-1889

  1776. 1776

    Andrea M. Russo, William Sauer, Edward P. Gerstenfeld, Henry H. Hsia, David Lin, Joshua M. Cooper, Sanjay Dixit, Ralph J. Verdino, Hemal M. Nayak, David J. Callans, Vickas Patel, Francis E. Marchlinski. (2005) Defibrillation threshold testing: Is it really necessary at the time of implantable cardioverter-defibrillator insertion?. Heart Rhythm 2:5, 456-461

  1777. 1777

    Paul S. Chan, Rodney A. Hayward. (2005) Mortality Reduction by Implantable Cardioverter-Defibrillators in High-Risk Patients With Heart Failure, Ischemic Heart Disease, and New-Onset Ventricular Arrhythmia. Journal of the American College of Cardiology 45:9, 1474-1481

  1778. 1778

    Krishnaswami Vijayaraghavan, Lawrence Santora, Joel Kahn, Norman Abbott, Julius Torelli, Gil Vardi. (2005) New Graduated Pressure Regimen for External Counterpulsation Reduces Mortality and Improves Outcomes in Congestive Heart Failure: A Report From the Cardiomedics External Counterpulsation Patient Registry. Congestive Heart Failure 11:3, 147-152

  1779. 1779

    Lilian Kornet, Arnold PG Hoeks, Ben JA Janssen, Alphons J Houben, Peter W De Leeuw, Robert S Reneman. (2005) Neural activity of the cardiac baroreflex decreases with age in normotensive and hypertensive subjects. Journal of Hypertension 23:4, 815-823

  1780. 1780

    Andrea Di Cori, Maria Grazia Bongiorni, Giuseppe Arena, Ezio Soldati, Gabriele Giannola, Giulio Zucchelli, Alberto Balbarini. (2005) New-Onset Ventricular Tachycardia After Cardiac Resynchronization Therapy. Journal of Interventional Cardiac Electrophysiology 12:3, 231-235

  1781. 1781

    Gerald V. Naccarelli, Mary Ann Lukas. (2005) Carvedilol's antiarrhythmic properties: Therapeutic implications in patients with left ventricular dysfunction. Clinical Cardiology 28:4, 165-173

  1782. 1782

    HIROSHI WATANABE, MASAOMI CHINUSHI, TAKASHI WASHIZUKA, HIROTAKA SUGIURA, TAKASHI HIRONO, SATORU KOMURA, YUKIO HOSAKA, YASUTAKA TANABE, HIROSHI FURUSHIMA, SATOSHI FUJITA, KIMINORI KATO, YOSHIFUSA AIZAWA. (2005) Electrophysiologic Study-Guided Therapy with Sotalol for Life-Threatening Ventricular Tachyarrhythmias. Pacing and Clinical Electrophysiology 28:4, 285-290

  1783. 1783

    Anne B Curtis. (2005) Do implantable cardioverter-defibrillators benefit patients immediately after acute myocardial infarction?. Nature Clinical Practice Cardiovascular Medicine 2:4, 192-193

  1784. 1784

    JONATHAN S. STEINBERG, AVI FISCHER, PAUL WANG, CLAUDIO SCHUGER, JAMES DAUBERT, SCOTT MCNITT, MARK ANDREWS, MARY BROWN, W. JACKSON HALL, WOJCIECH ZAREBA, ARTHUR J. MOSS, . (2005) The Clinical Implications of Cumulative Right Ventricular Pacing in the Multicenter Automatic Defibrillator Trial II. Journal of Cardiovascular Electrophysiology 16:4, 359-365

  1785. 1785

    Hugh Calkins. (2005) Risk stratification in postmyocardial infarction patients: Is there reason to hope?. Heart Rhythm 2:4, 365-366

  1786. 1786

    S. Serge Barold, Bengt Herweg, Michael O. Sweeney. (2005) Minimizing right ventricular pacing. The American Journal of Cardiology 95:8, 966-969

  1787. 1787

    G. Klein, T. Korte. (2005) Differentialdiagnose Synkope. Intensivmedizin + Notfallmedizin 42:3, 290-298

  1788. 1788

    (2005) K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. American Journal of Kidney Diseases 45, 16-153

  1789. 1789

    (2005) Implantable Cardioverter–Defibrillator Therapy after Myocardial Infarction. New England Journal of Medicine 352:10, 1039-1041
    Free Full Text

  1790. 1790

    J. HOLLENBERG, A. BANG, J. LINDQVIST, J. HERLITZ, R. NORDLANDER, L. SVENSSON, M. ROSENQVIST. (2005) Difference in survival after out-of-hospital cardiac arrest between the two largest cities in Sweden: a matter of time?. Journal of Internal Medicine 257:3, 247-254

  1791. 1791

    Timothy D. Brennan, Garrie J. Haas. (2005) The role of prophylactic implantable cardioverter defibrillators in heart failure: Recent trials usher in a new era of device therapy. Current Heart Failure Reports 2:1, 40-45

  1792. 1792

    D. Bcker, R. Gradaus. (2005) Kardiale Resynchronisationstherapie und Arrhythmien. Herzschrittmachertherapie & Elektrophysiologie 16:1, 28-31

  1793. 1793

    William H Maisel. (2005) Cardiovascular Device Development: Lessons Learned from Pacemaker and Implantable Cardioverter-Defibrillator Therapy. American Journal of Therapeutics 12:2, 183-185

  1794. 1794

    Robert P Giugliano, Eugene Braunwald. (2005) 2004 ACC/AHA guideline for the management of patients with STEMI: the implications for clinicians. Nature Clinical Practice Cardiovascular Medicine 2:3, 114-115

  1795. 1795

    Eric J. Rashba. (2005) Should T-wave alternans testing be used to risk stratify candidates for prophylactic implantable cardioverter-defibrillator therapy?. Heart Rhythm 2:3, 242-244

  1796. 1796

    Sanjiv M. Narayan, Joseph M. Smith, Kenneth B. Schechtman, Bruce D. Lindsay, Michael E. Cain. (2005) T-wave alternans phase following ventricular extrasystoles predicts arrhythmia-free survival. Heart Rhythm 2:3, 234-241

  1797. 1797

    Eyal Herzog, Cathleen Varley, Marrick Kukin. (2005) Pathway for the Management of Acute Heart Failure. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 4:1, 37-42

  1798. 1798

    Chris Baessler, Sheryl Murphy, Laura Gebhardt, Trevor Tso, Kenneth Ellenbogen, Robert Leman. (2005) Time to resumption of driving after implantation of an automatic defibrillator (from the Dual chamber and VVI Implantable Defibrillator [DAVID] trial). The American Journal of Cardiology 95:5, 665-666

  1799. 1799

    B. Lemke. (2005) Aktuelle Leitlinien. Herzschrittmachertherapie & Elektrophysiologie 16:1, 38-43

  1800. 1800

    G. Frhlig. (2005) Besonderheiten der Nachsorge nach kardialer Resynchronisationstherapie. Herzschrittmachertherapie & Elektrophysiologie 16:1, 44-57

  1801. 1801

    MARK H. SCHOENFELD, DWIGHT W. REYNOLDS. (2005) Sophisticated Remote Implantable Cardioverter-Defibrillator Follow-Up: A Status Report. Pacing and Clinical Electrophysiology 28:3, 235-240

  1802. 1802

    Peter Cram, Sandeep Vijan, David Katz, A. Mark Fendrick. (2005) Cost-effectiveness of In-home Automated External Defibrillators for Individuals at Increased Risk of Sudden Cardiac Death. There's No Place Like Home?. Journal of General Internal Medicine 20:3, 251-258

  1803. 1803

    Steven Higgins, David Mann, Hugh Calkins, N.A.Mark Estes, S.Adam Strickberger, David Breiter, Douglas Lang, Stephen Hahn. (2005) One conversion of ventricular fibrillation is adequate for implantable cardioverter-defibrillator implant: An analysis from the Low Energy Safety Study (LESS). Heart Rhythm 2:2, 117-122

  1804. 1804

    John McMurray, Lars Køber, Michele Robertson, Henry Dargie, Wilson Colucci, Jose Lopez-Sendon, Willem Remme, D. Norman Sharpe, Ian Ford. (2005) Antiarrhythmic effect of carvedilol after acute myocardial infarction. Journal of the American College of Cardiology 45:4, 525-530

  1805. 1805

    MICHAEL O. SWEENEY, MARK H. SCHOENFELD, DAVID S. CANNOM. (2005) Rules of Evidence:. CMS and Primary Prevention of Sudden Cardiac Death in Systolic Heart Failure. Pacing and Clinical Electrophysiology 28:2, 81-88

  1806. 1806

    Audrey H. Wu, Keith D. Aaronson, Steven F. Bolling, Francis D. Pagani, Kathy Welch, Todd M. Koelling. (2005) Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. Journal of the American College of Cardiology 45:3, 381-387

  1807. 1807

    CECILIA FANTONI, MIHOKO KAWABATA, RAIMONDO MASSARO, FRANCOIS REGOLI, SANTI RAFFA, VANITA ARORA, JORGE A. SALERNO-URIARTE, HELMUT U. KLEIN, ANGELO AURICCHIO. (2005) Right and Left Ventricular Activation Sequence in Patients with Heart Failure and Right Bundle Branch Block: A Detailed Analysis Using Three-Dimensional Non-Fluoroscopic Electroanatomic Mapping System. Journal of Cardiovascular Electrophysiology 16:2, 112-119

  1808. 1808

    Amit B. Guttigoli, Brian F. Wilner, Kenneth M. Stein, Steven M. Markowitz, Sei Iwai, Bindi K. Shah, Ravi K. Yarlagadda, Bruce B. Lerman, Suneet Mittal. (2005) Usefulness of prolonged QRS duration to identify high-risk ischemic cardiomyopathy patients with syncope and inducible ventricular tachycardia. The American Journal of Cardiology 95:3, 391-394

  1809. 1809

    Kathy A. Hodgkinson, Patrick S. Parfrey, Anne S. Bassett, Christine Kupprion, Jörg Drenckhahn, Mark W. Norman, Ludwig Thierfelder, Susan N. Stuckless, Elizabeth L. Dicks, William J. McKenna, Sean P. Connors. (2005) The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5). Journal of the American College of Cardiology 45:3, 400-408

  1810. 1810

    Bardy , Gust H. , Lee , Kerry L. , Mark , Daniel B. , Poole , Jeanne E. , Packer , Douglas L. , Boineau , Robin , Domanski , Michael , Troutman , Charles , Anderson , Jill , Johnson , George , McNulty , Steven E. , Clapp-Channing , Nancy , Davidson-Ray , Linda D. , Fraulo , Elizabeth S. , Fishbein , Daniel P. , Luceri , Richard M. , Ip , John H. , . (2005) Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure. New England Journal of Medicine 352:3, 225-237
    Free Full Text

  1811. 1811

    McClellan , Mark B. , Tunis , Sean R. , . (2005) Medicare Coverage of ICDs. New England Journal of Medicine 352:3, 222-224
    Full Text

  1812. 1812

    Kadish , Alan , . (2005) Prophylactic Defibrillator Implantation — Toward an Evidence-Based Approach. New England Journal of Medicine 352:3, 285-287
    Full Text

  1813. 1813

    Gillian A Whalley, Cara A Wasywich, Helen Walsh, Robert N Doughty. (2005) Role of echocardiography in the contemporary management of chronic heart failure. Expert Review of Cardiovascular Therapy 3:1, 51-70

  1814. 1814

    Shahriar Iravanian, Aysha Arshad, Jonathan S. Steinberg. (2005) Role of Electrophysiologic Studies, Signal-Averaged Electrocardiography, Heart Rate Variability, T-Wave Alternans, and Loop Recorders for Risk Stratification of Ventricular Arrhythmias. The American Journal of Geriatric Cardiology 14:1, 16-19

  1815. 1815

    Peter Ott. (2005) Cardiac Resynchronization Therapy: A New Therapy for Advanced Congestive Heart Failure. The American Journal of Geriatric Cardiology 14:1, 31-34

  1816. 1816

    Takashi Washizuka, Masaomi Chinushi, Hiroshi Watanabe, Yukio Hosaka, Satoru Komura, Hirotaka Sugiura, Takashi Hirono, Hiroshi Furushima, Yasutaka Tanabe, Yoshifusa Aizawa. (2005) Nifekalant Hydrochloride Suppresses Severe Electrical Storm in Patients With Malignant Ventricular Tachyarrhythmias. Circulation Journal 69:12, 1508-1513

  1817. 1817

    Dominic A.M.J. Theuns, A. Peter J. Klootwijk, Maarten L. Simoons, Luc J. Jordaens. (2005) Clinical variables predicting inappropriate use of implantable cardioverter-defibrillator in patients with coronary heart disease or nonischemic dilated cardiomyopathy. The American Journal of Cardiology 95:2, 271-274

  1818. 1818

    Bertram Pitt. (2005) The Role of Aldosterone Blockade in Patients with Heart Failure. Heart Failure Reviews 10:1, 79-83

  1819. 1819

    Marek Malik. (2005) Repolarization morphology in standard short-term electrocardiogram and cardiac risk stratification. Heart Rhythm 2:1, 79-81

  1820. 1820

    Kaoru Tanno, Fumito Miyoshi, Norikazu Watanabe, Yoshino Minoura, Mitsuharu Kawamura, Syunsho Ryu, Taku Asano, Youichi Kobayashi, Takashi Katagiri. (2005) Are the MADIT II Criteria for ICD Implantation Appropriate for Japanese Patients?. Circulation Journal 69:1, 19-22

  1821. 1821

    Sanjeev Saksena. (2005) Federal Guidelines for Prophylactic ICD Therapy in High Risk Populations for Sudden Cardiac Death: Is this a Necessary Course Correction?. Journal of Interventional Cardiac Electrophysiology 12:1, 5-7

  1822. 1822

    L. Fauchier, H. de Bouët du Portal, C. Giraudeau, S. Froger, P. Cosnay, D. Babuty. (2005) Aspects généraux et réglementaires de la matériovigilance des stimulateurs et des défibrillateurs cardiaques. Annales de Cardiologie et d Angéiologie 54:1, 38

  1823. 1823

    Ronald E. Vlietstra, Arshad Jahangir, Win K. Shen. (2005) Choice of Pacemakers in Patients Aged 75 Years and Older: Ventricular Pacing Mode vs. Dual-Chamber Pacing Mode. The American Journal of Geriatric Cardiology 14:1, 35-38

  1824. 1824

    Sergio Richter, Gabor Duray, Gerian Grönefeld, Carsten W Israel, Stefan H Hohnloser. (2005) Prevention of Sudden Cardiac Death. Circulation Journal 69:6, 625-629

  1825. 1825

    Mamoru Hase, Kazufumi Tsuchihashi, Noriyuki Fujii, Kimio Nishizato, Nobuaki Kokubu, Satoshi Nara, Yoshihiko Kurimoto, Akiyoshi Hashimoto, Kikuya Uno, Tetsuji Miura, Nobuyuki Ura, Yasufumi Asai, Kazuaki Shimamoto. (2005) Early Defibrillation and Circulatory Support Can Provide Better Long-Term Outcomes Through Favorable Neurological Recovery in Patients With Out-of-Hospital Cardiac Arrest of Cardiac Origin. Circulation Journal 69:11, 1302-1307

  1826. 1826

    Kevin J. Ferrick. (2005) Antiarrhythmic Therapy in Elderly Persons: A Device-Based Approach. The American Journal of Geriatric Cardiology 14:1, 10-15

  1827. 1827

    Johnson Francis, Mari A. Watanabe, Georg Schmidt. (2005) Heart Rate Turbulence: A New Predictor for Risk of Sudden Cardiac Death. Annals of Noninvasive Electrocardiology 10:1, 102-109

  1828. 1828

    Eric J. Rashba, Stephen R. Shorofsky, Traci Brown, Robert W. Peters, Michael R. Gold. (2005) Clinical predictors of atrial defibrillation thresholds with a dual-coil, active pectoral lead system. Heart Rhythm 2:1, 49-54

  1829. 1829

    Mevan Wijetunga, S Adam Strickberger. (2005) Cardiac resynchronization therapy for congestive heart failure. Expert Review of Cardiovascular Therapy 3:1, 107-110

  1830. 1830

    Y. Juillière. (2005) Stratification du risque dans l'insuffisance cardiaque chronique. Annales de Cardiologie et d Angéiologie 54:4, 172

  1831. 1831

    ALEXANDER DELVECCHIO, HEATHER A. TRIVEDI, JOHN D. FISHER, SOO G. KIM, KEVIN J. FERRICK, JAY N. GROSS, EUGEN C. PALMA. (2005) Value of Pre-Hospital Discharge Defibrillation Testing in Recipients of Implanted Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 28:s1, S260-S262

  1832. 1832

    C. Leclercq. (2005) La resynchronisation cardiaque : quel type d’appareil utiliser ?. Annales de Cardiologie et d Angéiologie 54:1, 12

  1833. 1833

    Ketil Lunde, Svein Solheim, Svend Aakhus, Harald Arnesen, Michael Abdelnoor, Kolbjørn Forfang. (2005) Autologous stem cell transplantation in acute myocardial infarction: The ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects. Scandinavian Cardiovascular Journal 39:3, 150-158

  1834. 1834

    John E. Madias, Ramin Ashtiani, Himanshu Agarwal, Virenjan K. Narayan, Moethu Win, Anjan Sinha. (2005) Diagnosis of Ventricular Aneurysm and Other Severe Segmental Left Ventricular Dysfunction Consequent to a Myocardial Infarction in the Presence of Right Bundle Branch Block: ECG Correlates of a Positive Diagnosis Made via Echocardiography and/or Contrast Ventriculography. Annals of Noninvasive Electrocardiology 10:1, 53-59

  1835. 1835

    WOLFRAM GRIMM, MICHAEL CHRIST, JULIA SHARKOVA, BERNHARD MAISCH. (2005) Arrhythmia Risk Prediction in Idiopathic Dilated Cardiomyopathy Based on Heart Rate Variability and Baroreflex Sensitivity. Pacing and Clinical Electrophysiology 28:s1, S202-S206

  1836. 1836

    DAN WICHTERLE, JAN ŠIMEK, JOHN CAMM, MAREK MALIK. (2005) Predictive Characteristics of Holter-Based Postinfarction Risk Stratifiers Appear Superior to Electrophysiological Testing. Pacing and Clinical Electrophysiology 28:s1, S182-S186

  1837. 1837

    LAURENT FAUCHIER, NICOLAS SADOUL, CLAUDE KOUAKAM, FLORENT BRIAND, MICHEL CHAUVIN, DOMINIQUE BABUTY, JACQUES CLEMENTY. (2005) Potential Cost Savings by Telemedicine-Assisted Long-Term Care of Implantable Cardioverter Defibrillator Recipients. Pacing and Clinical Electrophysiology 28:s1, S255-S259

  1838. 1838

    Gillis , Anne M. , . (2004) Prophylactic Implantable Cardioverter–Defibrillators after Myocardial Infarction — Not for Everyone. New England Journal of Medicine 351:24, 2540-2542
    Full Text

  1839. 1839

    Jauhar , Sandeep , Slotwiner , David J. , . (2004) The Economics of ICDs. New England Journal of Medicine 351:24, 2542-2544
    Full Text

  1840. 1840

    Hohnloser , Stefan H. , Kuck , Karl Heinz , Dorian , Paul , Roberts , Robin S. , Hampton , John R. , Hatala , Robert , Fain , Eric , Gent , Michael , Connolly , Stuart J. , . (2004) Prophylactic Use of an Implantable Cardioverter–Defibrillator after Acute Myocardial Infarction. New England Journal of Medicine 351:24, 2481-2488
    Free Full Text

  1841. 1841

    Dominic A.M.J. Theuns, A. Peter J. Klootwijk, Dick M. Goedhart, Luc J.L.M. Jordaens. (2004) Prevention of inappropriate therapy in implantable cardioverter-defibrillators. Journal of the American College of Cardiology 44:12, 2362-2367

  1842. 1842

    CYNTHIA M. DOUGHERTY, FRANCES MARCUS LEWIS, ELAINE ADAMS THOMPSON, JUSTIN D. BAER, WOOKSOO KIM. (2004) Short-Term Efficacy of a Telephone Intervention by Expert Nurses After An Implantable Cardioverter Defibrillator. Pacing and Clinical Electrophysiology 27:12, 1594-1602

  1843. 1843

    David S. Schreibman, Craig A. McPherson, Lynda E. Rosenfeld, William P. Batsford, Rachel Lampert. (2004) Usefulness of procainamide challenge for electrophysiologic arrhythmia risk stratification. The American Journal of Cardiology 94:11, 1435-1438

  1844. 1844

    YADAVENDRA S. RAJAWAT, VICKAS V. PATEL, EDWARD P. GERSTENFELD, HEMAL NAYAK, FRANCIS E. MARCHLINSKI. (2004) Advantages and Pitfalls of Combining Device-Based and Pharmacologic Therapies for the Treatment of Ventricular Arrhythmias:. Observations from a Tertiary Referral Center. Pacing and Clinical Electrophysiology 27:12, 1670-1681

  1845. 1845

    Kumaraswamy Nanthakumar, Andrew E. Epstein, G. Neal Kay, Vance J. Plumb, Douglas S. Lee. (2004) Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction. Journal of the American College of Cardiology 44:11, 2166-2172

  1846. 1846

    Wojciech Zareba. (2004) Implantable cardioverter defibrillator therapy in postinfarction patients. Current Opinion in Cardiology 19:6, 619-624

  1847. 1847

    Robert M. Lobel, Daniel L. Lustgarten. (2004) Treatment of arrhythmias in patients with congestive heart failure. Current Treatment Options in Cardiovascular Medicine 6:6, 519-529

  1848. 1848

    John C Somberg, Janos Molnar. (2004) The Pharmacologic Treatment of Heart Failure. American Journal of Therapeutics 11:6, 480-488

  1849. 1849

    Lofty L. Basta. (2004) End-of-Life Medical Treatment of Older Cardiac Patients. The American Journal of Geriatric Cardiology 13:6, 313-315

  1850. 1850

    Arthur J. Moss. (2004) The heart does not have Alzheimer's disease. Journal of the American College of Cardiology 44:9, 1889-1890

  1851. 1851

    Peter A McCullough. (2004) Cardiovascular disease in chronic kidney disease from a cardiologistʼs perspective. Current Opinion in Nephrology and Hypertension 13:6, 591-600

  1852. 1852

    H.J Kaup, M Hexamer, J Werner. (2004) Morphological detection algorithms for the automatic implantable cardioverter/ defibrillator (AICD) / Morphologische Detektionsalgorithmen für den automatischen implantierbaren Kardioverter/Defibrillator (AICD). Biomedizinische Technik/Biomedical Engineering 49:11, 306-310

  1853. 1853

    Maher Nahlawi, Michael Waligora, Stewart M. Spies, Robert O. Bonow, Alan H. Kadish, Jeffrey J. Goldberger. (2004) Left ventricular function during and after right ventricular pacing. Journal of the American College of Cardiology 44:9, 1883-1888

  1854. 1854

    W. S. Aronow. (2004) Management of the Elderly Person After Myocardial Infarction. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 59:11, 1173-1185

  1855. 1855

    Hanne Elming, Bente Brendorp, Steen Pehrson, Ole Dyg Pedersen, Lars Køber, Christian Torp-Petersen. (2004) A benefit–risk assessment of class III antiarrhythmic agents. Expert Opinion on Drug Safety 3:6, 559-577

  1856. 1856

    Richard Balasubramaniam, Sangeeta Chawla, Lauren Mackenzie, Christof J. Schwiening, Andrew A. Grace, Christopher L.-H. Huang. (2004) Nifedipine and diltiazem suppress ventricular arrhythmogenesis and calcium release in mouse hearts. Pflgers Archiv - European Journal of Physiology 449:2, 150-158

  1857. 1857

    Bruce D. Gunderson, Amisha S. Patel, Chad A. Bounds, Richard K. Shepard, Mark A. Wood, Kenneth A. Ellenbogen. (2004) An algorithm to predict implantable cardioverter-defibrillator lead failure. Journal of the American College of Cardiology 44:9, 1898-1902

  1858. 1858

    Velislav N. Batchvarov, Katerina Hnatkova, Jan Poloniecki, A. John Camm, Marek Malik. (2004) Prognostic value of heterogeneity of ventricular repolarization in survivors of acute myocardial infarction. Clinical Cardiology 27:11, 653-659

  1859. 1859

    T.Jared Bunch, Roger D. White, G.Keith Bruce, Stephen C. Hammill, Bernard J. Gersh, Win-Kuang Shen, Mathew A. Carter, Douglas L. Packer. (2004) Prediction of short- and long-term outcomes by electrocardiography in survivors of out-of-hospital cardiac arrest. Resuscitation 63:2, 137-143

  1860. 1860

    GERALD V. NACCARELLI. (2004) Can We Predict Antiarrhythmic Efficacy or Inefficacy of Amiodarone or Any Other Antiarrhythmic? What This Patient Needs Is a Doctor!. Journal of Cardiovascular Electrophysiology 15:10, 1155-1156

  1861. 1861

    H.-P. Hermann, G. Hasenfuss. (2004) Therapie der Herzinsuffizienz. Intensivmedizin und Notfallmedizin 41:7, 451-464

  1862. 1862

    Mark C. Haigney, Wojciech Zareba, Philip J. Gentlesk, Robert E. Goldstein, Michael Illovsky, Scott McNitt, Mark L. Andrews, Arthur J. Moss. (2004) QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. Journal of the American College of Cardiology 44:7, 1481-1487

  1863. 1863

    Arash Rashidi, Dale S. Adler. (2004) Brain natriuretic peptide as a predictor of sudden cardiac death in patients with myocardial infarction. Journal of the American College of Cardiology 44:7, 1528-1529

  1864. 1864

    Robyn L. Walker, Karen A. Campbell, Samuel F. Sears, Beth A. Glenn, Rebecca Sotile, Anne B. Curtis, Jamie B. Conti. (2004) Women and the implantable cardioverter defibrillator: A lifespan perspective on key psychosocial issues. Clinical Cardiology 27:10, 543-546

  1865. 1865

    Carlos A. Morillo, Adrián Baranchuk. (2004) Current management of syncope: Treatment alternatives. Current Treatment Options in Cardiovascular Medicine 6:5, 371-383

  1866. 1866

    Arthur J. Moss. (2004) Noninvasive Electrocardiology Has Come of Age. Annals of Noninvasive Electrocardiology 9:4, 307-308

  1867. 1867

    Jill Vesty, Kismet D. Rasmusson, Jill Hall, Sandy Schmitz, Sally Brush. (2004) Cardiac Resynchronization Therapy and Automatic Implantable Cardiac Defibrillators in the Treatment of Heart Failure: A Review Article. Journal of the American Academy of Nurse Practitioners 16:10, 441-450

  1868. 1868

    MANINDER S. BEDI, LISA A. POSTAVA, SRINIVAS MURALI, GUY A. MACGOWAN, MICHAEL MATHIER, DENNIS M. MCNAMARA, BARRY LONDON. (2004) Interaction of Implantable Defibrillator Therapy with Angiotensin-Converting Enzyme Deletion/Insertion Polymorphism. Journal of Cardiovascular Electrophysiology 15:10, 1162-1166

  1869. 1869

    Heather M. Ross, Dusan Z. Kocovic. (2004) Cardiac resynchronization therapy for heart failure. Current Treatment Options in Cardiovascular Medicine 6:5, 365-370

  1870. 1870

    Roy M. John. (2004) Sudden cardiac death. Current Treatment Options in Cardiovascular Medicine 6:5, 347-355

  1871. 1871

    Philip B. Adamson, William T. Abraham, Charles Love, Dwight Reynolds. (2004) The evolving challenge of chronic heart failure management. Journal of the American College of Cardiology 44:7, 1354-1357

  1872. 1872

    Shrikanth P.Y. Upadya, Artyom Sedrakyan, Clara Saldarriaga, Karin Nystrom, Janis Bozzo, Forrester A. Lee, Stuart D. Katz. (2004) Comparative costs of home positive inotropic infusion versus in-hospital care in patients awaiting cardiac transplantation. Journal of Cardiac Failure 10:5, 384-389

  1873. 1873

    Abrar H. Shah, David T. Huang, Spencer Z. Rosero, James P. Daubert. (2004) Update on implantable cardioverter defibrillator trials. Current Cardiology Reports 6:5, 327-332

  1874. 1874

    ANNE B. CURTIS. (2004) Prevention of Sudden Cardiac Death:. When Is a Woman Just Like a Man?. Journal of Cardiovascular Electrophysiology 15:9, 999-1001

  1875. 1875

    Anne B. Curtis, Kenneth A. Ellenbogen, Stephen C. Hammill, David L. Hayes, Dwight W. Reynolds, David J. Wilber, Michael E. Cain. (2004) Clinical competency statement: Training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices. Heart Rhythm 1:3, 371-375

  1876. 1876

    BRUCE L. WILKOFF, MIKE HESS, JAMES YOUNG, WILLIAM T. ABRAHAM. (2004) Differences in Tachyarrhythmia Detection and Implantable Cardioverter Defibrillator Therapy by Primary or Secondary Prevention Indication in Cardiac Resynchronization Therapy Patients. Journal of Cardiovascular Electrophysiology 15:9, 1002-1009

  1877. 1877

    BRIAN F. MCBRIDE, DANETTE GUERTIN, C. MICHAEL WHITE, JEFFREY KLUGER. (2004) Inappropriate Implantable Cardioverter Defibrillator Discharge Following Consumption of a Dietary Weight Loss Supplement. Pacing and Clinical Electrophysiology 27:9, 1317-1320

  1878. 1878

    Sidney Goldstein. (2004) The changing epidemiology of sudden death in heart failure. Current Heart Failure Reports 1:3, 93-97

  1879. 1879

    ANDREA M. RUSSO, NICHOLAS J. STAMATO, MICHAEL H. LEHMANN, GAIL E. HAFLEY, KERRY L. LEE, KAREN PIEPER, ALFRED E. BUXTON, . (2004) Influence of Gender on Arrhythmia Characteristics and Outcome in the Multicenter UnSustained Tachycardia Trial. Journal of Cardiovascular Electrophysiology 15:9, 993-998

  1880. 1880

    Samuel F. Sears, Eva R. Serber, Tara Saia Lewis, Robyn L. Walker, Nancy Conners, John T. Lee, Anne B. Curtis, Jamie B. Conti. (2004) Do Positive Health Expectations and Optimism Relate to Quality-of-Life Outcomes for the Patient With an Implantable Cardioverter Defibrillator?. Journal of Cardiopulmonary Rehabilitation 24:5, 324-331

  1881. 1881

    Steven Kang, David S. Cannom. (2004) Current role of device therapy to reduce sudden cardiac death in heart failure. Current Heart Failure Reports 1:3, 104-110

  1882. 1882

    Sri Sundaram, Jeffrey J. Goldberger. (2004) Risk stratification and epidemiology of sudden death. Current Cardiology Reports 6:5, 333-338

  1883. 1883

    T.Jared Bunch, Roger D. White, Paul A. Friedman, Thomas E. Kottke, Lambert A. Wu, Douglas L. Packer. (2004) Trends in treated ventricular fibrillation out-of-hospital cardiac arrest: A 17-year population-based study. Heart Rhythm 1:3, 255-259

  1884. 1884

    Hein J.J. Wellens. (2004) Cardiac arrhythmias: The quest for a cure. Journal of the American College of Cardiology 44:6, 1155-1163

  1885. 1885

    Tomasz Siminiak, Ryszard Kalawski, Dorota Fiszer, Olga Jerzykowska, Janusz Rzeźniczak, Natalia Rozwadowska, Maciej Kurpisz. (2004) Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: Phase I clinical study with 12 months of follow-up. American Heart Journal 148:3, 531-537

  1886. 1886

    Liviu Klein, Mihai Gheorghiade. (2004) Coronary artery disease and prevention of heart failure. Medical Clinics of North America 88:5, 1209-1235

  1887. 1887

    Leonard I. Ganz. (2004) Primary prevention of sudden cardiac death. Current Cardiology Reports 6:5, 339-347

  1888. 1888

    Merritt H. Raitt. (2004) Have increasing rates of defibrillator implantation reduced the incidence of out-of-hospital cardiac arrest?. Heart Rhythm 1:3, 260-261

  1889. 1889

    Susan C. Brozena, Carol Twomey, Lee R. Goldberg, Shashank S. Desai, Brian Drachman, Andrew Kao, Eric Popjes, Ross Zimmer, Mariell Jessup. (2004) A prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home. The Journal of Heart and Lung Transplantation 23:9, 1082-1086

  1890. 1890

    Islam Bolad, Carolyne MacLellan, Sree Karanam, Florence Parrella, Gregory Michaud, Richard D'Agostino, David Shahian, Roy John, David Martin. (2004) Effectiveness of early implantation of cardioverter defibrillator for postoperative ventricular tachyarrhythmia. The American Journal of Cardiology 94:3, 376-378

  1891. 1891

    ANDREW E. EPSTEIN. (2004) Jumping in Before the Water Is Hot:. Journal of Cardiovascular Electrophysiology 15:8, 867-869

  1892. 1892

    JOHN R. PAISEY, ARTHUR M. YUE, FREDERICK BESSOULE, STUART ALLEN, PAUL R. ROBERTS, JOHN M. MORGAN. (2004) Examination of a Middle Cardiac Vein Defibrillation Coil as Stand-Alone Anode, Auxiliary Anode, and Bystander Electrode in a Transvenous Defibrillation Circuit. Pacing and Clinical Electrophysiology 27:8, 1089-1093

  1893. 1893

    Béatrice Brembilla-Perrot, Christine Suty-Selton, Daniel Beurrier, Pierre Houriez, Marc Nippert, Arnaud Terrier de la Chaise, Pierre Louis, Olivier Claudon, Marius Andronache, Ahmed Abdelaah, Nicolas Sadoul, Yves Juillière. (2004) Differences in Mechanisms and Outcomes of Syncope in Patients With Coronary Disease or Idiopathic Left Ventricular Dysfunction as Assessed by Electrophysiologic Testing. Journal of the American College of Cardiology 44:3, 594-601

  1894. 1894

    VITHIDA SUEBLINVONG, MARC OVADIA. (2004) Defibrillator for Primary Prevention in Congenital Heart Disease. Pacing and Clinical Electrophysiology 27:8, 1167-1169

  1895. 1895

    LEONARD GANZ. (2004) Mechanisms of Ventricular Tachycardia Induction. Journal of Cardiovascular Electrophysiology 15:8, 908-910

  1896. 1896

    S SHAH. (2004) Highlights from the American College of Cardiology Annual Scientific Sessions 2004: March 9?12, 2004. American Heart Journal 148:2, 254-262

  1897. 1897

    Arthur J Moss, Anant Vyas, Henry Greenberg, Robert B Case, Wojciech Zareba, W.Jackson Hall, Mary W Brown, Scott A McNitt, Mark L Andrews. (2004) Temporal aspects of improved survival with the implanted defibrillator (MADIT-II). The American Journal of Cardiology 94:3, 312-315

  1898. 1898

    CENGIZ ERMIS, KEITH G. LURIE, ALAN X. ZHU, JOANNE COLLINS, LAURA VANHEEL, SCOTT SAKAGUCHI, FEI LU, SCOTT PHAM, DAVID G. BENDITT. (2004) Biventricular Implantable Cardioverter Defibrillators Improve Survival Compared with Biventricular Pacing Alone in Patients with Severe Left Ventricular Dysfunction. Journal of Cardiovascular Electrophysiology 15:8, 862-866

  1899. 1899

    Peter Ammann, Hanspeter Brunner-La Rocca, Thomas Fehr, Thomas Mnzer, Markus Sagmeister, Walter Angehrn, Hans Rickli. (2004) Coronary anatomy and left ventricular ejection fraction in patients with type 2 diabetes admitted for elective coronary angiography. Catheterization and Cardiovascular Interventions 62:4, 432-438

  1900. 1900

    Olaf Hedrich, Mark Jacob, Paul J. Hauptman. (2004) Progression of coronary artery disease in non-ischemic dilated cardiomyopathy. Coronary Artery Disease 15:5, 291-297

  1901. 1901

    Peter A McCullough. (2004) Opportunities for improvement in the cardiovascular care of patients with end-stage renal disease. Advances in Chronic Kidney Disease 11:3, 294-303

  1902. 1902

    Tom D.J Smilde, Hans L Hillege, Adriaan A Voors, Peter H.J Dunselman, Dirk J van Veldhuisen. (2004) Prognostic importance of renal function in patients with early heart failure and mild left ventricular dysfunction. The American Journal of Cardiology 94:2, 240-243

  1903. 1903

    S.Adam Strickberger, George J Klein. (2004) Is defibrillation testing required for defibrillator implantation?. Journal of the American College of Cardiology 44:1, 88-91

  1904. 1904

    Amy N Solan, Merrill J Solan, Greg Bednarz, Michael B Goodkin. (2004) Treatment of patients with cardiac pacemakers and implantable cardioverter-defibrillators during radiotherapy. International Journal of Radiation Oncology*Biology*Physics 59:3, 897-904

  1905. 1905

    Rajan Krishnamani, David DeNofrio. (2004) Device therapy for the management of advanced heart failure. Expert Review of Cardiovascular Therapy 2:4, 573-580

  1906. 1906

    Julia H Indik. (2004) The evolution and revolution of the implantable cardioverter defibrillator. Expert Review of Cardiovascular Therapy 2:4, 461-464

  1907. 1907

    F. JAMES BRENNAN. (2004) Ethical Issues with Implantable Defibrillators. Pacing and Clinical Electrophysiology 27:7, 897-898

  1908. 1908

    Gerald V Naccarelli. (2004) Implantable cardioverter-defibrillators: expanding indications. Current Opinion in Cardiology 19:4, 317-322

  1909. 1909

    Alexander Berkowitsch, Wojciech Zareba, Thomas Neumann, Ali Erdogan, Scott Mc Nitt, Arthur J. Moss, Heinz F. Pitschner. (2004) Risk Stratification Using Heart Rate Turbulence and Ventricular Arrhythmia in MADIT II: Usefulness and Limitations of a 10-Minute Holter Recording. Annals of Noninvasive Electrocardiology 9:3, 270-279

  1910. 1910

    Mitchell I Cohen, Larry A Rhodes, Thomas L Spray, J.William Gaynor. (2004) Efficacy of prophylactic epicardial pacing leads in children and young adults. The Annals of Thoracic Surgery 78:1, 197-202

  1911. 1911

    Terrence UH Chun, Kathryn K Collins, Anne M Dubin. (2004) Implantable cardioverter defibrillators in children. Expert Review of Cardiovascular Therapy 2:4, 561-571

  1912. 1912

    Vincent Dor. (2004) Left ventricular reconstruction: The aim and the reality after twenty years. The Journal of Thoracic and Cardiovascular Surgery 128:1, 17-20

  1913. 1913

    Nanette K. Wenger, Gabriel Gregoratos, Dalane W. Kitzman, Stephen Scheidt, Michael A. Weber, Joseph S. Alpert. (2004) Guidelines of the Cardiogeriatrics Department of the Brazilian Cardiology Society: Commentary by Editorial Board Members of The American Journal of Geriatric Cardiology. CARDIAC ARRHYTHMIAS. HEART FAILURE. CORONARY ARTERY DISEASE (CHRONIC STABLE ANGINA, ACUTE CORONARY SYNDROME, ACUTE MI). SYSTEMIC ARTERIAL HYPERTENSION. VALVULOPATHIES. CARDIOVASCULAR RISK PREVENTION. The American Journal of Geriatric Cardiology 13:4, 209-209

  1914. 1914

    RAKESH K. PAI, STEVEN A. PERGAM, ANITA KEDIA, CHRISTOPHER S. CADMAN, LARRY A. OSBORN. (2004) Pacemaker Lead Infection Secondary to Haemophilus Parainfluenzae. Pacing and Clinical Electrophysiology 27:7, 1008-1010

  1915. 1915

    Harald P Kühl, Marcus Schreckenberg, Dierk Rulands, Markus Katoh, Wolfgang Schäfer, Georg Schummers, Arno Bücker, Peter Hanrath, Andreas Franke. (2004) High-resolution transthoracic real-time three-dimensional echocardiography. Journal of the American College of Cardiology 43:11, 2083-2090

  1916. 1916

    Eric D Peterson, John W Hirshfeld, T.Bruce Ferguson, Judith M Kramer, Robert M Califf, Larry G Kessler. (2004) Part II: sealing holes in the safety net. American Heart Journal 147:6, 985-990

  1917. 1917

    MARK H. SCHOENFELD, STEVEN J. COMPTON, R. HARDWIN MEAD, DANIEL N. WEISS, LOU SHERFESEE, JENNIFER ENGLUND, LUC R. MONGEON. (2004) Remote Monitoring of Implantable Cardioverter Defibrillators:. A Prospective Analysis. Pacing and Clinical Electrophysiology 27:6p1, 757-763

  1918. 1918

    George A. Diamond, Sanjay Kaul. (2004) Prior convictions. Journal of the American College of Cardiology 43:11, 1929-1939

  1919. 1919

    MICHAEL GLIKSON, IGOR LIPCHENCA, SAMI VISKIN, KARLA V. BALLMAN, JANE M. TRUSTY, OSNAT T. GUREVITZ, DAVID M. LURIA, MICHAEL ELDAR, STEPHEN C. HAMMILL, PAUL A. FRIEDMAN. (2004) Long-Term Outcome of Patients Who Received Implantable Cardioverter Defibrillators for Stable Ventricular Tachycardia. Journal of Cardiovascular Electrophysiology 15:6, 658-664

  1920. 1920

    Sarah J. Goodlin, Paul J. Hauptman, Robert Arnold, Kathleen Grady, Ray E. Hershberger, Jean Kutner, Frederick Masoudi, John Spertus, Kathleen Dracup, James F. Cleary, Ruth Medak, Kathy Crispell, Ileana piña, Brad Stuart, Christy Whitney, Thomas Rector, Joan Teno, Dale G. Renlund. (2004) Consensus statement: palliative and supportive care in advanced heart failure. Journal of Cardiac Failure 10:3, 200-209

  1921. 1921

    Gillick , Muriel R. , . (2004) Medicare Coverage for Technological Innovations — Time for New Criteria?. New England Journal of Medicine 350:21, 2199-2203
    Full Text

  1922. 1922

    Kadish , Alan , Dyer , Alan , Daubert , James P. , Quigg , Rebecca , Estes , N.A. Mark , Anderson , Kelley P. , Calkins , Hugh , Hoch , David , Goldberger , Jeffrey , Shalaby , Alaa , Sanders , William E. , Schaechter , Andi , Levine , Joseph H. , . (2004) Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy. New England Journal of Medicine 350:21, 2151-2158
    Free Full Text

  1923. 1923

    Bristow , Michael R. , Saxon , Leslie A. , Boehmer , John , Krueger , Steven , Kass , David A. , De Marco , Teresa , Carson , Peter , DiCarlo , Lorenzo , DeMets , David , White , Bill G. , DeVries , Dale W. , Feldman , Arthur M. , . (2004) Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure. New England Journal of Medicine 350:21, 2140-2150
    Free Full Text

  1924. 1924

    Rogers , Joseph G. , Cain , Michael E. , . (2004) Electromechanical Associations. New England Journal of Medicine 350:21, 2193-2195
    Full Text

  1925. 1925

    P CAWLEY. (2004) Amiodarone versus implantable cardioverter defibrillator for asymptomatic nonsustained ventricular tachycardia in nonischemic dilated cardiomyopathy. American Heart Journal 147:5, 790-791

  1926. 1926

    Andrew D Krahn, Stuart J Connolly, Robin S Roberts, Michael Gent. (2004) Diminishing proportional risk of sudden death with advancing age: implications for prevention of sudden death. American Heart Journal 147:5, 837-840

  1927. 1927

    Francois Philippon. (2004) Cardiac Resynchronization Therapy:. Device-Based Medicine for Heart Failure. Journal of Cardiac Surgery 19:3, 270-274

  1928. 1928

    ANTONIS A. ARMOUNDAS, CHRISTINE M. ALBERT, RICHARD J COHEN, THEOFANIE MELA, . (2004) Utility of Implantable Cardioverter Defibrillator Electrograms to Estimate Repolarization Alternans Preceding a Tachyarrhythmic Event. Journal of Cardiovascular Electrophysiology 15:5, 594-597

  1929. 1929

    JOSEPH JOHN and, GERALD C. KAYE. (2004) Shock Coil Failure Secondary to External Irradiation in a Patient with Implantable Cardioverter Defibrillator. Pacing and Clinical Electrophysiology 27:5, 690-691

  1930. 1930

    Tapan Rami, Hue-Teh Shih. (2004) Update of implantable cardioverter/defibrillator and cardiac resynchronization therapy in heart failure. Current Opinion in Cardiology 19:3, 264-269

  1931. 1931

    Jenny Tagney. (2004) Can nurses in cardiology areas prepare patients for implantable cardioverter defibrillator implant and life at home?. Nursing in Critical Care 9:3, 104-114

  1932. 1932

    JAMES N. WEISS, PENG-SHENG CHEN, TSU-JUEY WU, CARIN SIEGERMAN, ALAN GARFINKEL. (2004) Ventricular Fibrillation: New Insights into Mechanisms. Annals of the New York Academy of Sciences 1015:1, 122-132

  1933. 1933

    T. Jared Bunch, Roger D. White, Bernard J. Gersh, Win-Kuang Shen, Stephen C. Hammill, Douglas L. Packer. (2004) Outcomes and In-hospital Treatment of Out-of-Hospital Cardiac Arrest Patients Resuscitated From Ventricular Fibrillation by Early Defibrillation. Mayo Clinic Proceedings 79:5, 613-619

  1934. 1934

    Charles A. Herzog. (2004) Cardiac Arrest in Dialysis Patients: Taking a Small Step. Seminars in Dialysis 17:3, 184-185

  1935. 1935

    Paul A. Friedman. (2004) Will all postinfarction patients receive defibrillators? Recent trials and expanding indications. International Congress Series 1262, 360-363

  1936. 1936

    Henry Krum, Danny Liew. (2004) Eplerenone in the treatment of chronic heart failure. Expert Review of Cardiovascular Therapy 2:3, 315-320

  1937. 1937

    ANDREW D. KRAHN, GEORGE J. KLEIN, ALLAN C. SKANES, RAYMOND YEE. (2004) Insertable Loop Recorder Use for Detection of Intermittent Arrhythmias. Pacing and Clinical Electrophysiology 27:5, 657-664

  1938. 1938

    Irandi Jayatilleke, Alessandra Doolan, Jodie Ingles, Mark McGuire, Virginia Booth, David R. Richmond, Christopher Semsarian. (2004) Long-term follow-up of implantable cardioverter defibrillator therapy for hypertrophic cardiomyopathy. The American Journal of Cardiology 93:9, 1192-1194

  1939. 1939

    ERIC J. RASHBA. (2004) Assessment of Ventricular Repolarization Abnormalities in Congenital Long QT Syndrome. Journal of Cardiovascular Electrophysiology 15:5, 557-559

  1940. 1940

    DAVID NEWMAN, EUGENE CRYSTAL, BERNARD GOLDMAN. (2004) The Recall Genie:. Time to Go Back in the Bottle. Pacing and Clinical Electrophysiology 27:4, 435-436

  1941. 1941

    Chandra Kunavarapu, Daniel M. Bloomfield. (2004) Role of noninvasive studies in risk stratification for sudden cardiac death. Clinical Cardiology 27:4, 192-197

  1942. 1942

    Shrikanth Upadya, Forrester A Lee, Clara Saldarriaga, Sumit Verma, Artyom Sedrakyan, Karin Nystrom, Stuart D Katz. (2004) Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure. The Journal of Heart and Lung Transplantation 23:4, 466-472

  1943. 1943

    Henry Greenberg, Robert B. Case, Arthur J. Moss, Mary W. Brown, Elizabeth R. Carroll, Mark L. Andrews. (2004) Analysis of mortality events in the multicenter automatic defibrillator implantation trial (MADIT-II). Journal of the American College of Cardiology 43:8, 1459-1465

  1944. 1944

    Douglas P Zipes. (2004) The year in electrophysiology. Journal of the American College of Cardiology 43:7, 1306-1314

  1945. 1945

    (2004) American Heart Journal 147:4, 606-607

  1946. 1946

    Elena Biagini, Tjebbe W Galema, Arend F.L Schinkel, Willem B Vletter, Jos R.T.C Roelandt, Folkert J Ten Cate. (2004) Myocardial wall thickness predicts recovery of contractile function after primary coronary intervention for acute myocardial infarction. Journal of the American College of Cardiology 43:8, 1489-1493

  1947. 1947

    WILLIAM H. MAISEL. (2004) Physician Management of Pacemaker and Implantable Cardioverter Defibrillator Advisories. Pacing and Clinical Electrophysiology 27:4, 437-442

  1948. 1948

    B BREMBILLAPERROT. (2004) La syncope change-t-elle les rsultats de la stimulation ventriculaire programme chez les patients ayant un antcdent d?infarctus du myocardeB?. Annales de Cardiologie et d?Angiologie 53:2, 66-70

  1949. 1949

    Eldrin F. Lewis, Sui W. Tsang, James C. Fang, Gilbert H. Mudge, John A. Jarcho, Carol M. Flavell, Anju Nohria, Michael M. Givertz, Gregory S. Couper, John G. Byrne, Lynne Warner Stevenson. (2004) Frequency and impact of delayed decisions regarding heart transplantation on long-term outcomes in patients with advanced heart failure. Journal of the American College of Cardiology 43:5, 794-802

  1950. 1950

    WILLIAM J. GROH, DEEPAK BHAKTA, MIRIAM R. LOWE, SUSAN J. BENNETT. (2004) Come See the Softer Side of Clinical Outcomes:. Journal of Cardiovascular Electrophysiology 15:3, 292-294

  1951. 1951

    DAVID S. CANNOM, ERIC N. PRYSTOWSKY. (2004) The Evolution of the Implantable Cardioverter Defibrillator. Pacing and Clinical Electrophysiology 27:3, 419-431

  1952. 1952

    Javed Butler, Ghazanfar Khadim, Kimberly M. Paul, Stacy F. Davis, Marvin W. Kronenberg, Don B. Chomsky, Richard N. Pierson, John R. Wilson. (2004) Selection of patients for heart transplantationin the current era of heart failure therapy. Journal of the American College of Cardiology 43:5, 787-793

  1953. 1953

    DAVID S. CANNOM, ERIC N. PRYSTOWSKY. (2004) Evolution of the Implantable Cardioverter Defibrillator. Journal of Cardiovascular Electrophysiology 15:3, 375-385

  1954. 1954

    Silvia G. Priori, Leo L. Bossaert, Douglas A. Chamberlain, Carlo Napolitano, Hans R. Arntz, Rudolph W. Koster, Koen G. Monsieurs, Alessandro Capucci, Hein H. Wellens. (2004) Policy Statement. Resuscitation 60:3, 245-252

  1955. 1955

    Andrew Robert John Mitchell, Philip Anthony Roworth Spurrell, Lana Elizabeth Boodhoo, Neil Sulke. (2004) Long-term care of the patient with the atrial defibrillator. American Heart Journal 147:2, 210-217

  1956. 1956

    Ole A. Breithardt, Christoph Stellbrink. (2004) Current status of cardiac resynchronization therapy. Current Opinion in Anaesthesiology 17:1, 75-83

  1957. 1957

    Philippe Menasché. (2004) Myoblast transfer in heart failure. Surgical Clinics of North America 84:1, 125-139

  1958. 1958

    Chiara Pedone, Francesco Grigioni, Giuseppe Boriani, Carla Lofiego, Pier Luigi Vassallo, Luciano Potena, Fabio Coccolo, Gaia Magnani, Mauro Biffi, Cristian Martignani, Lorenzo Frabetti, Romano Zannoli, Carlo Magelli, Angelo Branzi. (2004) Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation. The American Journal of Cardiology 93:3, 371-373

  1959. 1959

    CARSTEN W. ISRAEL, H. STEFAN, HOHNLOSER. (2004) Electrophysiologic Refinement of Risk Stratification:. Can We Achieve the Goal?. Journal of Cardiovascular Electrophysiology 15:2, 177-178

  1960. 1960

    J. Jason Sims, Michael R. Ujhelyi. (2004) Better Living Through Medical Device Technology. Pharmacotherapy 24:2, 298-306

  1961. 1961

    Glenys A. Hamilton, Diane L. Carroll. (2004) The effects of age on quality of life in implantable cardioverter defibrillator recipients. Journal of Clinical Nursing 13:2, 194-200

  1962. 1962

    ERIC J. RASHBA, AHMED F. OSMAN, KAREN MACMURDY, MALCOLM M. KIRK, SAMANTHA E. SARANG, ROBERT W. PETERS, STEPHEN R. SHOROFSKY, MICHAEL R. GOLD. (2004) Enhanced Detection of Arrhythmia Vulnerability Using T Wave Alternans, Left Ventricular Ejection Fraction, and Programmed Ventricular Stimulation:. A Prospective Study in Subjects with Chronic Ischemic Heart Disease. Journal of Cardiovascular Electrophysiology 15:2, 170-176

  1963. 1963

    Dulce Obias-Manno, Mevan Wijetunga. (2004) Risk Stratification and Primary Prevention of Sudden Cardiac Death. AACN Clinical Issues: Advanced Practice in Acute and Critical Care 15:3, 404-418

  1964. 1964

    Barry D Bertolet. (2004) Precautions for Use and Adverse Effects of Vesnarinone Potential Mechanisms and Future Therapies. Drug Safety 27:Supplement 1, 11-18

  1965. 1965

    Zoran Cosic, Dragan Tavciovski, Aleksandra Jovelic, Radoslav Romanovic. (2004) Late ventricular potentials in risk assessment of the occurrence of complex ventricular arrhythmia in patients with myocardial infarction and heart failure. Vojnosanitetski pregled 61:6, 589-597

  1966. 1966

    Samuel F. Sears, Adrienne H. Kovacs, Jamie B. Conti, Eileen Handberg. (2004) Expanding the Scope of Practice for Cardiac Rehabilitation. Journal of Cardiopulmonary Rehabilitation 24:4, 209-215

  1967. 1967

    Julie B. Shea. (2004) Quality of Life Issues in Patients With Implantable Cardioverter Defibrillators. AACN Clinical Issues: Advanced Practice in Acute and Critical Care 15:3, 478-489

  1968. 1968

    Steven L. Higgins, Sharon G. O'Grady, Isabelle Banville, Fred W. Chapman, Paul W. Schmitt, Paula Lank, Robert G. Walker, Marina Ilina. (2004) E FFICACY OF L OWER-ENERGY B IPHASIC S HOCKS FOR T RANSTHORACIC D EFIBRILLATION : A F OLLOW-UP C LINICAL S TUDY. Prehospital Emergency Care 8:3, 262-267

  1969. 1969

    ANNIE DORE, PATRIZIA SANTAGATA, MARC DUBUC, LISE-ANDREE MERCIER. (2004) Implantable Cardioverter Defibrillators in Adults with Congenital Heart Disease:. A Single Center Experience. Pacing and Clinical Electrophysiology 27:1, 47-51

  1970. 1970

    Rosemary S. Bubien, Elizabeth A. Ching, G. Neal Kay. (2004) Cardiac Defibrillation and Resynchronization Therapies. AACN Clinical Issues: Advanced Practice in Acute and Critical Care 15:3, 340-361

  1971. 1971

    Yoshifusa AIZAWA, Masaomi CHINUSHI, Takashi WASHIZUKA. (2004) Indications for an Implantable Cardioverter Defibrillator (ICD). Internal Medicine 43:5, 360-367

  1972. 1972

    Samuel F. Sears, Adrienne H. Kovacs, Lora Azzarello, Karin Larsen, Jamie B. Conti. (2004) Innovations in Health Psychology: The Psychosocial Care of Adults With Implantable Cardioverter Defibrillators.. Professional Psychology: Research and Practice 35:5, 520-526

  1973. 1973

    Melanie T. Gura, Lynne Foreman. (2004) Cardiac Resynchronization Therapy for Heart Failure Management. AACN Clinical Issues: Advanced Practice in Acute and Critical Care 15:3, 326-339

  1974. 1974

    John Gorcsan, Prasant Pandey, L.Elif Sade. (2004) Influence of hand-carried ultrasound on bedside patient treatment decisions for consultative cardiology. Journal of the American Society of Echocardiography 17:1, 50-55

  1975. 1975

    Andrew E. Epstein. (2004) An update on implantable cardioverter-defibrillator guidelines. Current Opinion in Cardiology 19:1, 23-25

  1976. 1976

    MARK E. ALEXANDER, FRANK CECCHIN, EDWARD P. WALSH, JOHN K. TRIEDMAN, LAURA M. BEVILACQUA, CHARLES I. BERUL. (2004) Implications of Implantable Cardioverter Defibrillator Therapy in Congenital Heart Disease and Pediatrics. Journal of Cardiovascular Electrophysiology 15:1, 72-76

  1977. 1977

    Anne B Curtis. (2004) Filling the need for new antiarrhythmic drugs to prevent shocks from implantable cardioverter defibrillators. Journal of the American College of Cardiology 43:1, 44-46

  1978. 1978

    LOU-ANNE M. BEAUREGARD. (2004) Personal Security:. Clinical Applications of the Wearable Defibrillator. Pacing and Clinical Electrophysiology 27:1, 1-3

  1979. 1979

    XIAOHONG ZHOU, BRUCE D. GUNDERSON, WALTER H. OLSON, . (2004) Incidence of Nonsustained and Sustained Ventricular Tachyarrhythmias in Patients with an Implantable Cardioverter Defibrillator. Journal of Cardiovascular Electrophysiology 15:1, 14-20

  1980. 1980

    Julio Martí Almor, Marta Delclós Baulies, Joaquim Delclós Urgell, Josep Comín Colet, Mercè Cladellas Capdevila, Jordi Bruguera Cortada. (2004) Prevalencia y evolución en España de los pacientes con infarto agudo de miocardio y fracción de eyección severamente deprimida, con criterios de implantación de desfibrilador automático. Revista Española de Cardiología 57:7, 705-708

  1981. 1981

    Antonio Hernández Madrid, Carlos Escobar Cervantes, Blanca Blanco Tirado, Irene Marín Marín, José L. Moya Mur, Concepción Moro. (2004) Resincronización cardíaca en la insuficiencia cardíaca: bases, métodos, indicaciones y resultados. Revista Española de Cardiología 57:7, 680-693

  1982. 1982

    Julián Villacastín, Ramón Bover, Nicasio P. Castellano, Javier Moreno, Ricardo Morales, Arturo García-Espinosa. (2004) Estratificación del riesgo y prevención de la muerte súbita en pacientes con insuficiencia cardíaca. Revista Española de Cardiología 57:8, 768-782

  1983. 1983

    Rajan Krishnamani, Mohamad El-Zaru, David DeNofrio. (2003) Contemporary medical, surgical, and device therapies for end-stage heart failure. Current Treatment Options in Cardiovascular Medicine 5:6, 487-499

  1984. 1984

    ANDREA M. RUSSO, HEMAL NAYAK, RALPH VERDINO, JAMIE SPRINGMAN, EDWARD GERSTENFELD, HENRY HSIA, FRANCIS E. MARCHLINSKI. (2003) Implantable Cardioverter Defibrillator Events in Patients with Asymptomatic Nonsustained Ventricular Tachycardia:. Pacing and Clinical Electrophysiology 26:12, 2289-2295

  1985. 1985

    Eugene Braunwald. (2003) Cardiology: the past, the present, and the future. Journal of the American College of Cardiology 42:12, 2031-2041

  1986. 1986

    DAN M. RODEN. (2003) Antiarrhythmic Drugs:. Pacing and Clinical Electrophysiology 26:12, 2340-2348

  1987. 1987

    DiMarco , John P. , . (2003) Implantable Cardioverter–Defibrillators. New England Journal of Medicine 349:19, 1836-1847
    Full Text

  1988. 1988

    CHIA-TI TSAI, SHOEI K. STEPHEN HUANG, JIUNN-LEE LIN, LING-PING LAI, . (2003) Distinct Clinical Features in the Recipients of the Implantable Cardioverter Defibrillator in Taiwan:. A Multicenter Registry Study. Pacing and Clinical Electrophysiology 26:11, 2083-2090

  1989. 1989

    Barry J. Maron, William J. McKenna, Gordon K. Danielson, Lukas J. Kappenberger, Horst J. Kuhn, Christine E. Seidman, Pravin M. Shah, William H. Spencer, Paolo Spirito, Folkert J. Ten Cate, E.Douglas Wigle, Robert A. Vogel, Jonathan Abrams, Eric R. Bates, Bruce R. Brodie, Peter G. Danias, Gabriel Gregoratos, Mark A. Hlatky, Judith S. Hochman, Sanjiv Kaul, Robert C. Lichtenberg, Jonathan R. Lindner, Robert A. O’rourke, Gerald M. Pohost, Richard S. Schofield, Cynthia M. Tracy, William L. Winters, Werner W. Klein, Silvia G. Priori, Angeles Alonso-Garcia, Carina Blomström-Lundqvist, Guy De Backer, Jaap Deckers, Markus Flather, Jaromir Hradec, Ali Oto, Alexander Parkhomenko, Sigmund Silber, Adam Torbicki. (2003) American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. Journal of the American College of Cardiology 42:9, 1687-1713

  1990. 1990

    Lofty L. Basta. (2003) Routine Implantation of Cardioverter/Defibrillator Devices in Patients Aged 75 Years and Older With Prior Myocardial Infarction and Left Ventricular Ejection Fraction <30: Antagonist Viewpoint. The American Journal of Geriatric Cardiology 12:6, 363-365

  1991. 1991

    Arthur E. Fass. (2003) Perspectives in the Management of Chronic Coronary Artery Disease. Heart Disease 5:6, 365-367

  1992. 1992

    NABIL EL-SHERIF, GIOIA TURITTO. (2003) Risk Stratification and Management of Sudden Cardiac Death:. Journal of Cardiovascular Electrophysiology 14:10, 1113-1119

  1993. 1993

    Michiel J. Janse. (2003) A brief history of sudden cardiac death and its therapy. Pharmacology & Therapeutics 100:1, 89-99

  1994. 1994

    Silvia G. Priori, Massimiliano Grillo. (2003) To the Editor. Journal of Cardiovascular Electrophysiology 14:10, 1131-1133

  1995. 1995

    Eldrin F Lewis, Lemuel A Moye, Jean L Rouleau, Frank M Sacks, J.Malcolm O Arnold, J.Wayne Warnica, Greg C Flaker, Eugene Braunwald, Marc A Pfeffer. (2003) Predictors of late development of heart failure in stable survivors of myocardial infarction. Journal of the American College of Cardiology 42:8, 1446-1453

  1996. 1996

    Andreas Jeron, Tanja Kaiser, Christian Hengstenberg, Hannelore Lowel, Gunter AJ Riegger, Stephan Holmer. (2003) Association of the Heart Rate Turbulence with Classic Risk Stratification Parameters in Postmyocardial Infarction Patients. Annals of Noninvasive Electrocardiology 8:4, 296-301

  1997. 1997

    Tamara Horwich, Seung-Joon Lee, Leslie Saxon. (2003) Usefulness of QRS prolongation in predicting risk of inducible monomorphic ventricular tachycardiain patients referred forelectrophysiologic studies. The American Journal of Cardiology 92:7, 804-809

  1998. 1998

    Vidyasagar Kalahasti, Vijay Nambi, David O Martin, Cathy T Lam, David Yamada, Bruce L Wilkoff, Mark J Niebauer, Fredrick J Jaeger, Patrick J Tchou, Mina K Chung. (2003) QRS duration and prediction of mortality in patients undergoing risk stratification for ventricular arrhythmias. The American Journal of Cardiology 92:7, 798-803

  1999. 1999

    ERIC J. RASHBA, MATT BONNER, JOHN WILSON, STEPHEN R. SHOROFSKY, ROBERT W. PETERS, MICHAEL R. GOLD. (2003) Distal Right Ventricular Coil Position Reduces Defibrillation Thresholds. Journal of Cardiovascular Electrophysiology 14:10, 1036-1040

  2000. 2000

    SVEN REEK, J. CHRISTOPH GELLER, ULF MELTENDORF, ANKE WOLLBRUECK, STEVEN J. SZYMKIEWICZ, HELMUT U. KLEIN. (2003) Clinical Efficacy of a Wearable Defibrillator in Acutely Terminating Episodes of Ventricular Fibrillation Using Biphasic Shocks. Pacing and Clinical Electrophysiology 26:10, 2016-2022

  2001. 2001

    Stephen J. Hahn, Joseph M. Smith. (2003) ICD therapy for the prevention of sudden cardiac death in post-MI patients. Current Treatment Options in Cardiovascular Medicine 5:5, 369-376

  2002. 2002

    B. Hygriv Rao, Sanjeev Saksena. (2003) Implantable cardioverter-defibrillators in cardiovascular care: technologic advances and new indications. Current Opinion in Critical Care 9:5, 362-368

  2003. 2003

    K CRISPELL. (2003) Common cardiovascular issues encountered in geriatric critical care. Critical Care Clinics 19:4, 677-691

  2004. 2004

    Aun-Yeong Chong, Gregory Lip. Treatment of Ventricular Arrhythmias. In: Atherosclerosis and Heart Disease. CRC Press, 2003:191-204.

  2005. 2005

    ARTHUR J. MOSS. (2003) MADIT-I and MADIT-II. Journal of Cardiovascular Electrophysiology 14, S96-S98

  2006. 2006

    Joao A.C. Lima. (2003) Myocardial viability assessment by contrast-enhanced magnetic resonance imaging. Journal of the American College of Cardiology 42:5, 902-904

  2007. 2007

    A. JOHN CAMM. (2003) Translation of Clinical Trials into Clinical Practice:. Journal of Cardiovascular Electrophysiology 14, S9-S14

  2008. 2008

    Elijah R. Behr, William J. McKenna. (2003) Genetic risk for acquired arrhythmia. Trends in Genetics 19:9, 470-473

  2009. 2009

    Marina Roshini Sooriyarachchi, John Whitehead, Kim Bolland, Anne Whitehead. (2003) Incorporating Data Received after a Sequential Trial Has Stopped into the Final Analysis: Implementation and Comparison of Methods. Biometrics 59:3, 701-709

  2010. 2010

    LARRY D. LYND, BERNIE J. O'BRIEN. (2003) Cost-Effectiveness of the Implantable Cardioverter Defibrillator:. Journal of Cardiovascular Electrophysiology 14, S99-S103

  2011. 2011

    Gian Franco Gensini, Antonio Michelucci, Andrea A Conti. (2003) Non-invasive stratification of patients at high risk from coronary disease. The Lancet 362:9387, 921

  2012. 2012

    Etienne J. Pruvot, David S. Rosenbaum. (2003) T-wave alternans for risk stratification and prevention of sudden cardiac death. Current Cardiology Reports 5:5, 350-357

  2013. 2013

    Béatrice Brembilla-Perrot, Hielko Miljoen, Pierre Houriez, Daniel Beurrier, Marc Nippert, Anne Claire Vançon, Arnaud Terrier de la Chaise, Pierre Louis, Laurent Mock, Nicolas Sadoul, Marius Andronache. (2003) Causes and prognosis of cardiac arrest in a population admitted to a general hospital; a diagnostic and therapeutic problem. Resuscitation 58:3, 319-327

  2014. 2014

    Richard F. Wright. (2003) Therapies for preventing heart failure. Current Treatment Options in Cardiovascular Medicine 5:4, 337-343

  2015. 2015

    S.Serge Barold. (2003) Adverse effects of ventricular desynchronization induced by long-term right ventricular pacing. Journal of the American College of Cardiology 42:4, 624-626

  2016. 2016

    Arthur J Moss. (2003) Dead is dead, but can we identify patients at increased risk for sudden cardiac death?. Journal of the American College of Cardiology 42:4, 659-660

  2017. 2017

    Heikki V Huikuri, Jari M Tapanainen, Kai Lindgren, Pekka Raatikainen, Timo H Mäkikallio, K.E Juhani Airaksinen, Robert J Myerburg. (2003) Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. Journal of the American College of Cardiology 42:4, 652-658

  2018. 2018

    James O. O’Neill, Randall C. Starling. (2003) Surgical remodeling in ischemic cardiomyopathy. Current Treatment Options in Cardiovascular Medicine 5:4, 311-319

  2019. 2019

    Philip B. Adamson, William T. Abraham. (2003) Cardiac resynchronization therapy for advanced heart failure. Current Treatment Options in Cardiovascular Medicine 5:4, 301-309

  2020. 2020

    Joshua M. Rosenow, Howard Tarkin, Elias Zias, Carmine Sorbera, Alon Mogilner. (2003) Simultaneous use of bilateral subthalamic nucleus stimulators and an implantable cardiac defibrillator. Journal of Neurosurgery 99:1, 167-169

  2021. 2021

    Antonio Pacifico, Philip D. Henry. (2003) Structural Pathways and Prevention of Heart Failure and Sudden Death. Journal of Cardiovascular Electrophysiology 14:7, 764-774

  2022. 2022

    John Gorcsan. (2003) Utility of Hand-Carried Ultrasound for Consultative Cardiology. Echocardiography 20:5, 463-469

  2023. 2023

    W. H. Wilson Tang, Gary S. Francis. (2003) Trends and Treatment of Heart Failure Developing After Acute Myocardial Infarction. The American Heart Hospital Journal 1:3, 216-218

  2024. 2024

    WALTER F. KERWIN, OFFIR PAZ. (2003) Cardiac Resynchronization Therapy: Overcoming Ventricular Dyssynchrony in Dilated Heart Failure. Cardiology in Review 11:4, 221-239

  2025. 2025

    Arthur J. Moss. (2003) Correcting Misconceptions. Annals of Noninvasive Electrocardiology 8:3, 177-178

  2026. 2026

    Thomas F. Oppelt, Rodel V. Bobadilla. (2003) Better Living Through Chemistry: Does It Still Apply to Patients After Myocardial Infarction?. Pharmacotherapy 23:6, 816-822

  2027. 2027

    Branislav Radovancevic, Bojan Vrtovec, O. H. Frazier. (2003) Left ventricular assist devices: an alternative to medical therapy for end-stage heart failure. Current Opinion in Cardiology 18:3, 210-214

  2028. 2028

    Erica D Engelstein. (2003) Prevention and management of chronic heart failure with electrical therapy. The American Journal of Cardiology 91:9, 62-73

  2029. 2029

    Mandeep R Mehra, Patricia A Uber, Gary S Francis. (2003) Heart failure therapy at a crossroad: are there limits to the neurohormonal model?. Journal of the American College of Cardiology 41:9, 1606-1610

  2030. 2030

    Carlo Pappone, Gabriele Vicedomini, Giuseppe Augello, Patrizio Mazzone, Stefano Nardi, Salvatore Rosanio. (2003) Combining electrical therapies for advanced heart failure: the Milan experience with biventricular pacing–defibrillation backup combination for primary prevention of sudden cardiac death. The American Journal of Cardiology 91:9, 74-80

  2031. 2031

    Dennis L. DeSilvey. (2003) MADIT II: Lessons to Learn. The American Journal of Geriatric Cardiology 12:3, 214-214

  2032. 2032

    Douglas S Lee, Lawrence D Green, Peter P Liu, Paul Dorian, David M Newman, F.Curry Grant, Jack V Tu, David A Alter. (2003) Effectiveness of implantable defibrillators for preventing arrhythmic events and death. Journal of the American College of Cardiology 41:9, 1573-1582

  2033. 2033

    Robin J. Trupp, William T. Abraham. (2003) Nonpharmacologic options for the management of heart failure. Current Cardiology Reports 5:3, 243-246

  2034. 2034

    J.Vijay Jayachandran, Douglas P. Zipes. (2003) Say no to primary prophylaxis with implantable cardioverter-defibrillators in asymptomatic nonischemic dilated cardiomyopathy?. Journal of the American College of Cardiology 41:10, 1713-1715

  2035. 2035

    Anne M. Gillis, Robert S. Sheldon, D. George Wyse, Henry J. Duff, Margaret R. Cassidy, L. Brent Mitchell. (2003) Clinical and Electrophysiologic Predictors of Ventricular Tachyarrhythmia Recurrence in Patients with Implantable Cardioverter Defibrillators. Journal of Cardiovascular Electrophysiology 14:5, 492-498

  2036. 2036

    Andrew D. Feingold, David DeNofrio. (2003) Management issues for patients with coronary artery disease and heart failure. Current Cardiology Reports 5:3, 216-222

  2037. 2037

    Philippe Menasché, Albert A Hagège, Jean-Thomas Vilquin, Michel Desnos, Eric Abergel, Bruno Pouzet, Alain Bel, Sorin Sarateanu, Marcio Scorsin, Ketty Schwartz, Patrick Bruneval, Marc Benbunan, Jean-Pierre Marolleau, Denis Duboc. (2003) Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. Journal of the American College of Cardiology 41:7, 1078-1083

  2038. 2038

    W. Bruce Fye. (2003) The power of clinical trials and guidelines,and the challenge of conflicts of interest. Journal of the American College of Cardiology 41:8, 1237-1242

  2039. 2039

    Henry W. Sesselberg, Arthur J. Moss, Jonathan Steinberg, Elizabeth Carroll, Wojciech Zareba, James Daubert, David T. Huang. (2003) Factors associated with ventricular inducibility in the MADIT-II study population. The American Journal of Cardiology 91:8, 1002-1004

  2040. 2040

    Jan Nemec, Win-Kuang Shen. (2003) Antiarrhythmic drugs: new agents and evolving concepts. Expert Opinion on Investigational Drugs 12:3, 435-453

  2041. 2041

    Peter Lercher, Brigitte Rotman, Daniel Scherr, Wilfried Kraxner, Olef Luha, Werner Klein. (2003) Die Auswirkungen nach dem Multicenter Automatic Defibrillator Implantation Trial II in einem kardiologischen Schwerpunktzentrum — müssen alle Postinfarktpatienten mit reduzierter Linksventrikelfunktion einen implantierbaren Kardioverter-Defibrillator erhalten?. Wiener Klinische Wochenschrift 115:5-6, 167-174

  2042. 2042

    Samuel F. Sears, Jamie B. Conti. (2003) Understanding implantable cardioverter defibrillator shocks and storms: Medical and psychosocial considerations for research and clinical care. Clinical Cardiology 26:3, 107-111

  2043. 2043

    N.A.Mark Estes, Jonathan Weinstock, Paul J Wang, Munther K Homoud, Mark S Link. (2003) Use of antiarrhythmics and implantable cardioverter-defibrillators in congestive heart failure. The American Journal of Cardiology 91:6, 45-52

  2044. 2044

    Helmut U. Klein. (2003) MADIT II — oder wie ernst nehmen wir Primärprävention des Plötzlichen Herztodes?. Wiener Klinische Wochenschrift 115:5-6, 152-154

  2045. 2045

    J. G.F. Cleland, J. Ghosh, N. K. Khan, S. Ghio, L. Tavazzi, G. Kaye. (2003) Multi-chamber pacing: a perfect solution for cardiac mechanical dyssynchrony?. European Heart Journal 24:5, 384-390

  2046. 2046

    David Martin. (2003) Using implantable devices to improve end-of-life care. The American Journal of Cardiology 91:5, 583-584

  2047. 2047

    John P Boehmer. (2003) Device therapy for heart failure. The American Journal of Cardiology 91:6, 53-59

  2048. 2048

    Philip B Adamson, Anthony Magalski, Frieder Braunschweig, Michael Böhm, Dwight Reynolds, David Steinhaus, Allyson Luby, Cecilia Linde, Lars Ryden, Bodo Cremers, Teri Takle, Tom Bennett. (2003) Ongoing right ventricular hemodynamics in heart failure. Journal of the American College of Cardiology 41:4, 565-571

  2049. 2049

    PATRICK T. ELLINOR, MARY L. GUY, JEREMY N. RUSKIN, BRIAN A. MCGOVERN. (2003) Variability in Implantable Cardioverter Defibrillator Pulse Generator Longevity Between Manufacturers. Pacing and Clinical Electrophysiology 26:1p1, 71-75

  2050. 2050

    Yoshito Koseki, Jun Watanabe, Tsuyoshi Shinozaki, Masahito Sakuma, Tatsuya Komaru, Mitsumasa Fukuchi, Masahito Miura, Akihiko Karibe, Yuji Kon-no, Hirotaka Numaguchi, Mototsugu Ninomiya, Yutaka Kagaya, Kunio Shirato, the CHART Investigators. (2003) Characteristics and 1-Year Prognosis of Medically Treated Patients With Chronic Heart Failure in Japan. Circulation Journal 67:5, 431-436

  2051. 2051

    MICHAEL R. GOLD, DAVID BREITER, ROBERT LEMAN, ERIC J. RASHBA, STEPHEN R. SHOROFSKY, STEPHEN J. HAHN. (2003) Safety of a Single Successful Conversion of Ventricular Fibrillation Before the Implantation of Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 26:1p2, 483-486

  2052. 2052

    Augustus O Grant. (2003) Recent Advances in the Treatment of Arrhythmias. Circulation Journal 67:8, 651-655

  2053. 2053

    DIRK VOLLMANN, LARS LUETHJE, DIETER ZENKER, SEBASTIAN DOMHOF, CHRISTINA UNTERBERG. (2003) Subthreshold Test Pulses Versus Low Energy Shock Delivery to Estimate High Energy Lead Impedance in Implanted Cardioverter Defibrillator Patients. Pacing and Clinical Electrophysiology 26:1p2, 457-460

  2054. 2054

    Thomas Klingenheben, Stefan H. Hohnloser. (2003) Usefulness of Risk Stratification for Future Cardiac Events in Infarct Survivors with Severely Depressed Versus Near-Normal Left Ventricular Function: Results From a Prospective Long-Term Follow-Up Study. Annals of Noninvasive Electrocardiology 8:1, 68-74

  2055. 2055

    L. Fauchier. (2003) L'année 2002 en rythmologie : pour des changements radicaux ?. Annales de Cardiologie et d Angéiologie 52:1, 52

  2056. 2056

    MAURIZIO GASPARINI, MAURIZIO LUNATI, MARIO BOCCHIARDO, MASSIMO MANTICA, EDOARDO GRONDA, MARIA FRIGERIO, DOMENICO CAPONI, ANGELO CARBONI, GIUSEPPE BORIANI, GABRIELE ZANOTTO, PIER ANTONIO RAVAZZI, ANTONIO CURNIS, ANDREA PUGLISI, CATHERINE KLERSY, ILARIA VICINI, SERGIO CAVAGLIA, . (2003) Cardiac Resynchronization and Implantable Cardioverter Defibrillator Therapy: Preliminary Results from the InSync Implantable Cardioverter Defibrillator Italian Registry. Pacing and Clinical Electrophysiology 26:1p2, 148-151

  2057. 2057

    Andrs Jnosi, Jalal K Ghali, Johan Herlitz, Istvn Czuriga, Michael Klibaner, John Wikstrand, ?ke Hjalmarson. (2003) Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF. American Heart Journal 146:4, 721

  2058. 2058

    CHRISTOPHER J. PLUMMER, R. JOHN IRVING, JANET M. MCCOMB. (2003) Implications of National Guidance for Implantable Cardioverter Defibrillation Implantation in the United Kingdom. Pacing and Clinical Electrophysiology 26:1p2, 479-482

  2059. 2059

    John M. Field. (2003) Update on cardiac resuscitation for sudden death: International Guidelines 2000 on Resuscitation and Emergency Cardiac Care. Current Opinion in Cardiology 18:1, 14-25

  2060. 2060

    Rishi Arora, Daniel R. Frisch, Alan H. Kadish. The Role of Implantable Cardioverter-Defibrillators in Primary and Secondary Prevention of Sudden Cardiac Death. In: Cardiovascular Therapeutics. Elsevier, 2003:459-471.

  2061. 2061

    Linda R Peterson, Kenneth B Schechtman, Gregory A Ewald, Edward M Geltman, Timothy Meyer, Pamela Krekeler, Joseph G Rogers. (2003) The effect of β-adrenergic blockers on the prognostic value of peak exercise oxygen uptake in patients with heart failure. The Journal of Heart and Lung Transplantation 22:1, 70-77

  2062. 2062

    MAURIZIO GASPARINI, MASSIMO MANTICA, PAOLA GALIMBERTI, LUCA GENOVESE, DANIELA PINI, FRANCESCO FALETRA, UGO LA MARCHESINA, MAURIZIO MANGIAVACCHI, CATHERINE KLERSY, EDOARDO GRONDA. (2003) Is the Outcome of Cardiac Resynchronization Therapy Related to the Underlying Etiology?. Pacing and Clinical Electrophysiology 26:1p2, 175-180

  2063. 2063

    Mario Jorge García. (2003) Diagnóstico y guía terapéutica de la insuficiencia cardíaca diastólica. Revista Española de Cardiología 56:4, 396-406

  2064. 2064

    J.M. Porres aracama, P. Marco garde. (2003) Muerte súbita cardíaca y MADIT II. Medicina Intensiva 27:6, 410-416

  2065. 2065

    Josefa González Carrillo, Arcadi García Alberola, Daniel Saura Espín, Pilar Carrillo Sáez, Ramón López Palop, Juan J. Sánchez Muñoz, Juan Martínez Sánchez, Mariano Valdés Chávarri. (2003) Impacto de la angioplastia primaria en la indicación de desfibrilador implantable en pacientes con infarto de miocardio. Revista Española de Cardiología 56:12, 1182-1186

  2066. 2066

    Bernard J. Gersh. (2003) El pronóstico cambiante del infarto de miocardio en la era de la reperfusión: implicaciones para la evaluación y el tratamiento de las arritmias ventriculares. Revista Española de Cardiología 56:6, 535-542

  2067. 2067

    Ángel Arenal Maíz. (2003) Indicación de desfibrilador automático implantable después de angioplastia coronaria transluminal percutánea primaria. Revista Española de Cardiología 56:12, 1163-1164

  2068. 2068

    Robert M Califf, Eric D Peterson, Raymond J Gibbons, Arthur Garson, Ralph G Brindis, George A Beller, Sidney C Smith. (2002) Integrating quality into the cycle of therapeutic development. Journal of the American College of Cardiology 40:11, 1895-1901

  2069. 2069

    Michael E. Bourke, Jeffrey S. Healey. (2002) Pacemakers, recent directions and developments. Current Opinion in Anaesthesiology 15:6, 681-686

  2070. 2070

    Gabriel Gregoratos, Jonathan Abrams, Andrew E Epstein, Roger A Freedman, David L Hayes, Mark A Hlatky, Richard E Kerber, Gerald V Naccarelli, Mark H Schoenfeld, Michael J Silka, Stephen L Winters, Raymond J Gibbons, Elliott M Antman, Joseph S Alpert, Gabriel Gregoratos, Loren F Hiratzka, David P Faxon, Alice K Jacobs, Valentin Fuster, Sidney C Smith. (2002) ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—Summary Article. Journal of the American College of Cardiology 40:9, 1703-1719

  2071. 2071

    B. John Hynes, Jerry C. Luck, Deborah L. Wolbrette, John Boehmer, Gerald V. Naccarelli. (2002) Arrhythmias in patients with heart failure. Current Treatment Options in Cardiovascular Medicine 4:6, 467-485

  2072. 2072

    Paul A Gould, David M Kaye. (2002) Clinical treatment regimens for chronic heart failure: a review. Expert Opinion on Pharmacotherapy 3:11, 1569-1576

  2073. 2073

    Mohamad El-Zaru, David Nofrio. (2002) End-stage heart failure: Surgical therapy and implantable devices. Current Treatment Options in Cardiovascular Medicine 4:6, 511-520

  2074. 2074

    Eric J. Topol. (2002) Economics and quality of care for patients with acute coronary syndromes: The impending crisis. Clinical Cardiology 25:S1, 9-15

  2075. 2075

    Seah Nisam, Sophie Henry, David J. Wilber. (2002) Implementation of MADIT and MUSTT in Clinical Practice: Results of an International Survey. Annals of Noninvasive Electrocardiology 7:4, 399-405

  2076. 2076

    J. Moss. (2002) The ECG: Predicting Cardiac Events After Myocardial Infarction with A Brief Historical Perspective. Annals of Noninvasive Electrocardiology 7:4, 279-280

  2077. 2077

    Paveljit S Bindra, Jeremy N Ruskin, David Keane. (2002) Usefulness of predischarge defibrillation testing after defibrillator implantation in hospitalized patients. The American Journal of Cardiology 90:7, 798-799

  2078. 2078

    Maisel , William H. , Stevenson , William G. , . (2002) Syncope — Getting to the Heart of the Matter. New England Journal of Medicine 347:12, 931-933
    Full Text

  2079. 2079

    L Fauchier. (2002) Défibrillateur implantable prophylactique et stimulation biventriculaire dans l'insuffisance cardiaque. Annales de Cardiologie et d'Angéiologie 51:4, 232-237

  2080. 2080

    Marc A Pfeffer. (2002) Myocardial infarction and heart failure—a dangerous intersection. The American Journal of Medicine 113:4, 341-343

  2081. 2081

    Andreas Kliegel, Philip Eisenburger, Fritz Sterz, Michael Holzer, Heidrun Losert, Christof Havel, Günter Stix, Anton N Laggner. (2002) Survivors of ventricular tachyarrhythmias due to a transient or reversible disorder have a high recurrence rate of lethal cardiac events. Resuscitation 54:3, 237-243

  2082. 2082

    Eugene S. Smith, Suzanne Trussell, Laura J. Mencer. (2002) Prevention of heart failure. Current Opinion in Cardiology 17:5, 512-517

  2083. 2083

    (2002) Implantable Cardiac Defibrillators. New England Journal of Medicine 347:5, 365-367
    Free Full Text

  2084. 2084

    Juha S Perkiomaki, Wojciech Zareba, Henry M Greenberg, Arthur J Moss. (2002) Usefulness of standard electrocardiographic parameters for predicting cardiac events after acute myocardial infarction during modern treatment era. The American Journal of Cardiology 90:3, 205-209

  2085. 2085

    Steven L. Higgins. (2002) Automatic implantable cardiac defibrillators. Current Treatment Options in Cardiovascular Medicine 4:4, 287-293

  2086. 2086

    Joel Kupersmith. (2002) The past, present, and future of the implantable cardioverter defibrillator. The American Journal of Medicine 113:1, 82-84

  2087. 2087

    Arthur J. Moss. (2002) MADIT-II and Implications for Noninvasive Electrophysiologic Testing. Annals of Noninvasive Electrocardiology 7:3, 179-180

  2088. 2088

    Hare , Joshua M. , . (2002) Cardiac-Resynchronization Therapy for Heart Failure. New England Journal of Medicine 346:24, 1902-1905
    Full Text

  2089. 2089

    A Coletta. (2002) Clinical trials update: highlights of the scientific sessions of The American College of Cardiology 2002: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL. European Journal of Heart Failure 4:3, 381-388

  2090. 2090

    Carmine A. Sorbera, Evelyn J. Cusack. (2002) Indications for Implantable Cardioverter Defibrillator Therapy. Heart Disease 4:3, 166-170

  2091. 2091

    Eugene Crystal, Stuart J Connolly. (2002) Evolution of the implantable cardioverter defibrillator. The Lancet 359:9315, 1362-1363

  2092. 2092

    Bigger , J. Thomas , . (2002) Expanding Indications for Implantable Cardiac Defibrillators. New England Journal of Medicine 346:12, 931-933
    Full Text

  2093. 2093

    &NA;. (2002) Implantable defibrillators on top in MADIT II. Inpharma Weekly &amp;NA;:1331, 15

  2094. 2094

    Marian A. Spath, Bernie J. O??Brien. (2002) Cost Effectiveness of Implantable Cardioverter Defibrillator Therapy versus Drug Therapy for Patients at High Risk of Sudden Cardiac Death. PharmacoEconomics 20:11, 727-738

  2095. 2095

    Jan P. Amlie, S. Bertil Olsson. (2002) Should we Implant ICDs in More Patients after Myocardial Infarction? Can we Define the Patient Groups that Benefit Most?. Scandinavian Cardiovascular Journal 36:5, 259-261

Letters

Trends

Most Viewed (Last Week)